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Abstract
Cyclopropenes are unsaturated, three-membered ring systems that are highly
strained and as a result, serve as highly useful building blocks in the field of synthetic
chemistry. The electron rich double bond of cyclopropenes makes them ideal substrates
for electrophilic Lewis acids, such as gold catalysts. Gold catalysts readily activate
cyclopropenes towards ring-opening and given the strain of these ring systems, reactions
are often highly facile and can result in substantial increases in molecular complexity.
Thus, the gold-catalysed reactions of cyclopropenes represent a highly versatile field of
chemistry, especially considering that substitution around the cyclopropene ring can be
used to control regio-, diastereo- and enantioselectivity. Despite this potential however,
research into gold-catalysed reactions of cyclopropenes remains relatively undeveloped
compared to the gold-catalysed reactions of other C–C multiple bonds (i.e. alkynes,
alkenes and allene). It has therefore been the aim of this thesis to help contribute to this
field by investigating the rearrangements that occur when derivatives of cyclopropenyl
carbinols are reacted with gold catalysts. Cyclopropenyl carbinols are a particularly useful
class of cyclopropene given that the alcohol moiety serves as a tethering point for further
functionalisation. It has been the discovery of this thesis that cyclopropenyl propargyl
ethers, derived from C1-substituted cyclopropenyl carbinols, undergo initial ring-opening
followed by a Claisen rearrangement in the presence of a gold catalyst, to form highly
substituted furans. Cyclopropenyl allyl ethers can also undergo gold-catalysed ringopening and a Claisen rearrangement (followed by additional chemical transformations)
to diastereoselectively form highly substituted tetrahydrofurans. Alternatively,
cyclopropenyl sulfonamides obtained from the Mitsunobu coupling of C3-substituted
cyclopropenyl carbinols, have also been reacted with gold catalysts. Cyclopropene–furan
systems were found to undergo a [4C+3C] dearomative cycloaddition reaction to form
i

5,7-fused heterocyclic scaffolds with an oxa-bridge, while cyclopropene–indole (and
pyrrole) systems were found to undergo a Friedel–Crafts cyclisation to generate
tetrahydro-β-carboline scaffolds. All of these heterocyclic skeletons feature in a variety
of natural and synthetic products which have numerous pharmacological, agricultural and
industrial applications. The work presented in this thesis may therefore represent new
methods for the synthesis of these compounds and provides valuable insight into the
molecules that can be accessed through the gold-catalysed rearrangement of these unique
three-membered carbocycles.
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1. Chapter 1. Introduction
1.1.

Introduction to Gold Catalysis

1.1.1. Gold- A Brief Historical Overview
Gold has been an obsession for human civilisation for thousands of years. It has
inspired beautiful works of art; determined the economic state of societies; driven men to
endure harsh and dangerous conditions; and has encouraged horrible acts of violence. [1]
The discovery of gold has not been attributed to any single chemist;[2] however, evidence
suggests that the Egyptians began separating gold from ores by melting, as early as 3600
B.C.[1b] Gold symbolised perpetuity in ancient Egyptian culture due to its shining
appearance and durability and was exclusively available to the pharaohs (Figure 1.1a).[1]
From the infamous golden temple built in Israel by King Solomon, to the legends of the
Greek king Midas with the power to transform anything he touched into gold (Figure
1.1b), to Paititi the Inca lost city of gold;[1b] this precious metal has been revered by many
cultures. Given that monetary systems were based on gold until recently, the Spanish
invasion of America in the 16th century likely occurred to procure the gold of the Inca
Empire (Figure 1.1c).[1b,

3]

Gold rushes were also common and gained worldwide

attention with Australia’s largest gold rush occurring from the mid to the late 1800s
(Figure 1.1d).
(a)

(b)

(c)

(d)

Figure 1.1. Historical depictions of gold
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1.1.2. Applications of gold
Gold has had many applications and as mentioned above it was historically used
in art, monetary exchange and jewellery.[1b] Indeed in today’s modern society the biggest
use of gold is still the jewellery industry which accounted for 52.44% of the global
demand for gold (based on industry) in 2017.[4] With advances in research and technology
more versatile uses for gold have also been developed. For example, Auranofin is a
commercially available drug which consists of a gold(I) salt and is widely used in the
treatment of rheumatoid arthritis.[1b] The inertness and biocompatibility of gold has also
lead to its use in dentistry and it has more recently been investigated for its potential anticancer activity.[2] Gold is also malleable, ductile, is resistant to oxidation and corrosion
and possesses excellent electrical and thermal conductivity. [1b, 5] These properties make
gold ideal in the fields of electronics, engineering and telecommunications. [1b, 5]
Despite the rest of society’s obsession with gold, chemists did not show much
interest in it as a catalyst until recently. The reason for this disinterest is likely two-fold:
1) the inertness of elemental gold probably lead early chemists to believe it had low
catalytic activity[2, 6] and 2) due to the high value of gold, any catalyst made from it would
have been presumed to be too expensive.[2] During the 1970s and 1980s work by Bond,
Haruta and Hutchings sparked a massive development in the field of heterogeneous gold
catalysis; [7] however, this thesis is focused on homogeneous gold catalysis and a similar
expansion in this area was not initiated until much later. Homogeneous catalysis of course
means that the catalyst and the substrate(s) are in the same state, which for gold is usually
the liquid state as the catalysts and substrate(s) are typically dissolved in a solution.[8]
One of the most notable early examples of homogeneous gold catalysis was
published in 1986 by Ito and Hayashi, who described the first gold-catalysed C–C bond
forming reaction.[8] This work involved asymmetric aldol reactions between aldehydes 1
2

and isocyanoacetate, catalysed by a chiral ferrocenylphosphine-gold(I) complex to
produce optically active 5-alkyl-2-oxazoline-4-carboxylates 3 with high yields and
diastereoselectivities (Scheme 1.1). Enantioselectivities were high in the case of the transisomers but low for the cis. The chiral catalyst had been generated in situ from
bis((cyclohexyl-isocyanide)gold(I) tetrafluoroborate and the ferrocenyl phosphine
complexes 2a or 2b. The authors made a particular note that gold was essential for the
high stereoselectivity of the reaction as silver and copper catalysts had resulted in poorer
selectivity.[9]

Scheme 1.1. Gold(I)-catalysed asymmetric aldol reaction between aldehydes 1 and isocyanoacetate

Following some of the earlier studies utilising gold as a catalyst, it was realised
that this noble metal was not in fact “catalytically dead” and was a highly active and
useful species. Besides elemental gold, various oxidation states are accessible ranging
from -1 to +5;[1b] however, homogeneous gold catalysis relies on the gold(I) and gold(III)
species. These cationic species are incredibly strong Lewis acids and have a high affinity
for π-bonds such as alkynes, alkenes and allenes. This results in the formation of new C–
C and C–heteroatom bonds by nucleophilic attack on these π-systems.[10] Many gold
catalysed reactions are possible, including metathesis and cycloisomerisation reactions
of enynes, as well as hydrofunctionalisation reactions of allenes, alkenes and alkynes with
various nucleophiles to create C–C, C–O, C–S, and C–N bonds.[10d] Therefore many

3

useful and versatile chemical transformations are accessible that proceed with high atom
efficiency and often result in a remarkable increase in molecular complexity.[11] Along
with its exceptional ability to activate π-bonds, the effectiveness of gold catalysts also
stems from excellent functional group compatibility.[10d, 11]
One of the greatest benefits of gold is that it is not as oxophilic as many other
Lewis acids.[1b, 10d] Therefore, gold catalysed reactions are typically compatible with
aqueous conditions and can be performed in the presence of air.[1b, 10d] Gold catalysts are
typically effective in small amounts under mild conditions.[10d] Another advantage is that
both gold(I) and gold(III) species possess diamagnetic character which allows chemists
to monitor gold-catalysed reactions by nuclear magnetic resonance (NMR)
spectroscopy.[2] Another advantage of gold catalysis that can result in increased product
selectivity is that the Au–C bond, while labile towards protodeauration, is not vulnerable
to β-hydride elimination, an occurrence that is facile for other common transition-metal
catalysts, such as palladium.[10d] Asymmetric control is also possible and there are some
reports of enantioselective gold-catalysed reactions.[12] However, the ability to develop
efficient asymmetric transformations with chiral gold catalysts has been restricted by one
crucial factor – the preferred linear coordination of gold(I).[10d, 12h] This places the reacting
substrate and the chiral ligand (L*) on opposing sides of the gold so the chiral ligand is
less able to exert its effects on the conformation of the substrate (Figure 1.2).[10d, 12h] This
issue is further exacerbated if one considers the outer-sphere pathways that gold-catalysed
π-activation proceeds through, which circumvents nucleophilic interaction prior to C–X
formation.[10d, 12h] Promising strategies have been developed to facilitate the expansion
of gold-catalysed enantioselective reactions;[12h] however, they will not be discussed here.
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Figure 1.2. Linear coordination mode for gold catalysis shows reduced ability of chiral ligand (L*) to exert
effects on conformation of substrate (figure adapted from Toste et al.[12h])

Following the seminal work performed by Ito and Hayashi and the increasing
awareness that gold could be a very powerful tool in the field of homogeneous catalysis,
in 1991 Utimoto described the hydration of alkynes 4 to ketones 5 and 6 using NaAuCl4
(2 mol%) in refluxing aqueous methanol (Scheme 1.2a). Other metals such as mercury(II),
palladium(II) and Reise-type platinum had various short-comings; however, the gold(III)
catalyst was able to convert terminal alkynes 4 to the corresponding methyl ketones 5 in
excellent yields (83-96%). Internal alkynes could also be hydrated in high yields (94%,
one example only 28%) although a mixture of ketones 5 and 6 were obtained due to a
lack of regioselectivity. The reaction was also proven to be selective for alkynes as a
competitive reaction between an alkyne and an alkene lead to conversion of the alkyne
with a near quantitative recovery of the alkene. When anhydrous methanol (2 equiv.) was
used as the solvent, terminal alkynes 4 were converted to acetals 7 in excellent yields (9596%), while an internal alkyne example afforded a 1:1 mixture of acetals 7 and 8 in 93%
yield (Scheme 1.2b).[13]

Scheme 1.2. Gold(III)-catalysed hydration of alkynes 4 to ketones 5 and 6 (a); and acetals 7 and 8 (b)
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Another important paper that pioneered the expansion of homogeneous gold
catalysis was published in 1998 by Teles, who performed gold(I)-catalysed additions of
alcohols to alkynes to form acetals 10 from internal alkynes 9 (Scheme 1.3a) and acetals
12 from terminal alkynes 11 (Scheme 1.3b). Prior to this work, mercury(II) was used as
the catalyst for similar reactions; however, the considerable disadvantage was that
mercury(II) was toxic and rapidly reduced to the catalytically inactive metallic mercury
and only 100 moles of product were produced per mole of mercury(II) catalyst. Following
the work of Utimoto, Teles developed gold(I) complexes bearing phosphane, phosphite
and arsine ligands that were well suited for catalysing the addition of alcohols to alkynes.
These catalysts were stable to air and moisture and the reactions did not require solvent.
Total turnover numbers (TONs) of up to 105 moles of product per mole of gold(I) catalyst
could be achieved with turnover frequencies (TOFs) of 5400 h-1.[14]

Scheme 1.3. General AuL/MsOH catalysed addition reactions of alcohols to alkynes

These key papers by Ito and Hasyashi, Utimoto and Teles demonstrated that
homogeneous gold catalysis was a field that possessed enormous potential and in the
cases of Utimoto and Teles’ work, had proven superior to the previously developed
methods. Early works by other chemistry groups especially Hashmi,[15] Yamamoto[16] and
Arcadi[17] further exemplified homogeneous gold catalysis as an important and promising
field which has now grown exponentially over the last 30 years.
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1.1.3. Types of Homogeneous Gold Catalysts
In homogeneous gold catalysis there are three main classes of catalysts including
inorganic, gold(III) complexes and gold(I) complexes. Inorganic gold catalysts refer to
gold salts such as gold(I) and gold(III) halides (i.e. AuCl, AuCl3, AuBr3), tetrachloroauric
acid (HAuCl4) as well as sodium and potassium tetrachloroaurate (NaAuCl4 and
KAuCl4).[1b] Much of the early work in the field of homogeneous catalysis (with the
exception of Ito and Hayashi) was performed with these salts. [1b, 8] While these catalysts
are still used, a decline in their application has been observed as gold complexes have
become far more popular and prevalent in the field of homogeneous gold catalysis. The
primary reason for this is due to the presence of the ligand in the complex which can be
sterically and electronically altered to optimise the selectivity and reactivity of a chemical
reaction.[1b, 10c] These gold complexes can either be classified as a pre-catalysts or are
catalytically active species that can be used directly.[1b]
The use of gold(III) complexes was first reported by the Hashmi group in 2004.[1b,
18]

Previously the Hashmi group had reported on a AuCl3 catalysed phenol 14 synthesis

from furan-ynes 13 (Scheme 1.4).[15a] The report in 2004 demonstrated the improved
stability of pyridine gold trichloro complexes 15-16 in comparison to AuCl3, as well as
increased product selectivity.[18] Gold(III) complexes have been less investigated
compared to gold(I) complexes in homogeneous catalysis most likely because unlike
gold(I) catalysts, the nature in which gold(III) complexes coordinate to their substrates is
less well understood due to the high complexity of the bonding characteristics.[19] Square
planar coordination geometry of the gold(III) centre is however preferred and allows
greater influence from anionic or neutral ligands in the trans- or cis- positions relative to
the inbound substrate.[19]
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Scheme 1.4. Gold(III) catalysed conversion of furan-ynes 13 to phenols 14

Gold(I) complexes are far more numerous and varied in the field of homogeneous
gold catalysis, the magnitude of which cannot be adequately covered in this introduction.
Probably the most commonly employed gold(I) complexes are linear L–Au–Cl
complexes where L can represent a phosphine, carbene, phosphoramidite or phosphite
ligand (Figure 1.3a).[1b] These gold(I) chloride complexes are considered pre-catalysts
and require a co-catalyst such as a silver salt to abstract the chloride and generate the
electrophilic gold species in situ.[1b, 20] It is important to note that the less coordinating the
counterion is, the more Lewis acidic the gold species is.[1b] A limitation of gold(I) chloride
complexes is that the silver salts typically used as co-catalysts are all very hygroscopic
making weighing the reagents and keeping the reactions non-acidic, difficult.[21] There

Figure 1.3. Various types of gold(I) chloride complexes (a); active gold(I) complexes (b)
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are also several gold(I) complexes that have been developed that do not require the
presence of a co-catalyst to active them. These include bistrifluoromethanesulfonimidate
gold(I) complexes 17 (LAuNTf2), hexafluoroantimonate nitrile gold(I) complexes 18
(LAu(NCR)SbF6) and benzotriazole gold(I) complexes 19 which were developed by the
Gagosz,[21] Echavarren[20, 22] and Shi[23] groups, respectively (Figure 1.3b). Unlike the
silver salts, these gold(I) complexes are typically crystalline and stable to both moisture
and air. In the case of the benzotriazole gold(I) complexes, they were also found to be
more thermally stable compared to other popular gold(I) catalysts. [23]
1.1.4. Gold-Catalysed Reactions
A significant amount of research has gone into determining the mechanistic
pathways by which gold catalysts activate π-bonds. It is now commonly accepted that
most gold-catalysed reactions progress as follows: 1) activation of the π-bond by a
electrophilic L–Au+ species; 2) attack of the gold-π complex 20 by a nucleophile to form
a trans-alkenyl (for alkynes) or a trans-alkyl (for alkenes) gold complex 21; 3) the gold
intermediate 21 then reacts with an electrophile such as a proton, which liberates the final
product 22 and regenerates the catalyst by protodeauration (Scheme 1.5).[1b, 10c] The ligand
plays a crucial role in the reaction as demonstrated by Xu et al. in 2012.[24] They found
that the electronic activation of the alkyne/alkene/allene and subsequent nucleophilic
attack steps were faster in the presence of gold catalysts bearing an electron-poor
ligand.[24] Electron-poor ligands would create greater electron deficiency at the gold
centre which would in turn pull more electron density from the π-bond thus making it
more electrophilic and susceptible to attack from a nucleophile. [10c] Conversely the
protodeauration step converting intermediate 21 to product 22, was faster in the presence
of a gold catalyst bearing an electron-rich ligand.[24] Electron-rich ligands would supply
more electron-density to the gold centre and would make intermediate 21 more attractive
9

to the electrophilic species.[10c] This knowledge can facilitate the rational design/selection
of gold catalysts for reactions. For example, reactions where π-bond activation and
nucleophilic attack are the turnover limiting step (i.e. nucleophile is weak or substrate is
less reactive) would benefit from electron-deficient ligands. Reactions where the
protodeauration step is the turnover limiting step (i.e. nucleophile is strong or substrate is
reactive) would benefit from electron-rich ligands.[10c]

Scheme 1.5. General mechanism for the gold-catalysed reaction of alkynes/alkenes

In the above general example, the gold intermediate 21 is a neutral species.
However, it has also been reported in the literature that some gold-catalysed reactions
may proceed via a carbocationic intermediate. An early example was reported by
Echavarren and co-workers who proposed that dienyne 23 undergoes cycloisomerisation
in the presence of gold, to form the tetracyclic compound 26 via the gold(I) carbene
intermediate 25 (Scheme 1.6). A 5-exo-dig cyclisation of 23 catalysed by gold would have
generated the gold-alkenyl intermediate 24. Electron donation from the gold would then
induce cycloisomerisation with the tertiary stabilised carbocation to generate the gold
carbene intermediate 25 that can undergo intramolecular cyclopropanation with the
alkene to generate product 26.[25]
10

Scheme 1.6. Gold(I)-catalysed intramolecular cyclopropanation of dienyne 23

In a study by Fürstner and Morency however, a series of cycloisomerisation
experiments were performed to confirm the validity of gold-stabilised carbocationic
intermediates. Initially enyne 27a was treated with Ph3PAuCl/AgSbF6 and a mixture of
butyrolactone 28a and annulated bicycle 29a where obtained in poor yields (Scheme
1.7a). However, simply adding a methyl group to C4 resulted in 82% yield of
butyrolactone 28b (Scheme 1.7b), while a methyl group at C5 resulted in 80% yield of

Scheme 1.7. Gold(I)-catalysed cycloisomerisations of enynes 27. E = CO2Me
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the annulated bicycle 29b (Scheme 1.7c). The authors explained that if the reaction
proceeded by a gold cyclopropylcarbene intermediate such as 25 (Scheme 1.6), it would
not account for the increase in efficiency when a methyl group is at C5 (Scheme 1.7c), as
it would require the carboxylate to attack at the more highly substituted carbon of the
cyclopropyl ring.[26] They proposed that the reaction outcome was more adequately
explained by the gold-stabilised carbocationic intermediates 30 and 31 where the
regioselectivity is determined by attack at the more stabilised tertiary cation. [26-27]
A lot of debate has been stirred about the electronic structure of gold cationic
intermediates which will be discussed in detail in Section 1.3.1.1. The crux of the debate
is the extent of d → p back bonding from the gold to the C1 atom which determines the
relative resonance contributions of the gold-stabilised carbocation (Au–CR2+) and the
gold carbene (Au+=CR2) species.[27] There is a lot of experimental evidence to indicate
that both types of reactivity are accessible with the type of organogold species being
dependent on both the nature of the substrate (i.e. substitution pattern) and the nature of
the gold catalyst (i.e. type of ligand, oxidation state of gold). [1b] A commonly accepted
bonding model for gold(I) carbene complexes proposed by Toste[28] was published in
2009 while some more recent reviews on the topic of gold cationic intermediates have
been published by Echavarren[29] and Widenhoefer.[27] While it has already been
mentioned that alkynes, allenes and alkenes have been reacted with gold catalysts, this
thesis is concerned with the gold catalysed reactions of a special class of π-bond found in
the ring of a cyclopropene – a structure that will be discussed in the following sections.
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1.2.

Introduction to Cyclopropenes

1.2.1. Structure and Properties of Cyclopropenes
Cyclopropenes are unsaturated, three-membered carbocycles that have become
exceptionally important building blocks in organic chemistry, [30] and have been the
subject of many experimental and theoretical studies.[31] Research into cyclopropene
chemistry began in the 19th century; however, the synthesis and isolation of a
cyclopropene was not accomplished until 1922 by Demjanov and Doyarenko.[31-32] Much
of the intrigue surrounding cyclopropenes is attributable to them arguably being the most
highly strained single-ring organic molecules[33] and that their unique electronic and
structural properties allow them to undergo many interesting chemical transformations. [30,
34]

The high degree of strain possessed by cyclopropenes stems from angular strain within

the ring that is the result of the conformation forcibly adopted by these carbocycles. [35]
The bond lengths within cyclopropene were experimentally determined by
Stigliani et al.,[36] to be 1.509 Å for the C–C bonds and 1.2959 Å for the C=C double bond
(Figure 1.4a). These results were supported by computational calculations performed by
Staley and Harmony,[37] who reported the bonds lengths to be 1.495 Å and 1.276 Å,
respectively. As a result of the bond lengths, the bond angles imposed within
cyclopropenes are 64.58° at the sp2-hybridised centres and 50.84° at the sp3-hybridised
centre which are far from the ideal bond angles of 120° and 109.5° for sp 2- (Figure 1.4b)
and sp3-hybridised centres

(Figure 1.4c), respectively.

[36, 38]

These bond angles

contribute to angular strain and as a consequence, the ring-strain energy of cyclopropenes
is also incredibly high with a reported value of 54.5 kcal/mol.[31, 35, 39] Comparatively, the
ring-strain energy of cyclopropane is 27.5 kcal/mol, virtually half that of cyclopropene. [35]
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Figure 1.4. Bond lengths and angles of cyclopropene (a); ideal bond angles of sp2-hybridised centres (b);
ideal bond angles of sp3-hybridised centres (c)

The relief of the ring-strain within cyclopropenes is a major contributing factor to
their extraordinary reactivity and allows these carbocycles to undergo many chemical
transformations that are often thermodynamically unfavourable for other olefins. [30, 34, 40]
In order to compensate for the strain and distortion within the three-membered ring,
cyclopropenes possess increased s-character within their olefinic C–H bonds.[34-35, 40] To
explain this, there are two commonly proposed bonding models for cyclopropenes (and
cyclopropanes): the Walsh model and the bent-bond model.[38] For the Walsh model
(Figure 1.5a), C1 and C2 are sp-hybridised and one p-orbital from each contributes to the
double bond while the other contributes to the ring.[38, 41] The third carbon, C3, is then sp2hybridised.[38, 41] Alternatively, the bent-bond model proposed by Coulson and Moffitt
(Figure 1.5b), suggests that the σ-framework of the cyclopropene is formed from two sp5
hybrids at C3 and four sp3 hybrids (two each) from C1 and C2.[38, 42] Overall, the hybrids
used to form bonds with substituents at vinylic carbons are sp-hydrised, while the
substituent hybrids at C3 are sp2-hydrised.[38, 42] As a result of the increased C–H bond scharacter (approx. 43%), the behaviour of π-bond within cyclopropenes can sometimes
resembles that of a terminal alkyne which adds to their unique reactivity. [31, 34, 38, 43]
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Figure 1.5. Bonding models for cyclopropene: Walsh model (a); bent-bond model (b) (figure adapted from
Allen[38])

As previously stated, the length of the double bond in a cyclopropene molecule is
1.2959 Å, which is shorter than that of other typical olefins, such as ethylene (1.335 ±
0.003 Å).[38, 44] The shortening of the cyclopropene double bond is a result of the increased
s-character in the σ-component of the molecule, combined with a strong pπ overlap.
Ultimately the double bond of cyclopropene has a high π-density making is very attractive
to π-philic transition-metals, such as gold salts – [30-31, 45] a property that will be discussed
in Section 1.3.
1.2.2. Synthesis of Cyclopropenes
Many methods for synthesising cyclopropenes have been developed which are
summarised in Figure 1.6. Some of the most common and important methods for
synthesising cyclopropenes include: 1,2-elimination from a cyclopropane precursor (a);
[2 + 1] cycloadditions between alkynes and carbenoids generated from idonium ylides[46]
or diazocompounds[47] (b); functionalising other pre-formed cyclopropenes (c); cascade
1,3/1,2-elimination reactions from 1,3-dihalopropanes[48] (d); in situ generation of vinyl
carbenes from diazoalkenes,[49] allyl halides,[50] epoxides,[51] vinyldiazirines[52] or tosyl
hydrazones[53] and performing a cycloisomerisation (e); or by the transition-metal or
photochemical catalysed extrusion of nitrogen from 3H-pyrazoles[54] (f). Of the above
methods the (a) and (b), are the most important to this thesis and will be discussed in
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more depth in Sections 1.2.2.1 and 1.2.2.2. Other less common methods of synthesising
cyclopropenes include: ring contraction of furan-2(5H)-ones by the extrusion of carbon
dioxide[55] (g); 1,2-silicon shift in a 2-silylcyclopropylidene[56] (h); rearrangements of
methylenecyclopropanes[57] (i); retro-cycloaddition reactions[37,

58]

(j); photochemical

rearrangements of alkynes[59] (k); 1,3-elimination reactions from 1,3-dihalopropenes[60]
(l); ring-contraction of cyclobutenes[61] (m); nucleophilic addition to cyclopropylium salts
(n); and cycloisomerisation reactions of allenes[62] (o).

Figure 1.6. Summary of methods for the synthesis of cyclopropenes (figure adapted from Rubin et al.[34])

1.2.2.1.

1,2-Eliminations from a Cyclopropane Precursor

Arguably, the most common method for the synthesis of 3,3-disubstituted
cyclopropenes is summarised in Scheme 1.8. The synthesis first involves
cyclopropanation of the desired alkene 32 with a dibromocarbene generated in situ from
CHBr3 and NaOH, to obtain a dibromocyclopropane 33.[31] The dibromocyclopropane 33
then undergoes hydrodebromination in the presence of Ti(OiPr)4 and EtMgBr to produce
a monobromocyclopropane 34.[31, 63] A detailed study by Nizovtsev et al., describes that
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this step occurs by a radical pathway (other explanations have also been proposed). [63]
The final step then involves a base-catalysed 1,2-elimination (method A) of the
monobromocyclopropane 34 in anhydrous dimethyl sulfoxide (DMSO) to produce
cyclopropene 35.[31] Alternatively, this step can also be performed in the presence a
catalytic amount of 18-crown-6 in tetrahydrofuran (THF) (method B), and generally
results in higher yields of the final product 35.[31]

Scheme 1.8. Synthesis of 3,3-disubstituted cyclopropenes 35 via 1,2-elimination from cyclopropanes 34

Another important synthesis of cyclopropene derivatives related to this thesis, is
the synthesis of cyclopropenyl carbinols (Scheme 1.9). Much like the synthetic scheme
above, the first step of making these cyclopropenes involves cyclopropanation of an
appropriate bromoalkene 36 with a dibromocarbene to give a 1,1,2-tribromocyclopropane 37. The next step in the synthesis was developed by Baird et al. and
involves the use of an alkyl lithium reagent such as MeLi, to form a lithiated 2,3,3substituted cyclopropene 38.[64] The reaction proceeds by a lithium-halogen exchange that
facilitates the 1,2-elimination of LiBr, thereby generating the C=C bond, followed by a
second lithium-halogen exchange to give the lithiated cyclopropene species 38. [64] These
lithiated cyclopropenes can then be reacted with electrophiles such as aldehydes thereby
forming cyclopropenyl carbinols 39 after an acidic work-up.[64-65]
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Scheme 1.9. Synthesis of 2,3,3-substituted cyclopropenyl carbinol 39 from 1,1,2-tribromocyclopropane 37

1.2.2.2.

[2 + 1] Cycloadditions between Alkynes and Carbenoids

A common method for the synthesis of cyclopropenyl carboxylates 42 involves a
transition-metal catalysed [2 + 1] cycloaddition between an alkyne 40 and a carbenoid
species (Scheme 1.10) with one of the first examples being a Cu-catalysed cycloaddition
reported by D’jakonov and Komendantov.[31, 66] Since then, this method has been widely
used, particularly as it yields cyclopropenyl carboxylates in good yields in a single step.
Rhodium catalysts are often more preferable due to the lower catalyst loading required
and as higher reactivity can be achieved.[31] There have also been reports of silver
catalysts[67] and gold/silver catalyst systems[68] being used. In general, the reaction
proceeds by the metal assisted extrusion of nitrogen gas from the diazo compound 41,
thereby forming a reactive metal carbenoid species.

Scheme 1.10. Synthesis of cyclopropenyl carboxylates 42 by transition-metal catalysed [2 + 1]
cycloadditions
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1.2.2.3.

Enantioselective Synthesis of Cyclopropenes

The ability to synthesise enantiomerically pure compounds is a very important
aspect of organic synthesis, particularly in the pharmaceutical industry where
approximately 80% of drugs are chiral.[69] It has been determined that cyclopropenyl
carbinols (±)-43 can be made enantiomerically pure through a Sharpless kinetic resolution
as seen in Scheme 1.11a.[70] Epoxidation conditions in the presence of the chiral ligand,
(R,R)-(+)-diethyl tartrate, are used to convert the racemic cyclopropenyl carbinol (±)-43
into a single enantiomer, ent-43.[70] This occurs despite the nature of the highly reactive
cyclopropene double bond, with ent-43 being obtained with an enantiomeric excess (ee)
of 95-99% and isolated yields of 40-47%.[70] The other enantiomer however, becomes
epoxidised resulting in 2-oxabicylo[1.1.0]butane 44 which is highly unstable and
isomerises to the enantiomerically pure α,β-unsaturated ketols 45 and 46.[70-71] While the
ee of the products obtained from the Sharpless kinetic resolution were excellent, Marek
and co-workers acknowledged that a major disadvantage of the reaction was the loss of
half the starting material to the formation of ketols 45 and 46. To rectify this issue, Marek
et al. also investigated a bio-catalytic resolution (Scheme 1.11b).[70b]

Commercially

available Pseudomonas AK (Amano K-10) carried out an irreversible, enzyme-mediated
acylation on the racemic cyclopropenyl carbinol substrate (±)-43 to produce
enantiomerically pure cyclopropenyl carbinol ent-43 (ee > 95%, 24-41%) and
cyclopropenyl acetate ent-47 (ee > 95%, 25-48%).[70b]
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Scheme 1.11. Enantiomeric enrichment of racemic cyclopropenyl carbinols (±)-43: Sharpless kinetic
resolution (a); bio-catalytic resolution (b)

1.2.2.4.

Functionalisation of Cyclopropene Side Chains

Of crucial importance to this thesis is the ability to functionalise cyclopropenes so
that reactive appendages may be added to the molecule. These reactive appendages are
what allows for increased molecular complexity when the cyclopropenyl substrates are
subjected to gold catalysis – a point that will be made clear throughout this thesis. For
example, the cyclopropenyl carbinols 39 described in Scheme 1.9 (Section 1.2.2.1, pg 18)
have the carbinol unit in the C1 position of the cyclopropene ring that serves as an
important tethering point. As a result, cyclopropenyl carbinols 39 have been
functionalised numerous times as shown in Scheme 1.12 to make cyclopropenylcarbinyl
ethers 48;[72] cyclopropenylcarbinyl acrylates 49;[72b] allyl cyclopropenylsilyl ethers
50;[72b, 72c] cyclopropenyl methoxymethyl ethers 51;[73] cyclopropenylcarbinyl glycolates
52;[74] and cyclopropenyl acetates 53.[43, 75]
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Scheme 1.12. Examples of functionalisation reactions performed with the alcohol group of cyclopropenyl
carbinols 39

Further functionalisation of the cyclopropenyl carboxylates 42 described in
Scheme 1.10 (Section 1.2.2.2, pg 18) has also been important for the development of this
thesis. For example cyclopropenyl carboxylates 42 can undergo saponification to produce
the corresponding cyclopropenyl carboxylic acids 54 that can undergo further reactivity
(Scheme 1.13).[76] For instance in the presence of N,N'-dicyclohexylcarbodiimide (DCC),
4-(dimethylamino)pyridine (DMAP) and an appropriate alcohol, cyclopropenyl
carboxylic acids 54 can undergo a Steglich esterification to form more complex and
versatile cyclopropenyl carboxylates 42’.[77] Cyclopropenyl carboxylic acids 54 can also
undergo condensation reactions with amines in the presence of coupling agents such as
carbonyldiimidazole (CDIM)[53] or 2-(6-chloro-1-H-benzotriazole-1-yl)-1,1,3,3-tetra21

methylaminium hexafluorophosphate (HCTU),[55] to form cyclopropenyl amides 56.
Alternatively, cyclopropenyl amides 56 can be formed by reacting 54 with oxalyl chloride
and catalytic N,N-dimethylformamide (DMF) to generate acyl chloride 55, followed by
the addition of a 1° or 2° amine to give the amide. [78] Cyclopropenyl carboxylates 42 can
also be reduced to the corresponding cyclopropenyl carbinols 57 with excess
diisobutylaluminium hydride (DIBAL-H), which can undergo further reactivity.[79] For
example, a Mitsunobu reaction with a sulfonamide, PPh3 and diethyl azodicarboxylate
(DEAD) or diisopropyl azodicarboxylate (DIAD), generates cyclopropenyl sulfonamides
58.[80] Cyclopropenyl carbinols 57 can also undergo protection reactions with reagents
such as tosyl chloride to generate cyclopropenyl tosylates 59, thus generating a good
leaving group and facilitating further functionalisation.[81] Other reactions with 57 can
involve propargylation or allylation reactions with propargyl or alkenyl halides to
generate cyclopropenylcarbinyl ethers 60.[80]

Scheme 1.13. Examples of functionalisation reactions performed with the functional groups of
cyclopropenyl carboxylates 42
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1.2.3. Reactions of Cyclopropenes
As mentioned previously, cyclopropenes undergo numerous transformations that
are unfavourable for other alkenes, as they are not strained carbocycles.[34] Therefore, the
intelligent design of cyclopropenes can lead to the synthesis of a diverse range of
chemically useful products that would otherwise be difficult to access.[30] Stereo- and
regio-control over products is also feasible due to the conformational restrictions of
cyclopropenes and can enable the selective synthesis of enantiomers and diastereomers
of important biological compounds.[34] There are numerous reviews which extensively
cover the reactions undergone by cyclopropenes, some of which include those by Shi, [31]
Marek,[40] Carter and Frampton,[82] Gevorgyan,[30, 34] Vicente,[83] Baird[84] and Fox.[85] A
general overview of the reactions possible with cyclopropenes is shown in Figure 1.7
including: ring-expansions (a); cycloadditions that involve either opening or conservation
of the ring (b); ring-opening metathesis (c); migration of the double bond of the
cyclopropene to a side chain (d); various examples of cross-couplings, substitutions and
functionalisations (e); ene reactions (f); and addition reactions involving the opening or
conservation of the ring (g).[30-31, 34, 83] However, this thesis is focused on the reaction of
cyclopropenes with gold catalysts which will be discussed in Section 1.3.

Figure 1.7. Possible reactions of cyclopropenes (figure adapted from Rubin et al.[34])
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1.3.

Gold-Catalysed Transformations of Cyclopropenes

1.3.1. Activation of Cyclopropenes by Gold
As previously mentioned in Section 1.2.1, the double bond of cyclopropenes has
a very high π-density making them attractive to π-philic transition metals. Relief of ringstrain energy is the primary driving force behind the coordination of a metal centre to a
cyclopropene.[31] Typically, donation of electrons from the filled π-orbitals of the
cyclopropene to the spd-hybrid orbital of a metal occurs, along with formation of π-back
bonding which weakens the double bond.[30-31] In the majority of cases, the π-bond of the
cyclopropene 61 acts as a ligand for gold, thus activating the bond towards ring-opening
to generate an organogold species that is thought of as a hybrid between a gold-carbene
62 and a gold-stabilised carbocation 63 (Scheme 1.14a).[86] These organogold species can
participate in a plethora of reactions including cyclopropanations with alkenes and selfor cross-couplings (carbene-like behaviour), as well as nucleophilic addition reactions
with alcohols, thiols, carbonyls and arenes (carbocation-like behaviour).[86] Alternatively,
the π-bond of cyclopropenes can act as a nucleophile in the presence of gold if another
functional group, such as an alkyne, is preferentially activated (Scheme 1.14b).[86] While
alkenes, alkynes and allenes have all been widely investigated as substrates in the field of
gold catalysis, cyclopropenes have only recently been studied in the last 10 years.

Scheme 1.14. General reactivity of cyclopropenes with gold catalyst complexes
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1.3.1.1.

Gold Carbene or Gold-Stabilised Carbocation Intermediate

Much like other gold-catalysed reactions with π-bonds, the nature of the
organogold intermediates generated from the ring-opening of cyclopropenes by gold is a
topic of debate. Various studies have been performed to elucidate the exact nature of these
intermediates which has aided the understanding of other organogold intermediates
formed from other π-bonds.[86] In 2009, Fürstner et al. published a study that attempted
to perform NMR characterisation on organogold species generated from the reaction of
3,3-disubstituted cyclopropenes with stoichiometric amounts of R3PAuNTf2 catalysts.[87]
When cyclopropene 64 (R = Ph or Me) was reacted with Ph3PAuNTf2 (CD2Cl2, –78 °C,
argon), rapid oligomerisation was observed (Scheme 1.15a). However, when the
cyclopropenyl acetal 65 was reacted under the same conditions, the organogold species
(Z)-66 was obtained which could isomerise to (E)-66 when temperatures were increased
(Scheme 1.15b). The organogold intermediates were determined to be cationic in nature
given the two -O-CH2- groups of the ketal ring appeared as a single signal in the 1H and
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C NMR spectra, indicating rapid rotation about the C2–C3 bond. It was also observed

from (Z)-66 and (E)-66 that it was the C1–C2 bond that possessed a high degree of double
bond character. Attempts were made to generate organogold intermediates displaying
carbene-like characteristics by using more electron-donating trialkylphosphine ligands
such as Me3PAuNTf2 and Cy3PAuNTf2. However, gold-stabilised carbocation
intermediates were still observed. Cyclopropene 67 was also reacted with Me3PAuNTf2
(CD2Cl2, –80 °C) and the corresponding organogold intermediate (Z)-68 was obtained
which was far less stable (Scheme 1.15c). The results of the experiments were useful in
determining the carbenic or cationic nature of organogold intermediates, although the
authors conceded that the oxygen substituents of the cyclopropenone acetals may have
resulted in a bias that favoured the cationic form.
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Scheme 1.15. Organogold intermediates generated from 3,3-disubstituted cyclopropenes

To expand on the conclusions of Fürstner et al., a computational study was
performed by Toste et al. The rotational barriers for (Z)-66 and (Z)-69 where calculated
by the M06 functional of density functional theory (DFT) and the theoretical values were
found to be in excellent agreement with the experimental values obtained by Fürstner,
thus validating the computational method (Figure 1.8).[28] The rotational barrier for the
allyl cation 70, the metal-free equivalent of (Z)-66, was calculated and Toste came to the
same conclusion as Fürstner, that the gold had little effect on the rotational barrier in (Z)66. In the absence of carbocation-stabilising oxygens however, such as the cation 71 and
the Me3PAu-substituted organogold species 72, the difference in the rotational barriers
was substantially greater. Given the higher rotation barrier, the organogold species 72
would be more accurately described as a gold carbene.[28, 86]
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Figure 1.8. Rotational barriers for the C2–C3 bond

Calculations were also performed to obtain the bond lengths of Ph3P-Ausubstituted allylic cations (Figure 1.9). The bond lengths were expressed as a ratio where
A ≡ (C1–C2)/(C2–C3) which indicated whether the positive charge was more stabilised by
the substituents on C1 or C3. If A values was <1, the positive charge was more stabilised
at C3 corresponding to carbocationic behaviour, whereas if A values were >1, the positive
charge was more stabilised as C1 corresponding to carbene like behaviour. For the acetal
organogold species 73, A = 0.954 (charge at C3), whereas for the dicarbomethoxy
organogold species 75, A = 1.029 (charge at C1). However, for the dimethyl organogold
species 74, A = 0.993 which suggested that positive charge was just as stable at C1 as it
was at C3. The results revealed that the magnitude of stabilisation from the gold moiety
rose with increasing electrophilicity from the allylic carbocation. The effect of the ligand
on the gold was also investigated to determine its influence on the electronic nature of the
organogold species. It was found that the C1–Au bond lengthened and carbocation-like
behaviour was displayed when there was increased trans-σ-donation from the ligand and
when strongly π-acidic ligands (i.e. phosphites) were used. Conversely, shortening of the
C1–Au bond and carbene-like behaviour was observed when the ligand either reduced C1to-Au σ-donation or increased Au-to-C1 π-donation (i.e. N-heterocyclic carbene (NHC)
ligands).[28, 86]
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Figure 1.9. Calculated ratios of bond distances (A ≡ (C1–C2)/(C2–C3)) and natural charges at C1, C2 and C3

Evidently the nature of the organogold intermediates generated from
cyclopropenes can also display both cationic and carbene reactivity depending on the
substitution of the cyclopropene ring as well as the nature of the ligand on the gold
catalyst. The following sections will discuss reported reactions between gold and
cyclopropenes. The scope of this review has been restricted to homogeneous gold
catalysis examples where the cyclopropene substrates have been isolated and subjected
to the catalysis conditions. Reactions where cyclopropenes were not the main subject of
the study (i.e. have been proposed/proven as an intermediate in a gold-catalysis pathway)
will not be discussed.[88] An excellent review by Meyer and Cossy[86] was published
summarising all the work involving reactions between gold and cyclopropenes from 2008
to 2011; however, no further reviews on the topic has since been published.

1.3.2. Gold-Catalysed Intermolecular Reactions of Cyclopropenes
1.3.2.1.

Nucleophilic Addition Reactions

Oxygen Nucleophiles
One of the first published reports involving activation of the cyclopropene double
bond by a gold catalyst was described by Lee et al. in 2008 with a follow up study being
performed in 2010 (Shi et al. also published a study on gold catalysed reactions of
cyclopropenes in 2008 independently from Lee et al. which will be discussed vide infra).
Lee et al. reacted numerous 3,3-disubstituted cyclopropenes 76 with different alcohols 77
and discovered that tert-allylic ethers 79 could be obtained in moderate to high yields (3328

88%) with excellent regioselectivities of 79:80 (92:8 to >99:1) (Scheme 1.16). The
reaction conditions involved using Ph3PAuCl/AgOTf (method A, 5 mol%) or
Ph3PAuNTf2 (method B, 5 mol%) in dichloromethane (DCM) at 20 °C. Typically method
B was used as it was more efficient at catalysing the reaction but in some instances,
temperatures had to be reduced to maintain the regioselectivity. The mechanism was
proposed to proceed by activation of the π-bond followed by ring-opening of
cyclopropene 76 to the gold carbenoid intermediate 78. For the observed product to occur,
intermediate 78 must display carbocationic reactivity and nucleophilic attack of the
alcohol 77 at the C3 position, followed by protodeauration to generate the tert-allylic ether
79. The mechanism was supported by a deuterium-labelling experiment where CD3OD
was the nucleophile, which showed 90% D incorporation occurred at the C1 position.[89]

Scheme 1.16. Gold(I)-catalysed reactions of 3,3-disubstituted cyclopropenes 76 with alcohols 77

From the substrate scope, primary (R3 = alkyl, allyl, alkenyl or Bn groups) (7788%) and secondary (R3 = iPr) (70%) alcohols 77 were tolerated by the reaction but
tertiary alcohols (R3 = tBu) were not (Scheme 1.16). Diols could also be used in the
reaction, especially if one alcohol was more sterically hindered than the other (33% and
58%). Unfortunately, the reaction was not diastereoselective, as cyclopropenes reacted
with optically pure alcohols gave 1:1 diastereomeric ratios (dr) of 79 (46% and 65%,
regioselectivity 79:80 96:4 and >99:1, respectively). For cyclopropene 76, various
substituents including alkyl, spiro, benzyl and isopropyl groups all reacted smoothly with
primary alcohols (73-87%) but yields fell when a more sterically hindered cyclopropene
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(R1 = tBu, R2 = Me) (64%) was used. Yields and regioselectivities also decreased when
a more sterically hindered cyclopropene (R1 = iPr, R2 = Bn) was reacted with a secondary
alcohol (R3 = iPr) (45%, 79:80 92:8). Interestingly, a phenyl group on the cyclopropene
was tolerated and formed tert-allylic ether 79 regioselectively when reacted with n-BuOH
(65%), without undergoing intramolecular cyclisation to form indenes. This only
occurred though when lower temperatures and excess alcohol (15 equiv.) were used,
otherwise mixtures of 79 and 80 were obtained. The only instance where the primary
ether 80 occurred was when a cyclopropene bearing an aryl group was reacted with
phenylethyl alcohol (65%), which gave complete inversion of the regioselectivity 79:80
(1:99). It was suggested that the difference in regioselectivity was because n-BuOH was
more effective at preventing the isomerisation of the tert-allylic ether 79 to the primary
ether 80 (vide infra).[89]
Lee et al. also determined that the regioselectivity between the tert-allylic ether
79 and the primary ether 80, was highly dependent on the equivalents of alcohol. For
example, when 6 equiv. of alcohol were added, the ratio of 79:80 (Scheme 1.16) was
>99:1 but was reduced to 2:1 when 1 equiv. of alcohol was added. To investigate this,
tert-allylic ether 81 was subjected to Ph3PAuNTf2 in the presence of 5 equiv. of MeOH
and no reaction was observed (Scheme 1.17a). However, in the absence of MeOH, the
tert-allylic ether 81 isomerised irreversibly to the primary ether 82 (Scheme 1.17b).
Isomerisation of tert-allylic ethers to the primary ethers was catalyst dependent as
cyclopropene 83 in the presence of IPrAuCl/AgOTf and only 1 equiv. of EtOH,
selectively formed the tert-allylic ether 84 with no conversion to the corresponding
primary ether (Scheme 1.17c) (IPr = N,N’-bis(2,6-diisopropyl phenyl)imidazol-2ylidene). The authors suggested that the gold(I)-catalysed addition of alcohols to 3,3disubstituted cyclopropenes proceeded regioselectively to generate the kinetically
30

favoured tert-allylic ether 79 but in the absence of excess alcohol, gold isomerises 79 to
the more stable primary ether 80. In the presence of excess alcohol however, they
proposed that Ph3PAuNTf2 becomes deactivated and can no longer catalyse the
isomerisation.[89b]

Scheme 1.17. Control experiments to determine the importance of excess alcohol to the regioselectivity of
the gold(I)-catalysed addition of alcohols to 3,3-disubstituted cyclopropenes.

Nitrogen Nucleophiles
Following their success with reactions of 3,3-disubstituted cyclopropenes with
alcohols, Lee et al. investigated reactions with nitrogen nucleophiles. However,
preliminary studies demonstrated that the best obtainable conversion of cyclopropenes 85
to alkenyl amine 86 using an aryl amine, was 42% (Scheme 1.18). Lee et al. concluded
that the catalyst had likely undergone deactivation by the N-nucleophile.[90]

Scheme 1.18. Gold(I)-catalysed nucleophilic addition reaction of N-nucleophiles to cyclopropenes
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To investigate this further the gold–amine complex 87 was prepared and
characterised by NMR spectroscopy and X-ray crystallography. Following its
preparation, the gold–amine complex 87 was reacted with cyclopropene 88 and panisidine to determine its efficiency at catalysing the formation of alkenyl amine 89
(Table 1.1). Echavarren’s catalyst 90 was first used in the reaction which result in 27%
conversion to alkenyl amine 89 (entry 1). The gold–amine complex 87 resulted in 15%
conversion to 89 (entry 2). Lee et al. also investigated the reaction with 87 in the presence
of a Brønsted acid (HOTf), but no improvement in the conversion to 89 (13%) was
observed (entry 3). Other gold–amine complexes were also prepared and were used as
catalysts in the reaction between cyclopropenes and alcohol nucleophiles; however, these
reactions will not be discussed. The authors were therefore confident in their conclusion
that the poor conversions of cyclopropenes to alkenyl amines was due to deactivation of
the gold(I)-catalysts by the N-nucleophile.[91]
Table 1.1. Comparison of the reaction between cyclopropene 88 and p-anisidine in the presence of
Echavarren’s catalyst 90 and 87

Entry
1
2
3
a

Catalyst
90
87
87 + HOTf

x mol%
5
5
5+5

Conversiona
27
15
13

Determined from the 1H NMR of the crude mixture
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Sulfur Nucleophiles
Undeterred by the results obtained from the gold-catalysed reactions of
cyclopropenes with N-nucleophiles, Lee et al. published a paper in 2012 on the gold(I)catalysed addition reactions of thioacids and thiols to 3,3-disubstituted cyclopropenes.
This was an intriguing paper as reports on the use of S-nucleophiles with late transition
metals are fairly scarce compared to other nucleophiles given their tendency to
poison/deactivate the catalysts. Gold also coordinates strongly with sulfur and Lee et al.
initially presumed that S-nucleophiles would perform even worse than N-nucleophiles.
However, from a reaction screen it was determined that a thioacid nucleophile could react
with cyclopropene 85 in the presence of Ph3PAuNTf2, to form primary allylic thioesters
91 fairly selectively over tert-allylic thioesters 92 (Scheme 1.19). Thiol nucleophiles
however, deactivated the Ph3PAuNTf2 catalyst so Echavarren’s catalyst 90 was used
instead and resulted in the formation of vinyl thioethers 93 (Scheme 1.19). Interestingly,
thiols bearing other pendant nucleophiles reacted chemoselectively at the thiol end. Lee
et al. concluded that the thiols reduced the activity of the gold(I)-catalyst so that the more
reactive nucleophiles (i.e. alcohol or furan) were deactivated under the reaction
conditions thus facilitating the selective reaction of the –SH group of the nucleophile.[90]

Scheme 1.19. Gold(I)-catalysed reactions of cyclopropene 85 in the presences of thioacids and thiols

The reaction scope was further investigated by varying the substituents on the
cyclopropene. With thiobenzoic acid as the nucleophile, Ph3PAuNTf2 catalysed the
formation of primary allylic thioesters 91 in good to excellent yields (62-94%) and in
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generally good regioselectivities over the tert-allylic thioester 92 (91:92 6:1 to 14:1). The
E isomer for the primary allylic thioester 91 was favoured when the substituents of the
cyclopropene were sterically different. Deactivating ester groups on the cyclopropene
were not tolerated even when the reactions were heated to 70 °C in 1,2-dichloroethane
(DCE). With thiophenol as the nucleophile, Echavarren’s catalyst 90 catalysed the
formation of vinyl thioethers 93 in moderate to excellent yields (56-90%) with excellent
diastereoselectivity for the E isomer (E:Z 16:1 to 20:1). Having benzyl substituents on the
cyclopropene were not tolerated and the authors proposed that decomposition/further
reaction of the vinyl thioethers had occurred.[90]
Mechanistically, primary allylic thioesters 91 could be formed by the activation
of cyclopropene 85 to form the gold(I) carbenoid intermediate 94 which could be attacked
by the thioacid nucleophile to obtain the allylic organogold intermediate 95 (Scheme
1.20). Protodeauration would subsequently generate the primary allylic thioester 91. For
the formation of the vinyl thioethers 93, the allylic organogold intermediate 95 was
proposed to undergo an SE′-type protodeauration (Scheme 1.20). Formation and
isomerisation of a primary allylic thioester 91 to a vinyl thioether 93 was proven not to
occur by a deuterium-labelling study with deuterated thiophenol, as there was no D
incorporation at the C1 position (only at the C3). Additionally when a primary allylic
thioester 91 was resubjected to the reaction conditions, no isomerisation occurred. [90]

Scheme 1.20. Mechanisms for the formation of primary allylic thioesters 91 and vinyl thioethers 93
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Much like the gold-catalysed reactions of cyclopropenes with N-nucleophiles, a
dampening effect was also observed when the gold(I)-catalysts were in the presence of
thiols. To confirm and evaluate this dampening effect, digold–thiolate complexes were
synthesised and characterised by NMR and X-ray crystallography. The digold–thiolate
complex 96 was then used to catalyse the reaction of cyclopropene 97 and 1 equiv. of
thiophenol, which could result either in the gold(I)-catalysed product 98 or the
uncatalysed background product 99 (Table 1.2). Echavarren’s catalyst 90 gave the desired
alkenyl thioether 98 solely (entry 1) while in the absence of any catalyst, cyclopropyl
thioether 99 was obtained (entry 2). The digold–thiolate complex 96 gave only a small
amount of 98 and primarily formed 99 (98:99 = 1:20) (entry 3). The main difference
between the results in entry 1 and entry 3, was that 96 was generated in situ in entry 1
(cyclopropene 97 added after pre-mixing of 90 and PhSH) and thus H+ was generated
upon the conversion of 90 to 96. It was proposed that the formation of 96 from 90 was
reversible and that the presence of residual H+ might allow the equilibrium to shift toward
the more active 90 species. Hence when HOTf was added with 96, the ratio of 98:99
increased to 2:1 (entry 4). The Brønsted acid alone only resulted in cyclopropane 99 (entry
5). Other digold–thiolate complexes were reacted with cyclopropenes and alcohols and a
general trend was established whereby the higher the Lewis basicity of the parent thiol,
the more the equilibrium would shift towards the inactive 96 species (i.e. yields of product
were diminished). Lee et al. concluded that thiols deactivate the gold(I)-catalysts by
forming digold–thiolate complexes; however, the presence of residual H+ shifts the
equilibrium towards the active catalyst species.[91]
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Table 1.2. Comparison of the reaction between cyclopropene 97 and PhSH in the presence of Echavarren’s
catalyst 90 and 96 plus control reactions

Entry
1b
2
3
4
5

Catalyst
90
No catalyst
96
96 + HOTf
HOTf

x mol%
5
N/A
2.5
2.5
2.5

98:99a
98 only
99 only
1:20
2:1
99 only

a

Ratio determined from 1H NMR of the crude reaction mixture; b catalyst 90 was pre-mixed with PhSH in
DCM before cyclopropene 97 was added

Indole Nucleophiles
Following their investigations with O-, N- and S-nucleophiles, Lee et al. published
a study into the divergent outcomes of gold(I)-catalysed addition reactions of indole to
3,3-disubstituted cyclopropenes 85 to afford 3-(E)-vinylindoles 101 and bisindolylalkanes 103 (Scheme 1.21). It was determined that bis-indolylalkanes 103 could
be derived from 3-(E)-vinylindoles 101. To explain this mechanistically, gold activation
of the π-bond of cyclopropene 85 resulted in ring-opening to the gold carbenoid 94. Indole
then attacks as a nucleophile to generate intermediate 100 which can undergo
protodeauration to produce 3-(E)-vinylindoles 101. Further activation of 101 by either H+
or AuL+ results in intermediate 102. Control experiments where 101 was subjected to
gold-catalysis conditions with and without a base, demonstrated that the reaction could
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not proceed without the presence of residual acid. The second equivalent of indole then
attacks intermediate 102 to generate bis-indolylalkanes 103.[92]

Scheme 1.21. Mechanistic proposal for the gold(I)-catalysed formation of 3-(E)-vinylindole 101 and bisindolylalkane 103

Given that bis-indolylalkanes 103 could be obtained from 3-(E)-vinylindoles 101,
Lee et al. optimised the conditions to either trap out 102 or force the reaction to
completion to obtain 103 (Scheme 1.22). Using Echavarren’s catalyst 90 (5 mol%), under
mild conditions of DCM at 0 °C, 3-(E)-vinylindoles 101 could be isolated selectively. In
general, the reaction tolerated electron-donating groups (EDGs) and electronwithdrawing groups (EWGs) on the indole 104 as well as a methyl group in the R3 and
R4 positions. Variation of cyclopropene 85 with different alkyl groups as well as an aryl
group and bulky substituents at R2, were also tolerated. In total 13 examples of 101 were
prepared in 63-91% yields. When both R1 and R2 on cyclopropene 85 were bulky
however, yields dropped (28% and 7%). To push the reaction to completion and obtain
bis-indolylalkanes 103, refluxing conditions in DCM were used and the reactions were
left for a longer period of time. The same substrates used for the scope of 101 were used
for the scope of 103 and 13 examples were synthesised in yields of 48-79%. As with the
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scope for 101, when bulky substituents were in both the R1 and R2 positions, yields of
103 diminished 29% and 0%.[92]

Scheme 1.22. Gold(I)-catalysed addition reactions of cyclopropenes 85 and indoles 104

Interestingly, when indole 104 was reacted with cyclopropene 85 bearing bulky
groups in R1 and R2, oxidation products 106 and 107 were obtained (Scheme 1.23). This
reaction was highly unusual as gold is well documented to be stable to oxidation by air at
rt. Control reactions revealed that products 106 and 107 only formed when O2 was
available and in the absence of O2, allyl indole 108 was obtained which was presumably
the direct protodeauration product of intermediate 100 from Scheme 1.21 (pg 37). It was
proposed that the bulky substituents (i.e. Cy, Bn and iPr) stabilised intermediate 105
making subsequent conversion to 3-(E)-vinylindole 101 less facile (Scheme 1.23). The
allyl gold intermediate 105 could then either undergo oxidation in the presence of O2 to
form 106 and 107 or, if under stringent O2-free conditions, would undergo direct
protodeauration to form 108. Lee et al. were particularly excited by this result as
extraordinarily mild gold oxidation reactions under air, were potentially attainable. [92]
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Scheme 1.23. Reaction outcomes when bulky cyclopropenes are reacted with gold(I)-catalysts in the
presence and absence of O2

Ynamide Nucleophiles
Recently in 2017, Chen and Huang published a study on the gold(I)-catalysed
intermolecular cycloisomerisation of 3,3-disubstituted cyclopropenes 85 with ynamides
109 to form cyclopentadienes 110 (Scheme 1.24). Work by Gagosz and Skrydstrup[93]
had shown that gold-catalysed dimerisation of ynamides could result in cyclopentadienes
while Hashmi et al.[94] had shown that dimerisation of ynamides could be prevented once
another gold carbenoid (generated from propargylic carboxylates) had formed. Chen and
Huang therefore, recognised that cyclopropenes would be an excellent substitute for
propargylic carboxylates. Optimisation of the reaction conditions revealed that the NHCgold(I)-catalyst IPrAu(PhCN)SbF6 produced the best results (Scheme 1.24). From the
substrate scope, the R3 position of ynamides 109 tolerated aryl rings bearing EDGs and
EWGs in the para-position, aryl rings bearing chloro substituents in the meta- and orthopositions as well as naphthyl,

n

Bu and cyclopropyl substituents, providing the

corresponding cyclopentadienes 110 in 70-99% yields. However, when R3 was a
thiophenyl group, yields dropped (48%). All ynamides typically possessed an
oxazolidinone moiety; however, the reaction could also proceed when a sulfonamide
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group was used (56%). Variation of cyclopropene 85 revealed aryl rings bearing EDGs
and EWGs at different positions around the ring were well tolerated as were naphthyl and
alkyl substituents, producing cyclopentadienes 110 in yields of 71-99%.[95]

Scheme 1.24. Gold(I)-catalysed cycloisomerisation of 3,3-disubstituted cyclopropenes 85 with ynamides
109

Mechanistically, the formation of cyclopentadiene 110 likely proceeded by
activation of the π-bond of cyclopropene 85 to generate the gold carbenoid intermediate
94 (Scheme 1.25). Gold-activation of the ynamide was ruled out due to the observed
regioselectivity of the final product. Following path 1, nucleophilic attack of ynamide 109
on the gold carbenoid 94 would result in intermediate 111 which could undergo
intramolecular cyclisation to produce the final product 110. Another plausible pathway
involves a cyclopropenation reaction of ynamide 109 by the gold carbenoid 94 to give
intermediate 112 as shown in path 2. Enamide triggered ring-opening of intermediate 112,
followed by an intramolecular cyclisation of intermediate 113 can then also result in the
final product 110.[95]

Scheme 1.25. Mechanistic proposal for the gold(I)-catalysed formation of cyclopentadienes 110
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Chen and Huang additionally found that a one-pot procedure for the formation of
cyclopentenones 114 was possible by first subjecting cyclopropenes 85 and ynamides 109
to the gold(I)-catalysis condition, followed by an acidic work-up (Scheme 1.26). A
substrate scope with 11 examples was performed providing 114 in yields of 64-84%.[95]

Scheme 1.26. One-pot synthesis of cyclopentenones 114 from cyclopropenes 85 and ynamides 109

The reactions and mechanisms described in this section have all been dependent
upon the gold carbenoid intermediate generated from the ring-opening of the
cyclopropene, displaying carbocation-like reactivity. However, it has also been observed
in the literature that when reacted with gold, some cyclopropenes form products that can
only be rationalised if the gold carbenoid intermediate displays carbene-like reactivity.
The following section will discuss these types of gold-catalysed intermolecular reactions.

1.3.2.2.

Cyclopropanation Reactions

Cyclopropanation Reactions with Olefins
In the 2008 paper by Lee et al. where they disclosed the gold(I)-catalysed reaction
of cyclopropenes 76 with alcohols 77 (Scheme 1.16, Section 1.3.2.1, pg 29), they also
described an intermolecular cyclopropanation reaction between styrene and cyclopropene
83 (Scheme 1.27). When cyclopropene 83 was reacted with Ph3PAuNTf2 in the presence
of excess styrene, the cyclopropene underwent ring-opening with the gold to form the
gold-carbene intermediate 115. Cyclopropanation between intermediate 115 and styrene
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then gave alkenyl cyclopropane 116 (72%) as a 6:1 cis/trans diastereomeric mixture as
well as a 1.6:1 mixture of the Z/E isomers.[86, 89a]

Scheme 1.27. Gold(I)-catalysed cyclopropanation of styrene by cyclopropene 116

An intermolecular cyclopropanation reaction between an olefin and a
cyclopropene derivative was also performed in the 2009 study by Toste et al. In this study,
cyclopropenone acetal 65 was subjected to a gold(I)-catalyst in the presence of an olefin
and it was observed than no cyclopropanation product 117 was formed (Scheme 1.28a)
which was consistent with the computational results discussed in Section 1.3.1.1. When
cyclopropenone acetal 118 was subjected to a gold(I)-catalyst in the presence of (Z)stilbene, cyclopropanation occurred to give product 120 (Scheme 1.28b). The outcome of

Scheme 1.28. Gold(I)-catalysed cyclopropanation of olefins by cyclopropenes
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the reaction varied greatly with the nature of the ligand associated with the gold, but as
expected based on computational results: π-acidic phosphites (favour cation-like
behaviour) gave little to no cyclopropanation product 120; phosphines gave moderate
yields and diastereoselectivities; while the NHC ligand IPr, gave a good yield (80%) and
diastereoselectivity (cis/trans 11:1) of 120 (favour carbene-like behaviour).[28, 86]

Cyclopropanation Reactions with Furans
In 2011, Lee and Hadfield also reported that cyclopropenes could undergo a
gold(I)-catalysed cyclopropanation reaction with furans to form conjugated trienes.
Initially, cyclopropene 85a (R1 = Me, R2 = Bn) and 2-methylfuran were subjected to a
catalyst screen and Echavarren’s catalyst 90 was found to be best for obtaining the desired
trienes 121a and 122a (91% yield, 121:122 2.2:1) (Scheme 1.29a). While the goldcatalysed ring-opening of the cyclopropene was very facile, isomerisation to the desired
products was slow but this could be rectified by adding a crystal of iodine to the reaction
(after 15 mins) and isomerisation was typically complete within 1 h. Other catalysts such
as PtCl2 and [Ru(CO3)Cl2]2 were not as efficient at catalysing the reaction while
Rh2(OAc)4 resulted in a complex mixture of products. It was also discovered that with
Echavarren’s catalyst 90, loadings of 0.01 mol% could be achieved without considerable
impact on yields and reaction times. The substrate scope for other 3,3-disubstituted
cyclopropenes 85 with 2-methylfuran demonstrated that numerous alkyl substituents
could be used to produce 121 and 122 in high yields (82-91%) with diastereoselectivities
of 121:122 ranging from 1.5:1 to >95:5 (Scheme 1.29a). Pleasingly, phenyl or ester
groups at the C3 position, gave the triene products in good yields (64% and 75%) with
excellent diastereoselectivities (>95:5) rather than the cyclopropenes undergoing an
intramolecular cyclisation (vide infra, Section 1.3.3).[86, 96]
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Scheme 1.29. Gold(I)-catalysed cyclopropanation reactions of furans by cyclopropenes

Cyclopropenes bearing substituents at C1 and C2 with an ester moiety at C3, were
also reacted with 2-methylfuran (Scheme 1.29b). When R3 = Ph, cyclopropene 123 and
2-methylfuran (1.5 equiv.) generated (E,E,E)-triene 124 (77%) with excellent selectivity
(E/Z >95:5) although harsher conditions (80 °C) were required to push the reaction. When
R3 = nPr, cyclopropene 125 could still be converted selectively (E/Z > 95:5) to the desired
triene 126 under milder conditions; however, 12 equiv. of 2-methylfuran were required
and the yield of 126 was reduced to 37% due to the competing formation of diene 127
(Scheme 1.29b). Successful conversion of cyclopropenes bearing carboxylate groups,
into the conjugated trienes was particularly beneficial, as it meant that handles were
available at both ends of the triene for further functionalisation. The substrate scope also
investigated different furans 128 with 3-tert-butyl-3-methylcyclopropene under the
standard gold(I)-catalyst/iodine conditions (Scheme 1.29c). An unsubstituted, as well as
various mono- and disubstituted furans bearing alkyl substituents, were tolerated giving
triene 129 in yields of 61-89%. An electron-withdrawing ester group in the R5 position
also gave triene 129 in 75% yield (1 equiv. furan). Trisubstituted furans however, did not
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react effectively under the gold(I)-catalysis conditions and a complex mixture of products
were obtained.[86, 96]
Mechanistically, gold activates cyclopropene 130 towards ring-opening, thus
generating intermediates 131 and 132 (Scheme 1.30). Assuming carbene reactivity, a
cyclopropanation reaction occurs between intermediate 131 and furan 128, to give
intermediate 133 by path 1. Ring-opening of intermediate 133 occurs to generate a
mixture of trienes 135 which can isomerise to the more thermodynamically stable
products observed in Scheme 1.29 (pg 44). Alternatively, if carbocationic reactivity is
displayed, furan 128 can attack intermediate 132 as a nucleophile to give intermediate
134 by path 2. Ring-opening of 134 and protodeauration then forms the trienes.[86, 96]

Scheme 1.30. Mechanism for the intermolecular gold(I)-catalysed formations of conjugated trienes

The gold-catalysed reactions of cyclopropenes discussed thus far have all been
examples where gold has reacted preferentially with the π-bond of the cyclopropene. The
substitution around the ring can be altered however, to make the cyclopropene less
aurophilic so that other π-bonds may be preferentially activated by the cationic gold
species. An intermolecular example of this will be discussed in the following section.
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1.3.2.3.

Ring-Expanding Spiroannulation of Cyclopropenones

In 2014, Matsuda and Sakuri described a gold(I)-catalysed ring-expanding
spiroannulation reaction between cyclopropenones 136 and enynes 137 to produce
spirocyclic cyclopentenones 138 (Scheme 1.31). This is a special case given the different
reactivity of cyclopropenones compared with typical cyclopropenes, as cyclopropenones
are polarised due to the presence of the carbonyl group and are also aromatic.
Optimisation of the conditions showed that IPrAuNTf2 was best for catalysing the
reaction. From the substrate scope, the X position of enyne 137 tolerated oxygen,
–C(CO2Me)2 and various N-protected groups, as well as Me, Cy and Ph groups in the R3
position to give 138 in yields of 53-91%. Only a phenyl protected nitrogen in the X
position gave low yield (11%). Symmetrical cyclopropenones 136 bearing aryl rings with
EDGs in the para-position as well as propyl groups, gave 138 in yields of 85-97%. An
asymmetrical cyclopropenone (R1 = Me, R2 = Ph), also regioselectively formed the
spirocyclic cyclopentenone 138 in 85% yield.[97]

Scheme 1.31. Gold(I)-catalysed ring-expanding spiroannulation of cyclopropenones 136 with enynes 137

A mechanism for the above reaction has been proposed in Scheme 1.32. As
mentioned above, instead of activating the cyclopropene, the gold(I)-catalyst activates the
triple bond of enyne 139 and a 5-exo-dig cyclisation occurs to give intermediate 140
which can undergo a cyclisation reaction to generate the (cyclopropylcarbene)gold(I)
species 141. The carbonyl group of cyclopropenone 136 then causes the cyclopropane
ring in 141 to open which forms the oxocarbenium ion intermediate 142. The
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alkenylgold(I) moiety of 142 can then attack the carbonyl carbon to form the gold carbene
species 143. Ring-expansion of the spirocyclopropene moiety by migration of the sp 2
carbon onto the α-carbon to the gold centre forms the tricyclic oxocarbenium intermediate
144. Hydrolysis of 144 then liberates the final product 138. Chemical transformations of
the spirocyclic cyclopentenones 138 were also performed; however, the results will not
be discussed in this introduction.[97]

Scheme 1.32. Mechanistic proposal for the gold(I)-catalysed spiroannulation of enynes 139 with
cyclopropenones 136

Having reviewed the intermolecular examples of gold-catalysed reactions of
cyclopropenes, it was evident that various products could be obtained in high yields and
selectivities that may have important applications as building blocks in organic synthesis
or in the pharmaceutical industry. Another advantage of intermolecular reactions is that
the starting materials are often obtained in fewer synthetic steps. However, a major issue
with intermolecular reactions is that they are entropically disfavoured as two molecules
(usually a gold carbenoid and nucleophile) must come together before they can react. This
is especially problematic for gold-catalysed reactions of cyclopropenes, given the facile
generation and high reactivity of the gold carbenoids and as seen above, often requires
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large excesses of one reactant over the other for the desired reaction to be achieved. From
this standpoint, intramolecular gold-catalysed reactions of cyclopropenes are in many
ways superior (although multi-step synthesis is usually required) and can result in the
formation of useful cyclic products which will be discussed in the following sections.

1.3.3. Gold-Catalysed Intramolecular Reactions of Cyclopropenes
1.3.3.1.

Friedel–Crafts Reactions

In 2008, Shi and Zhu were the first to perform a gold-catalysed intramolecular
reaction with cyclopropenes. With optimisation, Shi and Zhu found that arylvinylcyclopropene 145 (Ar = Ph, R1 = H, R2 = R3 = Me) could be selectively converted to
indene 146 in 97% yield using the catalyst system Ph3PAuCl/AgOTf (AgSbF6 and AgBF4
were also effective) with diazabicyclo[5.4.0]undec-7-ene (DBU) as an additive (Scheme
1.33). Prior to optimisation, the indene regioisomer 147 was also obtained as a minor
product from the reaction. Electrophilic AuL+ was confirmed to be the active catalyst as
other Lewis acids, Brønsted acids and Ph3PAuCl in the absence of AgOTf, failed to
catalyse the reaction. An investigation into the scope of the reaction demonstrated that
spiro- groups at the C3 position of the cyclopropene and substrates bearing EDGs and
EWGs on the aryl rings, all resulted in excellent yields of indene 146 (85% to >99%).
However, AgSbF6 had to be used for the substrates bearing aryl rings with EWGs. It was
found that the reaction only proceeded cleanly to 146 when the C3 position of the
cyclopropene was disubstituted as mono- or unsubstituted examples resulted in a mixture
of products due to the reduced stabilisation of the carbocation at C3 position.[98]
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Scheme 1.33. Gold(I)-catalysed intramolecular cycloisomerisation of arylvinylcyclopropene 145

A plausible mechanism for the formation of the major product 146 was proposed
to proceed by activation of the cyclopropene π-bond by gold, to generate the gold
carbenoid 148 by preferential cleavage of the C2–C3 bond (Scheme 1.34). A Friedel–
Crafts reaction and protodeauration would then generate indene 146. In contrast,
activation of the cyclopropene π-bond and cleavage of C1–C3 would instead generate the
gold carbenoid 149 and a Friedel–Crafts reaction would instead produce the minor
product 147. Shi and Zhu proposed that addition of DBU improved the chemoselectivity
for 146 by weakly coordinating to the gold and affecting its activity. [98]

Scheme 1.34. Mechanistic proposals for the gold-catalysed formation of indenes 146 and 147

In a separate but related study by Wang et al. in 2009, it was reported that indenes
152 could be obtained from 1,2,3-triphenylcyclopropenes 150 by a Friedel–Crafts
cyclisation between the gold carbenoid 151 and the phenyl ring attached to the C3 position
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(Scheme 1.35). The reaction proceeded efficiently using Ph3PAuCl/AgOTf and the R
group could be H, Ph, Me, nBu or –(CH2)3Ph (97-99%).[99] The R group could also be a
phenylethynyl group however, the yield of indene 152 dropped (54%) and an unknown
by-product was obtained most likely because the alkyne competed with the cyclopropene
for coordination with the gold.[86, 99]

Scheme 1.35. Gold(I)-catalysed Friedel–Crafts cyclisation of triphenylcyclopropenes 150

For the above reaction (Scheme 1.35), chemoselective ring-opening of the
cyclopropene was not an issue as the substituents attached to the π-bond were chemically
equivalent, hence indene 152 was obtained as a single regioisomer. Therefore, Wang et
al. also investigated the gold(I)-catalysed Friedel–Crafts cyclisation of 3-arylcyclopropenes 153 bearing a protected hydroxymethyl group at the C3 position (Scheme 1.36).
Ring-opening of 153 occurred regioselectively via the secondary cyclopropyl
intermediate 154 to generate the gold carbenoid 155. A Friedel–Crafts reaction followed
by protodeauration generates indene 156 which can eliminate acetic acid (assisted by
DBU) to generate the final conjugated indene 157. The optimum conditions were
determined to be Ph3PAuCl/AgOTf (1 mol%) in DCM at rt for 1 min followed by the
addition of DBU. It was found that the choice of protecting group was important (free
OH, TMS, MOM and C(=NH)CCl gave poor yields). Other metal catalysts (CuI, PtCl 2,
Rh2(OAc)4, Rh2(pfb)4, AuCl3) and the Brønsted acid TfOH, were ineffective at catalysing
the reaction. Using the optimised conditions, indenes 157 could be synthesised with
various EDGs and EWGs in the X and R positions (38-92%).[99]
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Scheme 1.36. Gold(I)-catalysed Friedel–Crafts cyclisation of 3-arylcyclopropenes 153 to indenes 157

1.3.3.2.

Friedel–Crafts Reactions in Competition with Nucleophilic Addition with
Carbonyl Groups

While a phenyl group at the C3 position of the cyclopropene results in a Friedel–
Crafts reaction to produce indenes, the carbonyl group of esters can also react with the
gold carbenoid generated from the ring-opening of cyclopropenes. This was demonstrated
by Lee et al. who determined that 3-arylcyclopropen-2-yl carboxylates 158 could undergo
competitive gold(I)-catalysed pathways to form inseparable regioisomeric mixtures of
indenes 164 and 165 and furanones 166. The reactions were performed with
Ph3PAuCl/AgOTf (10 mol%) and typically in DCM at 20 °C (reaction with cyclopropene
158a was performed in toluene at 80 °C). The indenes could be generated by a similar
mechanism to that in Scheme 1.36; however, chemoselective ring-opening did not occur
and cleavage of the C2–C3 bond resulted in indene 164 while cleavage of C1–C3 resulted
in indene 165 (Scheme 1.37). Formation of the furanones 166 occurred by electrophilic
activation of the cyclopropene and ring-opening by cleavage of the C1–C3 bond to form
the gold carbene 161. Nucleophilic attack from the carbonyl group on C1 to generated
intermediate 162 followed by protodeauration and hydrolysis then generates the observed
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furanone 166. Cyclopropenes 158a-e bearing various substituents in the R position were
reacted under the gold(I)-catalysis conditions to generate indenes 164 and 165 in yields
of 18-39% and furanones 166 in 35-53% yields. When R = TMS, the final products
underwent protodesilylation to generate the same indene and furanone products obtained
when R = H.[89a]

Scheme 1.37. Competitive gold(I)-catalysed reactions of 3-arylcyclopropen-2-yl carboxylates 158

To better understand the observed experimental results, Lee and Macgregor
performed DFT calculations to explain: 1) why butenolides 166 were formed
preferentially over indenes 164; 2) why only a single regioisomer of butenolides 166 were
observed. For the cyclopropene 158a seen in Scheme 1.37, it was determined that binding
of the gold to the cyclopropene occurred preferentially through the carbonyl oxygen and
C1 (167B) rather than through both C1 and C2 (167I) (Scheme 1.38). Thus the more
favourable ring-opening pathway proceeds via TS(167-168)B to give the more stable gold
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carbenoid 168B at -13.2 kcal/mol. The conformation of 168B places the ester group in the
cis position to the gold centre and allows the carbonyl group to attack at the Cα position,
which ultimately results in butenolide 166a seen in Scheme 1.37. The barrier for this
nucleophilic attack was 5.9 kcal/mol and the intermediate 169B was very stable
(E = -35.7 kcal/mol). In comparison, intermediate 169I that results in indene 164a in
Scheme 1.36 (pg 51), is 9.7 kcal/mol less stable than 169B (Scheme 1.38). These
computational results therefore explain why butenolide 166a is the major product (52%)
as it is more accessible thermodynamically and kinetically compared to the minor indene
product 164a (20%).[100]

Scheme 1.38. DFT calculation profiles (kcal/mol) for the rearrangement of cyclopropene 167 with AuPPh3+

Using cyclopropene 158c from Scheme 1.37 (pg 52) as a model, Lee and
Macgregor also endeavoured to explain why only butenolide 166c was observed and not
butenolide 173 (Scheme 1.39). DFT calculations demonstrated that there was not much
difference in the energies of the gold bound reactants, 170Ph(O) (most stable) and
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170Ph(C) (energy difference +0.5 kcal/mol). The ring-opened gold carbenoid
intermediates 171Phα and 171Phβ were calculated to form from 170Ph(O) via TS(170171)Phα and 170Ph(C) via TS(170-171)Phβ, respectively. Therefore, the observed
butenolide 166c is obtained from 170Ph(C). Looking at intermediate 171Phβ, the ester
moiety is in the correct configuration to attack the Cα position. While intermediate 171Phα
has the lower energy due to greater stabilisation of the electrophilic charge, ring-opening
to form 171Phβ has the lower energy barrier (+7.3 kcal/mol compared to 17.1 kcal/mol),
thus 171Phβ is more kinetically favoured. It was determined that nucleophilic attack of the
carbonyl group at the Cα position was less accessible for 171Phβ with TS(171-172)Phβ
having an energy of +8.4 kcal/mol (TS(171-172)Phα, E = -3.3 kcal/mol) but intermediate
172Phβ was calculated to be 11.7 kcal/mol more stable compared to 172Phα. Therefore, it
was established that butenolide 166c formed over 173 due to kinetic selectivity in the
rearrangement process while a thermodynamic preference for the butenolide precursor
172Phβ, further favoured the pathway. Comparing the calculations in Scheme 1.38 to
those in Scheme 1.39, because the rearrangement of cyclopropene 158c to butenolide

Scheme 1.39. DFT calculations (kcal/mol) for the rearrangement of cyclopropene 170 with AuPPh3+

54

166c had a lower energy barrier (8.4 kcal/mol) compared to the rearrangement of
cyclopropene 158a to butenolide 166a (12.0 kcal/mol), it explained why the former
rearrangement could be proceed under milder conditions experimentally. [100]
Referring back to Scheme 1.37 (pg 52), indenes 164c and 165c had also been
formed in 18% yield (164:165 = 1:1) compared to the 53% yield of butenolide 166c. The
energy barrier for the indene formation was calculated to be 9.8 kcal/mol, thus the
pathway leading to butenolide 166c should (and was) favoured. Lee and Macgregor also
performed some more generalised calculations to determine how different substituents on
the cyclopropene might influence the selectivity of the rearrangements; however, these
results will not be discussed.[100]

1.3.3.3.

Ring-Preservation Reactions

In contrast to all the other reactions presented in this review, some gold-catalysed
reactions of cyclopropenes result in ring-preservation rather than ring-opening which is
largely dependent on having an EWG at the C3 position of the cyclopropene. This was
first demonstrated in 2015, by Shi and Tang who published an investigation into the
synthesis of spiroazepino[4,5-b]indoles 176 by the gold(I)-catalysed intramolecular
cyclisation of indolylcyclopropenes 174 (Scheme 1.40). Optimisation of the reaction
demonstrated that the cationic gold(I) complex 175 was best for the formation of 176.
During investigations into the scope of the reaction, it was discovered that Bs-, Ns- and
Ts-protected nitrogens were tolerated in the X position; however, a gem-diester linker
resulted in a complex mixture of products. A variety of EDGs (Me, OMe) and EWGs (Br,
Cl, F) were tolerated in the 5, 6 and 7 positions of the indole scaffold and both benzyl and
alkyl groups were permitted at R2. An attempt was also made to extend the chain between
the indole and the X linker by one carbon; however, the reaction was not successful.
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Overall derivatives of 176 could be synthesised in yields of 43-68% which was an
excellent result given the high degree of molecular complexity achieved in one step. [101]

Scheme 1.40. Gold(I)-catalysed intramolecular cyclisation of indolylcyclopropenes 174

To gain a better understanding of the reaction mechanism, deuterium labelling
experiments were performed with indolylcyclopropenes [D]-174a and [D]-174a’
(Scheme 1.41). The first reaction performed was with [D]-174a (95% D content) which
reacted with the gold(I)-catalyst to afford [D]-176aa (94% D content) stereospecifically
in 68% yield where the D atom was trans to the ester moiety (Scheme 1.41a). The reaction
of [D]-174a’ (99% D content) however, produced [D]-176ab in 24% yield (67% D
content) where the D atom was cis to the ester moiety (Scheme 1.41b). The results
suggested that gold induced electrophilic activation of the cyclopropene double bond
from the same side as the ester moiety. Therefore nucleophilic attack had to occur from
the opposite side (anti addition).[101]

Scheme 1.41. Deuterium-labelling experiments for the gold(I)-catalysed cyclisation of [D]-174
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Based on the results of the deuterium-labelling experiments, the authors proposed
a plausible reaction mechanism shown in Scheme 1.42. The gold(I)-catalyst coordinates
with both the carbonyl group of the ester and the double bond of the cyclopropene moiety
in indolylcyclopropene [D]-177a, which activates the cyclopropene. A Friedel–Crafts
reaction at the C2 position of the indole moiety (anti addition) then generates intermediate
178 which can subsequently undergo rearomatisation and protodeauration to generate the
final product [D]-176aa. [101]

Scheme 1.42. Mechanistic proposal for the gold(I)-catalysed formation of spiroazepino[4,5-b]indoles 176

In 2016, Tang and Shi also published an investigation into the gold(I)-catalysed
cycloisomerisation of cyclopropenyl propargylic esters 179 to 5-azaspiro[2.5]oct-7-enes
180 when R3 is not a hydrogen (Scheme 1.43). From the investigation into the scope of
the reaction, it was determined that aromatic groups bearing EWGs (F and Br) and EDGs
(3,5-di-methyl) at R3 were well tolerated as were alkyl substituents (54-90%). Methyl and
cycloalkyl groups at the R1 positions gave a single isomer; however, longer alkyl chains
gave 1:1 mixtures of the E and Z geometric isomers (53-97%). In the X position, NTs,
NBs and NNs all reacted smoothly as did Ac and Piv groups at R2 (up to 99%). A substrate
bearing an oxygen atom in the X position and a tBu group in the R4 position also reacted
under the conditions to give 180, albeit in a lower yield (47%).[102]
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Scheme 1.43. Gold(I)-catalysed cycloisomerisation of cyclopropenyl propargylic esters 179

To assist in proposing a plausible reaction mechanism, a deuterium-labelling
experiment with [D]-179a (99% D content) was performed that under the gold(I)catalysed conditions, resulted in [D]-180a (52%) with 99% D incorporation at the phenylsubstituted carbon (Scheme 1.44a). The D atom in this case was trans to the ester moiety
and indicated that syn-addition during the cyclisation had occurred. Based on this
information it was proposed that the gold activated the alkyne group of [D]-181a to
catalyse a [3,3]-sigmatropic rearrangement to produce the carboxyallene intermediate 182
(Scheme 1.44b). Two plausible pathways were then suggested. Path 1 involved activation
of the allene in 182 by the gold to give intermediate 183 which could then undergo synaddition of the C–Au bond to the cyclopropene moiety to form the cyclopropyl gold
intermediate 184. Alternatively, by path 2, gold could instead active the π-bond of the
cyclopropene in 182, to result in the cationic cyclopropane intermediate 185. The
stereochemistry by this pathway was rationalised by the gold catalyst coordinating on the
opposite face to the ester due to unfavourable steric interactions between the phosphine
ligand on the gold and the ester group (thus forces the phenyl and ester groups on the
same face). Nucleophilic attack by the allene would then also generate intermediate 184.
Protodeauration of 184 would then liberate the final product [D]-180a.[102]

58

Scheme 1.44. Deuterium-labelling experiments (a); Proposed mechanism for the gold(I)-catalysed
cycloisomerisation of cyclopropenyl propargylic ester [D]-181a (b)

The literature reviewed thus far has demonstrated the broad range of inter- and
intramolecular reactions that are accessible when cyclopropenes are reacted with gold
catalysts. However, the reactions of greater pertinence to this thesis are those published
by Hyland and Ariafard;[75b, 103] Meyer and Cossy;[104] and Wang and Li.[105] These studies
all utilised the cyclopropenyl carbinol derivatives discussed in Scheme 1.12 and Scheme
1.13. Specifically, Hyland and Ariafard and Meyer and Cossy employed cyclopropenyl
carbinols such as 39 (Scheme 1.12, Section 1.2.2.4, pg 21) where substitution by the
carbinol moiety occurred in the C1 position of the cyclopropene ring. In contrast, Wang
and Li employed cyclopropenyl carbinol derivatives such as 57 (Scheme 1.13, Section
1.2.2.4, pg 22) where substitution by the carbinol moiety occurred at the C3 position of
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the cyclopropene ring. Given that the carbinol unit for both substrates 39 and 57 serve as
a tethering point for reactive groups to the molecule, many interesting products can be
obtained from the gold-catalysed rearrangement of these highly strained compounds and
some of these will be discussed in the following sections.

1.3.3.4.

Rearrangement of Cyclopropenylmethyl Acetates

In 2010, Hyland and Ariafard performed experimental and theoretical
investigations on gold(I)-catalysed rearrangements of cyclopropenylmethyl acetates 186
(Scheme 1.45) that had been obtained from cyclopropenyl carbinols 39 (Scheme 1.12).
Under the optimised conditions (5mol% Ph3PAuNTf2, DCM, –50 °C), cyclopropenylmethyl acetates 186, where R was various aryl rings bearing EWGs, were converted to Zacetoxy dienes 187 in excellent yields (80-99%) and high diastereoselectivities (Z:E 10:1
to 41:1) as the low temperatures favoured Z-selectivity. However, the diastereoselectivity
was significantly reduced (Z:E 1.8:1) when R was a –(CH2)10CH3 group (80%). The only
R substituent not tolerated was a -pMeC6H4 group which resulted in decomposition.[75b]

Scheme 1.45. Gold(I)-catalysed rearrangement of cyclopropenylmethyl acetates 186 to Z-acetoxy dienes
187

Mechanistically, the π-bond of cyclopropene 186 becomes activated and
chemoselective ring-opening by cleavage of C1–C3 bond occurs to form the goldstabilised allylic cation 188 (Scheme 1.46).[75b] Chemoselective ring-opening was
supported by a follow-up computational study by Hyland and Ariafard, which reported
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that having a strong π-donating substituent (i.e. methyl group) in the C2 position promoted
gold(I)-induced polarization of the cyclopropene double bond towards C1, thus
facilitating the preferential cleavage of C1–C3.[103] Intermediate 188 can then undergo a
1,2-acetate transfer which can progress by two possible 5-membered ring transition states
TS(186-187)Z and TS(186-187)E. If the reaction progressed via TS(186-187)Z then Zacetoxy diene (Z)-187 was obtained while TS(186-187)E resulted in the E-acetoxy diene
(E)-187. DFT calculations revealed that for steric reasons, the reaction prefers to progress
through TS(186-187)Z. The calculations also revealed that the difference in energy barrier
for when R = Ph (5.7 kcal/mol) was much larger than when R = Et (1.6 kcal/mol) and
thus explained the lower Z:E selectivity when R = –(CH2)10CH3.[75b]

Scheme 1.46. Mechanistic proposal for the gold(I)-catalysed rearrangement of cyclopropenylmethyl
acetates 186

1.3.3.5.

Cyclopropanation Reactions

Cyclopropanation Reactions of Alkenes
In 2010, Meyer and Cossy were the first to report an intramolecular
cyclopropanation reaction between an olefin and a gold carbene that had been generated
from a cyclopropene. Cyclopropenylcarbinyl ethers 189 were also prepared from
cyclopropenyl carbinols 39 (Scheme 1.12, Section 1.2.2.4, pg 21), and it was found that
in the presence of gold(I)-catalysts, 189 rearranged to form 3-oxabicyclo[4.1.0] heptanes
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190 (Scheme 1.47). The gem-dimethyl substitution at the C3 position of the cyclopropene
was critical for substrate stability and to avoid geometric isomers. The reaction was most
effectively catalysed by AuCl and the scope of the reaction was investigated with a broad
number of substrates where substituents on the alkene, as well as at R4, were varied.
Yields (93-99%) and diastereoselectivities (>96:4) of 3-oxabicycloheptanes 190 were
excellent

when

α,β-disubstituted

and

α,β,β-trisubstituted

alkenes

were

used

(R4 = –CH2OBn) and lead to the conclusion that the configuration of the alkene could be
retained and that the reaction was stereospecific. However, when an α,α-disubstituted
substrate was investigated, the yield (72%) and dr (87:13) were reduced. The R4 group
was also varied and benzylic ethers tethered by different linear and branched alkyl chains
were investigated which gave the corresponding 3-oxabicycloheptanes 190 in excellent
yields (87-98%) and diastereoselectivities (>96:4). The reaction was proposed to occur
regioselectively by first forming the secondary cyclopropyl cation 191 followed by ringopening to generate the gold carbene 192. Intramolecular cyclopropanation then occurs
with the alkene to generate either 3-oxabicyloheptane 190 or 3-oxabicyloheptane 190’.
The diastereomeric outcome was determined by the conformation of the 6-membered
cyclic transition state. For example, the chair-like transition state TS(189-190’), places
both R4 and the gold centre in axial positions thus resulting in unfavourable steric
interactions and gives the minor diatereoisomer 190’. The twisted-boat transition state
TS(189-190) however, results in less steric interactions between R4 and the gold centre
and thus gives the major diastereoisomer 190. For the α,α-disubstituted cyclopropene
example (R1 = R2 = H, R3 = Me, R4 = –CH2OBn), TS(189-190) can result in unfavourable
steric interactions between R3 and R4 so cyclopropanation can competitively proceed via
TS(189-190’) thus explaining the reduced dr.[72a, 104b]
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Scheme 1.47. Gold(I)-catalysed ring-opening and intramolecular cyclopropanation reactions of
cyclopropenylcarbinyl ethers 189 or cyclopropenyl carbinyl sulfonamides 193

After synthesising 17 examples of 3-oxabicycloheptanes 190, the authors
investigated cyclopropenes 193 where X was an NTs-linker. Gold(I)-catalysed
cycloisomerisation of six examples of cyclopropenyl sulfonamides 193 resulted in 3azabicyclo[4.1.0]heptanes 194 and 194’ in 89-99% yields with diastereoselectivities of
90:10 to >95:5 (Scheme 1.47). Given that reductive cleavage of tosyl groups is often
challenging, N-Boc protected cyclopropene 195 was synthesised and subjected to the
gold(I)-catalysis conditions (Scheme 1.48). The gold(I)-catalysed cycloisomerisation was
slower compared to the NTs susbtrates; however, it was discovered that the Boc group
could be removed in a one-pot manner by adding trifluoroacetic acid (TFA) to obtained
3-azabicycloheptane 196 as a single diastereomer in 83% yield (two steps). This of course
exposes a handle for further functionalisation of the product. [72a, 104b]
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Scheme 1.48. Gold(I)-catalysed intramolecular cyclopropanation and Boc deprotection of cyclopropene
195

The authors also investigated the gold(I)-catalysed cycloisomerisation of 1,6cyclopropene-enes where the hetereatom X, had been removed. Cyclopropene 197 was
subjected to the gold(I)-catalysis conditions to give the expected diastereomeric products
198 and 198’ in 93% yield with a dr = 85:15 (Scheme 1.49a). Epimeric cyclopropene-ene
examples were also synthesised and subjected to the gold(I)-catalysis conditions.
Reaction of the syn cyclopropene substrate 199 gave 82% yield of bicycle[4.1.0]heptanes
200 and 200’ as a diastereomeric mixture (dr = 90:10) (Scheme 1.49b). The relative

Scheme 1.49. Gold(I)-catalysed cycloisomerisations of 1,6-cyclopropene-enes 201-205
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configuration of the two stereocentres was shown not to be affected by the reaction as the
anti cyclopropene substrate 201 also gave good yield (75%) of bicycle[4.1.0]heptanes
202 and 202’ (dr = 91:9) (Scheme 1.49c). A tert-butyldimethylsilyl (TBS) protecting
group was required in these instances as a free hydroxyl group was shown to result in
further isomerisation of the desired products.[104b]
Dimethylvinylsilyl ethers 203 (1,6-cyclopropene-ene systems) could also
successfully undergo the gold(I)-catalysed cycloisomerisation to give 3-oxa-2silabicyclo[4.1.0]heptane 204 as a single diastereoisomer in 88% yield (Scheme 1.50a).
Synthesis of an allyldimethylsilyl ether 205 also allowed Meyer and Cossy to investigate
a 1,7-cyclopropene-ene system which successfully underwent the desired gold(I)catalysed cycloisomerisation to give the corresponding 3-sila-4-oxabicyclo [5.1.0]octane
206 in 66% yield with a dr = 90:10 (Scheme 1.50b). Various chemical transformations
were also performed on bicycles 204 and 206; however, these transformations go beyond
the scope of this review.[104b]

Scheme 1.50. Gold(I)-catalysed cycloisomerisations of dimethylvinylsilyl ether 203 (a); gold(I)-catalysed
cycloisomerisations of allyldimethylsilyl ether 205 (b)
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Different substitution patterns around the cyclopropene ring as well as a
quaternary centre in the α-position to the ether functional group, were also investigated.
When the 2-methyl substituted cyclopropenyl ether 207 was subjected to the reaction
conditions, 3-oxabicyclo[3.1.0]hexanes 208 and 208’ were believed to be obtained in a
ratio of 75:25 and a yield of ~50%, along with other complex side products (Scheme
1.51a). This result re-enforced the importance of gem-dimethyl substitution at the C3
position of the cyclopropene. The 2,3,3-trimethyl substituted analogue 209 was also
subjected to the reaction conditions; however, only a complex mixture of products was
obtained with no evidence of a cyclopropane ring (Scheme 1.51b). Given the substitution
pattern around the ring, 209 resembled that of the substrates used by Hyland and Ariafard
in Scheme 1.45 (Section 1.3.3.4, pg 60), therefore ring-opening would have occurred by
cleavage of the C2–C3 bond (Scheme 1.51b). This would have formed intermediate 210,
which would likely display carbocationic reactivity as opposed to carbenic reactivity thus
a cyclopropanation reaction with the alkene would not be expected to occur. Finally, allyl

Scheme 1.51. Gold(I)-catalysed cycloisomerisation of allyl cyclopropenylcarbinyl ethers 207-211
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cyclopropenyl ether 211 was investigated which gave a very poor diastereomeric ratio of
3-oxabicyclo[4.1.0]heptanes 212 and 212’ of 60:40 in 77% yield (Scheme 1.51c). The
poor dr was likely a reflection of the A1,3 strain energies between isopropylidene and
vinylic methyl substituents and the benzloxymethyl and methyl groups in the twistedboat transition states TS(211-212) and TS(211-212’), respectively.[104b]
After reviewing the investigations by Hyland and Ariafard [75b, 103] and Meyer and
Cossy [104], gaps were identified in the literature that will be discussed in Section 1.4.

Cyclopropanation Reaction of Allenes
Another example of a cyclopropanation reaction with a gold carbene generated
from a cyclopropene was published in the 2016 investigation discussed in Section 1.3.3.3,
by Tang and Shi. They found that cyclopropenyl propargylic esters 213 could undergo a
cycloisomerisation reaction in the presence of a gold(I)-catalyst to form bicycle[4.1.0]heptanes 217 in yields of 41-59% when C2 was substituted with a hydrogen (Scheme
1.52). It was proposed that the mechanism began with activation of the alkyne moiety in
214 by gold, to catalyse a [3,3]-sigmatropic rearrangement to give carboxyallene
intermediate 215. Due to the different substitution pattern around the cyclopropene
moiety, activation of the cyclopropene π-bond in 215 results in ring-opening to generate
the gold carbene intermediate 216. An intramolecular cyclopropanation reaction between
the gold carbene and the allene in 216, followed by protodeauration then furnishes the
final product 217.[102]
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Scheme 1.52. Gold(I)-catalysed cycloisomerisation of cyclopropenyl propargylic esters 213

1.3.3.6.

Cycloisomerisation of Cyclopropene-ynes

It has been demonstrated in this review that cyclopropenes are exceptional
substrates for gold-catalysed reactions and will often be activated preferentially by gold
when other alkenes and allenes are also present. However, it has also been established by
Matsuda and Sakuri (Scheme 1.31, pg 46) and Shi and Tang (Scheme 1.43, pg 58 and
Scheme 1.52) that activation of the cyclopropene π-bond does not usually occur in the
presence of an alkyne, which is instead preferred. This was further demonstrated in 2010
by Wang et al. who described a gold(I)-catalysed cycloisomerisation reaction of
cyclopropene-ynes 218 to phenols 219 (Scheme 1.53a). As mentioned above, these
substrates utilise cyclopropenes where the carbinol group is attached to the C3 position of
the cyclopropene ring. However, in this particular instance, the tethering point of the
carbinol group was not exploited. A catalyst screen demonstrated that Ph3PAuCl/AgOTf
was most efficient at catalysing the reaction. The reaction scope was very broad and 14
examples of phenol 219 were synthesised in good to excellent yields (71-97%) where R3
was either an aryl or an ester group (one benzene example also generated). However,
cyclopropenes 220a (R3 = nC5H11) and 220b (R3 = H) under the gold(I)-catalysis
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conditions, afforded 1:1 mixtures of the phenol regioisomers 221a and 222a in 91% yields
and 221b and 222b in 99% yield, respectively (Scheme 1.53b). This result indicated that
two reaction pathways could operate. Indeed, when cyclopropene-ynes 223 bearing an
n

Bu group and either nBu or a TMS group in the R5 position were reacted, phenols 224

were obtained selectively in 84-93% yields (Scheme 1.53c).[105a]

Scheme 1.53. Gold(I)-catalysed cycloisomerisations of cyclopropene-ynes 218-223

For the formation of the asymmetric phenols 219 and phenols 224, both reactions
require the gold catalyst to chemoselectively activate the alkyne (Scheme 1.54). For the
formation of phenol 219, the electron density of the cyclopropene double bond in 218
attacks the activated alkyne in a 5-endo-dig fashion to form the bicyclo[3.1.0]hexene
intermediate 225 (Scheme 1.54a). Back-donation of electrons from the gold results in the
collapse of the bicycle and ring enlargement to form the 6-membered gold carbene
intermediate 226. The R1 group can then undergo a 1,2-shift to generate the asymmetric
phenol 219, following protodeauration. The formation of the phenol 224 also involved
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formation of intermediate 225, and back donation of electrons from the gold instead
results in the formation of the bicycle[1.1.0]butane intermediate 227 (Scheme 1.54b).
Following the formation of 227, Wang et al. proposed that a Dewar-benzene type
intermediate 230 was formed following 3 consecutive 1,2-alkyl shifts via carbocation
species 228 and 229. Ring-opening of intermediate 230 was suggested to result in the
formation of the 6-membered ring intermediate 231. Phenol 224 could then be produced
by a 1,2-hydrogen shift and protodeauration of intermediate 231. Given the steric
crowding of intermediates 227-230 in Scheme 1.54b, this pathway was anticipated when
less bulky groups such as a hydrogen or an alkyl group were placed on the terminal end
of the alkyne. Likewise, having smaller groups such as nBu groups on the double bond of
the cyclopropene also favour Scheme 1.54b regardless of the group at R3.[86, 105a]

Scheme 1.54. Mechanistic proposals for the formation of asymmetric phenols 219 (a); and phenols 224 (b)

To support the proposed mechanisms for the formation of phenols 219 and 224 in
Scheme 1.54, one of Wang’s collaborators, Li, published a follow up computational study
on the gold(I)-catalysed cycloisomerisation of 1,5-enynes containing cyclopropene rings
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at the PBE1PBE/6-31+G**/SDD level. Li first investigated the ring-enlargement
pathway that resulted in phenol 219 from intermediate 225, and the proposed mechanism
in Scheme 1.54a was found to be valid. However, for the formation of phenol 224, DFT
calculations found that the proposed key intermediate 230 in Scheme 1.54b, was not a
stationary point on the potential energy surface, thus alternative mechanisms had to be
investigated. During the test calculations for the formation of 224, intermediates 232, 233,
234 and 235 were located and a revised reaction mechanism was proposed which is shown
in Scheme 1.55. This pathway suggests that 232 undergoes a 1,3-cationic alkylidene
migration whereby the C5–C6 bond is broken to establish a bond between C2 and C5
(shown in green), thus giving 233. For this to occur the π-electrons from the C1=C2 bond,
attack the cationic center at C5 and the bond between C5 and C6 simultaneously breaks to
form C1=C6 (shown in black). This reaction occurred readily with an energy barrier of
only 1.5 kcal/mol. Intermediate 233 then undergoes another 1,3-cationic alkylidene
migration where the π-electrons from the C1=C6 bond attack the cation at C5 thus causing
the C4–C5 bond to break to establish C4=C6 (shown in black). Overall a bond is formed
between C1 and C5 (shown in green) to generate 234. The barrier between 233 and the
transition state to 234 was 12.3 kcal/mol and was the largest energy barrier calculated for
the reaction, thus an experimental time frame of 5 mins was deemed reasonable.
Intermediate 234 can then undergo ring-enlargement to form 235 which following a 1,2hydrogen migration can afford the final product 224. DFT calculations also confirmed
that product distribution for phenol 219 vs. 224 was primarily controlled by the electronic
effects of the substituents with computational results being in good agreement with the
experimental results.[105b]
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Scheme 1.55. Revised mechanistic proposal for the formation of phenol 224

Wang et al. also performed other gold(I)-catalysed isomerisation reactions to
further probe the substituent effects governing the chemoselective activation of the alkyne
over the cyclopropene double bond. It was found that when cyclopropenyl carbinols 236
lacking an alkyne group (i.e. R1 = H, Ph or alkene) were subjected to gold, no reactions
took place suggesting that the cyclopropene had a low reactivity towards the gold
complex (Scheme 1.56a). Cyclopropenes 237 (1,6-enyne system) and 241 (1,7-enyne
system) both experienced preferential activation of the alkyne over the double bond. For
237, gold-catalysed activation of the alkyne followed by nucleophilic attack by the
cyclopropene in a 5-exo-dig fashion, was proposed to generate 238. Back-donation from
the gold and ring-opening of 238 resulted in 239 which could undergo a Friedel–Crafts
cyclisation to form indenes 240a and 240b (Scheme 1.56b). Via a similar mechanism,
cyclopropenyl sulfonamide 241 could also be reacted with JohnPhosAuSbF6 to catalyse
a 1,6-exo-dig attack, resulting in the tricyclic nitrogen heterocycle 242 (Scheme 1.56c).
In contrast, cyclopropenyl sulfonamides 243a bearing a pendant alkene, and 243b bearing
a pendant allene, were also reacted with JohnPhosAuSbF6 to form the indene derivatives
245a and 245b, respectively (Scheme 1.56d). Interestingly, the alkene and the allene had
remained intact and the mechanism was instead proposed to proceed by ring-opening of
the cyclopropene moiety to form the gold carbenoid 244 which could undergo a Friedel–
Crafts cyclisation to afford the final products. Based on the collective results it was
concluded that alkyne groups are more effectively activated by gold compared to alkenes
and allenes and in this particular example, cyclopropenes.[86, 105a]
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Scheme 1.56. Gold(I)-catalysed cycloisomerisations of cyclopropenes

After reviewing the investigations of Wang and Li[105] another gap was identified
in the literature. While Wang et al. had introduced a reactive alkyne moiety by ultilising
the carbinol unit as a tethering point to the cyclopropene moiety, no reports claimed to
have investigated cyclopropenes with other reactivity groups such as aromatic
heterocycles. This gap will be elaborated upon in Section 1.4.
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1.4.

Research Proposal and Project Aims
Based on the literature discussed in this introduction it is evident that gold can

react with cyclopropenes to catalyse many versatile reactions. However, research
investigating gold-catalysed reactions of cyclopropenes, especially the cyclopropenyl
carbinol scaffolds, is significantly underdeveloped compared with other gold-catalysed
reactions of alkynes, alkenes and allenes. This is despite the fact that the synthesis of
cyclopropene substrates are often more facile and require fewer synthetic steps compared
with substrates containing these other π-bonds.
Project 1
Hyland, Ariafard, Meyer and Cossy had utilised cyclopropenyl carbinols (carbinol
unit attached to C1 of the cyclopropene ring) in their investigations and the derivatisation
and subsequent gold-catalysed rearrangement of these substrates had provided different
products in high yields and diastereoselectivities. However, after comparisons between
these investigations, two gaps in the literature were identified. The first gap was that no
gold-catalysed reactions had been reported using 2,3,3-trimethylcyclopropenyl carbinol
derivatives bearing a tethered alkene and a stabilising aryl ring. Indeed, unpublished
preliminary results by the Hyland group had demonstrated that when subjected to
Ph3PAuNTf2, cyclopropenyl allyl ether 246 could undergo ring-opening and a hydrogen
elimination to obtain the proposed intermediate 248 (Scheme 1.57a). Immediate
subjection of 248 to toluene and refluxing conditions then generated the dienyl ketone
249 by a Claisen rearrangement in 55% yield over the two steps. [106] The dienyl ketone
product possessed numerous handles for further functionalisation and it was anticipated
that other interesting products might have been accessible. The second gap in the literature
was that there were no reports on the synthesis and gold-catalysed rearrangement of 2,3,374

trimethyl cyclopropenyl propargyl ethers 250 (Scheme 1.57b). The proposed substrate
250 contains two regions of π-density that gold could coordinate with and even though
prior literature would suggest that the alkyne should be preferentially activated,
determining the actual outcome was an intriguing prospect.

Scheme 1.57. Gold(I)-catalysed reactions of cyclopropenes 246 and 250 identified as gaps in the literature

Therefore, for the first part of this project, the aims were to: 1a) optimise the
reaction of cyclopropenyl allyl ether 246 to dienyl ketone 249; 2a) investigate possible
chemical transformations of dienyl ketone 249; 3a) if the subsequent products obtained
in aim 2 where interesting/important, perform a full reaction optimisation and substrate
scope. The aims for the second part of this project were then to: 1b) investigate and
identify the product(s) obtained from the gold-catalysed rearrangement of cyclopropenyl
propargyl ether 250 and propose plausible mechanisms; 2b) perform an optimisation of
the reaction conditions and; 3) perform a substrate scope if aims 1b and 2b are successful.
The results of this project are provided and discussed in chapter 2 of this thesis and is
titled: “Gold(I)-Catalysed Reactions of Cyclopropenylcarbinol Ethers to Form Highly
Substituted Heterocycles”.
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Project 2
The second gap in the literature this thesis aimed to target was related to the work
by Wang and Li. They had utilised cyclopropenyl carbinols derived from cyclopropenyl
carboxylates (carbinol unit attached to C3 of the cyclopropene ring) which as described
in Section 1.2.2.2, can be easily synthesised by a [2 + 1] cycloaddition of an alkyne and
a diazocompound in the presence of a catalyst. They then subsequently functionalised
these cyclopropenyl carbinols to form various substrates containing alkyne, phenyl,
alkene and allene moieties. It was noticed however, that no heteroaromatic systems such
as furans, thiophenes, pyrroles or indoles had been used to functionalise these
cyclopropenyl carbinols. Indeed, Shi and Tang had performed intramolecular goldcatalysed reactions of cyclopropenes tethered to indoles (Scheme 1.40, Section 1.3.3,3,
pg 56). However, in this instance tethering of the indole was to the double bond of the
cyclopropene rather than the C3 position, and the substitution of the cyclopropene moiety
meant that the gold did not catalyse ring-opening (ring-preservation was observed). It was
envisaged that cyclopropenes 251 such as those in Scheme 1.58, would be ring-opened
by a gold catalyst to form a gold carbenoid intermediate 252, which should undergo an
intramolecular cycloisomerisation reaction with a tethered heteroaromatic moiety,
ultimately leading to a heterocyclic skeleton.

Scheme 1.58. Proposed synthetic targets for this thesis
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Therefore, the aims for this second project were to: 1) synthesise a derivative of
cyclopropene 251 bearing a tethered furan moiety as the heteroaromatic group 2) subject
this cyclopropene–furan system to gold-catalysis conditions and evaluate the product(s)
obtained and propose reasonable mechanisms; 3) perform an optimisation of the reaction
conditions; 4) perform a screen of other heteroaromatics tethered to the cyclopropene
including thiophenes, pyrroles, indoles, benzothiphenes and benzofurans; 5) perform a
substrate scope(s) if aims 1-4 are successful; and 6) perform chemical transformations on
the products obtained from the gold-catalysed reaction. The results of this project are
provided and discussed in chapter 3 of this thesis and is titled: “Gold(I)-Catalysed
Cyclisation Reactions of Cyclopropenyl Sulfonamides Bearing Tethered Heteroaromatic
Systems”.
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2. Chapter 2. Gold(I)-Catalysed Reactions of Cyclopropenylcarbinol Ethers to Form Highly Substituted Heterocycles
2.1.

Background

on

Substituted

5-Membered,

Oxygen-Containing

Heterocycles
Substituted tetrahydrofurans are commonly occurring structural motifs in a range
of natural products and biologically active molecules (Figure 2.1).[107] For example,
tetrahydrofuran moieties occur in annonaceous acetogenins (ACGs) which are a large
family of natural products that have exhibited antiparasitic, anticancer, antimicrobial,
pesticidal and immunosuppressive activities.[108] Therefore, ACGs have potential
applications in both the pharmaceutical and agricultural industries. Tetrahydrofurans also
occur in a range of other natural products such as polyether ionophores (i.e. lasalocid A),
macrolides (i.e. paramycin) and lignans (i.e. machilin G) which exhibit a broad range of
biological activities including antimicrobial, antitumour, antimalarial, antiprotozoal and
antihelmic. [107, 109]

Figure 2.1. Examples of tetrahydrofurans in natural products
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As can be seen from the example structures in Figure 2.1, natural products
containing tetrahydrofurans often have stereodefined centres around the ring. Due to the
importance of these structural units, an extensive amount of effort has been devoted to
developing stereoselective methods for the synthesis of polysubstituted tetrahydrofurans.[107] For example, Johnson has performed numerous studies on [3 + 2]
cycloadditions of donor–acceptor (D–A) cyclopropanes 300 and aldehydes 301, to form
tetrahydrofurans 302 diastereoselectively (Scheme 2.1a). The D–A cyclopropanes 300
could be racemic or enantiomerically enriched, and catalysts such as Lewis acids (i.e.
Sn(OTf2), SnCl4, AlCl3 or MgI2) and transition-metals (i.e. Pd(0)) were successful in the
reaction.[110] For some examples (not shown in Scheme 2.1a), the D–A cyclopropane was
fused to another ring system; however, reasonable diastereoselectivities were still
achieved in these instances.[110g,

111]

Another interesting synthesis of polysubstituted

tetrahydrofurans was published by Lin and Feng in 2016, and involved a nickel-catalysed
[3 + 2] cycloaddition of hetero-substituted alkenes 304 with oxiranes 303 (Scheme 2.1b).
The reaction gave the cis-tetrahydrofurans 305 in good to excellent yields (66-99%) and
ee (86-99%) with the dr (cis/trans) ranging from 73/27 to 92/8.[112] Another common
method for the stereoselective preparation of polysubstituted tetrahydrofurans is to
perform nucleophilic addition reactions with cyclic oxonium ions derived from γ-lactols
or acetoxy-tetrahydrofurans. Organometallic reagents (i.e. Zn, Al, Sn),[113] allyl or
propargyl silanes,[114] Grignard reagents[115] and titanium enolates[116] have all been
documented to be effective nucleophiles in this reaction. A representative example is
shown in Scheme 2.1c, where commercially available 2-deoxy-D-ribose was converted
over numerous steps to obtain the corresponding acetoxy-tetrahydrofuran 306. The
reaction of 306 in the presence of the Lewis acid, SnBr4, and allyltrimethylsilane then
gave the trisubstituted tetrahydrofuran 307 diastereoselectively (≥97:3) in 94% yield.[117]
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Various other methods have also been published involving the diastereo- and/or
enantioselective synthesis of polysubstituted tetrahydrofurans, some of which are
summarised in a comprehensive review published by Wolfe in 2007.[107] Examples of
some other, more recent reviews focusing on specific methods or types of tetrahydrofurans, have been published by Johnson,[118] Soorukram,[119] and Tikad and Vincent.[120]

Scheme 2.1. Selected examples for the stereoselective synthesis of polysubstituted tetrahydrofurans

Another important class of 5-membered, oxygen-containing heterocycles are
polysubstituted furans. These aromatic heterocycles occur in a large range of natural
products and pharmaceutical compounds[121] and have a broad range of biological
activities including – but not limited to – antimicrobial, antidepressant, antihypertensive,
antitumour and analgesic activities.[122] Some examples of natural products containing
furan motifs are shown in Figure 2.2. For example, pukalide was extracted from
octocorals and has been shown to have emetic properties in fish and can inhibit the
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settlement of certain marine invertebrate larvae. Therefore, pukalide could have potential
applications as a deterrent to fish predation as well as preventing biofouling.[123] Another
natural product that contains a polysubstituted furan is gnididione, which was isolated
from the plant Gnidia latifolia by Kupchan et al., while they performed an extensive
search for tumour inhibitor compounds.[124] Roseophilin, which was an antibiotic isolated
from Streptomyces griseoviridis in 1992, by Seto et al., is another example of a heavily
substituted furan. In addition to being an antibiotic, roseophilin was also found to be
active against K562 human erythroid leukemia cells (IC50, 0.34 µM) as well as KB cells,
a human nasopharyngeal carcinoma cell line (IC50, 0.88 µM).[125]

Figure 2.2. Natural products that contain highly substituted furans

While furans occur in a range of natural products and bioactive compounds, they
also serve as versatile building blocks in organic synthesis. [121, 126] This is because furans
can behave in a manner comparable to other aromatic systems (i.e. undergo direct
metallations and electrophilic aromatic substitution reactions) and can also display
behaviour characteristic of dienes and alkenes (i.e. undergo addition and cycloaddition
reactions).[127] Consequently, an extensive amount of effort has also gone into the
synthesis of these useful, oxygen-containing heteroaromatics. Some of the more classical
methods used for the synthesis of furans include the Paal–Knorr synthesis and the Feist–
Benary synthesis.[121] However new methods are constantly emerging, some of which
81

utilise transition-metal catalysts such as gold, which are highly efficient at generating
polysubstituted furans. A synthetic method that is specifically related to this thesis
includes an investigation by Kirsch et al. In this 2005 investigation, an intramolecular
gold-catalysed propargyl-Claisen rearrangement was performed with propargyl vinyl
ethers 308, to obtain tri- and tetrasubstituted furans 310 in moderate to excellent yields
(Scheme 2.2a).[128] A similar study was then published by Hiersemann et al., which
investigated the gold-catalysed Gosteli-Claisen rearrangement of 2-alkoxy-carbonylsubstituted propargyl vinyl ethers 311 to generate tetrasubstituted furans 313 in yields of
48-96% (Scheme 2.2b). The rearrangement of propargyl vinyl ethers 311 to furans 313
could also be catalysed by the Brønsted acid, HOTf. However, yields of 313 obtained in
the presence of HOTf were much lower and depending on the R substituent, starting
material and/or the β-allenic ketone 312 were recovered in varying amounts in addition
to 313.[129] Subsequently in 2015, Shi et al. investigated the gold-catalysed reaction of
propargyl alcohols 314 and alkynes 315, which reacted intermolecularly to produced triand tetrasubstituted furans 317 in 50-98% yields (Scheme 2.2c).[130] As can be seen in
Scheme 2.2, all of the reactions discussed were proposed to form β-allenic ketones 309,
312 and 316 in situ, which could then cyclise to form the observed furan products. The
reactions in Scheme 2.2 will be discussed in more detail in Section 2.3.3.3. Many other
gold-catalysed methods have been reported for the synthesis of polysubstituted furans
which cannot be adequately covered in this thesis; however, various reviews

[131]

and

recent publications [132] have been cited.
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Scheme 2.2. Gold-catalysed synthesis of polysubstituted furans

As can be concluded from this brief introduction, polysubstituted tetrahydrofurans
and furans are important structural motifs given their broad range of biological activities
and versatile use in organic reactions. The development of facile and stereoselective (in
the case of tetrahydrofurans) methods for the synthesis of complex tetrahydrofurans and
furans is therefore crucial and became one of the central focuses in this chapter by
harnessing cyclopropene reactivity.
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2.2.

Part A: Gold(I)-Catalysed Reactions of Cyclopropenyl Allyl Ethers

2.2.1. Preliminary Results
2.2.1.1. Previous Results Obtained
Investigations for this project begun with the continuation of work on the
reactivity of allylated cyclopropenyl carbinols performed by Honours student, Jack
Rimington (see Scheme 1.57a, Section 1.4, pg 75).[106] Initial work performed by this
student involved the synthesis of cyclopropenyl carbinol 319a from the lithium-halogen
exchange between n-BuLi and cyclopropane 318, followed by electrophilic trapping with
2-bromobenzaldehyde (Scheme 2.3a). Cyclopropenyl carbinol 319a was then subjected
to an allylation reaction to obtain cyclopropenyl allyl ether 320a. Substrate 320a was
subjected to the gold(I)-catalyst, Ph3PAuNTf2 (13 mol%), in DCM followed by heating
in toluene (115 °C, 48 h) to provide the dienyl ketone 322a in 55% yield over two steps.
These dienyl ketones have enormous synthetic potential with the ketone, as well as the
mono- and tetrasubstituted alkenes, all serving as potential sites for functionalisation. As
an example of this potential, the Honours student subjected dienyl ketone 322a to a
Johnson–Lemieux oxidation using the conditions developed by Jin et al.[133] These
conditions were used given the improved yields of the oxidative cleavage product in the
presence of 2,6-lutidine. It was determined that selective oxidative cleavage of the
monosubstituted alkene in 322a could be achieved to obtain the benzoyl hexenal 323a in
57% yield (Scheme 2.3b). While the yield was only moderate, the 1H NMR spectrum of
the crude mixture of 323a was very clean and there was no evidence to suggest that the
tetrasubstituted alkene had also been cleaved.[106]
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Scheme 2.3. Preliminary synthesis and reactivity of cyclopropenyl allyl ether 320a performed by Honours
student, Jack Rimington

Continuing on from the work performed by the Honours student, this thesis first
aimed to determine whether the gold(I)-catalysed ring-opening of cyclopropenyl allyl
ether 320a, and the Claisen rearrangement of dienyl ether 324a to dienyl ketone 322a,
could be accomplished in a one-pot procedure. This thesis also aimed to investigate
possible chemical transformations of these dienyl ketones 322 to determine whether
useful molecules, such as tetrahydrofurans, could be synthesised.

2.2.1.2. One-Pot Procedure for the Synthesis of Dienyl Ketone 322a and Further
Chemical Transformations
Given the need for elevated temperatures in the Claisen rearrangement step as
determined by the Honours student, toluene was selected as the solvent for the one-pot
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procedure. Cyclopropenyl ether 320a was stirred at 50 °C in the presence of PPh3AuNTf2
(6 mol%), with monitoring by thin-layer chromatography (TLC) and after 2 h, the spot
consistent with 320a had disappeared, and dienyl ether 324a was presumed to have
formed (Scheme 2.4). The reaction was then heated to reflux and left stirring overnight.
Once the reaction was complete according to TLC analysis, 322a was successfully
isolated in an improved yield of 72%.

Scheme 2.4. One-pot procedure for the gold(I)-catalysed synthesis of dienyl ketone 322a from
cyclopropenyl allyl ether 320a

Following confirmation that dienyl ketone 322a could be synthesised in a one-pot
procedure from cyclopropenyl ether 320a, chemical transformations of 322a were
investigated. Dienyl ketone 322a was again subjected to the Johnson–Lemieux oxidation
conditions provided by the Honours student, to obtain benzoyl hexenal 323a.[106] In an
attempt to determine whether intramolecular cyclisation to lactol 326 was possible, 323a
was exposed to reducing conditions (Scheme 2.5). However as expected, the lactol did
not form in solution and the hydroxyl ketone 325 was obtained in 55% yield.1 Literature
evidence suggested that cyclisation to lactol 326 may occur in the presence of a Lewis
acid such as BF3·Et2O, which should form the oxonium intermediate, 327 (Scheme 2.5).
Nucleophilic trapping of 327 by an allyl or propargyl silane could then generate the
tetrahydrofuran 328.[134] However, this reaction was not attempted as another route to
tetrahydrofurans proved more promising.

1

Reaction quenched after the TLC (taken after 15 min) showed that multiple products were forming
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Scheme 2.5. Synthesis of hydroxy ketone 325 from dienyl ketone 322a. Literature suggests that hydroxyl
ketone 325 could be converted to tetrahydrofuran 328 if reacted with a Lewis acid and an organosilane.

It was subsequently determined that dienyl ketone 322a could be successfully
reduced by NaBH4, to give the corresponding dienyl alcohol 329a as the major isomer in
57% yield (Scheme 2.6). The diastereoselectivity of the reaction was determined to be
~9:1 (329:329’) from the 1H NMR spectrum of the crude mixture. The reduction of the
ketone to the alcohol was known to have occurred based on the loss of the carbonyl signal
at δ 203.3 ppm in the 13C NMR spectrum (and subsequent appearance of new CH signal
at δ 3.02 ppm in the 1H NMR spectrum) for 329a. The presence of a strong, broad O–H
stretch (3468 cm-1) in the infrared (IR) spectrum also supported the reduction of the
ketone to the alcohol. The relative stereochemistry for the major isomer 329a was
predicted by the Felkin–Anh model. As shown in Scheme 2.6, the approaching hydride
ion would prefer to attack conformer 322-A of the dienyl ketone. This presents the least
hindered trajectory for the nucleophile and results in the two chiral centres being in the
anti-configuration for dienyl alcohol 329. In contrast, the trajectory for the nucleophile to
attack conformer 322-B of the dienyl ketone would be hindered by both the tetra- and
monosubstituted alkenes and would therefore be less favoured. The two chiral centres
generated from this attack would be in the syn-configuration for dienyl alcohol 329’.
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Scheme 2.6. Reduction of dienyl ketone 322a to dienyl alcohol 329a

Following reduction, dienyl alcohol 329a was subjected to the Johnson–Lemieux
oxidation conditions to selectively cleave the monosubstituted alkene. After 22.5 h, TLC
analysis showed that 329a had been consumed and that a more polar product had formed.
Indeed, analysis of the 1H NMR spectrum of the crude mixture showed that the
monosubstituted alkene had been cleaved based on the loss of the 1H signals at δ 4.99 and
δ 5.10 ppm that represented the terminal CH2 group of the alkene. No 1H signals in the
δ 9-10 ppm region were observed that would indicate the presence of an aldehyde. It was
therefore assumed that following the oxidative cleavage of the monosubstituted alkene,
the nucleophilic alcohol cyclised with the electrophilic carbonyl group of the aldehyde,
thus forming lactol 330a (Scheme 2.7). Lactol 330a apparently decomposed when
attempts were made to isolate it for characterisation. Therefore, to trap out the lactol,
alcohol 329a was again subjected to the oxidative cleavage conditions, and following
work-up after 2 h,2 the crude mixture was immediately subjected to allyltrimethylsilane
(2 equiv.) and BF3·Et2O (3 equiv.),3 according to the procedure outlined by Schmitt and

2
3

TLC analysis showed that some starting material was still present in the reaction.
Equivalents of the silane and BF3·Et2O were based on the moles of the dienyl alcohol 329a used
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Reiβig.[114a] The reaction resulted in the selective formation of the trisubstituted
tetrahydrofuran 331a, in 32% yield over two steps (Scheme 2.7). It should be noted that
only one diastereoisomer of 331a was observed in the 1H NMR spectrum of the crude
mixture. Once tetrahydrofuran 331a had been obtained, efforts were made to confirm the
relative stereochemistry and rationalise the outcome mechanistically.

Scheme 2.7. Oxidative cleavage of dienyl alcohol 329a and nucleophilic trapping of lactol 330a to produce
tetrahydrofuran 331a

2.2.1.3. Mechanistic Proposal and Assignment of Stereochemistry for Tetrahydrofuran
331a
The mechanism for the formation of tetrahydrofuran 331a from lactol 330a was
proposed to proceed by the Lewis acid assisted generation of the cyclic oxocarbenium ion
332 (Scheme 2.8). The oxocarbenium ion 332 would be attacked by the π-electrons of the
double bond in allyltrimethylsilane to form intermediate 333. The silyl group of 333
would then eliminate to extinguish the carbocation and generate the observed
trisubstituted tetrahydrofuran 331a, where the allyl group was in the trans-position to
both the aryl group and the tetrasubstituted alkene. While lactol 330a could exist as a
linear hydroxyaldehyde 330a’, that would also react with the Lewis acid and the silane to
give 331a, this pathway did not explain the excellent diastereoselectivity observed, and
was consequently ruled out as a potential pathway.
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Scheme 2.8. Mechanism for the formation of tetrahydrofuran 331a

As can be seen in Scheme 2.8, the relative stereochemistry of tetrahydrofuran
331a places the allyl group in the trans-position relative the aryl group and the alkene
(aryl group and alkene are cis to one another). The excellent diastereoselectivity observed
from the nucleophilic trapping step to convert lactol 330a to tetrahydrofuran 331a, can
be justified by a Felkin–Anh-type model described by Schmitt and Reiβig.[114a] Drawing
Newman projections of the cyclic oxocarbenium ion 332 from Scheme 2.8, it can be seen
in 332T, that the pseudoequatorial tetrasubstituted alkene occupies a far more remote
position and has less steric interactions compared to the pseudoaxial alkene seen in 332C
(Figure 2.3). As a result, the conformation of 332T is far more stable than 332C, and the
trajectory of the incoming nucleophile is less impeded which results in the observed transstereochemistry of 331a.

Figure 2.3. Felkin-Anh-type model to explain the diastereoselectivity of tetrahydrofuran 331a
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To confirm the relative stereochemistry proposed above for tetrahydrofuran 331a,
the structure of 331a first had to be confirmed, and the 1H signals around the ring
assigned. In the 1H NMR spectrum for 331a (see appendix, pg 403), CH signals were
observed at δ 5.37 (Ha), δ 3.91 (Hb), δ 4.56 (Hc) and δ 5.89 (Hd) ppm. Proton Hd correlated
to two 1H signals between δ 5.08-5.18 ppm and two 1H signals at δ 2.32 and δ 2.49 ppm
in the COSY spectrum (Figure 2.4). The 1H signals between δ 5.08-5.18 ppm represented
a R=CH2 group (CH2e), while the 1H signals at δ 2.32 and δ 2.49 ppm represented a
R–CH2 group (CH2f). Consequently, the CH2e, CH2f and Hd signals were collectively
assigned as the allyl group. Other important 1H signals were observed at δ 1.94 (Hg) and
δ 2.20 (Hg’) ppm that correlated to the same

C signal at δ 35.1 ppm in the HSQC

13

spectrum (see appendix, pg 404). Protons Hg and Hg’ were therefore assigned as the CH2
group of the tetrahydrofuran ring. Analysing the COSY spectrum, Hc had correlations to
Hg and Hg’ as well as the CH2f 1H signals. Therefore, Hc must be the CH group in the 5position of the tetrahydrofuran ring, directly adjacent the allyl substituent. Similarly, Hb
correlated to Hg and Hg’ and had an additional correlation to Ha in the COSY spectrum.
Proton Hb (observed as a quartet in 1H NMR spectrum) was therefore assigned as the CH
in the 3-position of the tetrahydrofuran ring, directly adjacent to the tetrasubstituted
alkene. Consequently, Ha was the CH group directly adjacent to the aryl ring in the 2position of the tetrahydrofuran ring, which was consistent with both its chemical shift and
its multiplicity (doublet, therefore can only see Hb).
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Figure 2.4. COSY spectrum of tetrahydrofuran 331a with a labelled structure showing important
correlations

Having confirmed the positions of the important CH groups around the
tetrahydrofuran ring of 331a, a ROESY spectrum (Figure 2.5) was obtained to determine
the relative stereochemistry. From the ROESY spectrum, Ha had a through space
correlation to Hb, indicating that they were on the same face of the tetrahydrofuran ring.
Consequently, this confirmed that the aryl group and the tetrasubstituted alkene were cis
to one another. Proton Hb also had a through space correlation to Hg of the CH2 group of
the tetrahydrofuran ring. This meant that Hg had to be trans to the aryl group and the
alkene, while Hg’ had to be cis to the aryl group and the alkene. Proton Hc, which was
attached to the same carbon on the ring as the allyl group, it had a correlation to Hg’.
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Therefore, the allyl group had to be cis to Ha, Hb and Hg and confirmed its trans-position
relative to the aryl group and the tetrasubstituted alkene.

Ha

Hc

Hb

Hg’

Hg

Hg
Hg’

Hb

Hc

Ha

Figure 2.5. ROESY spectrum of tetrahydrofuran 331a with a labelled structure showing important
correlations

As the preliminary results showed that cyclopropenyl allyl ether 320a could be
transformed diastereoselectively into tetrahydrofuran 331a, it was decided that the
reaction would be investigated further and a research plan was formulated. The decision
to continue this work was due to the aforementioned importance of developing
stereoselective methods for the synthesis of polysubstituted tetrahydrofurans.
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2.2.2. Proposed Approach to Research Progression
From the preliminary results in Scheme 2.7 (Section 2.2.1.2, pg 89), the yield of
tetrahydrofuran 331a obtained from the dienyl alcohol 329a, was low (32%) but the
diastereoselectivity was high. This was a two-step process and given that the oxidative
cleavage of dienyl alcohol 329a to lactol 330a was worked-up before 329a had been fully
consumed (Scheme 2.7), it was highly likely that optimising the oxidative
cleavage/nucleophilic trapping conditions would increase the yields of tetrahydrofuran
331a. This would therefore be the starting point for further optimisation.
It was also envisaged that performing a reaction scope would result in the
synthesis of numerous tri- and tetrasubstituted tetrahydrofurans (Scheme 2.9) following
optimisation of the reaction conditions. It was decided that substitution at the α-positions
of the allyl group in 320 would be avoided. This was because, following ring-opening
and the Claisen rearrangement, any substituent in the α-position of the allyl group in 320,
would end up at the γ-position of the allyl group in 322 and would consequently be lost
after the oxidative cleavage step. It was also predicted that substitution of the β-position
of the allyl group in 320 may be problematic, as a substituent at the β-position would
result in β,β-disubstituted allyl group in 322. This might have slowed/hindered the
oxidative cleavage step due to the increased steric hindrance and may have also reduce
the selectivity for the disubstituted alkene over the tetrasubstituted alkene. It was therefore
planned that to begin with, substitution of cyclopropenyl ether 320 would to be limited to
the R1 position and the γ-position of the allyl group (R2 and R3). The nucleophile used in
the trapping step could also be varied as Schmitt and Reiβig had found that silanes i-iv
could successfully participate in the reaction, although silanes i and iii were determined
to result in the best trans:cis ratios.[114a] The use of silanes i-iv could therefore result in
tetrahydrofurans 331 with either allyl groups (from silanes i-iii) or allenes (from silane
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iv) in the 5-position of the ring. These allyl and allene groups could undergo numerous
functionalisation reactions to further expand the range of accessible products.

Scheme 2.9. Possible synthesis of tri- and tetrasubstituted tetrahydrofurans 331

2.2.3. Optimisation of the Oxidative Cleavage/Nucleophilic Trapping Reaction
The first conditions tested for the oxidative cleavage/nucleophilic trapping of
dienyl alcohol 329a were those outlined in Scheme 2.7 (Section 2.2.1.2, pg 89), which
are listed in Table 2.1, entry 1. This reaction was difficult to monitor by TLC analysis due
to the solvent used, and reactions typically were not left longer than a few hours to avoid
possible degradation of lactol 330. Ideally, the oxidative cleavage and nucleophilic
trapping reactions would be performed in a one-pot procedure to minimise the
degradation of lactol 330 upon work-up. However, this was not possible for this reaction
as H2O is important for the OsO4-NaIO4 catalytic cycle and is not compatible with the
Lewis acid, BF3.
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Table 2.1. Optimisation of the formation of tetrahydrofuran 331

Entrya
1d

2e

3d,f

4d

5f,g

6

7

8h

Condition A
5 mol% OsO4, 2.5 eq. 2,6-lutidine,
4 eq. NaIO4 (30% on silica),
1,4-dioxane:H2O (3:1), rt, 2 h
5 mol% OsO4, 4 eq. NaIO4 (30%
on silica), 1,4-dioxane:H2O (3:1),
rt, 1 h
1.2 eq. 2,6-lutidine, 7 mol% OsO4,
4 eq. NaIO4 (30% on silica),
1,4-dioxane:H2O (3:1), rt, 2.5 h
1 eq. 2,6-lutidine, 5.2 eq. NaIO4
(30% on silica), 10 mol% OsO4,
1,4-dioxane:H2O (3:1), rt, 1 h
1 eq. 2,6-lutidine, 10 mol% OsO4,
5 eq. PhI(OAc)2, THF:H2O (3:1),
rt, 23 h
1.1 eq. 2,6-lutidine, 2 eq. NaIO4,
5 mol% OsO4, THF:H2O (12:1),
rt, 1.5 h
0.6 eq. 2,6-lutidine, 4 eq. NaIO4,
5 mol% OsO4, THF:H2O (34:1),
rt, 1 h
1 eq. 2,6-lutidine, 2.5-3 eq. NaIO4,
5 mol% OsO4, THF:H2O (50:1), 0
°C, 1 h

Condition Bb

Yield 331ac

3.3 eq. BF3·Et2O, 2.2 eq. silane,
DCM, –78 °C to rt, 1 h

32%

3.2 eq. BF3·Et2O, 1.9 eq. silane,
DCM, –78 °C to rt, 1 h

21%

2.9 eq. BF3·Et2O, 1.8 eq. silane,
DCM, –78 °C to rt, 50 min

35%

3 eq. BF3·Et2O, 1.6 eq. silane,
DCM, –78 °C to rt, 5 min

29%

N/A

0%

1.4 eq. BF3·Et2O, 2.2 eq. silane,
DCM, –78 °C to rt, 5 min

31%

N/A

0%

0.8 eq. BF3·Et2O, 1.3 eq. silane,
DCM, –78 °C to rt, 5 min

18%

a

All reactions performed at 0.1 M unless otherwise specified; b equiv. of BF3·Et2O and allyltrimethylsilane
based on the moles of dienyl alcohol 329; c isolated yields; d oxidative cleavage did not go to full
completion; e additional (more polar) spot visualised upon TLC analysis; f OsO4 added portion-wise; g
PhI(OAc)2 added portion-wise; h reaction was worked up and then resubjected to the same oxidative
cleavage conditions

Following the initial reaction conditions listed in entry 1 (Table 2.1), the
importance of 2,6-lutidine to the reaction was evaluated. Dienyl alcohol 329a was
resubjected to condition A (and condition B) in the absence of 2,6-lutidine, and
tetrahydrofuran 331a was obtained in a reduced yield of 21% (Table 2.1, entry 2). In
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addition to a lower yield, TLC analysis of the oxidative cleavage reaction showed a more
polar side product had formed in addition to lactol 330a. While this side product was not
identified, based on the findings of Jin et al., it was likely that the α-hydroxy ketone was
obtained from over oxidation of the diol intermediate. [133] The conversion of dienyl
alcohol 329a to tetrahydrofuran 331a was repeated in the presence of 2,6-lutidine and it
was determined that 1.2 equiv. of the base could be used rather than 2.5 equiv., to obtain
331a in 35% yield over the two steps (entry 3). However, for entry 3, the oxidative
cleavage step still did not go to completion. In an attempt to get full conversion of 329a
during the oxidative cleavage step, the equivalents of NaIO4 and OsO4 were increased to
5.2 equiv. and 10 mol%, respectively. Nevertheless, full conversion of the reaction still
did not occur and 331a was isolated in a slightly lower yield, following subjection to
condition B (entry 4). Pleasingly however, the results in entry 4 demonstrated that the
nucleophilic trapping step could be completed in 5 mins rather than 1 h. Given the
possible instability of lactol 330a on silica, it was thought that using 30% NaIO4 absorbed
to silica gel might have been compromising the reaction. Using a slightly modified
version of the procedure outlined by Nicolaou et al.,[135] NaIO4 was replaced with
PhI(OAc)2 and the solvent was changed to THF:H2O (3:1) (entry 5). Initially, 2 mol% of
OsO4 and 2.5 equivalents of PhI(OAc)2 were added to the reaction; however, TLC
analysis showed that the conversion of 329a was very low so after 7 h, another 8 mol%
of OsO4 and 2.5 equiv. of PhI(OAc)2 were added. Despite this, the reaction still was not
complete and had to be left overnight for a total of 23 h (entry 5). After this time TLC
analysis of the reaction in entry 5 indicated that while full consumption of 329a had
occurred (confirmed by NMR), lactol 330a was no longer present so the crude mixture
was not subjected to condition B (entry 5). Given that PhI(OAc) 2 did not seem to be a
very effective oxidant in the reaction, pure NaIO4 (not absorbed to silica) was used and
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the amount of BF3·Et2O used was also reduced to 1.4 equiv. (based on moles of 329a)
(entry 6). While the 1H NMR spectrum of the crude lactol 330a mixture looked
remarkably clean, the ratio of 330:329 was still 2:1 and the yield of 331a obtained over
the two steps, was only 31% (entry 6). The amount of 2,6-lutidine was then reduced to
0.6 equiv. and the solvent was changed to THF:H2O (34:1); however, this had a
completely detrimental effect on the formation of lactol 330a and the crude mixture was
not subjected to condition B (entry 7). It was thought that a better conversion of dienyl
alcohol 329a to lactol 330a might be gained if the oxidative cleavage reaction was worked
up after 1 h and then resubjected to the same conditions. This however, was not successful
as 329a still remained in the 1H NMR spectrum of the crude mixture (even after
resubjection) and following subjection to condition B, 18% yield of 331a was obtained
(3 steps) (entry 8).
Given the results in Table 2.1, it was evident that the conditions tested had very
little effect on the yield of tetrahydrofuran 331a. Other conditions that were also
considered for the oxidative cleavage step included a second method by Nicolaou et al.
that utilised N-methylmorpholine N-oxide (NMO) and 2,6-lutidine in the presence of a
catalytic amount of OsO4, with acetone:H2O (20:1) as the solvent (Upjohn
dihydroxylation). This was followed by the addition of PhI(OAc) 2 as the oxidant (once
alkene starting material had been consumed) to cleave the olefinic bond (Scheme 2.10a).
This method had the notable advantage of being essentially homogeneous as opposed to
the Johnson–Lemieux type conditions, which were heterogeneous.[135] Given that
PhI(OAc)2 did not seem to be very effective for this particular reaction (Table 2.1, entry
5) a similar method using NMO and OsO4 with acetone:H2O (9:1) could be used (Scheme
2.10b). George et al. used NaIO4 in THF:H2O (2:1) for the cleavage

[136]

but the

disadvantage of this method was that a work-up of the diol had to be performed. This
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work-up may be avoided however, as there is literature precedence to suggest that NaIO4
could be added directly to the alkene/OsO4/NMO mixture in acetone.[137] Another method
that could be tested was an ozonolysis procedure reported by Švenda et al. They
performed a selective oxidative cleavage of a terminal alkene over a cyclic trisubstituted
alkene (340), by bubbling ozone in MeOH at –78 °C (3 mins until starting material
consumed) followed by addition of dimethyl sulfide and warming to rt (Scheme 2.10c) to
obtain the aldehyde 341 in 88% yield.[138] It was thought that the nucleophilic trapping
step might also be improved by testing different Lewis acids and reaction temperatures.
Also given that lactol 330a could not be purified, the number of moles of 330a present in
the crude mixture could be determined by adding a known amount of internal standard to
the NMR sample. This would allow a more accurate calculation of the equivalents of
Lewis acid and allyltrimethylsilane to be added and may result in improved yields. Before

Scheme 2.10. Other oxidative cleavage conditions reported in the literature
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any of these methods were investigated however, it was decided that other substrates
would be subjected to the current oxidative cleavage and nucleophilic trapping conditions
to determine if further optimisation was a worthwhile endeavour.

2.2.4. Substrate Scope for the Synthesis of Tetrahydrofurans 331
The first substrate to be investigated was the pure (E)-cyclopropenyl allyl ether
320b. Cyclopropenyl ether 320b was subjected to the gold(I)-catalysed ringopening/Claisen rearrangement and when the reaction was stopped, the crude residue was
analysed by NMR spectroscopy. 4 A

13

C NMR spectrum showed that even though one

major product spot was seen on the TLC, two dienyl ketones were present as evidenced
by two separate carbonyl signals at δ 200.6 and δ 202.2 ppm. Indeed, when a column was
performed to obtain a cleaner spectrum of the main product spot, a diastereomeric mixture
(~2:1) of dienyl ketones 322b and 322b’ had been obtained (Scheme 2.11). Evidently,
despite starting from the pure E-isomer of cyclopropenyl allyl ether 320b, the gold(I)catalysed ring-opening/Claisen rearrangement was not diastereoselective. As dienyl ether
324b was not isolated in this example, it is unknown whether non-selective ring-opening
of the cyclopropene moiety or poor selectivity for the chair transition state over the boat
transition state during the Claisen rearrangement, resulted in the observed dr between
322b and 322b’.

Scheme 2.11. Gold(I)-catalysed ring-opening/Claisen rearrangement of (E)-cyclopropenyl allyl ether 320b.
*Catalyst [(Ph3PAu)3O]BF4 (5mol%) also added but reaction did not progress according to TLC
4

Claisen step was not complete after 24 h but side products were developing so the reaction was stopped.

100

Given the unselective reaction shown in Scheme 2.11, dienyl ketones 322b and
322b’ were not subjected to the reduction conditions to obtain the corresponding dienyl
alcohols as this would have resulted four possible diastereomers that would be difficult
to separate. Further investigation into improving the diastereoselectivity of the ringopening/Claisen rearrangement of the cyclopropenyl allyl ethers 320 to dienyl ketones
322 would have to be performed before further synthetic manipulations are attempted.
Given that optimisation of the conditions for the oxidative cleavage/nucleophilic trapping
reactions also still had to be completed, it was decided that the focus of this project would
be directed towards the gold-catalysed reactions of cyclopropenyl propargyl ethers.

2.3.

Part B: Gold(I)-Catalysed Reactions of Cyclopropenyl Propargyl

Ethers 342
2.3.1. Preliminary Results and Proposed Approach to Research Progression
Experimental investigations for this project began with the synthesis of the
cyclopropenyl propargyl ether 342a (Scheme 2.12). Cyclopropenyl carbinol 319a was
prepared in 96% yield from cyclopropane 318, according to the same procedures reported
in Scheme 2.3 (Section 2.2.1.1, pg 85). Cyclopropenyl carbinol 319a was subjected to a
propargylation reaction to provide cyclopropenyl propargyl ether 342a, in 91% yield
(Scheme 2.12). Characteristic 1H signals of the cyclopropenyl carbinol 319a in the 1H
NMR spectrum were three singlets (integration 3H) appearing between δ 1-2 ppm that
represented the CH3 groups on the cyclopropene ring, as well as a CH signal occurring at
δ 5.99 ppm. A very characteristic 13C signal at δ 22.3 ppm also occurred in the 13C NMR
spectrum for 319a that represented the quaternary carbon at the C3 position of the
cyclopropene. Cyclopropenyl propargyl ether 342a was therefore known to have formed
when these peaks, in addition to a triplet at δ 2.46 ppm (terminal CH signal of the alkyne)
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and a 1H signal at δ 4.26 ppm (CH2 signal of the propargyl group), were observed in the
1

H NMR spectrum.

Scheme 2.12. Synthesis of cyclopropenyl propargyl ether 342a

Cyclopropenyl propargyl ether 342a was subjected to the gold(I)-oxo complex,
[(Ph3PAu)3O]BF4. The catalyst [(Ph3PAu)3O]BF4 was investigated first as Sherry and
Toste had shown it was very effective in catalysing a similar propargyl-Claisen
rearrangement of propargyl vinyl ethers to allenic alcohols (see Scheme 2.17, Section
2.3.3.3, pg 127).[139] The reaction was performed in CDCl3 and its progress was monitored
with 1H NMR spectroscopy. After 6.5 h, the 1H signals consistent with the starting
material, had disappeared so the crude mixture was purified. This led to the isolation of
the trisubstituted furan 343a in 17% yield (Scheme 2.13). Other products were also
formed according to the 1H NMR spectrum; however, attempts to isolated and
characterise these side products were unsuccessful. Characterisation data confirming the
structure of furan 343a will be discussed in Section 2.3.3.2. Having obtained furan 343a
from the gold-catalysed rearrangement of cyclopropenyl propargyl ether 342a, it was
proposed that the reaction proceeded by gold-activation of the cyclopropene double bond
to catalyse ring-opening, followed by a Claisen rearrangement. A plausible reaction
mechanism for this rearrangement will be discussed in Section 2.3.3.3.
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Scheme 2.13. Gold(I)-catalysed formation of cyclopropenyl propargyl ether 343a

Given the preliminary result obtained in Scheme 2.13, the focus of this project
was directed towards investigating this novel reactivity of cyclopropenes, given the
importance of developing new methods for the synthesis of polysubstituted furans. Due
to the poor yield of furan 343a obtained, the first objective of this project was to optimise
the reaction conditions by investigating other catalysts, solvents, temperatures and
counterions. Once optimisation of the reaction conditions were complete, it was
envisaged that numerous tri- and tetra-substituted furans 343 could be synthesised
through substitution of the R1 and R2 positions of cyclopropenyl propargyl ether 342
shown in Scheme 2.14. The R1 position could be an aryl or an alkyl group; however, the
α-carbon to the R1 position would have to remain tertiary, as a quaternary carbon would
prevent the rearrangement to furan 343 from occurring (see Section 2.3.3.3). The R2
position could be a hydrogen, to provide trisubstituted furans, or an alkyl/aryl group to
provide tetrasubstituted furans. While substitution at the R3 position could theoretically
be performed (would not be disallowed according to the mechanism), it was decided that
R3 would always be a hydrogen. The rationale for this was that the steric hindrance
created by a substituent at R3 would make the synthesis of the cyclopropenyl ethers 342
more challenging and it was not thought that it would prove much about the versatility of
the reaction. Therefore, variation of the cyclopropenyl ethers 342 would be limited to the
R1 and R2 positions, to probe the versatility gold-catalysed rearrangement.
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Scheme 2.14. Proposed positions for variation of the cyclopropenyl propargyl ethers 342 to obtained triand tetrasubstituted furans 343

2.3.2. Optimisation of the Reaction

Conditions for the Gold-Catalysed

Rearrangement of Cyclopropenyl Propargyl Ether 342a
The first set of conditions used for the rearrangement of cyclopropenyl propargyl
ether 342a to furan 343a (Scheme 2.13, pg 103) are listed in Table 2.2, entry 1. Given the
formation of side products in this initial reaction, it was thought that performing the
reaction at cooler temperatures might favour a more selective formation of furan 343a.
Therefore, 342a was reacted with [(Ph3PAu)3O]BF4 in toluene at –78 °C (entry 2).
However, after 30 mins at this temperature TLC analysis showed that only starting
material was present and it was noticed that the gold-catalyst was not dissolving.5 After
heating the reaction at 50 °C for 19 h, the starting material was consumed and 343a was
isolated in 26% yield (entry 2). Based on the preliminary findings obtained for the
rearrangement of cyclopropenyl allyl ether 320a and on the results in Table 2.2, entry 2,
it was thought that heat would assist the Claisen rearrangement to occur (see Section
2.3.3.3). Therefore, 342a was subjected to [(Ph3PAu)3O]BF4 (10 mol%) and heated to
100 °C in DCE to provide 343a in a slightly improved yield of 30% (entry 3). The catalyst
was then changed to Ph3PAuNTf2 (5 mol%); however, this resulted in a reduced yield of

5

Reaction had to be warmed to rt before conversion of starting material was observed. After 2 h at rt (3 h
total reaction time), a less polar spot was observed by TLC analysis that was consistent with furan 343a.
However, starting material was still present so the reaction temperature was increased to 50 °C.
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25% (entry 4). Using [(Ph3PAu)3O]BF4 as the catalyst and DCE as the solvent, it was
found that 342a could rearrange to 343a in 28% yield, when the temperature was lowered
to 40-65 °C (entry 5). The reaction in entry 5 was left for 23.5 h as TLC analysis indicated
that a small amount of starting material was still present after 7.5 h. While TLC analysis
indicated that the reaction had gone to completion after heating overnight, it was
suspected that the starting material spot may have in fact been a side product that had the
same Rf. The gold(I) salt, AuCl, was evaluated6 but 343a was not formed (entry 6). The
gold(III) salt, AuCl3, was also investigated and despite attempting the reaction at both
higher temperatures (25-100 °C) and lower temperatures (0 °C), the yields of furan 343a
obtained were poor (entries 7-8). The gold(III) complex, Au(pyridine)Cl3, was also tested
but after 24 h at 50 °C, starting material was mainly recovered (confirmed by NMR) and
no yield was obtained for 343a (entry 9). From the results of entry 6-9 (Table 2.2), it was
evident that for the successful conversion of cyclopropenyl propargyl ether 342a to furan
343a, a gold(I) complex (i.e. bearing a ligand) had to be used.
Table 2.2. Optimisation of the gold-catalysed rearrangement of cyclopropenyl propargyl ether 342a

Entrya

Catalyst (x mol%)

Solvent

Temp.

Time (h)

Yield 343ab

1

[(Ph3PAu)3O]BF4 (5)

CDCl3

rt

6.5

17

2

[(Ph3PAu)3O]BF4 (5)

PhMe

–78-50 °C

23

26

3

[(Ph3PAu)3O]BF4 (10)

DCE

100 °C

2

30

4

Ph3PAuNTf2 (10)c

DCE

–78-100 °C

5

25

6

Additional portions of catalyst and higher reaction temperatures applied to try and force the reaction to go
to completion
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5

[(Ph3PAu)3O]BF4 (5)

DCE

40-65 °C

23.5

28

6

AuCl (15)c

DCE

50-100 °C

23

0

7

AuCl3 (10)

DCE

25-100°C

4.5

13

8

AuCl3 (15)c

DCE

0 °C

25

5

9

Au(pyridine)Cl3 (5)

DCE

50 °C

24

Trace

10 d

IPrAuCl/AgBF4 (5)

DCE

50 °C

1

21

11 d

(tBu3P)AuCl/AgBF4 (5)

DCE

50 °C

1

31

12

Ph3PAuCl/AgBF4 (5)

DCE

50 °C

1.25

42

13

Ph3PAuCl/AgBF4 (5)

DCE

rt

5.5

38

14

Ph3PAuCl/AgBF4 (7.5)c

DCM

rt

25.5

21

15

Ph3PAuCl/AgSbF6 (5)

DCE

50 °C

2

34

a

All reactions were performed at 0.1 M unless otherwise specified; b isolated yields; c catalyst was added
portion-wise; d significant amounts of an unidentified side product were obtained based on NMR of crude
mixture

Focusing once more on gold(I) complexes, IPrAuCl/AgBF4 was investigated and
furan 343a was obtained in 21% yield (entry 10). The reduced yield of 343a in this
instance compared to entry 3, was most likely the result of a significant amount of side
product being generated that was not identified. Pleasingly, when cyclopropene 342a was
subjected to (tBu3P)AuCl/AgBF4, a 31% yield of furan 343a was isolated, albeit a
significant amount of an unidentified side product was also observed (entry 11). Given
the improved yield with a gold(I) complex bearing phosphine ligand, Ph3PAuCl/AgBF4
was used and 42% yield of 343a was obtained after heating at 50 °C in DCE (entry 12).
The reaction was also repeated with Ph3PAuCl/AgBF4 in DCE at rt, and the isolated yield
of 343a obtained was slightly lower at 38% (entry 13). This result suggested that while
heating the reaction could marginally improve the formation of 343a, it was not essential
for the Claisen rearrangement, as was the case when the substrate was cyclopropenyl allyl
ether 320a. It was therefore hypothesised that the gold catalyst might assist the Claisen
rearrangement to occur which will be discussed further in Section 2.3.3.3. Changing the
solvent to DCM, cyclopropene 342a was subjected to Ph3PAuCl/AgBF4 at rt, but the yield
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of 343a obtained was only 21% and indicated that DCE was a far superior solvent (entry
14). The counterion was also changed by adding Ph3PAuCl/AgSbF6; however, a lower
yield of 343a (34%) was isolated and the reaction was not as clean as it had been when
¯

BF4 was used (entry 15). It was therefore concluded that the best conditions for the gold-

catalysed rearrangement of cyclopropenyl propargyl ether 342a to furan 343a, were those
in entry 12 (Table 2.2).
Following the successful optimisation of the conditions for the rearrangement of
cyclopropenyl propargyl ether 342a to furan 343a, control experiments were performed
to ensure that neither Ph3PAuCl nor AgBF4, could catalyse the rearrangement by
themselves. Indeed, when 342a was reacted with Ph3PAuCl, no yield for 343a was
obtained and starting material was mainly recovered. Interestingly, when 342a was
reacted with AgBF4 and heated to 95-105°C for 28 h and then subjected to reducing
conditions, enol ether 344a and β-allenic alcohol 345 were obtained in 35% and 19%
yields, respectively (Scheme 2.15).7 The reaction with AgBF4 originally resulted in the
β-allenic ketone; however, this product was unstable on silica gel, hence the crude
mixture was subjected to reducing conditions to obtain the more stable alcohol.

Scheme 2.15. Control reactions for the gold(I)-catalysed rearrangement of cyclopropenyl propargyl ether
342a

7

Reaction heated to 95-105°C and excess catalyst was added as TLC analysis indicated that the starting
material was reacting but was not being fully consumed. However, following purification it was determined
that the spot thought to be the starting material on the TLC, was enol ether 344a.
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An example characterisation for enol ether 344 with Z-configuration about the
central double bond, is discussed in Section 2.3.3.2. The structure of the allenic alcohol
345 was confirmed using NMR spectroscopy, high resolution mass spectrometry
(HRMS) and IR spectroscopy. HRMS firstly confirmed that the mass of the allenic
alcohol 345 was consistent with the molecular formula, C16H20BrO. An IR spectrum then
supported the presence of the alcohol group with a broad, strong O–H stretch at
3429 cm-1. A strong peak at 1954 cm-1 in the IR spectrum was also observed that was
consistent with an allene functional group. From the 13C NMR spectrum, the presence of
an allene was further supported by the appearance of a distinctive quaternary 13C signal
at δ 208.8 ppm. In the 1H NMR spectrum, three singlet 1H signals were observed between
δ 1.65-1.80 ppm (integrations of 3H each) that represented three CH3 groups. Based on
the lack of a sp3 quaternary 13C signal around δ 20 ppm in the 13C NMR spectrum, and
the presence of two sp2 quaternary 13C signals at δ 125.4 and δ 130.9 ppm, it supported
that the cyclopropene moiety had ring-opened to form the tetrasubstituted alkene. In the
1

H NMR spectrum, a CH2 group was represented by 1H signals at δ 4.38 (Ha) and δ 4.53

(Ha’) ppm that correlated to a

13

C signal at δ 74.9 ppm in the HSQC spectrum (see

appendix, pg 444). The 1H and 13C chemical shifts for these signals were consistent with
those of the terminal end of an allene. There were also CH signals observed at δ 3.70 (Hb),
δ 5.08 (Hc) and δ 5.19 (Hd) ppm, but one proton was also observed at δ 2.15 ppm that did
not have a correlation in the HSQC spectrum. The peak at δ 2.15 ppm was therefore
assigned as the –OH signal. A COSY spectrum (Figure 2.6) revealed that the OH signal
had a correlation to Hd, thus suggesting that the OH functional group was attached to the
same carbon as Hd. Proton Hd also had correlations to Hb and Hc in the COSY spectrum.
Protons Ha and Ha’ had a strong correlation to Hc and a weak correlation to Hb in the
COSY spectrum. This supported that Hc was the CH group of the allene, while Hb was
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the CH group in the β position to both the –OH and aryl groups. Indeed, this assignment
was consistent with the chemical shifts of these CH groups in both the 1H and 13C NMR
spectra. Attempts were made to optimise the silver(I)-catalysed reaction to selectively
obtain the β-allenic alcohol 345 over the enol ether 344a, but these efforts were
unsuccessful. Therefore, the focus of this project was directed towards the substrate scope
for the gold(I)-catalysed formation of furans 343.

Hd Hc

Ha’ Ha

Hb

OH

OH

Hb

Ha

Ha’
Hc
Hd

Figure 2.6. COSY spectrum for the β-allenic alcohol 345 with a labelled structure showing important
correlations. Correlation with Ha are omitted for clarity as they are the same as Ha’

Having optimised the reaction conditions for the gold-catalysed rearrangement of
cyclopropenyl propargyl ether 342a to furan 343a, the scope of the reaction was
investigation by varying the R1 and R2 positions shown in Scheme 2.14 (Section 2.3.1,
pg 104). It was quickly realised however, that the formation of the desired furan 343 was
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heavily dependent on the substitution of cyclopropene 342, and that numerous products
could be obtained by various reaction pathways. These findings, including the different
products obtained and plausible reaction mechanisms for their formation, will be
discussed in the following sections.

2.3.3. Gold(I)-Catalysed Rearrangements of Cyclopropenyl Propargyl Ethers 342
when R1 = Aryl Group
2.3.3.1. Substrate Scope for Cyclopropenyl Propargyl Ethers 342 when R1 = Aryl Ring
The first substrates to be investigated as part of the reaction scope were
cyclopropenyl propargyl ethers 342 bearing an aryl group in the R1 position and the
results are shown in Table 2.3. Given that a hydrogen in the R2 position provided furan
343a in 42% yield (entry 1), an internal alkyne where R2 was an ethyl group, was next
investigated. Pleasingly, the resulting yield of furan 343b was 80% (entry 2). Driven by
this promising result, the R2 position was substituted with a TMS group and the
corresponding furan 343c, was obtained in 73% yield, although traces of 343a were
observed presumably due to desilylation of the furan during purification (entry 3). This
result was particularly important as the TMS group is placed in the 4-position of the furan
which is often a challenging position to vary given that furans tend to prefer electrophilic
substitution and lithiation at the 2- and 5-positions.[140] Given the results obtained here,
cross-coupling reactions such as those published by Wong et al.,[140-141] could be
performed with the silyl moiety to allow further variation at the 4-position of furan 343c.
The R1 substituent was replaced with an –oClC6H4 group (R2 = Et) and the corresponding
furan 343d was obtained in a slightly reduced yield of 62% (entry 4). Similarly, when R1
was a –oClC6H4 group, R2 could be changed to a TBS group to obtain furan 343e in 52%
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yield (entry 5).8 For both entries 4 and 5 (R1 = –oClC6H4), trace amounts of the
corresponding enol ether 344 were observed in the 1H NMR spectrum of the crude
reaction mixtures; however, these side products could not be isolated. With these results
in hand, it was decided that a –pClC6H4 group would be investigated in the R1 position.
Surprisingly, the corresponding furan 343f was obtained in a very poor yield of 3%
(compared to 62% for 343d, entry 4). In addition to furan 343f, enol ether 344f, where
the aryl group was in the Z-configuration relative to the propargyl group,9 and the furan
regioisomer 343f’, were both obtained in 9% yields (entry 6). Intrigued by this result,
substrates bearing unsubstituted phenyl rings in the R1 position were then investigated.
The first substrate with a phenyl ring at R1 possessed a terminal alkyne moiety (R2 = H).
The yield obtained for furan 343g was only 5% and enol ether 344g was also isolated in
10% yield (entry 7). Similarly, when R1 = Ph and R2 = Et, the yield of furan 343h was
4% and the Z-isomer of enol ether 344h, as well as the furan regioisomer 343h’, were
obtained in 12% yield and trace yield (2%), respectively. For entries 6 and 8, yields of
343 and 343’ may have in fact been higher, but given their close Rf values, product may
have been lost in an attempt to avoid contamination of the two regioisomers. Also for
entries 6-8, TLC analysis and 1H NMR spectroscopy indicated that these reactions were
not very selective for the desired furan 343, and multiple side/degradation products
occurred that could not be isolated or characterised.

8

TBS group was used instead of TMS to decrease the likelihood of desilylation of 343e during purification.
Throughout this chapter the major isomer obtained of the enol ether 344 will be referred to as the Z-isomer
based on the orientation of the aryl group relative to the propargyl group (as opposed to standard naming
conventions)
9
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Table 2.3. Substrate scope for the gold(I)-catalysed formation of furans 343

Entry

342

Substrate

Time

% Yields 343:343’:344

1

a

1.25 h

42:0:0

2

b

30 mins

80:0:0

3

c

2h

73:0:0

4a

d

2h

62:0:0

5a

e

2.5 h

52:0:0

6b

f

50 mins

3:9:9 (Z-isomer)c

7

g

45 mins

5:0:10 (Z-isomer)c
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8

h

1h

4:2:12 (Z-isomer)c

9b

i

1h

9:0:3 (Z-isomer)c

10b

j

2h

5d:2:6 (Z-isomer)c

11

k

1.5 h

19:3:25 e
(Z:E ratio 78:22)

12b

l

1h

5:11:22 (Z-isomer)c

15:7:24 e

13

m

40 mins

14

n

3.5 h

No products isolated

15

o

2h

23:0:0

(Z:E ratio 75:25)

a1

H NMR of crude reaction indicates trace amounts of 344 which could not be isolated; b 1H NMR of crude
reaction indicates presences of multiple complex products and/or degradation; c Z isomer refers to the
orientation of the aryl group to the propargyl group, it is not based on naming convention; d product was
contaminated with trace impurities of unidentified side product that could not be separated; e furans 343
and 343’ were obtained as an inseparable mixture, yields are based on the ratio of 343:343’ in the 1H NMR
spectrum
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Due to the poor results obtained in entries 6-8 (Table 2.3), it was decided that
substrates with a halogen in the meta- and para-positions of the aryl ring would be
synthesised to see if a reactivity trend could be established. Cyclopropenyl propargyl
ether 342i was synthesised with a –mBrC6H4 group in the R1 position, and an ethyl group
in the R2 position (entry 9). Curiously, the yield of the corresponding furan 343i obtained
was only 9% compared to the result of the o-Br derivative in entry 2, where the yield was
80%. In the case of the meta-substituted substrate, the Z-isomer of enol ether 344i was
also isolated in 3% yield (entry 9). The reaction seemed to perform even worse when the
Br-substituent was moved to the para-position of the aryl ring, as furan 343j was obtained
in poor yield (5%) (entry 10). Both the furan regioisomer 343j’ and the Z-isomer of enol
ether 344j were also obtained in 2% yield and 6% yield, respectively. It was evident from
the results thus far that some kind of stereoelectronic effect was influencing the reaction
pathway(s) occurring when the cyclopropenyl propargyl ethers 342 were reacted with the
gold(I)-catalyst. In an effort to experimentally probe this phenomenon, various
cyclopropenyl ethers 342, with ortho- or para-substituted aryl rings in the R1 position,
were subjected to the gold(I)-catalysis conditions.
F-substituted derivatives were next explored and it was found that when
cyclopropenyl ether 342k (R1 = –oFC6H4) was reacted under the gold(I)-catalysis
conditions, both furan 343k and the regioisomer 343k’ were obtained as a mixture in 19%
and 3% yields, respectively (entry 11). A mixture of both the Z- and the E-isomers of enol
ether 344k were also isolated in 25% combined yield (Z:E 78:22). When the F-substituent
was moved to the para-position of the aryl ring, the yield obtained for the desired furan
343l was 5%, while the furan regioisomer 343l’ and the Z-isomer of enol ether 344l, were
also obtained in 11% and 22% yields, respectively (entry 12). Clearly, having an o-F
substituent on the aryl ring was not as beneficial to the reaction as having an o-Br or o-Cl
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group. Following the investigation of inductively electron-withdrawing halogen groups
on the aromatic ring, mildly electron-donating methyl groups were next studied. When
cyclopropenyl propargyl ether 342m (R1 = –oMeC6H4) was reacted, a similar result to
that of the o-F derivative was observed whereby a mixture of furans 343m and 343m’
were obtained in 15% and 7% yields, respectively (entry 13). Both the Z- and the Eisomers of enol ether 344m were also obtained as a mixture in a combined yield of 24%
(Z:E 75:25). When the p-Me derivative 342n was attempted however, near total
decomposition resulted and only trace amounts of furan 343n were observed (entry 14).
The last substrate to be investigated with an aryl group in the R1 position, was
cyclopropenyl propargyl ether 342o where R1 was an electron-withdrawing –oNO2C6H4
group (entry 15). Unlike the o-F and o-Me derivatives, only furan 343o was obtained in
a 23% yield – there was no observable formation of the furan regioisomer 343’ or the
enol ether 344. There was however, another side product that formed according to the 1H
NMR spectrum of the crude reaction but this side product could not be identified as it
apparently degraded on the silica column during purification.
Following the substrate scope for cyclopropenyl propargyl ethers 342 bearing aryl
rings in the R1 position, it was clear that ortho-halogen substituents – specifically Br and
Cl – were required for the smooth rearrangement to obtain furan 343. For other orthosubstituents such as F or Me, yields of furan 343 were reduced and side products,
including the furan regioisomer 343’ and enol ether 344, were observed in more
substantial amounts. However, meta- or para-substituents on the aryl ring were almost
completely detrimental to the formation of furan 343. A computational study was
performed to provide more information on why only ortho-halogen substituents (Cl and
Br) are tolerated by this reaction, which will be discussed in detail in Section 2.3.3.4.
Given the divergence in product selectivity by simply changing the substituent around the
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aryl ring of cyclopropene 342, NMR spectroscopy had to be used in each case to confirm
the formation for furan 343, as well as the furan regioisomer 343’ and enol ether 344.

2.3.3.2. Characterisation of the Products Obtained from the Gold(I)-Catalysed
Rearrangement of Cyclopropenyl Propargyl Ethers 342 when R1 = Aryl Group
The first structure to be confirmed was that of the desired furan, with substrate
343a (R1 = –oBrC6H4, R2 = H) being characterised as an example. HRMS was performed
and confirmed the molecular weight of furan 343a. Ring-opening of the cyclopropene
moiety and formation of the tetrasubstituted alkene was first confirmed as the sp 3
quaternary 13C signal that had occurred at ~20 ppm for cyclopropene 342a, was gone in
the

13

C NMR spectrum for furan 343a. Instead two sp2 quaternary

13

C signals were

observed at δ 121.0 and δ 129.3 ppm, which correlated to the three singlets (integration
of 3H each) between δ 1.35-1.85 ppm, in the HMBC spectrum (Figure 2.7) that
represented three CH3 groups. An additional singlet (integration of 3H) was also observed
at δ 2.34 ppm (CH3a) and confirmed the presence of a fourth CH3 group. A 1H signal was
also observed at δ 5.97 ppm (Hb) that correlated to the 13C signal at δ 108.9 ppm (Cb) in
the HSQC spectrum (see appendix, pg 406) and represented a =CH group. In the HMBC
spectrum (Figure 2.7), the CH3a 1H signal correlated strongly to Cb and also had a strong
correlation to the quaternary 13C signal at δ 151.1 ppm (Cc). Proton Hb also had a strong
correlation to Cc. This suggested that the methyl group represented by CH3a was attached
to Cc and that the =CH group represented by Hb (and Cb) were directly adjacent to Cc.
Proton Hb also had strong correlations to the quaternary 13C signals at δ 127.1 (Cd) and δ
145.8 (Ce) ppm. The formation of the furan ring was thus supported as four quaternary
carbons not associated with either the aryl ring or the tetrasubstituted alkene (Cc, Cb, Cd
and Ce), were present that had strong correlations to Hb. The downfield chemical shifts of
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the aromatic quaternary carbons represented by Cc and Ce were also very consistent with
the 2- and 5-positions of a furan and provided more conclusive support. Therefore, CH3a
must be in the 5-position (correlation between CH3a and Cc) while Hb must be in the 4position of the ring. Looking at one of the aromatic 1H signals occurring as a multiplet
between δ 7.21-7.32 ppm (integration of 2H), this peak had a weak correlation to Ce in
the HMBC spectrum and supported that the aromatic group was in the 2-position of the
furan ring. The position of the tetrasubstituted alkene on the furan ring was then able to
be confirmed based on the weak correlation of the CH3 group represented by the singlet
at δ 1.66 ppm, to Cb and Ce in the HMBC spectrum. The alkene must therefore be in the

CH3a
Hb

Cb
Cd
Ce
Cc

Figure 2.7. HMBC spectrum for furan 343a with a labelled structure showing important correlations. Solid
lines indicate a known relationship between the 1H and 13C signals. Dashed lines indicate a relationship
exists between the functional group and the carbon on the furan ring but the exact identity of the group
represented by the 1H signal is uncertain.
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3-position of the furan ring for these correlations to exist and thus confirms the overall
structure – especially the regiochemistry – of furan 343a.
The structure of the furan regioisomer 343’ was next confirmed by NMR
spectroscopy and substrate 343f’ (R1 = –pClC6H4 and R2 = Et) was used as an example.
From the 1H and

13

C NMR spectra of 343f’, it was immediately suspected that a

regioisomer of furan 343f had been formed. The sp2 quaternary 13C signals of the furan
ring were observed at δ 145.6 (Ca), δ 120.2 (Cb), δ 150.0 (Cc) and δ 121.6 (Cd) ppm. A
methyl group was also represented by the singlet 1H signal at δ 2.26 (CH3e) that correlated
to the 13C signal at δ 11.7 ppm, in the HSQC spectrum (see appendix, pg 413). The CH3e
1

H signal correlated to Ca and Cb in the HMBC spectrum (Figure 2.8). The CH2 group of

the ethyl substituent was represented by the quartet 1H signal at δ 2.37 ppm (CH2f) that
also had correlations to Ca, Cb and the CH3e

13

C signal in the HMBC spectrum. These

correlations therefore confirmed that the CH3 group was attached to the 5-position of the
furan ring and that the ethyl group was attached to the 4-position of the furan ring. The
presence of the tetrasubstituted alkene was also confirmed by the presence of the three
methyl groups represented by singlets between δ 1.30-1.90 ppm that all correlated to the
sp2 quaternary 13C signals at δ 119.4 (Ch) and δ 133.6 (Ci) ppm, in the HMBC spectrum.
Specifically, the singlet at δ 1.84 (CH3g) was observed to have correlations to Ch and Ci,
as well as a correlation to Cc. This therefore suggested that that tetrasubstituted alkene
was in the 2-position of the furan ring. A doublet 1H signal at δ 7.13 ppm was then
observed that represented two chemically equivalent CHAr groups of the –pClC6H4
substituent. As these CHAr groups were more shielded, it suggested that they were in the
meta-position of the aryl ring relative to the Cl atom. This 1H signal was observed to
correlate to Cd in the HMBC spectrum, which supported that the –pClC6H4 group was
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attached to the 3-position of the furan and therefore confirmed the regiochemistry of
343f’.

CH3e
CH3g
CH2f

Ce

Ch
Cb
Cd
Ci

Ca

Figure 2.8. HMBC spectrum for rearranged furan 343f’ with a labelled structure showing important
correlations

Substrate f (R1 = –pClC6H4, R2 = Et) was also used as the example to confirm the
structure of enol ether 344. The structure of enol ether 344f was known to contain the
propargyl group as 1H and 13C signals consistent with this moiety were observed in the
NMR spectra. In particular the quaternary 13C signals at δ 74.6 and δ 89.4 ppm in the 13C
NMR spectrum were consistent with the sp quaternary carbons of an internal alkyne.
Ring-opening of the cyclopropene moiety to a tetrasubstituted alkene was known to have
occurred based on the lack of an sp3 quaternary 13C signal around δ 20 ppm in the

13

C

119

NMR spectrum and the occurrence of three CH3 groups represented by the singlet 1H
signals between δ 1.63-1.85 ppm in the 1H NMR spectrum. A CH signal was also
observed at δ 6.17 ppm (Ha) that correlated to the 13C signal at δ 143.3 (Ca) ppm in the
HSQC spectrum (see appendix, pg 415). The sp2 nature of Ca, as well as the downfield
chemical shift, suggested that these signals represented a =CH group directly adjacent to
either the oxygen atom or the aryl group. The 1H signal at δ 4.44 (CH2b) ppm (correlated
with δ 60.1 ppm in the HSQC spectrum), was also consistent with the chemical shift of
the –CH2 group adjacent to the oxygen atom in the propargyl substituent.
From the HMBC spectrum (Figure 2.9), Ha had strong correlations to the CH2b
13

C signal and quaternary 13C signals at δ 120.2 (Cc) and δ 135.0 (Cd) ppm. Carbon Cd

was consistent with the chemical shift of an aromatic quaternary signal (supported by
correlations with the aromatic 1H signals), therefore it was presumed that Cc was directly
attached to Ca via a double bond. As Cc was quaternary, it also indicated that the newly
formed double bond was trisubstituted. The CH2b 1H signal correlated to Ca and the not
any of the 1H signals of the aryl group which suggested that Ha and the oxygen atom of
the propargyl group were both attached to the carbon represented by Ca. It was also
observed that the 1H signal at δ 7.44 ppm that represented the two CHAr groups in the
ortho-position to the Cl atom of the aryl group, and the 1H signal at δ 1.68 ppm that
represented one of the CH3 groups of the tetrasubstituted alkene, both correlated to Cc in
the HMBC spectrum. This supported that the –pClC6H4 group and the tetrasubstituted
alkene were both connected to the carbon represented by Cc and consequentially
confirmed the overall structure – especially the regiochemistry – of enol ether 344f.
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CH2b
a

H

Ca

Cc
Cd
b

C

Figure 2.9. HMBC spectrum for enol ether 344f with a labelled structure showing important correlations.
Solid lines indicate a known relationship between the 1H and 13C signals. Dashed lines indicate a
relationship exists between the functional group and the 13C signal of the double bond but the exact methyl
group represented by the 1H signal is uncertain.

The orientation about the double bond in enol ether 344f was assigned by
performing 1D NOESY experiments (Figure 2.10). When one of the CH3 1H signals of
the tetrasubstituted alkene (δ 1.68 ppm)10 was irradiated, through space correlations to Ha
were observed. When Ha was irradiated, it had through space correlations to the CH2b 1H
signal, as well as correlations to the 1H signals representing the three CH3 groups of the
tetrasubstituted alkene. Proton Ha however, did not correlate to any of the aromatic 1H

Due to their closeness in the 1H NMR spectrum, both the 1H signals at δ 1.68 and δ 1.73 ppm were
irradiated. Therefore, the exact CH3 group resulting in the correlations observed, is unknown.
10
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signals. Based on the correlations observed, it was concluded that the tetrasubstituted
alkene had to be in the E-configuration relative to the propargyl group, while the aryl
group had to be in the E-configuration relative to Ha. Having the aryl group in the Zconfiguration relative to the propargyl group accounted for all the correlations (or lack
thereof) observed, thus the orientation of enol ether 344f was confirmed.

Figure 2.10. Labelled structure of enol ether 344f showing important NOE correlations

Once the structures of desired furan 343 and the two isolated side products, furan
regioisomer 343’ and enol ether 344, had been confirmed, mechanistic pathways were
proposed to account for their formation. In particular, the mechanism(s) had to account
for the observed change in product selectivity when the aryl group in the R1 position of
cyclopropenyl propargyl ether 342, was not substituted with an o-Br or o-Cl substituent.

2.3.3.3. Proposed

Mechanisms

for

the

Gold(I)-Catalysed

Rearrangement

of

Cyclopropenyl Propargyl Ethers 342 to Furan 343, Furan Regioisomer 343’ and
Enol Ether 344
Once the scope of the reaction had been investigated with cyclopropenyl
propargyl ethers 342 bearing aryl groups in the R1 position, reasonable conclusions could
be drawn about how gold was catalysing the rearrangement of these substrates to the
desired furan 343, furan regioisomer 343’ and enol ether 344. The first reaction
mechanism to be studied was the pathway resulting in the rearrangement of cyclopropene
342 to the desired furans 343 (Scheme 2.16). It was proposed that the mechanism first
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involved coordination of the electrophilic gold species to the double bond of the
cyclopropene moiety in 346. This activated the cyclopropene towards ring-opening by
cleavage of the C1–C3 bond and thus generated the gold-stabilised carbocation
intermediate 347. A 1,2-hydrogen shift (or hydrogen elimination) followed by deauration
was then proposed to occur by pathway A (red arrows), to generate the enol ether
intermediate 348. The next step of the reaction mechanism was proposed to involve a
gold-assisted propargyl-Claisen rearrangement. Given the π-rich nature of the triple bond
of 348, the electrophilic gold species would coordinate with the alkyne and activate it
towards a 6-endo-dig addition by the enol ether. The Claisen rearrangement would then
progress through the 6-membered ring intermediate 349, to form the allenic ketone
intermediate 350. The allene moiety would also be readily activated by gold. Thus,
coordination of gold to the distal double bond could facilitate a 5-exo-dig cyclisation to
generate the gold-oxocarbenium intermediate 351. Elimination of a hydrogen and
protodeauration would then result in the polysubstituted furan products 343 observed in
Table 2.3 (Section 2.3.3.1, pg 112).
Having determined a plausible mechanism for the formation of the desired furan
343, a mechanism for the formation of the furan regioisomer 343’ and enol ether 344 had
to be proposed. To account for the formation of these side products, it was still proposed
that the cyclopropene moiety of 342 was ring-opened by the gold catalyst to generate the
gold-stabilised carbocation intermediate 347 (Scheme 2.16). Divergence in the product
selectivity was then proposed to occur at this stage with a 1,2-aryl shift occurring by
pathway B (blue arrows), rather than the 1,2-hydrogen shift shown for pathway A. This
1,2-aryl shift followed by deauration would therefore explain the formation enol ether Z344, which was isolated in most cases when a substrate was reacted that did not bear an
aryl ring with an o-Br or o-Cl substituent (Table 2.3, pg 112). At this stage it was
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tentatively proposed that the Z-isomer of enol ether 344 was isolated due to slightly
greater steric repulsions of the propargyl group with the aryl ring and tetrasubstituted
alkene.11 The E-isomer of 344 however, may experience less steric repulsions thereby
allowing this isomer to undergo a gold-catalysed propargyl Claisen rearrangement.
Activation of the triple bond of E-344 followed by a 6-endo-dig cyclisation would result

Scheme 2.16. Proposed reaction mechanism for the gold(I)-catalysed rearrangement of cyclopropenyl
propargyl ethers 342 to furan 343, furan regioisomer 343’ and enol ether 344
Enol ether Z-344l (R1 = –pFC6H4, R2 = Et) was resubjected to [(Ph3PAu)3O]BF4 (10 mol%) in DCE with
heating (50 °C for 1 h then 85 °C overnight). 1H NMR spectrum revealed that substantial amounts of
Z-X344l were still present, therefore the Claisen rearrangement does not readily occur for this isomer.
11
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in the 6-membered ring intermediate 352, followed by a Grob-type fragmentation to give
the allenic aldehyde 353. A gold-catalysed 5-exo-dig cyclisation of the carbonyl group
with the allene of the allenic aldehyde 353, was then proposed to result in the formation
of the 5-membered ring oxocarbenium intermediate 354. At this stage one of two
migrations could occur. A 1,2-alkyl shift of the tetrasubstituted alkene (orange arrows),
followed by aromisation and protodeauration was proposed to result in the furan
regioisomer 343’. However, a 1,2-aryl shift (purple arrows), followed by aromisation and
protodeauration could also occur to result in the desired furan 343. As was observed in
the substrate scope when the R1 position was substituted with an aryl ring that did not
bear an o-Br or an o-Cl group (Table 2.3, pg 112), the yields of the desired furan 343 and
the furan regioisomer 343’ were very low. From the mechanism proposed in Scheme 2.16,
there are numerous opportunities for additional side reactions to occur. For example, the
1,2-migrations could have occurred earlier in the mechanism when the 6-membered ring
intermediate 352 was formed. This would have created a more stable intermediate
compared to 352 and may have been a more favourable side reaction that would have
resulted in different products. The reactions resulting in the furan regioisomer 343’ and
the enol ether 344 produced complex mixtures however, and not all side products could
be successfully isolated and characterised.
One of the key steps in the mechanisms for the formation of furan 343 and the
furan regioisomer 343’, was the gold(I)-assisted propargyl Claisen rearrangement of enol
ether 348 (or E-344) to the allenic ketone 350 (or allenic aldehyde 353), via the 6membered ring intermediate 349 (or 352) (Scheme 2.16). Experimental support for goldassisting this rearrangement could be ascertained by comparing the rearrangement of the
cyclopropenyl allyl ether 320a to the dienyl ketone 323a (Scheme 2.4, Section 2.2.1.2,
pg 86), and the rearrangement of cyclopropenyl propargyl ether 342a to furan 343a in
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Table 2.2, entry 13 (Section 2.3.2, pg 105). The gold(I)-catalysed rearrangement of 320a
to 323a had required excessive heating to force the Claisen rearrangement to occur, while
the gold(I)-catalysed rearrangement of 342a to 343a could progress at room temperature.
Evidently, heating was not essential for the propargyl Claisen rearrangement to proceed,
indicating that something had to be assisting the reaction. Literature precedence for a
gold-assisted propargyl Claisen rearrangement was then found to have been reported by
Sherry and Toste in a 2004 investigation. They had studied enantioenriched propargyl
vinyl ethers 355 (Scheme 2.17) that were very similar to enol ether intermediate 348,
proposed in Scheme 2.16 (pg 124). When subjected to gold(I)-catalysis conditions, the
gold activated the triple bond to facilitate a 6-endo-dig addition of the enol ether to the
gold–alkyne complex in 356, thus forming the 6-membered ring intermediate 357
(Scheme 2.17). The authors suggested that the excellent diastereoselectivity (>20:1) of
the reaction, was the result of the half-chair transition state leading to intermediate 357,
as the vinyl substituent (R1) would occupy the pseudoequatorial position while the
propargylic group (R2) would occupy the pseudoaxial position to avoid A1,2-strain with
the vinyl gold group. A Grob-type fragmentation of intermediate 357 was then proposed
to occur, resulting in the generation of the allenic aldehyde 358 which was isolated by
reduction to the corresponding alcohol 359, in good to excellent yields (76-98%) with
retention of ee. The authors also found that in the absence of gold, the reaction had to be
heated to 170 °C for 3 h to catalyse the Claisen rearrangement and that the
diastereoselectivity was lower and reversed to favour the opposite diastereomer to that
shown in Scheme 2.17 (1:1.5 dr), thus demonstrating the importance of the gold. [139]
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Scheme 2.17. Gold-assisted propargyl Claisen rearrangement of propargyl vinyl ethers 355 as proposed by
Sherry and Toste [139]

Literature support for the proposed mechanism in Scheme 2.16 (pg 124), was also
provided by the investigations by Kirsch, Hiersemann and Shi see in Scheme 2.2 (Section
2.1, pg 83). In these investigations, propargyl vinyl ethers 363 were reacted with a gold
catalyst (Scheme 2.18).[128-130] In the case of the intermolecular example reported by Shi,
et al., the gold catalyst activated the triple bond of alkyne 360, thus allowing the
nucleophilic oxygen of the propargyl alcohol 361 to attack the gold–alkyne complex 362
and form 363, following protodeauration.[130] These authors, like Sherry and Toste, had
proposed that the reaction mechanism involved a 6-endo-dig addition of the enol ether
onto the gold–alkyne complex shown in 364, to produce a 6-membered ring intermediate
365. Intermediate 365 was then proposed the collapse to the β-allenic ketone 366. A goldcatalysed 5-exo-dig cyclisation was then proposed to result in the observed furan products
368.[128-130]
As evidence for the proposed formation of the β-allenic ketone intermediate,
Kirsch et al. found that when a propargyl vinyl ether 363 was reacted with AuCl3, the
corresponding β-allenic ketone 366 could be isolated as an isomeric mixture in 47% yield.
Capillary gas chromatography also detected the β-allenic ketone 366 as an intermediate
during the gold-catalysed conversion of 363 to furan 368. The β-allenic ketone 366 could
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also be obtained by reacting the propargyl vinyl ether 363 with AgBF4 (10 mol%) with
no observable conversion to the corresponding furan 368.[128] Therefore, the results
obtained in this investigation when 342a was reacted with AgBF4 (Scheme 2.15, Section
2.3.2, pg 107), were consistent with the literature. Given the presence of the allene in
intermediate 366, the gold catalyst could have facilitated other cyclisation pathways that
are allowed according to Baldwin’s Guidelines. Indeed, Shi et al. suggested that the 6endo-trig cyclisation might be favourable due to the formation of the highly stable vinyl
gold complex 369. However, given the stability of 369, protodeauration would be
slow,[130] and as a result, the 5-exo-dig cyclisation pathway was preferred. The 5-exo-dig
cyclisation would also be favoured due as the formation of a 5-membered, aromatic
heterocycle as primary driving force.[142]

Scheme 2.18. Gold(I)-catalysed formation of furans 368 from propargyl vinyl ethers 363
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Having determined product selectivity for the gold(I)-catalysed rearrangement of
cyclopropenyl propargyl ethers 342 hinged upon a 1,2-migration of either the hydrogen
or the aryl group of the gold-stabilised carbocation 347 (Scheme 2.16, pg 124),
computational calculations were performed to further elucidate the stereoelectronic
effects governing this step. These results are discussed in the following section.

2.3.3.4. Computational Results
To study the 1,2-aryl shift shown in Scheme 2.16 (pg 124) and determine why this
rearrangement was prevented by placing either an o-Br or o-Cl substituent on the aryl
ring, DFT calculations were performed. These calculations were kindly performed and
processed by Professor Alireza Ariafard of the University of Tasmania, Australia. As
depicted in Scheme 2.16 the gold-stabilised carbocation 347, generated from the ringopening of the cyclopropenyl propargyl ether 342, was the point of divergence for the
two competing pathways. Pathway A resulted in high yields of furan 343 and involved a
1,2-hydrogen shift, while pathway B resulted enol ethers Z-344 (isolated) and E-344, the
latter of which formed the furan regioisomer 343’ and involved at 1,2-aryl shift. The
transition state energies for the 1,2-hydrogen shift (1TS) and the 1,2-aryl shift (2TS) were
calculated for numerous propynoxy gold carbenoids 370, bearing aryl groups with
different substituents around the ring (Table 2.4). If the energy of 1TS was lower than
2TS (i.e. values of ΔG1TS-2TS negative), than the 1,2-hydrogen shift was favoured, whereas
if the energy of 1TS was greater than 2TS (i.e. values of ΔG1TS-2TS positive), than the 1,2aryl shift was favoured. The first substrate to be investigated was an o-Br substituent
which gave a ΔG1TS-2TS value of -1.9 (Table 2.4, entry 1), while the o-Cl substituent gave
a ΔG1TS-2TS of -1.3 (Table 2.4, entry 2). These results were in excellent agreement with
the experimental results in Table 2.3 (entries 1-3 for o-Br and entries 4-5 for o-Cl) as it
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supported that the 1,2-hydrogen shift was in fact favoured and lead to good yields of the
desired furan 343. An unsubstituted phenyl ring however, resulted in a ΔG1TS-2TS value of
2.2 (Table 2.4, entry 3) and indicated that the 1,2-aryl shift was more favourable. Indeed,
this was observed experimentally in Table 2.3 (entries 6 and 7) as the yields of the desired
furan 343 were significantly lower and the enol ether Z-344 and furan regioisomer 343’
side products were observed. The strong correlation between the computational results in
Table 2.4 and the experimental results in Table 2.3 were further demonstrated by the pBr, p-Cl and p-F substituents all giving positive ΔG1TS-2TS values (Table 2.4, entries 4-6),
indicating that the 1,2-aryl shift was favoured over the 1,2-hydrogen shift. For the o-F
(Table 2.4, entry 7) and o-Me (Table 2.4, entry 8) substituents, the ΔG1TS-2TS values were
0.4 and 0.5, respectively. This suggested that the 1,2-aryl shift was only slightly favoured
over the 1,2-hydrogen shift and would explain why higher yields of the desired furans
343k (Table 2.3, entry 11) and 343m (Table 2.3, entry 13) were obtained in comparison
to other reactions were side products 344 and 343’ were also observed. A substrate of 370
bearing an aryl group with an o-NH2 substituent was also investigated which resulted in
a ΔG1TS-2TS value of 6.9 (Table 2.4, entry 9). This indicated that higher yields of enol ether
Z-344 and furan 343’ should be obtained. However, this substrate had not been
synthesised as cyclopropenyl carbinol derivatives bearing aryl groups with strongly
electron-donating substituents, are not typically stable. Interestingly, the DFT
calculations for the substrate bearing an o-NO2 substituent gave a ΔG1TS-2TS value of
-10.6 (Table 2.4, entry 10). This would suggest that the experimental yield of 343o (Table
2.3, entry 15) should have been higher. However, this calculation only indicated that the
1,2-hydrogen shift was favoured over the 1,2-aryl shift and did not account for any other
side reactions that may have occurred. Indeed, when considering the 1H NMR spectrum
of the crude mixture when cyclopropenyl propargyl ether 342o was reacted under the
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gold(I)-catalysis conditions, no evidence of enol ether Z-344 or the furan regioisomer
343’ were observed, thus a strong correlation between the computational and
experimental results still existed.
Table 2.4. Relative energies of 1TS and 2TS for different aryl groups

Entry

Ar

1TS

2TS

∆G1TS-2TS

1

o-Br

5.9

7.8

-1.9

2

o-Cl

6.8

8.1

-1.3

3

Ph

5.1

2.9

2.2

4

p-Br

7.1

4.4

2.7

5

p-Cl

8.2

5.1

3.1

6

p-F

7.1

4.6

2.5

7

o-F

5.1

4.7

0.4

8

o-Me

5.6

5.1

0.5

9

o-NH2

5.0

-1.7

6.9

10

o-NO2

3.8

14.5

-10.6

To explain why the o-Br, o-Cl and o-NO2 substituents favoured the 1,2-hydrogen
shift, it should be noted that the aryl ring in the 2TS structure possesses a positive charge
as shown in the scheme of Table 2.4. If this positive charge was not stabilised by the
substituent on the aryl ring, then the 1,2-aryl shift occurred slowly and the 1,2-hydrogen
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shift was favoured. The o-Br, o-Cl and o-NO2 substituents did not stabilise this charge
and as a result, the energy of 2TS was higher than the 1TS energy and the 1,2-hydrogen
shift occurred. This hypothesis was supported by isodesmic reactions shown in Scheme
2.19. From equations 1-3, the reaction potential energies were all positive. This indicated
that having a Br-, Cl- or NO2-substituent in the α-position relative to the sp3 carbon of the
carbocation, had a destabilising effect. In comparison, having a Br or a Cl substituent in
the γ-position to the sp3 carbon of the carbocation was far more stabilising as shown in
equations 4 and 5, respectively.

Scheme 2.19. Isodesmic reactions for stabilisation of the positive charge by substituents on the aryl ring
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The relative potential energies of 2TS were plotted against the isodesmic reaction
energies (Figure 2.11) and it was observed that a good correlation existed. This correlation
helped to support that the magnitude of the energy barrier to the 1,2-aryl migration, was
related intrinsically to the stability of the carbocation generated in the transition structure
of 2TS. Therefore, this explained why no enol ethers Z-344 or furan regioisomers 343’

(for isodesmic reactions given in Scheme 2.19)

∆E

were observed when the aryl ring was substituent with an o-Br, o-Cl or o-NO2 group.

∆E'
(activation potential energy for aryl migration )

Figure 2.11. Correlation between the relative potential energy of 2TS and the isodesmic reaction energies
from Scheme 2.19

In summary, it has been clearly demonstrated by experimental and computational
results that having an aryl group without an o-Br or an o-Cl substituent in the R1 position
of cyclopropene 342, results in the gold-stabilised carbocation 347 (Scheme 2.16, pg 124)
undergoing an undesirable 1,2-aryl shift that significantly decreases the yield of the
desired furan 343. To prevent this 1,2-aryl shift, the obvious solution was to substitute
the R1 position with an alkyl group. The outcome of the gold(I)-catalysed rearrangement
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of the cyclopropenyl propargyl ether bearing an alkyl group in the R1 position was
therefore investigated and will be discussed in the following section.

2.3.4. Gold(I)-Catalysed Rearrangements of Cyclopropenyl Propargyl Ethers 342
when R1 = Alkyl Chain
2.3.4.1. Products Obtained from the Gold(I)-Catalysed Rearrangement of Cyclopropenyl
Propargyl Ethers 342 when R1 = Alkyl Chain
In an attempt to avoid the 1,2-aryl shift that resulted in the formation of the furan
regioisomer 343’ and enol ether 344 and consequently reduced the yield of the desired
furan 343, cyclopropenyl propargyl ether 342p was synthesised and subjected to the same
gold(I)-catalysis conditions (Scheme 2.20) as those substrates in Table 2.3 (Section
2.3.3.1, pg 112). While the desired furan 343p was obtained in moderate yield (47%), a
side product was obtained in 38% yield that was identified to be tetrahydrofuran 371.
Evidently, changing the R1 position from an aryl group to an alkyl group had prevented
the 1,2-aryl shift but had instead allowed for a different side reaction to take place. Before
plausible mechanisms for the formation of tetrahydrofuran 371 were considered, analysis
of the characterisation data was performed to confirm the structure of the side product.

Scheme 2.20. Gold(I)-catalysed reaction of cyclopropenyl propargyl ether 342p
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2.3.4.2. Characterisation of Tetrahydrofuran 371
The structure of tetrahydrofuran 371 was confirmed by NMR spectroscopy. In the
1

H NMR spectrum, a CH signal occurred at δ 4.66 (He) ppm and correlated to the

13

C

signal at δ 82.2 (Ce) ppm in the HSQC spectrum (see appendix, pg 437). The downfield
chemical shift of this CH signal indicated that it must be adjacent to the oxygen atom.
Proton He was then observed to correlate to 1H signals associated with the dodecyl chain
in the COSY spectrum (Figure 2.12) and suggested that the alkyl substituent was directly
attached to the carbon represented by Ce. A singlet 1H signal (integration of 2H) was also
observed at δ 4.47 ppm that correlated to the

C signal at δ 69.3 ppm in the HSQC

13

spectrum and was assigned as CH2d. The downfield chemical shift of this CH2 signal
suggested that it must also be adjacent to the oxygen atom.

CH3c CH3b
g

H

Hf’ Hf eCH2
H

d

CH3a

a
CH3b CH3

CH3c

CH2d e
H
Hf
Hf’

Hg

Figure 2.12. COSY spectrum for tetrahydrofuran 371 with a labelled structure showing important
correlations. The correlations for Hf are omitted for clarity as they are the same as Hf’
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It was then observed in the 1H NMR spectrum that a doublet 1H signal (J = 7 Hz,
integration of 3H) occurred at δ 1.60 ppm. This doublet correlated to the

13

C signal at

δ 15.3 ppm in the HSQC spectrum and was assigned as a CH3 group (CH3a). A triplet of
doublets (J = 7.0, 4.5 Hz) was observed at δ 5.90 (Hg) ppm and correlated to the 13C signal
at δ 117.4 (Cg) ppm in the HSQC spectrum and was assigned as a =CH group based on
the sp2 nature of the carbon. Given the coupling constants of the CH3a and Hg signals and
their correlation to one another in the COSY spectrum, it indicated that the CH3 group
represented by the CH3a was directly attached to the carbon represented by Cg. It was then
observed in the HMBC spectrum (Figure 2.13) that the CH3a 1H signals had a correlation
to a sp2 quaternary 13C signal at δ 136.0 (Ck) ppm. Carbon Ck must therefore be connected
via a double bond to Cg and therefore supported the occurrence of a trisubstituted alkenyl
group in the structure of tetrahydrofuran 371. A correlation in the COSY spectrum
between the CH2d 1H signals and Hg also supported that the alkenyl group was directly
adjacent to the CH2 group represented by the CH2d signals. From another HMBC
spectrum (see appendix, pg 437) performed on a slightly less clean sample of 371, proton
Hg was also observed to have a correlation to a sp 2 quaternary 13C signal at δ 132.8 (Cj)
ppm. Given that the carbon represented by Ck was sp2 in nature, a bond must therefore
exist between Ck and Cj.
The final part of the structure that had to be confirmed for tetrahydrofuran 371
was the diene moiety. In the 1H NMR spectrum, two singlets were observed at δ 4.77 (Hf)
and δ 4.94 (Hf’) ppm that correlated to the same

13

C signal at δ 112.7 (Cf) ppm in the

HSQC spectrum. The chemical shift of these signals indicated that they represent the
terminal CH2 group of the disubstituted alkene. The two CH3 groups were also
represented by singlets at δ 1.78 (CH3b) and δ 1.84 (CH3c) ppm that correlated to the 13C
signals at δ 22.1 and δ 20.4 ppm, respectively in the HSQC spectrum. In the HMBC
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spectrum (Figure 2.13), Hf and Hf’ correlated to the CH3c 13C signal and a sp2 quaternary
13

C signal at δ 130.3 (Ch) ppm. Carbon Ch must therefore represent the quaternary carbon

of the disubstituted alkene. The CH3c 1H signal was then observed to have a correlation
to the quaternary 13C signal at δ 147.7 (Ci) ppm (as well as Cf and Ch). The sp2 nature of
Ci supported the presence of another alkene in close proximity to the disubstituted alkene.
Looking at the CH3b 1H signal, strong correlations to Ci, Ch and Cj were observed. These
correlations indicated that the CH3 group represented by the CH3b signals was attached to
the carbon represented that Ci and that a double bond existed between Ci and Cj. This
confirmed the presence of the diene moiety and due to the aforementioned correlation
between Hg and Cj, the diene moiety was directly adjacent to the alkenyl moiety and
therefore proved the overall structure of tetrahydrofuran 371.

CH3c CH3b
Hf’ Hf

CH2d

CH3a

e

H
Cc

Ce

Cfg
C
Ch
Cjk
C
Ci

Figure 2.13. HMBC spectrum for tetrahydrofuran 371 with a labelled structure showing important
correlations. The correlations for Hf have been omitted for clarity as they are the same as Hf’. Dashed arrow
from Hg indicates that the correlation was observed in the HMBC spectrum found in the appendix.
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2.3.4.3. Proposed Mechanisms for the Gold(I)-Catalysed Formation of Tetrahydrofuran
371
Having confirmed the structure of tetrahydrofuran 371, plausible mechanisms
were proposed to account for the formation of this side product (Scheme 2.21). For the
rearrangement of cyclopropene 342p, gold-activation of the cyclopropene π-bond as
shown in 372, followed by ring-opening to the gold-stabilised carbocation 373 and gold
carbene 373’, was first considered. If the gold-stabilised carbocation 373 were to undergo
a 1,2-hydrogen shift by ‘Pathway A’ (red arrows), then the enol ether intermediate 374
would be generated. The gold-catalyst could then activate the triple bond and facilitate a
5-exo-dig cyclisation to form the 5-membered ring intermediate 375. It was then proposed
that a 1,2-hydrogen shift would occur to give intermediate 376, as the tetrasubstituted
alkene and the alkenyl gold substituent would be able to provide more resonance
stabilisation of the carbocation. Elimination of a hydrogen from one of the gem-dimethyl
groups followed by protodeauration could then give the final product 371. If the goldstabilised carbene 373’ were to undergo a cyclopropenation reaction with the triple bond
by ‘Pathway B’ (blue arrows) however, then the 3-oxabicyclo[3.1.0]hex-5-ene
intermediate 377 would be formed. When the R position was an aryl group, elimination
of a hydrogen to form the enol ether intermediate may have been favoured due to
increased conjugation. When the R position is an alkyl group however, increased
conjugation may not be as strong of a driving force for the hydrogen elimination, thus the
cyclopropenation of the alkyne might be more probable. Gold activation of the
cyclopropene moiety in intermediate 377, may then result the cyclopropyl carbocationic
intermediate 378. Back donation of electrons from the metal centre would result in the
collapse of intermediate 378, thereby generating the 5-membered ring intermediate 376’.
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Elimination of a hydrogen from one of the gem-dimethyl groups of 376’, followed by
protodeauration could then give the final product 371.

Scheme 2.21. Proposed reaction mechanisms for the formation of tetrahydrofuran 371

It was also thought however, that the gold-catalyst might activate the alkyne of
cyclopropene 342 as shown in 379, to facilitate 5-exo-dig addition of the cyclopropene πbond to the gold–alkyne complex, thus resulting in the gold-bicyclic intermediate 380 by
‘Pathway C’ (green arrows). Back-donation of electrons from the gold centre would result
in the collapse of the cyclopropyl cation to form the tetrasubstituted alkene in intermediate
376’. Therefore, tetrahydrofuran 371 could also be formed via ‘Pathway C’ following
protodeauration.
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Of the reaction mechanisms proposed, only ‘Pathway A’ was dependent on a
1,2-hydrogen migration. Therefore, an experiment was designed that would either help
support ‘Pathway A’ as the potential mechanism or rule it out. The experiment involved
the synthesis of cyclopropenyl propargyl ether 342q, which had a quaternary carbon
adjacent the cyclopropene moiety (Scheme 2.22). Therefore, the hydrogen elimination
necessary to form the enol ether intermediate 374, would not be able to take place. If the
tetrahydrofuran 371 was still able to form, it would support ‘Pathways B’ and ‘Pathway
C’, which do not require the elimination of a hydrogen to proceed. However, if
tetrahydrofuran 371 was not formed, it would indicate that the hydrogen adjacent to the
cyclopropene moiety in 342 is crucial for reactivity and would support ‘Pathway A’.
When cyclopropenyl propargyl ether 342q was subjected to the gold(I)-catalysis
conditions, a 1H NMR spectrum of the resulting crude mixture suggested that numerous
side products had been formed. Given how clean the 1H NMR spectrum of the crude
reaction of cyclopropenyl propargyl ether 342p had been, it was thought that if ‘Pathway
B’ or ‘Pathway C’ were in operation, then tetrahydrofuran 381 should have been the major
product given that the competing formation of the furan was inhibited. As this was not
the case it was tentatively suggested that ‘Pathway A’, involving a 5-exo-dig cyclisation
of 374, was the major pathway resulting in the formation of tetrahydrofuran 371.

Scheme 2.22. Gold(I)-catalysed reaction of cyclopropenyl propargyl ether 342q

Currently, it is unknown why changing the R1 group to an alkyl chain suddenly
allowed a 5-exo-dig cyclisation of the enol ether intermediate to compete with the 6-endo140

dig cyclisation. Further computational calculations comparing the gold-catalysed 6-endodig pathway and the 5-exo-dig pathway would need to be performed for when R1 is an
aryl group and an alkyl chain. Calculations comparing the stability of the furan products
to the tetrahydrofuran products when R1 is an aryl group and an alkyl chain, may also
shed some light on why the gold(I)-catalysed rearrangement of cyclopropenyl propargyl
ether 342p underwent the competing 5-exo-dig cyclisation.

2.3.5. Gold(I)-Catalysed Rearrangements of Cyclopropenyl Propargyl Ethers 342
when R2 = Phenyl Ring
2.3.5.1. Products Obtained from the Gold(I)-Catalysed Rearrangement of Cyclopropenyl
Propargyl Ethers 342 when R2 = Phenyl Ring
As part of the investigation into the scope of the reaction for the gold(I)-catalysed
rearrangement of cyclopropenyl propargyl ethers where R1 = –oBrC6H4, substrate 342r
was investigated where the R2 position was substituted with a phenyl ring. Given that R1
was –oBrC6H4 group, based on the results of Table 2.3 (Section 2.3.3.1, pg 112), it was
anticipated that minimal rearrangement to the side products 343’ and 344, would occur.
However, when cyclopropenyl ether 342r was subjected the gold(I)-catalysis conditions,
the desired furan 343r was only obtained in 12% yield as dihydro-1H-cyclopenta[c]furan
382 and tetrahydroisobenzofuran 383 were obtained in 35% and 25% yields, respectively
(Scheme 2.23).12 Before plausible mechanisms for the formation of 382 and 383 were
considered, analysis of the characterisation data was performed to confirm the structures
of these side products.

12

Reaction left for a longer period of time as it was thought that side product 382 was a key intermediate
in the formation of furan 343r and that the reaction was slow due to the altered electronic nature of the
alkyne. However, after the addition of excess catalyst had no effect on the reaction according to TLC
analysis, the reaction was stopped and the three different products were isolated.
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Scheme 2.23. Gold(I)-catalysed rearrangement of cyclopropenyl propargyl ether 342r

2.3.5.2. Characterisation of the Side Products Obtained from the Gold(I)-Catalysed
Rearrangement of Cyclopropenyl Propargyl Ethers 342 when R2 = Phenyl Ring
For the first side product, dihydro-1H-cyclopenta[c]furan 382, the first part of the
structure to be confirmed was the 5-membered, oxygen containing ring. A CH signal was
observed at δ 6.06 (He) ppm that correlated to a 13C signal underneath the TMS signal at
δ 77.0 (Ce) ppm, in the HSQC spectrum (see appendix, pg 440). This CH group was quite
deshielded and was consistent with being adjacent to an aryl ring and an oxygen atom.
Indeed, He correlated to sp2 quaternary 13C signals at δ 123.8 (Cf) and δ 139.5 (Cg) ppm
in the HMBC spectrum (Figure 2.14). Carbons Cf and Cg were also found to correlate to
the aromatic 1H signal at δ 7.59 (Hh) ppm, which given its downfield chemical shift,
represented the CHAr group in the ortho-position to the Br substituent of the aryl ring and
thus confirmed that He was adjacent to the –oBrC6H4 group. Two doublets (J = 14 Hz)
were then observed at δ 4.92 (Hd) and δ 5.00 (Hd’) ppm, which correlated to the same 13C
signal at δ 67.5 (Cd) ppm in the HSQC spectrum. Given the chemical shift of these signals,
they represented a CH2 group directly adjacent to the oxygen atom. The splitting of 1H
signals representing the same CH2 group also supported a ring structure given that Hd and
Hd’ would be in different chemical environments depending on the face of the ring they
resided on. Correlations of the He and the Hd/Hd’ 1H signals in the HMBC spectrum were
then analysed to confirm the cyclic structure of the 5-membered, oxygen containing ring.
The He signal was observed to have a correlation to a sp2 quaternary 13C signal at δ 142.6
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(Ci) ppm. The Hd and Hd’ signals were also observed to have a correlation to Ci, as well
as Ce and thus supported the occurrence of the 5-membered, oxygen containing ring. The
Hd and Hd’ signals also had correlations in the HMBC spectrum to sp2 quaternary carbons
at δ 144.8 (Cj) and δ 138.9 (Ck) ppm. Of these two carbons, Cj was assigned as being part
of the 5-membered, oxygen containing ring as Ck had additional correlations to 1H signals
associated with the cyclopentadiene ring that will be discussed vide infra.
Once the presence of the 5-membered, oxygen containing ring had been
confirmed, the presence of the fused cyclopentadiene ring had to be proven. Given the
correlation to the Hd and Hd’ signals, Ck must be directly attached to the 5-membered,
oxygen containing ring. In the HMBC spectrum, Ck was also found to correlation to a
multiplet 1H signal between δ 7.30-7.33 ppm that represented two CHAr groups of the
monosubstituted phenyl ring13 which supported that the phenyl ring was directly attached
to Ck. The three CH3 groups of the cyclopentadiene ring were then observed as singlets
at δ 1.33 (CH3a), δ 1.34 (CH3b) and δ 1.60 ppm (CH3c) in the 1H NMR spectrum. Both
CH3a and CH3b correlated to a sp3 quaternary

13

C signal at δ 62.5 (Cm) ppm and a sp2

quaternary 13C signal at δ 142.9 (Cl) ppm. Given the CH3a and CH3b 1H signals appear as
singlets, and their chemical shifts are not downfield enough to be attached to a sp 2
quaternary carbon, it indicated that CH3a and CH3b were attached to Cm. The CH3a and
CH3b 1H signals also correlated to Ck which confirmed that the gem-dimethyl groups must
be adjacent to the phenyl ring and also confirmed that a double bond must exist between
the carbons represented by Ck and Cj, to satisfy the sp2 nature of Ck. The CH3c 1H signal
also had a correlation to Cm, as well as Cl. Given the downfield chemical shift of the CH3c
signal – compared to the CH3a and CH3b signals – it indicated that the CH3 group

13

Multiplet known to represent CHAr groups of the phenyl ring due to a correlation to the
δ 126.4 ppm in the HSQC spectrum which represents two chemically equivalent carbons

13

C signal at
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represented by CH3c was attached to the carbon represented by Cl, and that Cl and Cm
were adjacent to one another in the molecule. Given the limitations of gold-catalysed
ring-opening of cyclopropenes, this relationship made logical sense. A double bond also
had to exist between the carbons represented by Cl and Ci in order to satisfy the sp2 nature
of both these carbons. The proximity of the CH3 group represented by the CH3c signals to
the tetrahydrofuran ring was supported by a correlation in the COSY spectrum (see
appendix, pg 440) between the CH3c 1H signal and He.14 This therefore supported that a

CH3b CH3a
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Hh
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Figure 2.14. HMBC spectrum for dihydro-1H-cyclopenta[c]furan 382 with a labelled structure showing
important correlations

14

A correlation between CH3c and Ci more than likely exists in the HMBC spectrum; however, the chemical
shifts of Ci and Cl appear too closely to one another for the different correlations to be resolved.
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cyclopentadiene ring was fused to the 5-membered, oxygen containing ring through the
carbons represented by Ci and Cj and confirmed the overall structure of dihydro-1Hcyclopenta[c]furan 382.
Literature support for the structure for dihydro-1H-cyclopenta[c]furan 382 was
provided by an investigation performed by Shibata et al. In this study, cyclopropenyl
propargyl ether 384, which was very similar to the substrate used in this study, was
subjected to Rh(I)-catalysed conditions to result in the formation of the bicyclic diene 385
(Scheme 2.24).[143] Comparing the 1H and 13C signals of side product 382, to the 1H and
13

C signals reported for the literature compound 385, it was found that key signals

between the two sets of NMR data, were almost identical and further cemented the
assigned structure of dihydro-1H-cyclopenta[c]furan 382.

Scheme 2.24. Rh(I)-catalysed rearrangement of cyclopropenyl propargyl ether 384 to dihydro-1Hcyclopenta[c]furan 385

For the second side product, tetrahydroisobenzofuran 383, the first part of the
structure to be confirmed was the presence of the 5-membered, oxygen containing ring.
In the 1H NMR spectrum, a CH signal occurred as a triplet at δ 6.37 (Hf, J = 4.5 Hz) ppm
that correlated to the 13C signal at δ 86.3 (Cf) ppm, in the HSQC spectrum (see appendix,
pg 442). The chemical shift of Hf indicated that it was directly adjacent to both the oxygen
atom and an aryl ring. The Hf signal was observed to have a correlation to the sp2
quaternary 13C signal at δ 140.1 (Cg) ppm, in the HMBC spectrum (Figure 2.15). Carbon
Cg was also observed to have a correlation to the aromatic 1H signal at δ 7.58 (Hh) ppm,
which based on the chemical shift, represented the CHAr group in the ortho-position to
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the Br-substituent. This therefore confirmed that the CH group represented by Hf must be
attached to the same carbon as the –oBrC6H4 ring. In the 1H NMR spectrum, two 1H
signals (integration of 1H each), were observed as a doublet at δ 4.53 (He, J = 13 Hz) and
a doublet of doublets at δ 4.68 (He’, J = 13.5, 5.5 Hz) ppm. Both of these 1H signals
correlated to the same 13C signal at δ 75.4 (Ce) ppm in the HSQC spectrum, and given the
downfield chemical shift, these signals represented the CH2 group that is directly attached
to the oxygen atom. The split nature of the 1H signals representing this CH2 group also
supported the proposed ring structure. Correlations between Hf and the He/He’ signals
were observed in the COSY spectrum (see appendix, pg 442). In the HMBC spectrum,
the He and He’ signals also had correlations to the sp2 quaternary 13C signals at δ 135.8
(Ci) and δ 133.5 (Cj) ppm. The Hf signal was also observed to have a correlation to Ci and
collectively, the data supported the presence of the 5-membered, oxygen containing ring.
Not enough information had been gather yet however, to confirm that this was a 2,5dihydrofuran ring.
The next part of the structure to be confirmed was the presence of the fused sixmembered ring. In the 1H NMR spectrum, a CH signal was observed as a doublet of
doublet at δ 3.66 ppm (Hd, J = 10, 6 Hz) that correlated to the 13C signal at δ 38.2 (Cd)
ppm in the HSQC spectrum. The Hd signal was observed to correlate to Cj and indicated
that this CH group must be directly attached to the 5-membered, oxygen containing ring.
Therefore, this supported that a double bond must exist between the carbons represented
by Ci and Cj, to satisfy the sp2 nature of Cj and ultimately confirmed the presence of the
2,5-dihyrdofuran within the structure of 383. The Hd signal also had a correlation to a sp2
quaternary 13C signal at δ 143.1 (Cm) ppm. The Cm signal was assigned as the quaternary
carbon of the monosubstituted phenyl ring based on its correlation to 1H signals consistent
with the CHAr groups of this substituent, and therefore supported that the phenyl ring was
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attached to the carbon represented by Cd. A CH2 group was also observed which was
represented by two doublet of doublets at δ 2.43 (Hc, J = 17, 6 Hz) and δ 2.90 (Hc’,
J = 17, 10.5 Hz) ppm that correlated to the 13C signal at δ 40.1 (Cc) ppm in the HSQC
spectrum. Correlations of the Hc and Hc’ signals to Hd in the COSY spectrum and Cd and
Cm in the HMBC spectrum, supported that this CH2 group was adjacent the phenyl ring.
Two CH3 signals were then observed as singlets at δ 1.44 (CH3a) and δ 1.68 (CH3b) ppm
in the 1H NMR spectrum that correlated to

13

C signals at δ 14.1 and δ 19.0 ppm,
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Figure 2.15. HMBC spectrum for tetrahydroisobenzofuran 383 with a labelled structure showing
important correlations.
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respectively in the HSQC spectrum. The Hc signal was observed to have a correlation to
the CH3b 13C signal. Likewise, the CH3b 1H signal had correlations to Cc in the HMBC
spectrum and supported that the CH3 group represented by CH3b was adjacent to the CH2
group represented by Hc/Hc’ and Cc. The CH3b 1H signal also had correlations to two sp2
quaternary 13C signals at δ 120.5 (Ck) and δ 128.0 (Cl) ppm. The CH3a 1H signal also had
correlations to Ck and Cl, as well as a correlation to Ci, in the HMBC spectrum. The
correlation between the CH3a 1H signals and Ci therefore confirmed that a 6-membered
ring was fused to the dihydrofuran ring via the carbons represented by Ci and Cj. The CH3
groups represented by CH3a and CH3b must therefore be attached to the carbons
represented by Ck and Cl based on the observed correlations and the chemical shifts of
the CH3 signals. The CH3 group represented by CH3a was tentatively proposed to be
attached to the carbon represented by Ck as the He’ signal had a weak correlation to Ck,
thus suggesting this carbon had to be closer to the dihydrofuran ring. A double bond also
had to exist between Ck and Cl to satisfy the sp2 nature of these carbons and therefore
confirmed the structure of tetrahydroisobenzofuran 383.
Once the structure of dihydro-1H-cyclopenta[c]furan 383 and tetrahydroisobenzofuran 383 had been confirmed by NMR spectroscopy, reaction mechanisms were
proposed that would account for their formation from the gold-catalysed rearrangement
of cyclopropenyl propargyl ether 342r. Plausible reaction mechanisms for the formation
of these side products will be discussed in the following section.

2.3.5.3. Proposed Reaction Mechanism(s) for the Gold(I)-Catalysed Rearrangements to
dihydro-1H-cyclopenta[c]furan 382 and tetrahydroisobenzofuran 383
For the rearrangement of cyclopropenyl propargyl ether 342r to dihydro-1Hcyclopenta[c]furan 382 and tetrahydroisobenzofuran 383, gold-activation of the
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cyclopropene ring as shown in intermediate 386, was proposed to occur for the formation
of both side products (Scheme 2.25). This would result in ring-opening of the
cyclopropene moiety to form the gold carbenoid 387. Rather than undergoing elimination
of a hydrogen to form an enol ether intermediate, it was proposed that the triple bond
would directly attack the gold-stabilised carbocation of 387, to form the 5-membered ring
intermediate 388. Intermediate 388 was then thought to be the branch point for the two
different side products 382 and 383. If the tetrasubstituted alkene attacked the vinyl
carbocation stabilised by the phenyl ring, the gold could eliminate in a concerted manner
to generate the dihydro-1H-cyclopenta[c] furan 382 product, by pathway A (red arrows).
However, the gold could also eliminate from intermediate 388 to generate the carbene
intermediate 389, by pathway B (blue arrows). The carbene of intermediate 389 could
undergo a C–H insertion with one of the gem-dimethyl groups of the tetrasubstituted
alkene to produce the observed tetrahydroisobenzofuran 383. Both intermediates 388 and
389 were only possible due to the resonance stabilisation provided by the adjacent phenyl
ring, which explains why side products 382 and 383 were only obtained when the R2
position was substituted with an aryl group.

Scheme 2.25. Mechanistic proposals for the formation of dihydro-1H-cyclopenta[c]furan 382 and
tetrahydroisobenzofuran 383
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2.4.

Conclusions and Future Directions
This project has demonstrated that gold(I)-catalysed rearrangements of

cyclopropenyl carbinyl ethers can result in numerous products depending on the
substituents placed around the molecule. In the first part of this project, it was determined
that cyclopropenyl allyl ethers 320 could undergo a “one-pot” gold(I)-catalysed ringopening reaction followed by a Claisen rearrangement, to generate dienyl ketones 323.
These ketones were highly versatile and could either undergo a selective oxidative
cleavage of the monosubstituted alkene to form the benzoylhexenal 324 (as demonstrated
by the Honours student), or could be reduced to the alcohol, followed by selective
oxidation cleavage and nucleophilic substitution to obtain tetrahydrofuran 331a
stereoselectively (by Felkin–Ahn control), albeit in low yields. This project also
demonstrated that when reacted under gold(I)-catalysis conditions, cyclopropenyl
propargyl ethers 342(a-e) bearing an –oBrC6H4 or –oClC6H4 group, could undergo ringopening followed by a propargyl-Claisen rearrangement to form polysubstituted furans
343 in moderate to good yields. However, when 342 was not substituted with an
–oBrC6H4 or –oClC6H4 group, enol ether Z-344 and the furan regioisomer 343’, were
obtained. DFT calculations revealed that when stabilised, the carbocation generated on
the aryl ring could participate in a 1,2-aryl shift, thus forming the observed enol ether
Z-344 and furan regioisomer 343’ side products. However, when the aryl ring was
substituted with an o-Br or an o-Cl group, the carbocation was poorly stabilised, which
slowed the 1,2-aryl shift, thus allowing the 1,2-hydrogen shift to occur and produce the
desired furans 343. This is an important finding as these trends could aid other researchers
in the field when designing reactions that may involve the generation of a carbocation
near an aryl ring. It was also determined that changing the aryl ring to an alkyl chain in
342p could result in a 5-exo-dig cyclisation of the enol ether intermediate, to give the
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tetrahydrofuran side product 371 in addition to furan 343p. Another finding of this project
was that exchanging the alkyl group for an aryl group on the distal end of the alkyne,
resulted in the triple bond attacking the gold-stabilised allylic carbocation intermediate,
to form either dihydro-1H-cyclopenta[c]furan 382 via cyclisation, or tetrahydroisobenzofuran 383 via carbene formation and a C-H insertion. These pathways were facilitated by
the stabilising effect of the phenyl ring on the reactive vinyl carbocation/carbene species.
In terms of future directions for the tetrahydrofuran 331 synthesis from
cyclopropenyl allyl ethers 320, it was thought that further optimisation of the reaction
conditions might be viable. It would first have to be confirmed however, whether the poor
diastereoselectivity was the result of the non-selective formation of the Z- and E-isomers
of enol ether 324 following ring-opening of the cyclopropene, or if poor selectivity during
the Claisen rearrangement occurred. This could easily be elucidated by monitoring the
different stages of the reaction by 1H NMR spectroscopy. Once the problem(s) with the
gold-catalysed ring-opening/Claisen rearrangement are identified, evaluating other
catalysts, solvents and/or reaction temperatures may help improve the diastereoselectivity
of the rearrangement of cyclopropene 320 to dienyl ketone 322. Investigating other
methods for the oxidative cleavage of the dienyl ketone 322 such as those shown in
Scheme 2.10 (Section 2.2.3, pg 99), would also be a future direction for this project.
In terms of future directions for the gold(I)-catalysed rearrangement of
cyclopropenyl propargyl ethers 342, additional computational studies need to be
performed. For example, DFT calculations comparing the 6-endo-dig pathway to the 5exo-dig pathway when R1 is an aryl or an alkyl group, need to be performed to determine
why tetrahydrofuran 371 is form in addition to the desired furan 342p, when R1 is an alkyl
group. Given the interesting structures of the dihydro-1H-cyclopenta[c]furan 382 and
tetrahydroisobenzofuran 383 formed when the R2 position was a phenyl ring, further
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optimisation of the reaction conditions could be performed to favour one of these side
products over the other. If complete regioselectivity could be achieved (or at least
improved) an investigation into the substrate of the reaction could then be performed. As
these side products were not proposed to be dependent on the elimination of a hydrogen
to form an enol ether intermediate, substrates possessing a quaternary carbon in the αposition to the cyclopropene moiety could be reacted. This would prevent the competing
furan formation and could also result in more interesting products, especially if
spirocyclic groups were added at this position. Another future direction of this work could
be to investigate cyclopropenyl propargyl amines and sulfonamides such as 390 shown
in Scheme 2.26. Literature precedent exists to support that an gold(I)-catalysed azaClaisen rearrangement would occur,[144] thus highly substituted pyrroles 391 could be
synthesised when the R2 position is a hydrogen or an aliphatic group. This would expand
the range of heterocycles accessible with this reaction; however, the substrates would be
limited to aryl rings substituted with an o-Br or o-Cl atom. If the R2 position was an aryl
ring, it was predicted that tetrahydrocyclopenta[c]pyrroles 392 or tetrahydro-1Hisoindoles 393 could be obtained (depending on the optimisation of the reaction).

Scheme 2.26. Proposed gold-catalysed reactions of cyclopropenyl propargyl amines and sulfonamides 390

Another future direction could be to perform chemical transformations on the
furan 343 products. Some examples of chemical transformations that could be performed
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are shown in Figure 2.16. One transformation could involve a cross-coupling reaction
when the R2 position is a silane group, to achieve functionalisation of the 4-position of
the furan, as was mentioned in Section 2.3.3.1. Another chemical transformation that
could be performed is a Diels–Alder cycloaddition where furan 343 (the diene) is reacted
with an appropriate dienophile to obtain 7-oxabicyclo[2.2.1]hetp-2-enes, such as the endo
product 394, as an example. A hydrogenation reaction could also be performed on furan
343 to obtain the corresponding tetrahydrofuran 395. As can be seen from the structure
of 395, it is anticipated that the hydrogenation conditions (i.e. H2/Pd) would also affect
the tetrasubstituted alkene to convert it to the fully saturated, branched alkyl chain.

Figure 2.16. Examples of chemical transformations that could be performed with furans 343

In conclusion, this project has demonstrated that cyclopropenyl carbinyl ethers
prefer to undergo ring-opening of the cyclopropene moiety when in the presence of gold
catalysts. In fact, the gold(I)-catalysed rearrangement of the cyclopropenyl propargyl
ethers 342 performed in this project, is believed to be the first example of the preferential
activation of a cyclopropene double bond over an alkyne. Once ring-opened to the
corresponding gold carbenoids, numerous oxygen-containing heterocycles can then be
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obtained depending on the substitution pattern of starting material (Figure 2.17). Both
experimental and computational results have provided significant insight into the reaction
mechanisms governing the formation of furan 343, furan 343’ and enol ether Z-344.
However, more work still needs to be done to fully understand the formation of the
tetrahydrofuran 371, dihydro-1H-cyclopenta[c]furan 382 and tetrahydroisobenzofuran
383 side products. Given the importance of furans and tetrahydrofurans due to their
appearance in numerous natural products and drug targets, as well as their versatility as
organic synthons, this work may provide new pathways to the synthesis of these crucial
structural motifs.

Figure 2.17. Summary of the possible products resulting from the gold(I)-catalysed rearrangement of
cyclopropenyl allyl ethers 320 and cyclopropenyl propargyl ethers 342. * Indicates work was completed
by the Honours student.
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3. Chapter 3. Gold(I)-Catalysed Cyclisation Reactions of
Cyclopropenyl

Sulfonamides

Bearing

Tethered

Heteroaromatic Systems
3.1.

Background on the Gold(I)-Catalysed Reactions of Aromatic
Heterocycles with Carbon–Carbon Multi-Bonds
Aromatic heterocycles represent an extremely important class of organic

molecules. This thesis is particularly interested in 5-membered aromatic heterocycles
such as furans, pyrroles, and thiophenes, as well as fused aromatic heterocycles such as
benzo[b]furans, indoles and benzo[b]thiophenes (Figure 3.1). These aromatic
heterocycles have numerous applications such as in the pharmaceutical industry given
their broad spectrum of biological activities; agricultural industry as pesticides and
herbicides; natural product synthesis; and as highly versatile building blocks in synthetic
organic chemistry.[127, 145] Of the heterocycles shown in Figure 3.1, furan experiences a
resonance stabilisation energy of ~16 kcal/mol and as a consequence, is the least aromatic
system shown below.[127] However, due to a greater propensity to release electrons from
the heteroatom, pyrroles are typically the most reactive of the heterocycles mentioned,
closely followed by indoles.[146] While these heterocycles can technically undergo
electrophilic substitution at any position on the ring, the preference for attack is usually
the α-positions relative to the heteroatom.[146] The exception are indoles, which are
typically most reactive at the β-position to the heteroatom.[145c,

146]

Exploiting this

reactivity, especially when the aromatic heterocycle is tethered to the electrophilic source
such as a metal carbenoid, can lead to significant increases in molecular complexity. In
particular, the gold-catalysed reactions of heteroaromatic systems with alkynes, allenes
and alkenes has been well documented in the literature.[145c, 147]
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Figure 3.1. Some examples of aromatic heterocycles

Of the aromatic heterocycles shown in Figure 3.1, furans are arguably the most
versatile systems. As furans are aromatic molecules, they can undergo typical
electrophilic aromatic substitution reactions such as nitration, sulfonation and Friedel–
Crafts reactions. However as mentioned above, furans are the least aromatic systems
shown in Figure 3.1 and as a result, can undergo dearomative processes such as
electrophilic additions reactions and when reacted with an appropriate dienophile, furans
can also act as a cyclic diene in the classic [4 + 2] Diels–Alder reaction.[146, 148] General
representations of these important reactions of furans are shown in Figure 3.2. Given the
versatility of furans, they have regularly been exploited in the field of homogeneous gold
catalysis given their tendency to dearomatise and react with π–gold complexes and has
resulted in the formation of many interesting heteroatom scaffolds. Some of these
reactions will be discussed in the following section.

Figure 3.2. Generalised reactions that can be undergone by furans

3.1.1. Gold-catalysed reactions of C–C Multiple Bonds with Furans
One of the earliest examples of a gold-catalysed reaction between a C–C multiple
bond and an aromatic heterocycle, would be the cyclisation of furan-ynes to phenols,
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described by the Hashmi group in the year 2000 (Scheme 1.4, Section 1.1.3, pg 8).[15a]
Since this first publication on the gold(III)-catalysed rearrangement of furan-ynes, other
systems such as 400 and 408 in Figure 3.3, have been functionalised to give a broad range
of interesting heterocycles. For example, the scope of 1,6-enyne systems of furan-ynes
400,

possessing

a

terminal

alkyne,

were

expanded

to

include

various

dihydroisobenzofuranols, dihydrobenzofuranols, dihydroisoindolinols, dihydroindinols
and indanes 401.

[15c, 15d, 147a, 149]

In particular with the 1,6-enyne systems, it was found

that when the 5-position of the furan moiety was substituted with an alkynyl group, the
tricyclic dihydrofuroisoindole 402 could also be obtained.[15c] Alternatively, when the
distal end of the alkyne of 400 was substituted with an aryloxy group, chiral tetracyclic
heterocycles such as 403, were formed.[150] Also while studying 1,6-enyne systems of
furan-yne 400, it was found that dihydropyrroles and dihydrobifurans 404 could be
formed when a substituent was placed in the R3 position, as stabilisation of the generated
carbocation allowed re-aromatisation of the furan to occur.[151] When the 1,6-enyne
system of furan-yne 400 was substituted with an aryl or heteroaryl group on the distal end
of the alkyne, the benzanellated dihydroindole derivatives 405 were obtained.
Investigations have also been performed on 1,7-enyne systems of furan-yne 400. When
an aryl group was placed on the distal end of the alkyne of a 1,7-enyne system, the bicyclic
unsaturated ketone 406 could be obtained.[152] Alternatively, if a 1,7-enyne system of 400
possessed a terminal alkyne moiety (i.e. R4 = H), then tetrahydroquinolinol, chromanol,
tetrahydroisoquinolinol and isochromanol derivatives 407 could be prepared.[147a, 149a-c]
Examples of 3-silyloxy-1,5-enyne systems of furan-ynes, such as 408, have also been
reported to react with gold to form benzo[b]furans 409.[153] The different products
obtained from furan-ynes shown in Figure 3.3 are merely selected examples and does not
represent a comprehensive overview of this literature. Other related examples of gold157

catalysed reactions between alkynes and furans have also been published by the Hashmi
[154]

and the Liu groups.[155]

Figure 3.3. Examples of gold-catalysed reactions of furan-yne systems

Gold-catalysed reactions of furans with tethered allenes have also been reported.
For example in 2008, López and Mascareñas et al. published an investigation where the
tethered furan–allene system 410, was reacted with Ph3PAuCl/AgSbF6 to obtain the
5,7-fused heterocycle 411 in 30% yield (Scheme 3.1a).[156] It was then determined that
IPrAuCl/AgSbF6 vastly improved the yields of the 5,7-fused heterocycle 411. The yields
of 411 ranged from 50-85%; however, for one example a mixture of 411 and the
regioisomer 412 (411:412 3:1) was isolated in 82% combined yield (Scheme 3.1a).[157] In
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a study by Dai et al., enyne alcohol 413 was reacted with Ph3PAuCl/AgOTf to obtain the
furan–allene system 414 in yields of 64-72% (Scheme 3.1b). The furan–allene system
414 could then be reacted with tBuXPhosAuCl/AgSbF6 to obtain the 5,7,6-fused tricyclic
products 415 and 416 as a mixture of regioisomers (415:416 1.4:1 to 1.8:1) in 60-74%
yields (Scheme 3.1b).[158] The reaction mechanism for the gold-catalysed rearrangement
of furan–allenes systems 417 was proposed to involve gold activation the allene in 418,
to form the allylic cation–gold complex 419 (Scheme 3.1c). A [4C+3C] cycloaddition
between the gold carbenoid and the furan moiety was then proposed to proceed via
transition state 419, to explain the observed stereochemistry. Following the cycloaddition,
the gold-carbene 420 was proposed to form, which could undergo a 1,2-hydrogen shift to
provide the observed seven-membered ring with an oxa-bridge 421.[156-158] An excellent
review on the topic of [4C+3C] cycloaddition reactions was recently published by Chiu

Scheme 3.1. Gold-catalysed [4C+3C] reactions of furan–allene systems.
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et al.[159] While the gold-catalysed reaction of furans with C–C multiple bonds is certainly
interesting due to the propensity for these heterocycles to undergo dearomatisation, other
aromatic heterocycles can also react with π–gold complexes to form interesting and
potentially useful scaffolds.

3.1.2. Gold-Catalysed Reactions of C–C Multiple Bonds with Indoles
Indoles have also been heavily investigated for their reactions with C–C multiple
bonds in the presence of gold-catalyst, a topic that has been recently reviewed by Pirovano
in 2018.[145c] Some examples of indoles reacting with tethered alkynes and allenes are
shown in Scheme 3.2. Perumal and Praveen synthesised enynl indoles 422, which when
subjected to the Ph3PAuCl/AgSbF6 (5 mol%), formed carbazoles 425 in yields of 50-83%
(Scheme 3.2a). Activation of the triple bond as shown for 423, resulted in a 6-endo-dig
cyclisation from the 3-position of the indole to give the tricyclic intermediate 424. Rearomatisation and protodeauration then provided the observed final product 425.[160]
Similarly, the Hashmi group observed that indole-3-carboxamides 426 tethered to an
alkyne moiety, could cyclise to form azepino[3,4-b]indol-1-ones 430 in yields of 61-98%
(Scheme 3.2b). Upon activation of the triple bond by the gold-catalyst in 427,
nucleophilic attack from the 3-position of the indole to the gold–alkyne complex (5-exodig attack) was proposed to occur to give the spirocyclic cationic intermediate 428.
Migration of the acylamino group then resulted in the formation of intermediate 429,
followed by re-aromatisation and protodeauration to generate the observed final product
430.[161] In a slightly different reaction reported by Ma et al., indoles 431 were synthesised
with an electron-deficient allene in the 3-position (Scheme 3.2c). When reacted with
Ph3PAuCl/AgOTf (5 mol%), 431 cyclised to form dihydrocyclopenta[b]indoles 434 in
yields of 56-93%. Due to the electron-withdrawing group on the allene, the distal double
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bond was more electron-rich and was selectively activated by the gold-catalyst as shown
in 432 (or 432’). In contrast to the previously discussed mechanisms, the indole then
attacked the gold–allene complex from the 2-position to form the tricyclic cationic
intermediate 433, which could undergo rearomatisation and protodeauration to generate
434.[162]

Scheme 3.2. Gold-catalysed reactions of indoles with tethered C–C multi-bonds
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Examples of gold-catalysed rearrangements of pyrroles,[150, 163] thiophenes[150, 164],
benzo[b]furan[164] and benzo[b]thiophenes[163g, 164] have also been documented that will
not be discussed in this introduction. As can be seen from Figure 3.3 and Scheme 3.1,
furan heterocycles are capable of undergoing dearomative processes when reacted with
C–C multiple bonds in the presence of a gold-catalyst. In contrast however from Scheme
3.2, it is evident that indole heterocycles much prefer to rearomatise when reacted with
C–C multiple bonds in the presence of gold, unless another nucleophile is present that
can trap out the indolenyl iminium ions before rearomatisation occurs. [165] The
aromaticity and nucleophilicity of different heterocycles were important concepts for this
project. When tethered to cyclopropenes and reacted with a gold catalyst, the varying
tendencies of different heterocycles to undergo rearomatisation or completely
dearomatisation was predicted to result in different products and was ultimately the focus
of this project.

3.2.

Preliminary Results
This project was performed in collaboration with the Hashmi group of Heidelberg

University (Germany), through the generous funding provided by the DAAD Australia–
Germany Joint Research Co-operation Scheme. As can be seen from Figure 3.3 (Section
3.1.1, pg 158) and Scheme 3.2b (Section 3.1.2, pg 161), the Hashmi group has performed
numerous investigations into the gold-catalysed rearrangement of alkynes with aromatic
heterocycles such as furans and indoles. However, few studies have reported the goldcatalysed rearrangement of cyclopropenes with aromatic heterocycles. As discussed in
the Introduction chapter of this thesis, Lee et al. performed studies on the intermolecular
gold-catalysed reaction of 3,3-disubstituted cyclopropenes with indoles (Scheme 1.21,
Section 1.3.2.1, pg 37) and furans (Scheme 1.29, Section 1.3.2.2, pg 44) and Shi et al.
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reported the intramolecular gold-catalysed rearrangement of indoles tethered to
cyclopropenyl-3-carboxylates (Scheme 1.40, Section 1.3.3.3, pg 56). Therefore, as
proposed in the aims section of this thesis (Section 1.4, pg 76), this project endeavoured
to take the furan-yne systems studied by the Hashmi group (as well as other aromatic
heterocycles) and replace the triple bond with a cyclopropene moiety. It was anticipated
that a gold-catalyst would ring-open the cyclopropene to generate a gold-carbenoid,
which would cyclise with the tethered aromatic heterocycle (Scheme 3.3). Different
products were expected to be obtained depending on the aromatic heterocycle tethered to
the cyclopropene ring as these systems all differed in their aromaticity and the
nucleophilicity.

Scheme 3.3. Gold-catalysed reactions of cyclopropenes tethered to various aromatic heterocycles

3.2.1. Synthesis of Starting Materials
The project first began with developing a synthetic scheme for the desired
cyclopropenyl sulfonamide starting materials. It was determined that the cyclopropene
moiety and the heterocyclic sulfonamide moiety could be synthesised in two steps each,
followed by a final coupling step. The cyclopropenes were derived from commercially
available alkynes. These alkynes were stirred in DCM with a catalytic amount of
Rh2(OAc)4 dimer, and to this was added ethyl diazoacetate by syringe pump (Scheme
3.4). Cyclopropenyl carboxylates 435 were known to have been obtained based on
characteristic signals observed in both the 1H and

13

C NMR spectra. These signals

included a singlet (or doublet) between δ 1.9-2.3 ppm with an integration of 1H that was
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assigned as the CH group in the C3 position of the cyclopropene, and a quaternary carbon
between δ 175-180 ppm, assigned as the C=O of the ester group. The cyclopropenyl
carboxylates 435 were reduced to the corresponding alcohols 436, using DIBAL-H. The
cyclopropenyl alcohols 436 were known to have been obtained based on the loss of the
–CH2CH3 group in the 1H NMR spectrum and the loss of the C=O in the

13

C NMR

spectrum. The heterocyclic sulfonamides were prepared from commercially available
2-carbaldehydes (or 2-carboxylates) that were heated at reflux with tosyl amide and
Si(OEt)4 to obtain the imine intermediates 437. Formation of the imine 437 was
confirmed by the loss of the CHO signal typically around δ 9.5-10.0 ppm, and the
appearance of a N=CH signal around δ 8.7-9.3 ppm. Being unstable towards hydrolysis,
the imines 437 were immediately subjected to reducing conditions to obtain the desired
heterocyclic sulfonamides 438. The sulfonamides 438 were confirmed based on the
disappearance of the N=CH signal and the formation of a doublet with an integration of
2H that typically occurred around δ 4.1-4.4 ppm and was assigned as the CH2 group
adjacent to the NHTs group. An NH signal was also usually observed as a triplet or a
broad multiplet around δ 4.4-5.2 ppm. The final step of the synthesis to generate the
cyclopropenyl sulfonamides 439, involved a Mitsunobu coupling between the
cyclopropenyl alcohols 436 and sulfonamides 438. Formation of the cyclopropenyl
sulfonamides 439 was confirmed based on the appearance of a 1H signal consistent with
the CH2 group adjacent to both the cyclopropene and the NTs group. For symmetrical
examples, the signal representing this CH2 group typically occurred as a doublet
(integration of 2H) between δ 2.9-3.4 ppm, while for asymmetrical examples the signal
was observed as two doublet of doublets (integration of 1H each) between δ 2.5-3.7 ppm.
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Scheme 3.4. Synthetic route for the preparation of cyclopropenyl sulfonamides 439. (i) Rh2(OAc)4 (5
mol%), DCM, rt; (ii) DIBAL-H (3 eq), THF, –78 °C; (iii) Si(OEt)4 (1.1 eq), 140-150 °C; (iv) NaBH4 (0.51 eq), THF/MeOH (5:1); (v) PPh3 (1.3 eq), DIAD (1.3 eq), THF, rt

While the Mitsunobu coupling was very efficient at generating the cyclopropenyl
sulfonamides 439, an inseparable side product was also obtained from the reaction. For
some substrates the ratio of desired cyclopropenyl sulfonamide 439 to the amount of side
product was fairly minor (ratio 95:5 to 90:10), but for other substrates the ratio was much
poorer (up to 63:37). However, it was noted that the side product did not react under the
gold-catalysis conditions and could be separated thereafter. From one very clean gold(I)catalysed reaction of cyclopropenyl indolyl sulfonamide 439ba (the heterocycle obtained
from this reaction will be discussed in Section 3.5.2), a sufficient amount of the side
product obtained from the Mitsunobu reaction was isolated and determined to be
cyclobutenyl sulfonamide 440ba, a structural isomer of 439ba (Scheme 3.5).

Scheme 3.5. Isolation of cyclobutenyl sulfonamide 440ba
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The cyclobutene structure was confirmed based on some characteristic peaks in
both the 1H and 13C NMR spectra. In the 1H NMR spectrum for the cyclobutene isomer
440ba, no 1H signal was observed around δ 3.0 ppm that would represent the CH2 group
adjacent to both the cyclopropene moiety and the NTs group for the cyclopropene isomer
439ba. Instead, 1H signals occurred at δ 2.24 (Ha) and δ 1.85 (Ha’) ppm that correlated to
the same carbon at δ 33.7 (Ca) ppm in the HSQC spectrum (see appendix, pg 521) and
represented a more shielded CH2 group. A CH group was also represented by a multiplet
between δ 4.75-4.78 (Hb) ppm that correlated to a carbon at δ 54.9 (Cb) ppm in the HSQC
spectrum. This CH group was fairly deshielded and represented the CH group directly
adjacent to the NTs group. In the COSY spectrum (Figure 3.4), correlations were
observed between Hb and the Ha and Ha’ signals that supported that the CH and CH2

Hb

Ha

Ha’

Ha’
Ha

Hb

Figure 3.4. COSY spectrum for cyclobutenyl sulfonamide 440ba with a labelled structure showing
important correlations
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groups were next to one another in the structure. In the HMBC spectrum (Figure 3.5),
both Ha and Hb correlated to quaternary carbons at δ 142.7 and δ 140.4 ppm, which in
turn correlated to 1H signals associated with the propyl chains and helped confirm the
formation of a cyclobutene ring rather than a cyclopropene ring.

Hb

Ha Ha’

Ca

Cb

Figure 3.5. HMBC spectrum for cyclobutenyl sulfonamide 440ba with a labelled structure showing
important correlations

A reasonable explanation for the formation of the cyclobutene isomer 440, was
established by considering the mechanism for the Mitsunobu reaction (Scheme 3.6). The
first step of the Mitsunobu reaction involves the nucleophilic attack of PPh3, on the azo
group of DIAD to form a zwitterionic adduct that abstracts the most acidic proton
available, in this case the proton from sulfonamide 438. Having generated the active
species, the cyclopropenyl alcohol 436 undergoes nucleophilic attack on the
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phosphonium ion, thus generating the key oxophosphonium intermediate 442 and the
hydrazine by-product 441. Ordinarily in the Mitsunobu reaction, the next step would
involve attack of the deprotonated sulfonamide on the electrophilic CH2 group of
intermediate 442, resulting in the desired cyclopropenyl sulfonamide 439. However, due
to the electron-withdrawing nature of the protecting group on the nitrogen, this step is
slow and allows for the observed ring-expansion to compete with the desired reaction. In
support of this statement, it was observed that the more electron-withdrawing the
protecting group was, the higher the ratio of cyclobutene to cyclopropene in the final
product (i.e. Ns > Bs > Ts). Ring-expansion of 442 would eliminate triphenylphosphine
oxide and result in intermediate 443. The deprotonated sulfonamide would then attack
the less substituted end of the double bond of intermediate 443 to generate the more
thermodynamically stable cyclobutenyl sulfonamide 440. Given the ring-strain energy of
cyclobutene is only 28.4 kcal/mol, in comparison to 54.5 kcal/mol for cyclopropene, [35,
166]

the reduction in ring-strain may be a driving force for the competing side reaction.

Interestingly, 440 was only observed when dialkyl-substituted cyclopropenyl alcohols
were used. No observable cyclobutene occurred with phenyl- or monosubstituted
cyclopropenyl alcohols.

Scheme 3.6. Proposed reaction mechanism for the formation of cyclobutenyl sulfonamide 440
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In support of the above mechanism, a similar ring-expansion of a cyclopropene
was observed by Gensler et al. and is summarised in Scheme 3.7.[167] Gensler reduced
cyclopropenyl carboxylates 444 with LiAlH4 in the presence of aluminium chloride at
low temperatures and discovered that cyclobutenes 447 could be obtained. Reduction of
444 resulted in the corresponding alcohol 445, which presumably formed cation 446 in a
Lewis acid-catalysed abstraction of the hydroxy group with concomitant ring expansion.
The reducing agent then provided a hydride ion to result in the observed cyclobutene 447.
It is thought that with further development, this side reaction could represent a new
synthetic route for substituted cyclobutene structures and was thus considered as a
possible future direction for this project.

Scheme 3.7. Ring-expansion of cyclopropenyl carboxylates 444 (via cyclopropenyl alcohols 445) to
cyclobutenes 447

Once the side product of the Mitsunobu reaction in the current study had been
identified, alternative routes to synthesise the cyclopropenyl sulfonamides 439 without
the production of the cyclobutene isomer 440, were investigated. These attempts
primarily involved transforming the alcohol functional group of cyclopropene 436 into a
good leaving group so that a SN2 reaction could be performed with the heterocyclic
sulfonamides 438 (Scheme 3.8). Mesylation and tosylation of the alcohol group was
investigated; however, in all cases the reaction failed to go to completion and starting
material was recovered. An attempt was also made to convert the alcohol moiety into a
Br substituent. Treatment with N-bromosuccinimide (NBS) and PPh3 however, resulted
in substantial product decomposition/polymerisation – presumably due to the sensitivity
169

of the cyclopropene ring. It was therefore determined that converting the alcohol moiety
into a good leaving group, was not a feasible alternative to avoid the cyclobutene 440
isomer. Ultimately as the cyclobutenes 440 were found not to react under the goldcatalysis conditions and could easily be separated thereafter, it was decided that the
Mitsunobu reaction would still be used to synthesise the starting materials, and that the
yields of the heterocycles would be corrected for the amount of cyclobutene impurity.
Yields that have been corrected for the presence of cyclobutene isomer 440, have been
marked with an asterisks (*) throughout this chapter.

Scheme 3.8. Alternative synthesis scheme for preparing cyclopropenyl sulfonamides 439

3.2.2. Characterisation of Product(s) formed from the Gold-Catalysed Reaction of
Cyclopropenyl Furyl Sulfonamides
The first substrate to be synthesised was cyclopropenyl furyl sulfonamide 439aa.
This substrate was subjected to IPrAuNTf2 (5 mol%) in DCE and was stirred at rt for
1.25 h. The reaction TLC was clean, displaying one main product spot that was more
polar than the Rf of the starting material. The product formed was observed in 53% NMR
yield and was isolated and identified to be the 5,7-fused heterocycle 448a (Scheme 3.9).
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Scheme 3.9. Gold(I)-catalysed reaction of cyclopropenyl furyl sulfonamide 439aa

To confirm the proposed structure of the 5,7-fused heterocycle 448a, HRMS was
first performed to verify that the mass of the product obtained was the same as the mass
of the original starting material. The 1H NMR spectrum was then analysed. Two 1H
signals were observed as doublets with an integration of 1H each, at δ 6.18 (He) and
δ 5.70 (Hf) ppm that had coupling constants of ~6 Hz. Given the coupling constant of
furyl 1H signals are typically ~ 3 Hz, it indicated that dearomatisation of the furan moiety
had occurred. Upfield of these signals were four individual 1H signals with interesting
splitting patterns that were found to represent two CH2 groups. The 1H signals at
δ 2.97 ppm and δ 3.92 ppm (CH2b) occurred as doublet of doublets, while the signals at
δ 3.33 ppm and δ 3.80 ppm (CH2c) occurred as doublets. Given the chemical shift of these
1

H signals, they were assigned as the CH2 groups on either side of the NTs group. The

large difference in the chemical environments between protons attached to the same
carbon also suggested that a ring structure had formed.
After identifying some key 1H signals, the HMBC spectrum (Figure 3.6) was
analysed. The CH2b 1H signals correlated to a carbon at δ 43.5 ppm (Ca). This carbon was
found to correlate to a multiplet between δ 1.90-2.18 ppm with an integration of 4H in
the HSQC spectrum (see appendix, pg 495).15 Originally, Ca likely represented the CH
group of the former cyclopropene ring in the starting material. The CH2b 1H signals also

15

The HSQC spectrum indicated that Ca represented a CH group while the other 1H signals within the
multiplet represented the CH2 groups of the butyl chains.
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correlated with a sp2 quaternary carbon at δ 128.0 ppm (Ci) in the HMBC spectrum. A
multiplet signal between δ 1.66-1.78 ppm, which was associated with a CH2 group of one
of the butyl chains, correlated to Ci, Ca and another sp2 quaternary carbon at δ 139.3 (Ch)
ppm. Given that other protons associated with the butyl chains also correlated with Ci and
Ch, this was used to confirm that Ca, Ci and Ch were the carbons that originally formed
the cyclopropene ring. The CH2b 1H signals also correlated with a quaternary carbon at
δ 90.2 ppm (Cd). Given the chemical shift of this carbon, Cd was likely a sp3 quaternary
carbon directly attached to the electronegative oxygen atom. The CH2c 1H signals were
next evaluated and were found to correlate to Ca and Cd as well. This helped confirm that
the CH2b and CH2c groups, as well as Ca and Cd, formed a five-membered ring with the
NTs group. It was then observed that He correlated to Ca, Cd and a quaternary carbon at
δ 85.1 ppm (Cg). Given the downfield chemical shift, and that the 1H signal of a methyl
group (Me*) at δ 1.34 ppm also correlated to it in the HMBC spectrum, Cg was identified
as the former C5 position of the furan moiety in the starting material. This also supported
that an oxygen-bridge existed between quaternary carbons Cd and Cg. The HMBC
spectrum also revealed that Hf correlated to Cd and Cg as well as Ch. Given Hf correlated
to Ch and that He correlated with Ca, it supported that a second ring-structure had been
formed. Indeed, the Me* 1H signal also correlated to Ch, suggesting a direct attachment
between Ch and Cg. While no correlation between Ha and Cd was observed, the
correlations previously discussed are enough confirm a direct attached between Ca and
Cd. Based on the collective information, heterocycle 448a was confirmed to be a
5-membered ring fused to a 7-membered ring through carbons Ca and Cg, with an oxygen
bridge connecting Cg and Cd.
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Figure 3.6. HMBC spectrum for the 5,7-fused heterocycle 448a with a labelled structure showing important
correlations

3.2.3. Proposed Approach to Research Progression
Having confirmed the structure of the 5,7-fused heterocycle 448a obtained from
the gold-catalysed rearrangement of cyclopropenyl furyl sulfonamide 439aa, it was
proposed that the reaction proceeded by a [4C+3C] cycloaddition similar to that seen in
Scheme 3.1 (Section 3.1.1, pg 159). The proposed mechanism for the reaction will be
fully discussed in Section 3.6.1. The 5,7-fused heterocycle 448a was compared to the
literature and was found to structurally related to a class of natural products called
rhamnofolane diterpenes, specifically curcusones I and J (Scheme 3.10). This was based
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on an investigation by Dai et al. who had found that enyne alcohols 449 could be reacted
with a gold(I)-catalyst to form tethered furan–allene systems in situ, which could undergo
a [4C+3C] cycloaddition to produce 5,7-fused heterocycles 450 in 50-83% yields. After
the [4C+3C] cycloaddition for one particular example (R1 = Et, R2 = H, R3 = OTBS,
X = CH2), a total synthesis was able to be performed to obtain both curcusones I and J.[168]
Curcusones I and J had only been isolated recently in 2013 by Qiu et al., [169] and the total
synthesis published by Dai et al.[168] was believed to be the first reported for these natural
products. This was despite the fact that these curcusones possess extraordinary chemical
structures and may have potential therapeutic applications. No studies have been
published thus far on the biological activities of curcusones I and J, but other
rhamnofolane diterpenes such as curcusones B and C (Scheme 3.10), have been found to
display anti-metastatic effects and anti-tumour activity against multiple human cancer
cell lines in vitro.[170] Given the high degree of molecular complexity achieved from the
gold-catalysed rearrangement of a relatively simple starting material, and that this
reaction had the potential to synthesise important precursors for biologically significant
natural products, the development of this reaction became a top priority for future work.

Scheme 3.10. Gold(I)-catalysed rearrangement of enyne alcohols 449 to 5,7-fused heterocycles 450 which
are precursors for rhamnofolane diterpenes.
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The NMR yield determined for the 5,7-fused heterocycle 448a in Scheme 3.9 (pg
171), was 53% and represented a good starting point for the project. Further optimisation
of the reaction conditions was anticipated to improve the yield of 448a and would be the
first task to complete for further research progress. The versatility of the reaction would
also need to be evaluated and several substitution positions around the cyclopropenyl
furyl sulfonamide 439a were proposed (Scheme 3.11). It was thought that most positions
around 439a could be unsubstituted (i.e. hydrogen) or substituted with an aryl group or
an aliphatic group. However, there were a few exceptions to this. An attempt was also
going to be made to synthesise cyclopropene–furan system with a halogen in the R5
position, so that further derivatisation of 448 could be performed. Substitution at the R4
position of the furan was also limited to aliphatic groups, due to starting materials that are
commercially available. Different linkers at the X position would also be evaluated. For
example, different N-linkers with various protecting groups (i.e. Ts, Ns, Bn, etc.) could
be investigated as well as an O-linker to make the corresponding ethers. Ester (X = O)
and amide (X = NR) linkers could also be explored if the R3 position was a C=O group.
Another important substrate that was planned as part of the [4C+3C] cycloaddition
substrate scope was to synthesise an enantioenriched substrate by substituting the R3
position. The purpose of making such as substrate was to determine whether the [4C+3C]
cycloaddition is enantioretentive.

Scheme 3.11. Proposed positions for variation of the cyclopropene–furan systems 439 to obtain 5,7-fused
heterocycles 448
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As eluded to in Sections 3.1 and 3.2 of this chapter, this project not only aimed to
investigate tethered cyclopropene–furan systems but other aromatic heterocycles as well
(see Figure 3.1, Section 3.1, pg 156). Further research progression would therefore
involve performing a screen of different aromatic heterocycles to determine which
systems would react with the gold-carbenoid to form cyclic products. If any of these
heterocycles yielded interesting products, substrate scopes would be performed to probe
the versatility of those reactions as well.

3.3.

Optimisation of the Reaction Conditions for the Gold-Catalysed
Rearrangement of Cyclopropenyl Furyl Sulfonamide 439aa
For the optimisation of the gold-catalysed rearrangement of cyclopropenyl furyl

sulfonamide 439aa to the 5,7-fused heterocycle 448a, NMR yields were obtained for
comparison. The first set of conditions used for the gold-catalysed rearrangement of
cyclopropenyl furyl sulfonamide 439aa to 5,7-fused heterocycle 448a (Scheme 3.9, pg
171) are listed in Table 3.1, entry 1. It was decided that the effect of different ligands on
the gold catalyst would first be evaluated. Changing to the slightly smaller NHC ligand,
IMesAuNTf2 (IMes = N,N’-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene), resulted in a
36% yield of heterocycle 448a (entry 2). The reaction was also performed by adding
IMesAuCl and AgNTf2 separately to generate IMesAuNTf2 in situ. This also resulted in
36% yield of 448a and indicated that generating the active gold species in situ did not
have any significant impact on the reaction. With this knowledge in hand,
Ph3PAuCl/AgNTf2 was tested and a poor yield (4%) of 448a was obtained (entry 3).
Similarly, JohnPhosAu(MeCN)SbF6 also gave trace yields (2%) of 448a (entry 4). This
indicated that gold(I)-complexes bearing phosphine ligands could not catalyse the desire
reaction. A gold(I)-complex (L1) bearing the phosphite ligand, [tris(2,4-di-tert176

butylphenyl)phosphite]gold, was next tested but also gave a low NMR yield (13%) of
448a (entry 5). The importance of the ligand was again demonstrated when AuCl was
added (entry 6). In the case of entries 3, 4 and 5, while only small amounts of 448a were
observed, the reaction had still gone to full conversion. However, the conditions of entry
6 resulted in only trace amounts (≤1%) of 448a while 62% starting material remained.
Gold(III)-catalysts were also investigated including AuCl3 (entry 7) and dichloro(2pyridine carboxylate)gold (L2, entry 8). Both of these catalysts produced trace amounts
of the 448a and like AuCl, starting material was recovered. Focusing on NHC ligands,
the saturated unsymmetrical NHC gold(I)-complex, L3/AgNTf2 (L3 = 1-cyclopentadecyl3-(2,6-diisopropylphenyl)imidazolidin-2-yl)gold chloride) was investigated and gave a
30% yield of 448a (entry 9). The N-acyclic carbene (NAC) gold(I)-complex, L4/AgNTf2
(L4 = ((tert-butylamino)(diethyl amino)methyl)gold chloride), was also tested but only
produced a low yield of 448a (entry 10). From the above results it was evident that only
a gold(I)-complex bearing a NHC ligand could efficiently convert cyclopropenyl furyl
sulfonamide 439aa to heterocycle 448a, with the IPr ligand giving the best result overall.
Table 3.1. Optimisation conditions for the gold(I)-catalysed reaction of cyclopropenyl furyl sulfonamide
439aa to 5,7-fused heterocycle 448a

Entrya

Catalyst

1

IPrAuNTf2

2

Catalyst

NMR

Solvent

Temp.

5 mol%

DCE

rt

53%

IMesAuNTf2

5 mol%

DCE

rt

36%c

3

PPh3AuCl/AgNTf2

5 mol%

DCE

rt

4%

4

JohnPhosAu(MeCN)SbF6

5 mol%

DCE

rt

2%

5

L1

5 mol%

DCE

rt

13%

Loading

Yieldb

177

≤1%

6d

AuCl

5 mol%

DCE

rt

7d

AuCl3

5 mol%

DCE

rt

8

L2

5mol%

DCE

rt

9

L3/AgNTf2

5 mol%

DCE

rt

30%

10

L4/AgNTf2

5 mol%

DCE

rt

13%

11

IPrAuNTf2

5 mol%

CHCl3

rt

40%

12

IPrAuNTf2

5 mol%

DCM

rt

48%

13

IPrAuNTf2

5 mol%

PhMe

rt

36%

14

IPrAuNTf2

5 mol%

THF

rt

30%

15

IPrAuNTf2

5 mol%

MeCN

rt

9%

16

IPrAuNTf2

5 mol%

MeOH

rt

10%

17

IPrAuNTf2

5 mol%

DCE

0 °C

57%

18f

IPrAuNTf2

5 mol%

DCE

–30 to –20 oC

56%

19

IPrAuCl/AgSbF6

5 mol%

DCE

0 °C

57%

20

IPrAuCl/AgOTf

5 mol%

DCE

0 °C

60%

21

IPrAuCl/AgBF4

5 mol%

DCE

0 °C

22 f

IPrAuCl/AgBF4

2.5 mol%

DCE

0 °C

23 f

IPrAuCl/AgBF4

1 mol%

DCE

0 °C

24 f

IPrAuCl

5 mol%

DCE

0 °C

25 f

AgBF4

5 mol%

DCE

0 °C

d

26

HNTf2

5 mol%

DCE

0 °C

(62%)e
≤1%
(50%)e
≤1%
(4%)e

71%
(75%*)g
60%
46%
(5%)e
0%
(76%)e
0%
0%h
(59%) e

a

All reactions performed over 0.75-2 h at a conc. of 0.1 mol/L unless otherwise specified; b mesitylene
used as the internal standard and integrations of the singlet at δ 6.81 ppm for mesitylene and the doublet at
δ 6.18 ppm for heterocycle 448a were compared to calculate NMR yields; c reaction also attempted using
IMesAuCl/AgNTf2 and the same yield was obtained; d reaction time 18-22 h; e starting material recovered;
f
reaction time 4-5 h; g isolated yield corrected for the presence of cyclobutene; h cleavage product obtained
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Having determined IPrAuNTf2 to be the optimum catalyst, the solvent was next
evaluated. Other chlorinated solvents were investigated including CHCl3 (entry 11) and
DCM (entry 12). In comparison to DCE as the solvent (53%, entry 1), CHCl 3 resulted in
a slightly diminished yield of 448a (40%) while DCM gave only a slightly lower yield
(48%). Using PhMe or THF as the solvent gave modest yields, producing 448a in 36%
(entry 13) and 30% (entry 14), respectively. Using more polar, coordinating solvents such
as MeCN and MeOH however, was completely detrimental to the reaction, producing
448a in 9% (entry 15) and 10% (entry 16) yields, respectively. Given the results it was
decided that DCE would be used as the solvent in subsequent reactions given the slightly
higher yield, however, it was noted that DCM was equally valid choice.
Temperature was the next variable of the reaction to be optimised. The reaction
was subsequently tested at 0 °C and it was discovered that the yield of 448a increased
slightly to 57% (entry 17). Perhaps more importantly, side product signals observed when
the reaction was performed at rt (entry 1), were not as prominent in the 1H NMR spectrum
of the crude mixture when the reaction was performed at 0 °C, as indicated by the relative
integrations. To determine whether the formation of the side product could be further
reduced or even prevented all together, the reaction was repeated starting at a temperature
of –30 °C (entry 18). After 2 h TLC analysis revealed that the reaction was not
progressing, most likely due to the melting point of DCE being –35 °C. The reaction was
warmed to –20 °C and after another 3 h, the reaction was complete and the 1H NMR
spectrum of the crude reaction revealed 448a had be formed in 56% yield. Given the
collective data, 0 °C was chosen as the optimum temperature as rt resulted in greater
amounts of side product, while –20 °C caused the reaction to be much slower with no
significant difference in the yield obtained for 448a.
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Up until this stage, the counterion used in the reaction was typically −NTf2 so
others were investigated. Reactions were performed at 0 °C using IPrAuCl (5 mol%) as
the gold catalyst and DCE as the solvent, while various silver salts were evaluated.
Neither −SbF6 (entry 19) nor −OTf (entry 20) as the counterion made any significant
improvement on the formation of 448a. However, when −BF4 was used as the counterion,
the yield of 448a increased to 71% and an isolated yield of 75%* was obtained for the
desired 5,7-fused heterocycle 448a (entry 21). A catalyst system of IPrAuCl/AgBF4 was
therefore determined to be the best. The effect of catalyst loading was also investigated
and it was found that reducing the loading of IPrAuCl/AgBF4 to 2.5 mol%, gave 60%
yield of 448a (entry 22) while a 1 mol% loading gave 46% yield (entry 23). Therefore, it
was determined that the optimal set of conditions for the conversion of cyclopropenyl
furyl sulfonamide 439aa to heterocycle 448a was IPrAuCl/AgBF4 (5 mol%) in DCE at
0 °C (entry 21).
After determining the optimum set of conditions, control experiments were
performed at 0 °C in DCE. As expected, reacting cyclopropenyl furyl sulfonamide 439aa
with 5 mol% of IPrAuCl (entry 24) or AgBF4 (entry 25) alone, failed to produce the
desired product, proving that both species must be present for the reaction to occur. To
confirm that gold was important for catalysing the reaction, cyclopropenyl furyl
sulfonamide 439aa was also reacted with the 5 mol% of the strong Brønsted acid, HNTf2
(entry 26). From the 1H NMR spectrum of the crude mixture, it was determined that
approximately 59% of the starting material remained; however, a new spot had developed
and was identified to be cyclopropenyl sulfonamide 455 (Scheme 3.12). One possible
explanation for the formation of cyclopropenyl sulfonamide 455 could involve
protonation of the Ts-protected nitrogen by HNTf2 to produce 453, followed by cleavage
of the observed product 455 and the potential formation of the oxocarbenium intermediate
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454. Attack on 454 by a nucleophile such as H2O could then generate furan 456. However,
given that no evidence of 456 was observed in the 1H NMR spectrum of the crude mixture,
this mechanism cannot be confirmed. Alternatively, polymerisation of the oxocarbenium
intermediate 454 might occur which would explain why no furan derivative was observed
following cleave of cyclopropenyl sulfonamide 455.

Scheme 3.12. Proposed reaction mechanism for the Brønsted acid catalysed formation of cyclopropenyl
sulfonamide 455

Following the optimisation of the gold-catalysis conditions, cyclopropenes
tethered to different aromatic heterocycles were screened to determine whether they
would also undergo the [4C+3C] cycloaddition reaction or if they would undergo another
reaction pathway all together. It was thought that a screen of different aromatic
heterocycles would not only result in the formation of other interesting products but
would also help to establish important trends in the aromaticity and nucleophilicity of
various heterocyclic systems. The results of the heterocycle screen will be discussed in
the following section.
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3.4.

Screening of other Cyclopropene Tethered Aromatic Heterocyclic
Systems
Once optimisation of the gold(I)-catalysed [4C+3C] cycloaddition of

cyclopropenyl furyl sulfonamide 439aa was complete, cyclopropenes tethered to other
aromatic heterocycles were screened using the best set of conditions from Table 3.1
(Entry 21, Section 3.3, pg 177). Cyclopropenyl indolyl sulfonamide 439ba was first
investigated and when subjected to the gold(I)-catalysis conditions, tetrahydro-βcarbolines (E)-457 and (Z)-457 were obtained as a mixture in a ratio of ~8:1 (E/Z), in a
combined yield of 96%* (Scheme 3.13a). Pleasingly, when the heterocycle was changed
to a pyrrole, 439ca rearranged to form tetrahydro-1H-pyrrolo[2,3-c]pyridines (E)-458 and
(Z)-458 as a mixture in ratio of ~6:1 (E/Z), in a combined yield of 74%* (Scheme 3.13b).
Both heterocycles 457 and 458 were proposed to be formed by a gold(I)-catalysed
Friedel–Crafts cyclisation, which will be discussed in more depth in Section 3.6.2. The
next substrate to be investigated was the cyclopropenyl thiophenyl sulfonamide 439d. It
was hoped that 439d would undergo the same [4C+3C] cycloaddition as the
cyclopropene–furan substrate 439a; however, diene 459d was instead obtained as a
mixture of isomers in 85% yield (Scheme 3.13c). The Mitsunobu side product,
cyclobutenyl sulfonamide 440d, was also present in the sample of 459d (ratio 459:440 =
93:7) given the overlapping Rf values of these compounds. Dienes 459e and 459f were
also

obtained

when

cyclopropene–benzo[b]furan

439e

and

cyclopropene–

benzo[b]thiophene 439f systems were subjected to the gold(I)-catalysis conditions,
respectively – again both as mixtures of geometric isomers (Scheme 3.13d).
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Scheme 3.13. Screen of other cyclopropenes tethered to different aromatic heterocycles

Of the products formed, cyclopropenes tethered to thiophene, benzo[b]furan and
benzo[b]thiophene moieties resulted in the formation of dienes when subjected to the
gold(I)-catalysis conditions. Using 459d as an example, the structure of these dienes and
the configuration of the major isomer was confirmed by NMR spectroscopy. For diene
459d, it was observed in the 1H and 13C NMR spectra that all signals associated with the
thiophene moiety were still present. This indicated that the tethered thiophene had not
participated in the rearrangement. Another observation was that the new product had one
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less CH2 group signal in the region between δ 0.7-2.5 ppm and that three characteristic
CH signals had formed between δ 4.9-6.1 ppm. These CH signals included a triplet at
δ 4.98 (Ha, J = 7.2 Hz) ppm, a doublet of triplets at δ 5.75 (Hb, J = 15.6, 6.4 Hz) ppm and
a doublet of quartets at δ 6.03 (Hc, J = 15.8, 1.4 Hz) ppm. These 1H signals correlated to
13

C signals at δ 120.3 (Ca), δ 134.0 (Cb) and δ 124.2 (Cc) ppm, respectively in the HSQC

spectrum (see appendix, pg 528). A 1H signal was also observed as a doublet at δ 3.95
(CH2d, J = 7.2 Hz) ppm that represented a CH2 group. Based on the chemical shift of CH2d
protons, it most likely represented a CH2 group adjacent to the NTs group.
Once some key 1H and 13C signals had been identified, it was established through
coupling constants and multiplicities that Ha was adjacent to the CH2d 1H signals. Looking
at the HMBC spectrum (Figure 3.7), Ha was seen to correlate to the 13C signal (at δ 36.1
ppm) that represented the proximal CH2 group of the propyl chain. It was then determined
that protons Hb and Hc were adjacent to one another and connected via a double bond,
based on their coupling constants (J = 15.6 Hz and J = 15.8 Hz) and the sp2 nature of
carbons Cb and Cc. In the HMBC spectrum, it was observed that Hc had a strong
correlation to the

13

C signal of the proximal CH2 group of the propyl chain, as well as

weaker correlations to Ca and a sp2 quaternary carbon at δ 140.9 (Ce) ppm. As the 1H
signals of the propyl chain correlated to Ce in the HMBC spectrum, it supported that the
propyl chain was directly attached to this quaternary carbon. As it was already established
that Cc was connected via a double bond to Cb, carbon Ch must therefore be attached to
Ca via a double bond to satisfy the sp2 nature of both carbons. This therefore confirmed
the diene structure of 459d. From the HMBC spectrum, Hb also had correlations to the
13

C signals at δ 26.2 and δ 13.5 ppm that represented the CH2 and CH3 groups of the ethyl

substituent, respectively. This supported that the ethyl group was attached to a HC=C
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group and accounted for the loss of a CH2 group from one of the propyl chains and
ultimately confirmed the overall structure of diene 459d.

CH2d
c

b

H H

a

H

CH2Et
CH2Pr
Cd

Cc

Ca

Cb
Ch

Figure 3.7. HMBC spectrum for diene 459d with labelled structures showing important correlations.

Once the structure of diene 459d was confirmed, coupling constants and a
NOESY spectrum (see appendix, pg 528) were used to confirm the stereochemistry of the
major isomer (Figure 3.8). Proton Hc had a through space correlation to the CH2d 1H
signals while Ha was observed to have a correlation with the 1H signals of the proximal
CH2 group of the propyl chain. Given the observed correlations, Ha must be cis to the
propyl chain, thus the first double bond would be in the Z-conformation. For the
stereochemistry of the second double bond, the coupling constants of Hb (J = 15.6 Hz)
and Hc (J = 15.8 Hz) were considered. Given the large coupling constants, it would
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suggest that Hb and Hc were trans to one another across the double bond and was
supported by an apparent through space correlation between Hc and the CH2 group of the
ethyl substituent (suggested Hc and the Et group were cis to each other). Based on the
NMR data collected, the overall stereochemistry for the major isomer of diene 459d was
most likely the (Z,E)-conformation. Comparing the NMR spectra of diene 459d to the
spectra of the products obtained from the gold(I)-catalysed reaction of the cyclopropene–
benzo[b]furan 439e and cyclopropene–benzo[b]thiophene 439f systems, the structure of
dienes 459e and 459f were also confirmed.

Figure 3.8. NOESY correlations of diene 459d

Heterocycles 457a and 458 also had not been previously obtained so data was
collected to confirm the structures. Fortunately, the tetrahydro-β-carboline 457a was a
crystalline solid, so X-ray crystallography was performed and unambiguously confirmed
the structure of 457a. Signals in the 1H NMR spectrum that were characteristic of
tetrahydro-β-carboline 457a included the triplet (integration of 1H) at δ 5.09 ppm that
represented the CH of the double bond. A doublet and a doublet of doublets (integration
of 1H each) were also observed at δ 4.39 and δ 4.27 ppm, respectively that represented
the CH2 group adjacent to the NTs group and the sp2 quaternary carbon of the fused indole
ring. A triplet (integration of 1H) occurred at δ 3.66 ppm, which was found to represent
the CH group at the chiral centre of the molecule. Other 1H signals that were quite
characteristic of tetrahydro-β-carboline 457a occurred as doublet of doublets at δ 3.54
and δ 3.13 ppm and represented the CH2 group adjacent to the NTs group and the chiral
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centre. In 1H NMR spectrum for tetrahydro-1H-pyrrolo[2,3-c]pyridine 458, similar
chemical shifts and multiplicities of 1H signals representing the CH and CH2 groups were
observed, which confirmed the structure of the heterocycle (analysis of the 2D spectra
was also performed but this will not be discussed).
Upon comparing the scaffold of heterocycle 457a to the literature, it was
discovered that the tetrahydro-β-carboline core occurred in a number of natural products
and biologically active molecules.[171] For example, ajmalicine

(also known as

raubasine), is a natural product isolated from plants such as Rauwolfia serpentine and
Rauvolfia vomitoria and possesses antihypertensive properties (Figure 3.9).[171] The
tetrahydro-β-carboline core also occurs in some very prominent synthetic drugs such as
tadalafil (Figure 3.9).[171a] Tadalafil has been marketed as a drug for the treatment of
erectile dysfunction under the brand name Cialis and had generated just over $2.3 billion
in revenue by 2015.[172] Tadalafil has also been marketed under the brand name Adcirca,
for the treatment of pulmonary arterial hypertension.[171a] Other broad biological
properties displayed by compounds containing tetrahydro-β-carboline cores include
antiprotozoal, antiviral and anticancer activities.[171a] Given the high yields obtained for
heterocycles 457a and 458 and the biological importance of tetrahydro-β-carbolines, it
was decided that a substrate scope would also be performed for the gold(I)-catalysed
rearrangement of cyclopropenyl indolyl sulfonamides 439b (and cyclopropenyl pyrrolyl
sulfonamides 439c) as well as the cyclopropenyl furyl sulfonamides 439a. The results
from both substrate scopes will be discussed in the following section.
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Figure 3.9. Biologically activity compounds that contain a tetrahydro-β-carboline core

3.5.

Substrate Scope for the Gold(I)-Catalysed Rearrangements of
Cyclopropenyl Sulfonamides 439

3.5.1. Substrate Scope for the Gold(I)-Catalysed [4C+3C] Cycloaddition of
Cyclopropenyl Furyl Sulfonamides 439a
Following the successful gold(I)-catalysed [4C+3C] cycloaddition of 439aa,
cyclopropenyl furyl sulfonamide 439ab with R3 = H, was tested to determine whether
having a tertiary substituted carbon at the 5-position of the furan was crucial for reactivity.
Heterocycle 448b was obtained in 71%* yield; however, the 1H NMR spectrum indicated
that a small impurity (ratio ~90:10) was present (Table 3.2). The impurity could have
been the other diastereoisomer of 448b, or could have been the isomer 460 (see Scheme
of Table 3.2). Based on the literature,[156-158, 168] the impurity was most likely isomer 460,
but this was not conclusively proven as the impurity was not isolated. The impurity could
be removed by recrystallisation from pentane and pure white crystals of heterocycle 448b
were obtained that were suitable for X-ray crystallography – confirming the structure of
heterocycle 448b, including the relative stereochemistry. The next substrate attempted
was cyclopropenyl furyl sulfonamide 439ac (R1 = R2 = nPr, PG = Ts and R3 = Me), which
gave heterocycle 448c in 65%* yield. Having a –CH2OEt group in the R3 position of
cyclopropenyl furyl sulfonamide 439ad, resulted in 55%* yield of heterocycle 448d,
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while changing R3 position to a Br substituent gave heterocycle 448e in 14%* yield. The
[4C+3C] cycloaddition to generate 448e took considerably longer (~4 d) and required
excess gold catalyst to go to completion. It was believed that the diene isomer 459ae was
the main product formed for this particular substrate; however, 459ae could not be
isolated due to degradation.16 Regardless, the substantially lower yield of 448e was
potentially due to the inductive electron-withdrawing effect of the Br substituent, thus
hindering the ability of the furan to dearomatise and participate in the [4C+3C]
cycloaddition (see mechanism in Scheme 3.6.1). After altering the R3 position, different
protecting groups on the nitrogen were investigated. A brosyl group was well tolerated,
giving 61%* yield of heterocycle 448f while a nosyl group resulted in a slightly lower
yield of the desired heterocycle, providing 448g in 47%* yield.
Table 3.2. Substrate scope for the gold(I)-catalysed reaction of cyclopropenyl furyl sulfonamides 439a to
5,7-fused heterocycles 448

≡
448a: Yield 75%*

448b: Yield 71%*17

Characteristic triplet (δ 5.06 ppm) and doublet of triplets (δ 5.79 ppm) 1H signals in the 1H NMR spectrum
of a small sample taken from the reaction to monitor its progress
17
X-ray crystal structure obtained by Dr Christopher Richardson (CCDC 1909426)
16

189

a

448c: Yield 65%*

448d: Yield 55%*

448e: Yield 14%*a

448f: Yield 61%*

448g: Yield 47%*

448h: Yield 3%a

448i: Yield 24%

448j: Yield 33%

448k: Yield 17%

Significant amounts of diene 459e and 459h were formed

Up to this point, substrates 439aa-439ag had all been symmetrical cyclopropenes,
so efforts were focused towards developing a non-symmetrical, disubstituted substrate.
Cyclopropenyl furyl sulfonamide 439ah was prepared where R1 = nHex and R2 =
–CH2OTBS (R3 = Me and PG = Ts). The –CH2OTBS group was selected for two reasons:
1) following formation of the heterocycle, desilylation would result in a free hydroxyl
group that could be used for further functionalisation; and 2) R1 and R2 had to be different
enough so that regioselective ring-opening of the cyclopropene might still occur.[103]
When cyclopropenyl furyl sulfonamide 439ah was subjected to the gold(I)-catalysis
conditions, the corresponding heterocycle 448h was only obtained in 3% yield and the
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diene isomer 459ah was obtained in 33% yield. From the 1H NMR of the diene 459ah, it
appeared that all four possible isomers had been produced; however, the stereochemistry
could not be assigned due to significant overlapping of 1H signals. The ratio of the diene
459ah isomers was calculated to be 4.4:2.1:1.6:1 from the 1H NMR spectrum.
Given the non-symmetrical nature of cyclopropenyl furyl sulfonamide 439ah, two
possible isomers of the 5,7-fused heterocycle could have been formed. For example, goldactivation and ring-opening of the cyclopropene moiety by cleavage of the C1–C3 bond
would result in heterocycle 448h (Scheme 3.14). Alternatively, ring-opening of the
cyclopropene moiety by cleavage of the C2–C3 bond would have resulted in heterocycle
461h (not observed). The regioselectivity for the 5,7-fused heterocycle obtained from the
gold(I)-catalysed [4C+3C] cycloaddition of cyclopropenyl sulfonamide 439ah was
therefore confirmed based on 2D NMR characterisation data which will be discussed
below.

Scheme 3.14. Possible regioisomers from the gold(I)-catalysed [4C+3C] cycloaddition of cyclopropenyl
furyl sulfonamide 439ah

The core scaffold of heterocycle 448h was determined to be the same as that of
448a, therefore assignments of the proton and carbon signals will not be discussed,
although four important signals specific to heterocycle 448h need to be mentioned. In the
aliphatic region, two multiplets were observed between δ 1.74-1.82 and δ 1.99-2.07 ppm
(CH2j) that correlated to the same a 13C signal at δ 31.4 ppm in the HSQC spectrum (see
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appendix, pg 507).18 Given the chemical shifts of the CH2j 1H signals, they represented
the proximal CH2 group of the n-hexyl chain adjacent to either Ch or Ci. Two doublets
(J = 11.5 Hz) were also observed at δ 4.03 and δ 4.23 (CH2k) ppm that correlated to the
same 13C signal at δ 57.3 ppm in the HSQC spectrum. Given the chemical shifts of these
signals they were assigned as the –CH2OTBS group that would also be adjacent to either
Ch or Ci. Once key 1H and 13C signals had been identified, the HMBC spectrum (Figure
3.10) was analysed to confirm which regioisomer of heterocycle 448h had been obtained.

CH2b
He

Hf

CH2k

CH2c

Ha CH2j

Cj
Ca
Cb
Cc
Ck
Cg
Cd

Cf
Ci Ch
Ce

Figure 3.10. HMBC spectrum for 5,7-fused heterocycle 448h with a labelled structure showing important
correlations
The multiplet between δ 1.99-2.07 ppm had an integration of 2H, as one the CH2j protons was overlapped
with Ha.
18
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Both the CH2b 1H signals (δ 2.98 and δ 3.92 ppm) of the pyrrolidine ring and the CH2j 1H
signals of the n-hexyl chain, had a correlation to quaternary carbon Ci (130.7 ppm). The
CH2j 1H signals had weaker correlations to Ca (δ 43.2 ppm). Meanwhile, the CH2k 1H
signals next to the –OTBS group correlated to Ch, Ci and Cg (δ 84.8 ppm) but no
correlation was seen to Ca. The correlation of the CH2j 1H signals representing the CH2
group of the n-hexyl chain, to Ca and not Cg and the correlation of the CH2k 1H signals to
Cg not Ca therefore supported the formation of regioisomer 448h.
Given the complications with the asymmetric disubstituted example 448h,
monosubstituted cyclopropene–furan system where R2 = H, were synthesised. Based on
previous literature,[72a, 103, 173] it was expected that ring-opening of the cyclopropene would
occur regioselectively, resulting in the gold catalyst becoming situated at the least
sterically hindered C2 position. The first monosubstituted example to be tested was
cyclopropenyl sulfonamide 439ai where R1 = –(CH2)3OTBS and R2 = H, which gave
heterocycle 448i in 24% yield. Yields for the other two monosubstituted examples 448j
(R1 = –(CH2)2CH(CH3)2, R2 = H) and 448k (R1 = tBu, R2 = H) were also lower at 33%
and 17%, respectively.19 As with the 5,7-fused heterocycle 448h, NMR spectroscopy was
used to confirm that ring-opening of the cyclopropene occurred by cleavage of the C1–C3
bond to give 448, and not by cleavage of the C2–C3 bond to give 461 (Scheme 3.15) .
Heterocycle 448i was used as the example in this case and most of the chemical shifts for
the 1H and

13

C signals of the 5,7-fused core were the same as previously observed for

other related compounds. One key difference however for heterocycle 448i was that an
additional =CH group occurred at δ 5.66 (Hh) ppm and correlated to the carbon at δ 129.1
(Ch) ppm in the HSQC spectrum (see appendix, pg 510).

19

Once purified, monosubstituted cyclopropenyl furyl sulfonamides 439ai-439ak had to be used and
characterised immediately to avoid polymerisation/degradation of the materials.
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Scheme 3.15. Possible heterocycles that could be formed from the gold(I)-catalysed [4C+3C] cycloaddition
of monosubstituted cyclopropenyl furyl sulfonamide 439a

From the HMBC spectrum (Figure 3.11) of 5,7-fused heterocycle X337i, the CH2b
protons correlated to Ca (δ 43.4 ppm) and sp2 quaternary carbon Ci (δ 135.3 ppm).

Me*

CH2b

Hf He Hh

CH2c

Ha CH2j

Me*
Cj
Ca
Cb
Cc

Cg
Cd

Ce
h

C

Ci
Cf

Figure 3.11. HMBC spectrum for 5,7-fused heterocycle 448i with a labelled structure showing important
correlations.
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Looking at the CH2j 1H signals that represented the proximal CH2 of the –(CH2)3OTBS
group, strong correlations were observed with Ch and Ci as well as Ca; however, no
correlations to Cg were observed. The Me* group 1H signal was then observed and was
found to strongly correlate to Cg and Ch; however, no correlation was observed with the
CH2j 13C signal. Therefore, the 2D NMR data proved quite conclusively that heterocycle
448i had been obtained and that the monosubstituted cyclopropenyl sulfonamides
underwent ring-opening by cleavage of the C1–C3 bond when subjected to the gold(I)catalysis conditions.
Looking at the results for the monosubstituted examples 448i-448k, one possible
explanation for the reduced yields could have been that some of the starting material
degraded during the gold(I)-catalysed reaction. In an attempt to circumvent this potential
problem, substrate 439ai was subjected to IPrAuCl/AgBF4 (5 mol%) in DCM and the
reaction was started at –50 °C. However, the cooler temperature hindered the progression
of the reaction and conversion of the starting material was not observed until the reaction
was warmed to –15 °C and heterocycle 448i was obtained in 16% yield after 2 h. Thus,
yields could not be improved by performing the reaction at a lower temperature. Another
explanation for the poorer yields could have also been due to instability of the
heterocyclic products. From the reaction of cyclopropenyl furyl sulfonamide 448i,
tropone 462 was obtained in 9% yield in addition to the 24% yield of heterocycle 448i
(Scheme 3.16). Given that the tropone 462 1H signals were not observed in the 1H NMR
spectrum of the crude mixture, it suggested that the side product had formed during
purification, most likely when the sample had been absorbed to silica gel.
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Scheme 3.16. Isolation of tropone 462 following gold(I)-catalysed rearrangement of cyclopropenyl
sulfonamide 439ai and purification of heterocycle 448i

The structure of tropone 462 was confirmed by the various characterisation
methods. A HRMS revealed that a peak consistent with the [M + Na]+ ion of tropone 462
(C26H37NO4SSi), was detected at m/z 510.2111 (calc. m/z 510.2110). The carbonyl group
of tropone 462 was also supported by signal at 1694 cm-1 in the IR spectrum as well as a
sp2 quaternary 13C signal at δ 191.5 (Ca) ppm, in the 13C NMR spectrum. Looking at the
1

H NMR spectrum, two new 1H signals (integration 1H each) had formed in the aromatic

region, which occurred as doublet of doublets (J = 2.0, 1.0 Hz) at δ 7.56 (Hb) and δ 7.21
(Hc) ppm. Protons Hb and Hc were then observed to have correlations to the carbons at
δ 125.2 (Cb) and δ 136.1 (Cc) ppm, respectively in the HSQC spectrum (see appendix, pg
512). The formation of these two aromatic 1H signals in addition to the carbonyl groups
is what indicated to presence of a tropone structure. Two CH2 groups also occurred which
were represented by a singlet at δ 4.48 (CH2d) ppm and a doublet at δ 3.99 (CH2e,
J = 1.0 Hz) ppm. Based on the chemical shifts, these signals were assigned as the CH 2
groups on either side of the NTs group. The proximal CH2 of the –(CH2)3OTBS group
was then observed as a multiplet between δ 2.66-2.71 (CH2f) ppm. There was also a
methyl group represented by a singlet at δ 2.30 (Me*) ppm, which correlated to the carbon
at δ 20.9 ppm in the HSQC spectrum.
Having identified some key 1H and 13C signals, the HMBC spectrum (Figure 3.12)
for tropone 462, was analysed. The presence of the 5-membered ring was first confirmed.
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Firstly the CH2d 1H signal was observed to have correlations to the sp2 quaternary carbons
at δ 133.7 (Ch) and δ 130.2 (Ci) ppm. Looking at the CH2e 1H signal, it had a weak
correlation to Ci suggesting that CH2d, CH2e, Ch, Ci and the NTs group made up the 5membered ring. Once the signals associated with the 5-membered ring were identified,
the structure of the fused tropone ring had to be confirmed. In the HMBC spectrum, both
the CH2e 1H signal and Hb were observed to have strong correlations with the carbonyl
carbon represented by Ca. This shared correlation suggested that the carbonyl group was
directly adjacent to both carbons Cb and Ci. Carbons Cb and Ci would therefore be attached
to Ca via single bonds. As a consequence of this, a double bond would need to exist
between Ci and Ch, to satisfy the sp2 quaternary nature of Ci. The CH2d 1H signal was
observed to have a correlation to a sp2 quaternary 13C signal at δ 138.7 (Cg) ppm. Carbon
Cg also correlated with the CH2f 1H signal as well as other 1H signals (δ 1.74-1.81 ppm)
of the –(CH2)3OTBS group and indicated a direct attachment between the CH2f carbon
and Cg. The CH2f 1H signal was also observed to have a correlation to Cc which suggested
a direct attachment via a double bond between carbons Cc and Cg. Proton Hb was also
observed to correlate to Cc as well as the 13C signal of the Me* group. The Me* 1H signal
had a strong correlation to a sp2 quaternary

13

C signal at δ 137.3 (Cj) ppm. Given the

strong correlation, the Me* group was most likely directly attachment to the carbon
represented by Cj. Therefore, the =CH group represented by Hb and Cb must be directly
attached to the carbon represented by Cj, via a double bond. Consequently the =CH group
represented by Hc and Cc had to be attached to Cj via a single bond, and therefore
confirmed the structure of the tropone. It was highly likely that a correlation existed
between the Me* 1H signal and carbon Cc that would have further supported the structure
of the tropone; however, due to the closeness of the chemical shifts of Cc (δ 136.1 ppm)
and Cj (δ 137.3 ppm) this correlation could not be definitively resolved.
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Figure 3.12. HMBC spectrum for tropone 462 with a labelled structure showing important correlations.

Assuming tropone 462 came from the ring-opening of heterocycle 448i on silica
gel, a plausible mechanism could involve protonation of the oxygen atom of the oxabridge in 448i, followed by cleavage of the O–C6 bond to result in the resonance stabilised
tropylium cationic intermediate 463 (Scheme 3.17). Cleavage of the oxa-bridge would be
fairly selective for the O–C6 bond as intermediate 463 had more resonance contributors
to stabilise the carbocation compared to intermediate 464, which would be formed by
cleavage of the O–C3 bond. Nucleophilic attack of the alcohol to C4 in intermediate 463
would result in the formation of the epoxide intermediate 465, which could become
protonated under the acidic conditions. Elimination of a hydrogen and ring-opening of
the epoxide could generate the tropylium alcohol 466, which would likely oxidise
198

spontaneously to give the aromatic tropone 462. Evidence of tropone formation was also
observed following silica gel purification of heterocycle 448j (Table 3.2, pg 189, R1 =
–(CH2)2CH(CH3)2, R2 = H); however, it is unclear why only the monosubstituted
examples seemed to undergo the reaction.

Scheme 3.17. Plausible reaction mechanism for the formation of tropone 462 from heterocycle 448i

The results in Table 3.2 represent substrates that successfully underwent the
desired gold(I)-catalysed [4C+3C] cycloaddition reaction to some extent. However,
several other substrates were attempted that either formed products other than the
5,7-fused heterocycle 448, or did not furnish any isolatable products. These substrates are
shown in Table 3.3 and include the symmetrical cyclopropenyl sulfonamide 439al (R1 =
R2 = Ph) and the non-symmetrical cyclopropenyl sulfonamides 439am (R1 = Ph, R2 =
Me) and 439an (R1 = –(CH2)2CH(CH3)2, R2 = TBS). When substrates 439al-439an were
subjected to the gold(I)-catalysis conditions, the 1H NMR spectra of the crude residues
demonstrated that complex mixtures of products were obtained. Substrates 439al and
439am did not yield any of the desired 5,7-fused heterocycles, while trace amounts of the
bicycle 448n were obtained from the gold(I)-catalysed rearrangement of substrate 439an.
It should be noted that substrate 439an was not pure when it was subjected to the gold(I)catalysed conditions as it was contaminated with significant amounts of the allene 467
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(scheme of Table 3.3). The allene 467 was inert to the gold(I)-catalysis conditions and
was isolated thereafter, and its structure was confirmed. Characterisation of allene 467
will not be discussed; however, the allene moiety was known to be present based on the
sp2 quaternary

13

C signal at δ 206.8 ppm in the

13

C NMR spectrum, and the signal at

1926 cm-1 in the IR spectrum. Rearrangement of the cyclopropenyl sulfonamide 439an
to allene 467 had apparently occurred spontaneously without any deliberate exposure to
a catalyst. This suggested that 439an (and possibly cyclopropenyl alcohol 436i) were
sensitive to light or other atmospheric conditions. Rearrangement of silyl substituted
cyclopropenes to allenes under photochemical or thermal conditions has been reported by
several literature investigations by Kirms et al.,[174] Meijere et al.[175] and Padwa et al.,[176]
and therefore provides a likely explanation for the formation of allene 467.
Table 3.3. Cyclopropenyl furyl sulfonamide 439a that do not undergo the gold(I)-catalysed [4C+3C]
cycloaddition

439al

439am

439an

Another substrate that was investigated as part of the gold(I)-catalysed [4C+3C]
cycloaddition scope was the symmetrical cyclopropenyl furyl sulfonamide 439ao with a
Ph ring in the 5-position of the furan. Instead of undergoing the [4C+3C] cycloaddition,
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439ao instead formed diene 459ao (Scheme 3.18). The (Z,E)-isomer was determined to
be the major isomer obtained; however, two other isomers were also present, with the
ratio of the isomers determined to be 16:3:1 from the 1H NMR spectrum.20 Substrate
439ao likely resulted in diene formation due to the increased conjugation and electronwithdrawing nature of the Ph ring which would have disfavoured the dearomative
[4C+3C] cycloaddition.

Scheme 3.18. Gold(I)-catalysed rearrangement of cyclopropenyl furyl sulfonamide 439ao

Once the substrate scope for the gold(I)-catalysed [4C+3C] cycloaddition of
cyclopropenyl furyl sulfonamides 439a had been explored, the scope from the gold(I)catalysed Friedel–Crafts cyclisation of cyclopropenyl indolyl (and pyrrolyl) sulfonamides
439b (and 439c) was investigated and will be discussed in the following section.

3.5.2. Substrates Scope for the Gold(I)-Catalysed Friedel–Crafts Cyclisation of
Cyclopropenyl Indolyl (and Pyrrolyl) Sulfonamides 439b (and 439c)
Following the successful gold(I)-catalysed Friedel–Crafts cyclisation of
cyclopropenyl indolyl sulfonamide 439ba to the tetrahydro-β-carboline 457a and
cyclopropenyl pyrrolyl sulfonamide 439ca to heterocycle 458 (Table 3.4), other
substrates were investigated. The monosubstituted cyclopropenyl indolyl sulfonamide

20

Cyclobutene isomer 440ao was also present in the sample due to the overlapping Rf values with the diene
according to TLC analysis.
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439bb was next reacted under the gold(I)-catalysed conditions at –10 °C, and the desired
tetrahydro-β-carboline 457b was obtained in a good yield of 68%. This was a particularly
good result, giving the poorer conversions of the monosubstituted cyclopropenyl furyl
sulfonamides 439ai-439ak to the 5,7-fused heterocycles 448i-448k (17-33% yields,
Table 3.2, Section 3.5.1, pg 189). Pleasingly, the gold(I)-catalysed Friedel–Crafts
cyclisation proceeded efficiently when inductively electron-withdrawing halogen
substituents were placed in the 5-position of the indole ring. Heterocycle 457c with a Br
substituent was formed in 88%* yield with an E/Z selectivity of ~6:1, while heterocycle
457d with a Cl substituent was formed in 90%* yield with an E/Z selectivity of ~7:1. It
was determined that the protecting group on the nitrogen of the indole could also be
changed to a Bn group as tetrahydro-β-carboline 457e was obtained in 87%* yield with
an E/Z selectivity of ~6:1. However, an electron-withdrawing Ts-protecting group on the
nitrogen of the heterocycle was not tolerated. Cyclopropenyl pyrrolyl sulfonamide 439cb
was subjected to the gold(I)-catalysis conditions but no 1H signals consistent with the
corresponding tetrahydro-1H-pyrrolo[2,3-c]pyridines 458b were observed in the 1H
NMR spectrum of the crude mixture. Diene formation was evident but could not be
isolated and fully characterised due to the substantial amounts of cyclobutene regioisomer
in the sample.
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Table 3.4. Substrate scope for the gold(I)-catalysed rearrangement of cyclopropenyl indolyl sulfonamides
439b and cyclopropenyl pyrrolyl sulfonamides 439c

≡
457a: Yield 96%*21
E/Z = ~8:1

458: Yield 74%*
E/Z = ~6:1

457b: Yield 68%

457c: Yield 88%*
E/Z = ~6:1

457e: Yield 87%*
E/Z = ~6:1

439cb

457d: Yield 90%*
E/Z = ~7:1

Other substrates had been planned for the scope of the gold(I)-catalysed Friedel–
Crafts cyclisation as well as the [4C+3C] cycloaddition; however, problems were
experienced when synthesising these substrates. The attempts to synthesise other
cyclopropenyl sulfonamide substrates will be briefly discussed in the following section.

21

X-ray crystal structure obtained by Dr Christopher Richardson (CCDC 1909427)
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3.5.3. Attempts to Make Other Derivatives of Cyclopropenyl Sulfonamide 439
In addition to cyclopropenyl furyl sulfonamide 439ah, several attempts were
made to synthesise a non-symmetrical disubstituted cyclopropene with a tBu substituent
on one side of the cyclopropene double bond and an alkyl chain on the other. It was
assumed that the use of a bulky tBu group would be necessary to influence the
regioselectivity of the ring-opening of the cyclopropene. To synthesise this substrate the
monosubstituted cyclopropenyl carboxylate 435f was reduced to alcohol 436f, which was
deprotonated with n-BuLi and alkylated with iodopropane (Scheme 3.19). The desired
cyclopropenyl alcohol 436j was obtained in 16% yield over two steps; however, even
after purification, impurities were observed in the NMR spectra. Cyclopropenyl alcohol
436j was coupled with sulfonamide 438a to obtain the desired cyclopropenyl furyl
sulfonamide 439ap in 42% yield. Despite the apparently clean product according to TLC
analysis, impurities were observed in the NMR spectra of 439ap that could not be
removed from the desired compound. Given the impurities, cyclopropenyl sulfonamide
439ap was not subjected to the gold(I)-catalysis conditions and no further attempts were
made to synthesise other asymmetrical, disubstituted substrates.

Scheme 3.19. Attempts at synthesising asymmetrical disubstituted cyclopropenyl furyl sulfonamides

For the investigation into the scope of the reaction, it was also planned that
substituents would be placed on the carbon adjacent to the furan moiety to synthesise an
enantioenriched substrate that could determine whether the [4C+3C] cycloaddition
reaction was enantioretentive. To synthesise the necessary enantioenriched furyl
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sulfonamide, the furfural starting material was converted to an imine and was reacted
with a Grignard reagent to obtain the desired sulfinamide 469 (Scheme 3.20). Sulfinamide
469 was then oxidised to the desired sulfonamide (S)-438o using metachloroperoxybenzoic acid (m-CPBA) (Scheme 3.20). It should be acknowledged that (S)438o was prepared by a German collaborator, Dr Sebastian Arndt, as part of the DAAD
grant.

Scheme 3.20. Synthesis of chiral starting materials

Following the synthesis of the chiral sulfonamide (S)-438o, our collaborator
subjected this substrate to the Mitsunobu reaction conditions in an attempt to synthesise
the enantioenriched cyclopropenyl furyl sulfonamide 439ar (Scheme 3.21). However,
when subjected to the Mitsunobu conditions, 439ar was not obtained. As was previously
established in Section 3.2.1, the alcohol group of cyclopropene 436b, could not be
successfully converted to a good leaving group. Thus, cyclopropenyl sulfonamide 439ar
had to be abandoned as a substrate in the scope.

Scheme 3.21. Attempts to synthesise enantioenriched cyclopropenyl furyl sulfonamides 439a with
substituted N-linkers
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Difficulty was also experienced when synthesising a furyl sulfonamide with a
methyl group in the 3-position of the furan ring. Methyl 3-methylfuran-2-carboxylate was
reduced to the corresponding alcohol 470 and was reacted with tert-butyl tosylcarbamate
under Mitsunobu coupling conditions to obtain the furyl carbamate 471 in 66% yield,
over two steps (Scheme 3.22a). Removal of the Boc group using TFA was attempted to
obtain the desired furyl sulfonamide; however, product decomposition was instead
observed. The synthetic approach shown in Scheme 3.22a was attempted as furyl
carbamate 471 had a high molecular weight (365.44 g/mol) and would be easier to isolate
and handle. Oxidation of 470 to the corresponding aldehyde 472 was also attempted by
subjecting 470 to a TEMPO/NaOCl oxidation reaction[177] (Scheme 3.22b). From the 1H
NMR spectrum of the crude residue however, no peaks were observed between δ 9-10
ppm, indicating the aldehyde had not formed. Other oxidants such as MnO2 or Dess–
Martin periodinane (DMP) may been more successful at converting 470 to 472 and could
be investigated in future work.

Scheme 3.22. Synthetic attempts at preparing a 3-methyl furyl sulfonamide starting material
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The final substrate that was attempted as part of the scope for cyclopropene–furan
systems, was a cyclopropenyl furyl ether 473 (Scheme 3.23). As had already been
established, the alcohol moiety of cyclopropene 436 could not be easily transformed into
a good leaving group, so attempts were made to convert the alcohol moiety of (5methylfuran-2-yl)methanol into a leaving group instead. An SN2 reaction could then be
performed between cyclopropenyl alcohol 436b and furan 473, to obtain the desired
cyclopropenyl ether 474. As can be seen from Scheme 3.23, various attempts were made
to mesylate, tosylate or brominate the alcohol group of the furan. For almost every set of
conditions tested, decomposition/polymerisation of the furan was observed. The
exception was when a tosylation reaction was performed in pyridine with catalytic DMAP
and the reaction did not go to completion.

Scheme 3.23. Attempts at synthesising cyclopropenyl furyl ether 474

A likely explanation for why the desired furan 473 was not obtained, could be
related to investigations performed by Winberg and Fawcett in the 1960s. [178] They
determined that when the bromofuran 475 was reacted with trimethylamine, furyl
trimethylammonium bromide 476 formed, which could be converted to the corresponding
hydroxide derivative 477 when reacted with Ag2O and H2O (Scheme 3.24). The furyl
trimethylammonium hydroxide 477 could then react to form 2,5-dimethylene-2,5207

dihydrofuran 478 presumably by a Hofmann-type 1,6-elimination. The dihydrofuran 478
was isolated at –78 °C and when warmed in the absence of polymerisation inhibitors,
product 479 was formed.[178b] It is therefore reasonable to assume that attempts to convert
the alcohol functional group of (5-methylfuran-2-yl)methanol in this thesis, to a good
leaving group, would result in the formation of the furan polymer 479. Given the
difficulty experienced when trying to prepare the starting materials for cyclopropenyl
furyl ether 474, this substrate was also not pursued further.

Scheme 3.24. Polymerisation of furyl trimethylammonium hydroxides 477

3.6.

Proposed Mechanisms for the Gold(I)-Catalysed Rearrangements of
Cyclopropenyl Sulfonamides 439

3.6.1. Proposed Mechanism for the Formation of 5,7-Fused Heterocycle 448
As previously stated, the gold(I)-catalysed rearrangement of cyclopropenyl furyl
sulfonamide 439a to 5,7-fused heterocycle 448 involved a [4C+3C] dearomative
cycloaddition and a plausible mechanism has been proposed in Scheme 3.25. The gold(I)catalyst would first coordinate to the π-bond of the cyclopropene moiety as shown in 480,
which would result in ring-opening to obtain the gold(I)-carbene intermediate 481.
Following the formation of the gold-carbene, the furan moiety would attack the goldcarbene from the most nucleophilic C2-position. A bond would be established between
C2 of the furan and C6 of the carbenoid to generate the spirocyclic intermediate 482.
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Nucleophilic attack from C8 of the alkenyl gold moiety, to C5 of the oxonium ion would
then yield the observed heterocycle 448 and regenerate the gold(I)-catalyst.

Scheme 3.25. Plausible reaction mechanism for the formation of 5,7-fused heterocycles 448

Only a single diastereoisomer of heterocycle 448 was obtained from the gold(I)catalysed [4C+3C] cycloaddition and this matched the stereochemistry of the 5,7-fused
heterocycles reported by López and Mascareñas[156-157] as well as Dai et al. [158, 168] As
shown in Scheme 3.1 (Section 3.1, pg 159), these research groups synthesised 5,7-fused
heterocycles by a concerted gold-catalysed [4C+3C] cycloaddition of tethered allene–
furan systems. If the mechanism described in this thesis were to occur in a stepwise
fashion, then the diastereoselectivity would be determined by the initial nucleophilic
attack of the furan on the gold(I)-carbene. The rigid structure of the spirocyclic
intermediate 482 would mean that the alkenyl gold moiety could only attack the oxonium
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ion from the ‘bottom face’ and only one diastereoisomer of 482 is thought to undergo a
favourable cyclisation to form heterocycle 448. The other diastereoisomer 448’ (i.e. oxabridge cis to the proton) was not observed. It is uncertain whether this is because the
initial nucleophilic attack is potentially reversible, or because cyclisation of the other
diastereoisomer of 482 is unfavourable and results in degradation. While there have been
no reports in the literature of vinyl gold carbenoids such as 481 undergoing concerted
cycloaddition reactions, such a pathway cannot be discounted. If a concerted pathway
were to occur then the exo transition state TS481 would account for the stereochemistry of
the observed diastereoisomer 448 (Scheme 3.25).
The

regioselectivity

observed

for

heterocycles

448i-448k

when

the

monosubstituted cyclopropenyl furyl sulfonamides 439ai-439ak were subjected to the
gold(I)-catalysis conditions, can be explained by the preferential ring-opening of the
cyclopropene moiety to place the gold centre on the less substituted carbon atom. This
observation was consistent with the experimental results obtained by Meyer and
Cossy[104] as well as the computational results performed by Hyland and Ariafard.[103] The
lower yields of heterocycles 448i-448k may also be partially explained when looking at
intermediate 481 of the proposed mechanism (Scheme 3.25). When R2 = H, the resulting
gold carbene is less stabilised and less sterically hindered, thus the gold-carbene would
be more reactive and prone to side reactions. Possible degradation of the cyclopropenyl
furyl sulfonamides as well as the aforementioned ring-opening of heterocycle 448 to the
corresponding tropones 462, may also contribute to the lower yields observed for the
monosubstituted substrates.
It was also observed during the optimisation of the [4C+3C] cycloaddition, that
the reaction was only efficient in the presence of an NHC-gold(I)-complex. Given that
NHC ligands tend to favour carbene character over carbocation character at C8 of
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intermediate 481 (Scheme 3.25), this may have facilitated the furan moiety to undergo
conjugate attack on C6 rather than direct attack on C8. This would result in the formation
of the more favourable 5-membered ring observed in 482, over the alternative
7-membered ring. Literature support for the conjugate attack was provided by Iwasawa
et al. who reported the platinum-catalysed [3 + 2] cycloaddition between vinyl ethers and
α,β-unsaturated carbene complexes. As an example, the Pt(II)-catalyst was proposed to
activate the triple bond in substrate 483, which induced a 5-endo-dig attack of the amine
nitrogen onto the platinum–alkyne complex, thus generating intermediate 484 (Scheme
3.26). Electron back-donation from the platinum centre to eliminate the methoxy group,
and deprotonation of the ammonium nitrogen, was proposed to result in the key
α,β-unsaturated carbene complex 485. It was then proposed that butyl vinyl ether attacked
the β-carbon of the unsaturated carbene complex (rather than the carbene directly) to
generate alkenyl platinum intermediate 486. Intermolecular cyclisation of 486 was then
proposed to result in the final polycyclic product 487. The NHC ligand favouring
conjugate attack of the aromatic heterocycle on the gold-carbene, also likely effects the
Friedel–Crafts cyclisation of cyclopropenyl indolyl (and pyrrolyl) sulfonamides 439b
(and 439ca), which will be discussed in the following section.

Scheme 3.26. The [3+2] cycloaddition reaction between butyl vinyl ether and the α,β-unsaturated carbene
complex 486
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3.6.2. Proposed Mechanism(s) for the Formation of Tetrahydro-β-carbolines 457
and Tetrahydro-1H-pyrrolo[2,3-c]pyridines 458
As with the gold(I)-catalysed [4C+3C] cycloaddition mechanism shown in
Scheme 3.26, the mechanism for the gold(I)-catalysed Friedel–Crafts cyclisation of
cyclopropenyl sulfonamides 439b and 439ca, was first proposed to involve gold
activation of the cyclopropene π-bond as shown in 488 (Scheme 3.27). Ring opening of
the cyclopropene moiety would then lead to the gold carbene intermediate 489. As
mentioned in Section 3.1, indoles tend to be most nucleophilic at the 3-position, thus
nucleophilic attack from C3 of the indole onto C6 of the gold carbene, would result in
intermediate 491 (red arrows). Rearomisation and protodeauration of intermediate 491
would generate the observed tetrahydro-β-carboline 457. Alternatively, pyrroles tend to
be more nucleophilic at the 2-position. Thus, when substrate 439ca was subjected to the
gold(I)-catalysis conditions, nucleophilic attack from C2 of the pyrrole onto C6 of the gold
carbene in intermediate 489, would result in the spirocyclic intermediate 490 (green
arrows). A Wagner–Meerwein shift could then result in intermediate 491’ which,
following rearomisation and protodeauration, would form the observed heterocycle 458.
The observed regioisomer of tetrahydro-β-carboline 457b (R1 = –(CH2)3OTBS, R2 = R3
= H, PG = Me) was also consistent with the regioselective ring-opening of the
cyclopropene moiety, to place the gold on the less substituted carbon in intermediate 489.
A possible explanation as to why the yield of 457b (68%, Table 3.4, pg 203) was so much
higher compared to the yield of the 5,7-fused heterocycle 448i (24%, Table 3.2, pg 189),
could be explained by the greater nucleophilicity of indoles compared to furans. The
Friedel–Crafts cyclisation also results in rearomatisation, whereas the [4C+3C]
cycloaddition is a dearomative process. Therefore, it is likely that the Friedel–Crafts
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cyclisation occurs more rapidly than the [4C+3C] cycloaddition, thus limiting the
potential for the gold-carbene to undergo additional side reactions when R2 = H.

Scheme 3.27. Plausible reaction mechanism for the formation of tetrahydro-β-carbolines 457 and
tetrahydro-1H-pyrrolo[2,3-c]pyridines 458

3.6.3. Proposed Mechanism for the Formation of Dienes 459
The other major product that was observed from the gold(I)-catalysed
rearrangements of cyclopropenyl sulfonamides 439, was diene 459. Diene 459 was
observed in particularly high amounts when the tethered aromatic heterocycle was a
thiophene, benzo[b]furan or benzo[b]thiophene (81-89% yields). The mechanism for the
formation of diene 459 is relatively simple and cyclopropenyl thiophenyl sulfonamide
439d has been selected as the example (Scheme 3.28). Coordination of the gold catalyst
to the π-bond as shown in 492, results in ring-opening of the cyclopropene moiety to form
the gold-carbenoid intermediate 493. Due to the increased aromaticity and reduced
nucleophilicity of the thiophene compared to the furan or the pyrrole, dearomatisation of
the heterocycle to allow conjugate nucleophilic attack onto the gold carbene, does not
occur. Instead elimination of a hydrogen from intermediate 493, followed by
protodeauration results in the observed diene 459d.
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Scheme 3.28. Plausible reaction mechanism for the formation of diene 459d

3.7.

Chemical Transformations
Once the substrate scopes for the gold(I)-catalysed [4C+3C] cycloaddition and

Friedel–Crafts cyclisation reactions had been completed, it was desirable to determine the
versatility of the heterocyclic products obtained. The 5,7-fused heterocycle 448i was first
subjected to tetrabutylammonium fluoride (TBAF, 2 equiv.) to remove the TBS
protecting group and expose the free alcohol (Scheme 3.29a). This transformation
proceeded smoothly and heterocycle 494 was obtained in high yield. The tetrahydro-βcarboline 457a was then subjected to a deprotection reaction to remove the Ts group and
expose the free amine (Scheme 3.29b). Heterocycle 457a was sonicated in the presence
of excess magnesium powder and MeOH/THF (ratio 3:1)22 and tetrahydro-β-carboline
495 was obtained in 76% yield. Both heterocycle 494 and tetrahydro-β-carboline 495,
possessed tethering points for further functionalisation of these natural product
precursors. Another important chemical transformation was the Suzuki cross-coupling
performed on tetrahydro-β-carboline 457c that possessed a Br substituent in the
5-position of the indole ring. Tetrahydro-β-carboline 457c was reacted with phenyl
boronic acid under typical Suzuki cross-coupling conditions, to obtain the desired Ph
substituted derivative 457f in 80% yield (Scheme 3.29c). This was a pleasing result given
the wide range of commercially available boronic acids, as numerous tetrahydro-β-

22

THF was necessary for this reaction for the solubility of the starting substrate.
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carbolines substituted around the indole ring could be produced from a handful of
halogenated substrates.

Scheme 3.29. Chemical transformations of 5,7-fused heterocycles 448 and tetrahydro-β-carbolines 457

Other chemical transformations were also performed on heterocycles 448 and
457; however, these reactions were not as successful those shown in Scheme 3.29. A
deprotection reaction was attempted on the 5,7-fused heterocycle 448g, to remove the Nsprotecting group and expose the free amine (Scheme 3.30). The method reported by Node
et al.[179] was used due to the lower toxicity of the reported thiol reagent; however, the
desired free amine product 496 was not obtained. No attempts were made to identify the
products isolated following flash column chromatography; however, a ring-opened
adduct of the oxabicyclo[3.2.1]octa-2,6-diene structure was suspected due to the
appearance of diastereomers/regioisomers in the 1H NMR spectrum.
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Scheme 3.30. Attempted Ns-deprotection of 5,7-fused heterocycle 496

A hydroboration/oxidation reaction was also performed with the 5,7-fused
heterocycle 448b (Scheme 3.31). Pleasingly, the tetrasubstituted alkene did not appear to
be affected by the reaction; however, selectivity was not observed for the addition of H2O
across the disubstituted double bond. Both regioisomers of the hydroxylated 5,7-fused
heterocycle were obtained, with 7,8-dibutyl-2-tosyl-2,3,4,5,6,8a-hexahydro-1H-3a,6epoxycyclohepta[c]pyrrol-4-ol 497 being obtained in 44% yield and 7,8-dibutyl-2-tosyl2,3,4,5,6,8a-hexahydro-1H-3a,6-epoxycyclohepta[c]pyrrol-5-ol 498 being obtained in
14% yield (ratio 497:498 = ~3:1). Both diastereoisomers for each regioisomer (4 isomers
in total) also occurred which will be discussed below.

Scheme 3.31. Hydroboration/oxidation reaction of 5,7-fused heterocycle 448b

The structure for the major regioisomer 497 and the minor regioisomer 498, from
the hydroxylation of heterocycle 448b, were identified based on 2D NMR spectra. For
the major regioisomer 497, important 1H signals for confirming the position of the
hydroxyl group were identified. For the major diastereoisomer of 497, doublet 1H signals
occurred at δ 3.73 and δ 3.33 ppm (J = 11.5 Hz) and correlated to the 13C signal at δ 54.8
ppm in the HSQC spectrum (see appendix, pg 535). Multiplets were also observed
between δ 3.81-3.89 and δ 2.92-3.00 ppm and correlated to the 13C signal at δ 52.3 ppm
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in the HSQC spectrum. These signals represented the CH2c and CH2b groups, respectively
on either side of the NTs group. A doublet of doublets was also observed at δ 2.78 (Ha,
J = 11.2, 7.7 Hz) ppm that correlated to the

13

C signal δ 40.0 (Ca) ppm in the HSQC

spectrum, which represented the CH group adjacent to the tetrasubstituted alkene and
CH2b. A multiplet was then observed at δ 4.05 (Hg) ppm, which correlated to the

13

C

signal at δ 75.9 (Cg) ppm in the HSQC and represented the CH group adjacent to the oxabridge. A doublet of doublet of doublets was then observed at δ 1.53 ppm (J = 12.5, 3.0,
1.0 Hz) and correlated to the same 13C signal (at δ 41.4 ppm) as a multiplet peak occurring
between δ 2.37-2.46. These 1H signals were assigned as CH2f that represented the CH2
directly adjacent the hydroxyl moiety. Another important peak in the 1H NMR spectrum
was a doublet of doublets observed at δ 4.28 (He) ppm that correlated to the 13C signal at
δ 73.2 (Ce) ppm in the HSQC spectrum. It was assumed that the hydroxyl group was also
bound to carbon Ce, based on the observed chemical shifts of these signals. Other
important quaternary carbons for the major diastereoisomer occurred at δ 127.3 (Ci) and
δ 138.2 (Ch) ppm. Important 1H signals for the minor diastereoisomer of 497 were
identified and have been marked with an asterisk to distinguish them from the major
diastereoisomer signals. The CH2c* group 1H signals were also observed as doublets at
δ 3.97 and δ 3.29 ppm which correlated to the

C signal at δ 53.2 ppm in the HSQC

13

spectrum. Proton He* was overlapped with Hg of the major diastereoisomer but was still
found to correlate to the carbon at δ 76.1 (Ce*) ppm in the HSQC spectrum. The CH2f*
1

H signal occurred as a doublet of doublets at δ 2.33 ppm (J = 13.0, 7.5 Hz) and doublet

of doublet of doublets at δ 1.88 ppm (J = 13.0, 7.0, 3.0 Hz), both of which correlated to
the 13C signal at δ 46.1 ppm in the HSQC spectrum. Proton Hg* was then observed as a
doublet at δ 4.23 ppm which correlated to Cg* at δ 74.7 ppm in the HSQC spectrum.
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Quaternary carbons that were also important for confirming the structure of the minor
diastereoisomer, were observed at δ 90.2 (Cd*) and δ 138.5 (Ch*) ppm.
The HMBC spectrum (Figure 3.13) was next analysed to confirm the
regiochemistry of 497. Proton He was observed to have correlations to Ca and the CH2c
13

C signal. Similarly, the CH2c 1H signals were observed to have a reciprocal correlation

to Ce. This suggested a close proximity between the CH2c group and the carbon bearing
the hydroxyl moiety and supported the proposed regiochemistry. The CH2f protons were
then observed to correlate to Ch and Cg. Carbon Ch had been assigned as the quaternary
carbon of the double bond directly adjacent to Hg (and Cg) based on the weaker correlation
of Ha to Ch, as well as the lack of a correlation between the CH2b 1H signals and Ch. As
the CH2f 1H signals correlated to Cg and Ch but not the CH2c 13C signal, this confirmed
regiochemistry of the major diastereoisomer for 497. For the minor diastereoisomer of
497, Hg* was first observed to correlate strongly to Ch* and one of the

13

C signals that

represented a CH2 group of a butyl chain. These correlations supported that the doublet
at δ 4.23 ppm was in fact the CH group adjacent to the oxa-bridge. The CH2c* 1H signals
were then observed to correlated to Cd* and Ce*. There was no correlation however, to
the CH2f* 13C signal and supported the regiochemistry of the minor diastereoisomer. The
CH2f* 1H signals were also observed to correlate to Cd*, Ce* and Ch*. No correlations
from the CH2f* 1H signals to the CH2c*

13

C signal, was observed. Overall, the HMBC

spectrum confirmed that both isomers occurring in the mixture were the same regioisomer
of the hydroxylated 5,7-fused heterocycle 497.
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Figure 3.13. HMBC spectrum for the hydroxylation 5,7-fused heterocycle 497 with labelled structures of
the two diastereoisomers showing important correlations. Solid arrows indicate strong correlations while
dash arrows indicate weaker correlations

The minor regioisomer obtained from the hydroboration/oxidation reaction of the
5,7-fused heterocycle 448b, had to be that of 7,8-dibutyl-2-tosyl-2,3,4,5,6,8a-hexahydro1H-3a,6-epoxycyclohepta[c]pyrrol-5-ol 498 (Scheme 3.31, pg 216). This was supported
by the NMR spectra and important peaks associated with the major diastereoisomer of
498 were first identified. A singlet was observed at δ 4.04 (Hg) ppm (integration 1H) that
correlated to the 13C signal at δ 84.6 (Cg) ppm in the HSQC spectrum (see appendix, pg
537) and was assigned as the CH group directly adjacent to the oxa-bridge. The CH2c 1H
signals were then observed as doublets at δ 3.66 and δ 3.47 ppm (J = 11.6 Hz) that
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correlated to the 13C signal at δ 55.5 ppm in the HSQC spectrum. The CH2b 1H signals
then occurred as multiplets between δ 3.77-3.84 and δ 2.92-2.98 ppm and correlated to
the 13C signal at δ 52.2 (Cb) ppm in the HSQC spectrum. The CH2e 1H signals occurred
as a doublet of doublets at δ 2.19 ppm (J = 6.4 Hz, 13.7 Hz) and a doublet of triplets at
δ 1.75 ppm (J = 1.4 Hz, 14.0 Hz), which both correlated to the same 13C signal at δ 43.0
ppm in the HSQC spectrum. Quaternary carbons that were also important for confirming
the structure of the major diastereoisomer occurred at δ 86.3 (Cd), δ 128.2 (Ci) and δ 133.7
(Ch) ppm. Important signals associated with the minor diastereoisomer of 498 were also
identified. A multiplet occurred at δ 4.52 (Hf*) ppm that correlated to the 13C signal at
δ 75.7 (Cf*) ppm in the HSQC spectrum. Based on the chemical shift and the correlations
of Hf* and Cf* in the HMBC spectrum that will be discussed below, it was tentatively
determined that the hydroxyl moiety was attached to Cf*. The CH2c* 1H signals for the
minor diastereomer were then observed as doublets at δ 3.57 and δ 3.32 ppm
(J = 11.7 Hz) that both correlated to the 13C signal at δ 55.9 ppm in the HSQC spectrum.
The CH2e* 1H signals occurred as a doublet of doublets at δ 2.38 ppm (J = 13.6, 9.9 Hz)
and a doublet of triplets at δ 1.45 ppm (J = 13.4, 4 Hz) that both correlated to the

13

C

signal at δ 41.4 ppm in the HSQC spectrum. Important quaternary carbons were also
observed for the minor diastereoisomer at δ 85.1 (Cd*) ppm, as well as δ 130.4 and
δ 134.0 ppm that were tentatively assigned as Ch* and Ci*, respectively. Some important
peaks for the two diastereoisomers of heterocycle 498 were also observed to overlap.
These included the 1H signals of the CH group attached to the same carbon as the
hydroxyl moiety for the major diastereoisomer and the CH group directly adjacent to the
oxa-bridge for the minor diastereoisomer. These were observed as overlapped doublets at
δ 4.17 (Hf) and δ 4.19 (Hg*) ppm. These 1H signals then correlated to the 13C signals at
δ 76.8 (Cf) and δ 77.6 (Cg*) ppm, respectively in the HSQC spectrum.
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To confirm the assigned regiochemistry of heterocycle 498, the HMBC spectrum
was analysed (Figure 3.14). The order of assignments for Ci and Ch for the major
diastereoisomer of 498 were based on the correlation between the CH2b 1H signals and Ci
which indicated that Ci had to be within closer proximity to this CH2 group. The singlet
at δ 4.04 ppm was also confirmed to be Hg of the major diastereoisomer, based on its
correlations to Ci, Ch and the 1H signals representing a CH2 of one of the butyl chains.
The CH2c 1H signals were then observed which had correlations to Cd and the CH2e 13C
signal, but not Cf. The CH2e 1H signals were observed to have correlations to the CH2c

CH2b/CH2b
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Hg* Hf
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CH2e*
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Ca/Ca*
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Cf g
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Cf*
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Figure 3.14. HMBC spectrum for the hydroxylation 5,7-fused heterocycle 498 with labelled structures
showing important correlations
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13

C signal, Cf, as well as a carbon at δ 47.8 ppm which was assigned as Ca (carbon directly

adjacent to the CH2b group). This information therefore suggested that the CH2e group
was within closer proximity to the CH2c group and the CH group directly adjacent to the
CH2b group, which supported the assigned regiochemistry of the major diastereoisomer
of 498. For the minor diastereoisomer, the overlapped doublet peak at δ 4.19 ppm was
confirmed to be Hg* based on its correlations to Ci*, Ch* and a 1H signal that represented
a CH2 of one of the butyl chains. The CH2e* 1H signals were observed to have correlations
to the CH2c*

13

C signal, Cf*, Cd* and a carbon at δ 48.6 ppm that was assigned as Ca*

(carbon directly adjacent to the CH2b* group). Similarly, the CH2c* 1H signals had a
reciprocal correlation to the CH2e*

13

C signal and thus confirmed the assigned

regiochemistry of the minor diastereoisomer of heterocycle 498.
It was found that 2D NOESY and 1D NOESY experiments were unable to
determine relative stereochemistry of the major and the minor diastereoisomers for
heterocycles 497 and 498 (i.e. orientation of the hydroxyl group relative to the oxabridge). This was because the orientation of the hydrogen atom represented by Hg/Hg*,
was almost equidistant to the hydrogen atoms attached to the adjacent carbon represented
by Cf/Cf*. As a consequence, regardless of whether these hydrogen atoms were cis or
trans to the oxa-bridge, they still had a through space correlation to Hg/Hg*, hence the
stereochemistry of the major diastereoisomers of 497 and 498 could not be determined
from NMR spectroscopy. X-ray crystallography was not feasible as 497 and 498 were not
crystalline. Therefore, it was not possible to determine whether the major
diastereoisomers of 497 and 498 were in the cis-conformation or the trans-conformation
in terms of the orientation of the hydroxyl group relative to the oxa-bridge. Future work,
however, could investigate the hydroboration of a 5,7-fused heterocycle such as 448g,
which bears a nosyl protecting group on the N atom. The hydroxylated product(s)
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obtained from the hydroboration of 448g might be crystalline, allowing X-ray crystal
structure(s) to be obtained which could determine the cis/trans selectivity and the
regioselectivity of the reaction.
A hydroboration/oxidation reaction was also performed on the tetrahydro-βcarboline 457b (Scheme 3.32). It was assumed that regioselectivity for tetrahydro-βcarboline 499, with a primary alcohol group, would be achieved as the borane would add
across the double bond in an anti-Markovnikov fashion. Indeed, the desired hydroxylated
tetrahydro-β-carboline 499 was obtained in 45% yield. However, from the 1H NMR
spectrum, two diastereoisomers of 499 were observed in a ratio of 2.6:1, although the
identity of the major diastereoisomer could not be ascertained by simple NMR analysis.
The reaction had previously been attempted with the bulkier hydroboration reagent,
9-borabicyclo[3.3.1]nonane (9-BBN), to try and achieve better selectivity; however, the
reaction had not progressed with this reagent.

Scheme 3.32. Hydroxylation/oxidation reaction of the tetrahydro-β-carboline 457b

3.8.

Conclusions and Future Directions
In summary, divergence in the gold(I)-catalysed rearrangement of cyclopropenyl

sulfonamides 439 is observed and can be controlled by the tethered aromatic heterocycle.
In the presence of a tethered furan, the cyclopropene moiety undergoes ring-opening to
form a vinyl gold carbene followed by a dearomative [4C+3C] cycloaddition reaction to
produce highly complex 5,7-fused heterocycles 448, as a single diastereomer in moderate
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to good yields. Symmetrical, dialkyl substituted cyclopropenes typically gave the best
results; however, non-symmetrical monosubstituted cyclopropenes are still tolerated.
Alternatively, if a pyrrole or indole heterocycle was tethered to the cyclopropene, a
Friedel–Crafts cyclisation takes place between the heterocycle and the vinyl gold carbene
generated from the ring-opening of the cyclopropene. This resulted in the formation of
tetrahydro-β-carbolines 457 in good to excellent yields with moderate E:Z selectivities.
The additional benefit of these substrates was that when a Br substituent was place on the
indole ring, Suzuki cross-coupling reactions could be performed efficiently to further
expanded the range of accessible compounds. If the heterocycle tethered to the
cyclopropene possessed a higher degree of aromaticity however (i.e. thiophenes,
benzo[b]furans, benzo[b]thiophenes), then an elimination reaction occurred to provide
the corresponding dienes as a mixture of isomers, albeit in good yields.
In terms of future directions for the project, other linkers between the
cyclopropene and the aromatic heterocycle could be investigated. For example, an ester
linker between the cyclopropene and the furan moiety had not been tested. If
cyclopropenyl furyl carboxylates 500 could be successfully converted to the 5,7-fused
heterocycle 501, then the lactone could be a point of further functionalisation (Scheme
3.33). If the lactone was reduced to the lactol, a nucleophilic trapping reaction such as the
one reported in chapter 2 of this thesis (Scheme 2.7, Section 2.2.1, pg 89), could be
performed to obtained substituted 5,7-fused heterocycles such as 502.

Scheme 3.33. Possible gold(I)-catalysed [4C+3C] cycloaddition reaction of cyclopropenyl furyl
carboxylates 500
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Another future direction for the gold(I)-catalysed [4C+3C] cycloaddition of
cyclopropenyl furyl sulfonamides would be to see whether the 5,7-fused heterocycles 448
could be synthesised enantioselectively. Preliminary investigations have already been
performed by the German collaborator with some enantioselectivity being observed.
Further optimisation of the reaction conditions might therefore improve the
enantioselectivity of the [4C+3C] cycloaddition reaction. Further optimisation of the
gold(I)-catalysed Friedel–Crafts cyclisation of the cyclopropenyl indolyl sulfonamides
439b might also lead to the enantioselective synthesis of tetrahydro-β-carbolines 457
and/or could improve the E/Z selectivity of the double bond.
Another interesting prospect for this project could be to further investigate the
chemical transformations of the 5,7-fused heterocycles 448. For example, it was
discovered that heterocycle 448i obtained from the monosubstituted cyclopropenyl furyl
sulfonamide 439ai, could ring-open to form a tropone when absorbed to silica gel
(Scheme 3.17, Section 3.5.1, pg 199). Further investigation into this reaction could
provide a new efficient method for the synthesis of 5,7-fused tropones such as 462, which
incidentally is also a potential precursor for other curcusones. Further functionalisation
of the hydroxylated tetrahydro-β-carboline 499 was also proposed for future work. In the
presence of N-fluorobenzenesulfonimide (NFSI) and K2CO3,[180] the 3-position of the
indole within 499 may attack the electrophilic fluoride source to generate the indolenyl
iminium intermediate 503 (Scheme 3.34). The alcohol moiety could then attack the
iminium ion and trap out the polycyclic heterocycle 504.

Scheme 3.34. Possible reaction for the formation of the polycyclic heterocycle 504
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In conclusion, this project has led to the facile synthesis of novel cyclopropenyl
sulfonamides 439, in three generally high yielding steps starting from commercially
available alkynes. An additional benefit of this reaction compared to the literature is that
the alkene between C7 and C8 of the 5,7-fused heterocycle 448, can be disubstituted. With
the 5,7-fused heterocyclic systems reported by López and Mascareñas and Dai,
substitution is only possible at the C7 position as the C8 position corresponds to the former
quaternary carbon of the allene (Scheme 3.1, Section 3.1, pg 159). Pleasingly, the
[4C+3C] dearomative cycloaddition reported here is believed to be the first example
performed with a cyclopropene derived gold-carbene. Given that these relatively simple
cyclopropenyl sulfonamides can be transformed into highly complex heterocyclic
structures that are potential precursors for a number of biologically active natural products
and synthetic compounds, this work could represent a more efficient method for the
synthesis of these important molecules.
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4. Chapter 4. Experimental Section
4.1.

General Information

Chemicals and solvents were purchased from commercial sources (Sigma Aldrich, AK
Scientific, Chemsupply, Strem Chemicals, Fluka, Precious Metals Online) and were used
without further purification. Moisture sensitive reactions were performed using glassware
that had been dried in an oven (120 °C). Dry solvents were either obtained from
commercial sources or were preparing by passing the solvent through a column of
activated alumina. Solvents were then stored under nitrogen over 3Å or 4Å molecular
sieves.
Thin-layer chromatography was performed using Merck TLC Silica gel 60 F254
aluminium backed sheets. Reaction spots were viewed under a UV lamp (wavelength
254 nm) before being stained with one of the following: anisaldehyde (4 mL
4-methoxybenzaldehyde, 2 mL glacial acetic acid, 5 mL concentrated H2SO4 and 150 mL
EtOH) or potassium permanganate stain (1.5 g KMnO4, 10 g K2CO3, 1.25 mL aqueous
NaOH (10% w/v solution) and 200 mL water).
Flash column chromatography was conducted with chromatographic silica media (4063 µm) purchased from Grace Davison Discovery Science. The mobile phase in all cases
were mixtures of n-hexane, EtOAc, pentane, Et2O, petroleum ether (PE) and Et3N.
Nuclear magnetic resonance spectrometry experiments were performed at room
temperature in deuterated chloroform (CDCl3 or CDCl3 with 0.1% v/v TMS, Sigma
Aldrich). NMR spectrometry experiments were run on a Varian 500 spectrometer
(500 MHz 1H NMR, 125 MHz

13

C NMR) or on a Bruker 300 (300 MHz 1H NMR,

75 MHz 13C NMR), Bruker 400 (400 MHz 1H NMR, 100 MHz 13C NMR) or Bruker 500
(500 MHz 1H NMR, 125 MHz

13

C NMR) spectrometer. When reported the NMR
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chemical shifts were expressed in parts per million (ppm) and the coupling constants were
expressed in Hertz (Hz). Depending on the solvent, all chemical shifts are referenced to
either CDCl3 (7.26 ppm) or TMS (0.00 pm) for the 1H NMR spectra and CDCl3
(77.0 ppm) for the

13

C NMR spectra. The multiplicities of the 1H NMR peaks were

assigned as either a singlet (s), broad singlet (bs), doublet (d), doublet of doublets (dd),
doublet of doublet of doublets (ddd), triplet (t), doublet of triplets (dt), doublet of triplet
of triplets (dtt), triplet of doublets (td), triplet of triplets (tt), quartet (q), quartet of doublets
(qd), quartet of triplets (qt), pentet (p), or as a multiplet (m).
Low-resolution mass spectrometry (LRMS) was performed using either a Shimadzu
LC-2010 instrument, Shimaduz LCMS-2020-ESI, Shimaduz GCMS-QP2020-EI fitted
with a SH-Rxi-5Sil column or a Shimadzu GCMS-QP5050A instrument equipped with a
Shimadzu GC-17A chromatograph. All solvents used in the mass spectrometry
experiments were of high performance liquid chromatography (HPLC) grade.
High-resolution mass spectrometry was performed with a Waters Xevo G1 QTOF
instruments. All solvents used in the mass spectrometry experiments were of HPLC
grade.
Infrared spectra were collected using a Shimadzu IRAffinity-1 ‘Miracle 10’ Fourier
transform infrared spectrometer equipped with an ATR attachment or a Bruker Vertex 70
spectrometer. Values are reported in cm-1 units.
Melting points (MP) were obtained using a Buchi Melting point M-560 appartus with
temperatures increasing by 3 °C/min. Values are reported in °C.
In the case of known compounds, procedures were obtained from the literature and were
referenced for each compound.
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4.2.

General Procedures

General Procedure A
In accordance with the literature,[173] cyclopropane 318 (1 equiv.) was dissolved
in dry Et2O under a nitrogen atmosphere and cooled to –78 °C. A solution of
n-butyllithium in hexanes (n-BuLi, 1.9 equiv.) was then added dropwise to the reaction.
After 10 minutes, the reaction was warmed to –10 °C for 1 h and was then cooled back
to –20 °C and the selected aldehyde (1.2 equiv.) was added dropwise. The cooling bath
was removed and the reaction was warmed to rt. Once complete, the reaction was
quenched with saturated, aqueous NH4Cl. The organic phase was separated and the
aqueous phase was extracted (3x) with Et2O. The combined organic extracts were washed
with brine and dried over Na2SO4. The crude residue was filtered, concentrated under
reduced pressure and purified using flash column chromatography (generally 10:90
EtOAc:hex) on silica that had first been treated with the eluent and 1% Et 3N.
General Procedure A’
Using a modified literature procedure for closely related compounds, [65b]
cyclopropane 318 (1 equiv.) was dissolved in dry Et2O under a nitrogen atmosphere and
cooled to –78 °C. A solution of n-BuLi in hexanes (1.8 equiv.) was then added dropwise
to the reaction. The reaction was allowed to gradually warm –10 °C over 1 h. After this
time the reaction mixture was cooled to –50 °C and the selected aldehyde (1.2 equiv.)
was added dropwise. The reaction was warmed to –10 °C and was monitored by TLC.
Once completed, the reaction was worked-up and purified as in general procedure A.
General Procedure B
Selected alcohols 319 (1 equiv.) were added to a flask and dissolved in dry THF
(0.1 M) under nitrogen. The reaction was cooled to 0 °C before sodium hydride (NaH,
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60% w/w dispersion on mineral oil, 1.9-4.2 equiv.) was added and the reaction was left
to stir for at least 10 mins. The desired halocarbon or mesylate (1.4-2.5 equiv.) was added
and the reaction was warmed to rt and monitored by TLC. Once complete, the reaction
was quenched with saturated, aqueous NH4Cl and the THF solvent was removed under
reduced pressure. The aqueous phase was extracted (3x) with Et2O and the combined
organic extracts were washed with brine and dried over Na2SO4. The solution was filtered,
concentrated under reduced pressure and purified by flash column chromatography
(typically 3:96 EtOAc: hex) on silica that had been pre-treated with eluent and 1% Et3N.
General Procedure C
A round bottom flask was charged with the desired alcohol or amine (1 equiv.)
and Cs2CO3 (2.5 equiv.) and the flask was put under a nitrogen atmosphere. Dry MeCN
(0.2 M) was added and the reaction was stirred at 50 °C for 30 mins before the selected
electrophile (1.4-2.5 equiv.) was added. The reaction was left to stir at 50 °C until
complete according to TLC. If necessary, additional electrophile was added to push the
reaction the completion. Once complete, the reaction was filtered to remove the solids
and was washed thoroughly with additional MeCN. The filtrate was evaporated to
dryness, redissolved in DCM and filtered again to remove any further solids. The filtrate
was concentrated under reduced pressure and the resulting products were either used
directly or were purified by flash column chromatography.
General Procedure D
Selected cyclopropenyl propargyl ethers 342 (1 equiv.), were added to a reaction
vial under nitrogen and were dissolved in anhydrous DCE (0.1 M). To this was added
Ph3PAuCl (5 mol%) and AgBF4 (5 mol%) and the reaction was heated to 50 °C. The
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reaction was monitored by TLC and once complete, was concentrated under reduced
pressure and purified by flash column chromatography (typically 1:199.5 EtOAc: hex).
General Procedure E
In accordance with the literature,[80] a round bottom flask was charged with the
selected alkyne (1.5 equiv.), Rh2(OAc)4 (0.5 mol%) and DCM (2 M) under a nitrogen
atmosphere. A solution of ethyl diazoacetate (1 equiv.) in DCM (4 M) was prepared and
added to the reaction by syringe pump at a rate of 1 mL/h. Following the complete
addition of the ethyl diazoacetate the solvent was removed under reduced pressure. The
residue was purified by flash column chromatography (4:96 EtOAc:hex) on silica that
had first been treated with the eluent and 1% Et3N.
General Procedure F
Following a modified literature procedure,[80] to a flame-dried flask was added the
desired carboxylate (1 equiv.) and either dry THF (0.2 M) or dry DCM under nitrogen.
The mixture was cooled to –78 °C and to this was added diisobutylaluminium hydride
(DIBAL-H, 3 equiv.), dropwise. The reaction was either maintained at –78 °C or was
allowed to gradually warm to rt. Once complete according to TLC, the reaction was
quenched with NH4Cl and was stirred at rt for a few mins. The reaction mixture was
treated with aqueous HCl (2 M) until the white gel was dissolved. The aqueous phase was
extracted (3x) with Et2O and the combined organic layers were washed with brine and
dried over Na2SO4. The organic layer was filtered and concentrated under reduced
pressure to obtain the crude residue which was either used in the next reaction
immediately, or was purified by flash column chromatography (10:90 EtOAc:hex) using
silica gel that had been pre-treated with 1% Et3N.
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General Procedure G
In accordance with the literature procedure,[181] the selected alcohol (1 equiv.) was
dissolved in dry DCM under nitrogen and to this was added activated MnO2 (10 equiv.)
and the reaction was left to stir until complete. Once complete, the reaction was filtered
through a pad of celite and the solvent was evaporated under reduced pressure to afford
the corresponding aldehyde. Aldehydes were purified by flash column chromatography
(20:80 EtOAc:hex).
General Procedure H
Following a modified literature procedure,[182] to a round bottom equipped with a
reflux condenser was added the selected amide (1 equiv.), aldehyde (1 equiv.) and
Si(OEt)4 (1.1 equiv.). The reaction mixture was heated to 140-150 °C and the reaction
was monitored by TLC until complete. Following the completion of the reaction, the
solvent was removed under reduced pressure, and if necessary tituration with pentane was
performed to isolate the resulting imines which were used without further purification.
The imine was dissolved in THF/MeOH (ratio 5:1, 0.2 M) and to this was added NaBH 4
(0.5-1 equiv.). Reactions were typically complete after 30 mins and were quenched with
saturated NH4Cl and extracted (3x) with EtOAc. The organic layer was washed with
brine, dried over Na2SO4 and concentrated under reduced pressure. Purification by
column chromatography (typically 30:70 EtOAc:hex) was then used to obtain the final
product over a two-step process.
General Procedure I
Following a modified literature procedure,[80] a round bottom flask was charged
with the desired alcohol (1 equiv.), sulfonamide (1-1.1 equiv.), PPh3 (1.3 equiv.) and THF
(0.1 M) under a nitrogen atmosphere. While stirring at rt, DIAD (1.3 equiv.) was added
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to the reaction dropwise. The resulting mixture was stirred at rt overnight (typically 1518 h). Following the completion of the reaction, the solvent was removed under reduced
pressure and the residue was typically absorbed to celite and purified by flash column
chromatography (5:95 EtOAc:hex) using silica gel that was pre-treated with 1% Et3N,
unless otherwise specified.
General Procedure J
Cyclopropenyl sulfonamides 439 (1 equiv.) were dissolved in DCE (0.1 M) and
cooled down to 0 °C, under nitrogen. To this was added chloro[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]gold(I) (IPrAuCl, 5mol%) and AgBF4 (5 mol%) with stirring.
The reaction was left to stir at 0 °C until the reaction was complete. Once completed, the
solvent was removed under reduced pressure and the crude residue was absorbed to silica
and purified by flash column chromatography (10:90 EtOAc:hex).
General Procedure for Calculating NMR Yields
Once the gold(I)-catalysed [4C+3C] cycloaddition reaction was deemed complete
by TLC analysis, all crude mixtures were filtered over celite, concentrated under reduced
pressure and to this was added the internal standard, mesitylene. The crude residues and
the internal standard were dissolved in CDCl3 or CD2Cl2 and were homogenised before
being transferred to an NMR tube. A 1H NMR spectrum was obtained where the integrals
of the singlet signal at δ 6.8 ppm for mesitylene, and the doublet signal at δ 6.2 ppm for
the product, were compared and used to calculate NMR yields for the formation of 5,7fused heterocycle 448a.
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4.3.

Gold(I)-Catalysed Synthesis of Highly Substituted Five-membered
Heterocycles from Cyclopropenylcarbinol Ethers

4.3.1. Preparation of Starting Materials
4.3.1.1.

Synthesis of 1,1,2-tribromo-2,3,3-trimethylcyclopropane 318

In accordance with the literature,[64] to a solution of bromoform (50 mL,
0.572 mol) was added 2-bromo-3-methylbut-2-ene (6.6 mL, 56.9 mmol) with stirring. A
50% (w/v) solution of NaOH (19.7850 g) in H2O (20 mL) was added followed by
cetrimide (1.0029 g, 2.75 mmol) and the reaction was stirred vigorously at reflux (70 °C)
for 5 h. The reaction was left to cool to rt and to this was added H2O. The aqueous phase
was extracted (3x) with DCM and the combined organic extracts were washed with H2O
and dried over MgSO4. The mixture was filtered, concentrated under reduced pressure
and the crude residue was purified by recrystallion from EtOH (rinsing with cold hexanes)
to give the title compound 318 as an off-white, crystalline solid (11.5254 g, 35.9 mmol)
in 63% yield. 1H NMR (300 MHz, CDCl3): 𝛿 = 1.37 (s, 3H, CH3), 1.52 (s, 3H, CH3),
2.01 (s, 3H, CH3) ppm.
NMR data is in agreement with published data.[64]
4.3.1.2.

Preparation of Cyclopropenyl Alcohols 319
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(2-Bromophenyl)(2,3,3-trimethylcycloprop-1-en-1-yl)methanol 319a
Following general procedure A, cyclopropane 318 (2.2684 g,
7.07 mmol) was dissolved in Et2O (10 mL) and n-BuLi (1.32 M in
hexanes, 10.5 mL, 13.9 mmol) and 2-bromobenzaldehyde (0.99 mL, 8.48 mmol) were
added stepwise. After 2.5 h the reaction was worked-up and flash column
chromatography gave the title compound 319a as a pale yellow oil (1.8168 g, 6.80 mmol)
in 96% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.01 (s, 3H, CH3), 1.07 (s, 3H, CH3),
1.95 (d, 3H, J = 1.5 Hz, CH3), 2.37 (bs, 1H, OH), 5.99 (s, 1H, CH), 7.12 (td, 1H, J = 7.5,
1.5 Hz, CHAr), 7.31 (t, 1H, J = 7.5 Hz, CHAr), 7.51 (d, 1H, J = 8.0 Hz, CHAr), 7.57 (dd,
1H, J = 7.5, 1.5 Hz, CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.7, 22.3, 25.2, 25.6,
70.0, 121.8, 123.90, 123.93, 127.6, 127.8, 128.9, 132.6, 140.9 ppm.
NMR data is in agreement with published data.[173]
(2-Chlorophenyl)(2,3,3-trimethylcycloprop-1-en-1-yl)methanol 319b
Following general procedure A, cyclopropane 318 (886.7 mg,
2.76 mmol) was dissolved in Et2O (5.5 mL) and n-BuLi (1.5 M in
hexanes, 3.7 mL, 5.55 mmol) and 2-chlorobenzaldehyde (0.37 mL, 3.28 mmol) were
added stepwise. After 3 h the reaction was worked-up and flash column chromatography
gave the title compound 319b as a yellow oil (400.0 mg, 1.80 mmol) in 65% yield. 1H
NMR (500 MHz, CDCl3): 𝛿 = 1.00 (s, 3H, CH3), 1.07 (s, 3H, CH3), 1.95 (s, 3H, CH3),
2.38 (bs, 1H, OH), 6.03 (s, 1H, CH), 7.20 (t, 1H, J = 7.5 Hz, CHAr), 7.26 (t, 1H,
J = 7.5 Hz, CHAr), 7.32 (d, 1H, J = 8.0 Hz, CHAr), 7.56 (d, 1H, J = 7.5 Hz, CHAr) ppm;
13

C NMR (125 MHz, CDCl3): 𝛿 = 8.6, 22.3, 25.2, 25.6, 67.7, 123.8, 124.0, 126.9, 127.5,

128.6, 129.4, 131.9, 139.4 ppm.
NMR data is in agreement with published data.[173]
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(4-Chlorophenyl)(2,3,3-trimethylcycloprop-1-en-1-yl)methanol 319c
Following general procedure A’, cyclopropane 318 (1.1616 g,
3.62 mmol) was dissolved in Et2O (7.2 mL) and n-BuLi (2.1 M in
hexanes, 3.0 mL, 6.30 mmol) and 4-chlorobenzaldehyde (614.2 mg, 4.37 mmol) were
added stepwise. After 2 h the reaction was worked-up and flash column chromatography
gave the title compound 319c as a pale yellow oil (705.4 mg, 3.17 mmol) in 88% yield.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.04 (s, 3H, CH3), 1.10 (s, 3H, CH3), 1.97 (s, 3H, CH3),

2.14 (bs, 1H, OH), 5.63 (s, 1H, CH), 7.29-7.35 (m, 4H, 4CHAr) ppm;

13

C NMR

(125 MHz, CDCl3): 𝛿 = 8.6, 21.9, 25.5, 25.7, 69.9, 123.9, 124.6, 127.6, 128.5, 133.3,
140.5 ppm; HRMS (ASAP): m/z calcd for C13H16(35Cl)O [M + H]+ 223.0884, found
223.0883; IR (ATR): 3345 (br), 2958, 2912, 2854, 1490, 1436, 1405, 1364, 1091, 1014,
834, 779 cm-1.
Phenyl(2,3,3-trimethylcycloprop-1-en-1-yl)methanol 319d
Following general procedure A, cyclopropane 318 (595.8 mg, 1.86 mmol)
was dissolved in Et2O (3.7 mL) and n-BuLi (1.5 M in hexanes, 2.4 mL,
3.60 mmol) and benzaldehyde (0.23 mL, 2.26 mmol) were added stepwise. Once
complete the reaction was worked-up and flash column chromatography gave the title
compound 319d as an oil (315.9 mg, 1.68 mmol) in 90% yield. 1H NMR (500 MHz,
CDCl3): 𝛿 = 1.04 (s, 3H, CH3), 1.11 (s, 3H, CH3), 1.97 (s, 3H, CH3), 2.24 (bs, 1H, OH),
5.63 (s, 1H, CH), 7.26 (t, 1H, J = 7.0 Hz, CHAr), 7.33 (t, 2H, J = 7.5 Hz, 2CHAr), 7.38 (d,
2H, J = 7.5 Hz, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.5, 21.8, 25.4, 25.6,
70.6, 123.3, 124.9, 126.3, 127.6, 128.3, 142.0 ppm.
NMR data is in agreement with published data.[173]
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(3-Bromophenyl)(2,3,3-trimethylcycloprop-1-en-1-yl)methanol 319e
Following general procedure A, cyclopropane 318 (526.4 mg,
1.64 mmol) was dissolved in Et2O (3.3 mL) and n-BuLi (2.5 M in
hexanes, 1.2 mL, 3.00 mmol) and 3-bromobenzaldehyde (0.23 mL, 1.97 mmol) were
added stepwise. After 4 h the reaction was worked-up and flash column chromatography
gave the title compound 319e as a yellow oil (97.0 mg, 0.363 mmol) in 22% yield.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.06 (s, 3H, CH3), 1.12 (s, 3H, CH3), 1.99 (s, 3H, CH3),

2.04-2.07 (m, 1H, OH), 5.64 (bs, 1H, CH), 7.22 (t, 1H, J = 8.0 Hz, CHAr), 7.33 (d, 1H,
J = 7.5 Hz, CHAr), 7.41 (d, 1H, J = 8.0 Hz, CHAr), 7.58 (s, 1H, CHAr) ppm;

13

C NMR

(125 MHz, CDCl3): 𝛿 = 8.7, 22.1, 25.5, 25.7, 69.9, 122.4, 124.2, 124.5, 124.8, 129.4,
130.0, 130.6, 144.2 ppm; HRMS (ASAP): m/z calcd for C13H16(79Br)O [M + H]+
267.0379, found 267.0387; IR (ATR): 3357 (br), 2957, 2910, 2853, 1594, 1571, 1428,
1184, 1071, 765, 698 cm-1.
(4-Bromophenyl)(2,3,3-trimethylcycloprop-1-en-1-yl)methanol 319f
Following general procedure A’, cyclopropane 318 (1.0195 g,
3.18 mmol) was dissolved in Et2O (6.4 mL) and n-BuLi (2.1 M in
hexanes, 2.6 mL, 5.46 mmol) and 4-bromobenzaldehyde (708.3 mg, 3.83 mmol) were
added stepwise. After 2.5 h the reaction was worked-up and flash column
chromatography gave the title compound 319f as an oil (659.8 mg, 2.47 mmol) in 78%
yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.04 (s, 3H, CH3), 1.10 (s, 3H, CH3), 1.97 (s, 3H,
CH3), 2.09-2.17 (m, 1H, OH), 5.62 (s, 1H, CH), 7.27 (d, 2H, J = 8.2 Hz, 2CHAr), 7.47 (d,
2H, J = 8.3 Hz, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.6, 22.0, 25.5, 25.7,
70.0, 121.4, 123.9, 124.5, 128.0, 131.4, 141.0 ppm; HRMS (ASAP): m/z calcd for
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C13H16(79Br)O [M + H]+ 267.0379, found 267.0384; IR (ATR): 3353 (br), 2958, 2912,
2853, 1071, 1486, 1436, 1398, 1363, 1071, 1010, 832 cm-1.
(2-Fluorophenyl)(2,3,3-trimethylcycloprop-1-en-1-yl)methanol 319g
Following general procedure A’, cyclopropane 318 (1.0142 g,
3.16 mmol) was dissolved in Et2O (6.3 mL) and n-BuLi (2.1 M in
hexanes, 2.6 mL, 5.46 mmol) and 2-methylfluorobenzaldehyde (0.40 mL, 3.83 mmol)
were added stepwise. After 2 h the reaction was worked-up and flash column
chromatography gave the title compound 319g as a colourless oil (551.8 mg, 2.68 mmol)
in 85% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.02 (s, 3H, CH3), 1.09 (s, 3H, CH3),
1.96 (s, 3H, CH3), 2.31-2.42 (m, 1H, OH), 5.91 (d, 1H, J = 3.5 Hz, CH), 7.02 (t, 1H,
J = 9.5 Hz, CHAr), 7.12 (t, 1H, J = 7.5 Hz, CHAr), 7.25 (appar. q, 1H, J = 7.0 Hz, CHAr),
7.46 (t, 1H, J = 7.5 Hz, CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.5, 22.2, 25.2,
25.5, 64.9 (d, J = 3.8 Hz), 115.2 (d, J = 22.1 Hz), 123.7, 124.0, 124.1 (d,
J = 3.9 Hz), 127.7 (d, J = 4.9 Hz), 129.1 (d, J = 7.7 Hz), 129.2, 159.8 (d, J = 247.1 Hz)
ppm; HRMS (ASAP): m/z calcd for C13H14F [M + H – H2O]+ 189.1074, found 189.1071;
IR (ATR): 3447 (br), 2957, 1610, 1487, 1454, 1032, 754 cm-1.
(4-Fluorophenyl)(2,3,3-trimethylcycloprop-1-en-1-yl)methanol 319h
Following general procedure A, cyclopropane 318 (1.0339 g,
3.22 mmol) was dissolved in Et2O (6.4 mL) and n-BuLi (1.5 M in
hexanes, 4.0 mL, 6.00 mmol) and 4-fluorobenzaldehyde (0.41 mL, 3.82 mmol) were
added stepwise. After 3.5 h the reaction was worked-up and flash column
chromatography gave the title compound 319h as a yellow oil (357.9 mg, 1.74 mmol) in
54% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.04 (s, 3H, CH3), 1.10 (s, 3H, CH3), 1.97
(s, 3H, CH3), 2.22-2.32 (m, 1H, OH), 5.62 (s, 1H, CH), 7.02 (t, 2H, J = 8.5 Hz, 2CHAr),
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7.35 (dd, 2H, J = 8.5, 5.5 Hz, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.5, 21.9,
25.4, 25.6, 69.9, 115.1 (d, J = 21.4 Hz), 123.5, 124.8, 127.9 (d, J = 8.4 Hz), 137.8 (d,
J = 2.8 Hz), 162.2 (d, J = 246.3 Hz) ppm.
NMR data is in agreement with published data.[173]
o-Tolyl(2,3,3-trimethylcycloprop-1-en-1-yl)methanol 319i
Following general procedure A’, cyclopropane 318 (1.0000 g,
3.12 mmol) was dissolved in Et2O (6 mL) and n-BuLi (2.1 M in
hexanes, 2.4 mL, 5.04 mmol) was added. A solution of 2-methylbenzaldehyde (454.0 mg,
3.78 mmol) in Et2O was then added via cannula. After 1 h the reaction was worked-up
and flash column chromatography gave the title compound 319i as an oil (511.7 mg,
2.53 mmol) in 81% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.00 (s, 3H, CH3), 1.08 (s,
3H, CH3), 1.96 (s, 3H, CH3), 2.01-2.07 (m, 1H, OH), 2.36 (s, 3H, CH3), 5.84 (bs, 1H,
CH), 7.13 (d, 1H, J = 7.0 Hz, CHAr), 7.15-7.23 (m, 2H, 2CHAr), 7.46 (d, 1H, J = 7.0 Hz,
CHAr) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 8.6, 18.8, 21.9, 25.2, 25.7, 68.0, 122.9,
124.4, 125.8, 126.1, 127.4, 130.3, 134.8, 139.9 ppm; HRMS (ASAP): m/z calcd for
C14H19O [M + H]+ 203.1430, found 203.1434; IR (ATR): 3356 (br), 2956, 2910, 2853,
1458, 1436, 1363, 1178, 1022, 742 cm-1.
p-Tolyl(2,3,3-trimethylcycloprop-1-en-1-yl)methanol 319j
Following general procedure A, cyclopropane 318 (398.2 mg,
1.24 mmol) was dissolved in Et2O (3 mL) and n-BuLi (1.32 M in
hexanes, 2.0 mL, 2.64 mmol) and 4-methylbenzaldehyde (0.18 mL, 1.53 mmol) were
added stepwise. After 2 h the reaction was worked-up and flash column chromatography
gave the title compound 319j as an oil (89.2 mg, 0.441 mmol) in 36% yield. 1H NMR
(500 MHz, CDCl3): 𝛿 = 1.05 (s, 3H, CH3), 1.11 (s, 3H, CH3), 1.98 (s, 3H, CH3), 2.05 (bs,
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1H, OH), 2.34 (s, 3H, CH3), 5.61 (s, 1H, CH), 7.15 (d, 2H, J = 8.0 Hz, 2CHAr), 7.28 (d,
2H, J = 8.0 Hz, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.6, 21.1, 21.8, 25.5,
25.7, 70.5, 123.1, 124.9, 126.3, 129.0, 137.3, 139.1 ppm.
NMR data is in agreement with published data.[173]
(2-Nitrophenyl)(2,3,3-trimethylcycloprop-1-en-1-yl)methanol 319k
Following general procedure A’, cyclopropane 318 (971.4 mg,
3.03 mmol) was dissolved in Et2O (6 mL) and n-BuLi (2.5 M in
hexanes, 2.4 mL, 6.00 mmol) and 2-nitrobenzaldehyde (553.1 mg, 3.66 mmol) were
added stepwise. After 2 h the reaction was worked-up and flash column chromatography
gave the title compound 319k as an orange oil (645.7 mg, 2.77 mmol) in 91% yield. 1H
NMR (500 MHz, CDCl3): 𝛿 = 1.00 (s, 3H, CH3), 1.04 (s, 3H, CH3), 1.93 (d, 3H,
J = 1.5 Hz, CH3), 2.65 (bs, 1H, OH), 6.28 (s, 1H, CH), 7.42-7.47 (m, 1H, CHAr), 7.65 (td,
1H, J = 7.5, 1.5 Hz, CHAr), 7.84 (dd, 1H, J = 8.0, 1.5 Hz, CHAr), 7.95 (dd, 1H, J = 8.0,
1.5 Hz, CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.5, 22.5, 25.2, 25.3, 66.9, 123.8,
124.8, 124.9, 128.3, 128.5, 133.5, 137.3, 147.8 ppm; HRMS (ASAP): m/z calcd for
C13H16NO3 [M + H]+ 234.1125, found 234.1133; IR (ATR): 3410 (br), 2912, 1854, 1705,
1607, 1523, 1346, 1026, 729 cm-1.
1-(2,3,3-Trimethylcycloprop-1-en-1-yl)dodecan-1-ol 319l
Following general procedure A, cyclopropane 318 (619.5 mg,
1.93 mmol) was dissolved in Et2O (3.9 mL) and n-BuLi (1.5 M in
hexanes, 2.4 mL, 3.60 mmol) and dodecanal (0.51 mL, 2.30 mmol) were added stepwise.
After 3.5 h the reaction was worked-up and flash column chromatography gave the title
compound 319l as a colourless oil (309.2 mg, 1.16 mmol) in 60% yield. 1H NMR
(500 MHz, CDCl3): 𝛿 = 0.88 (t, 3H, J = 5.5 Hz, CH3), 1.12 (s, 6H, 2CH3), 1.20-1.46 (m,
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18H, 9CH2), 1.64 (q, 2H, J = 7.0 Hz, CH2), 2.00 (s, 3H, CH3), 4.60 (bs, 1H, CH) ppm;
13

C NMR (125 MHz, CDCl3): 𝛿 = 8.8, 14.1, 21.1, 22.7, 25.3, 25.8, 26.1, 29.3, 29.55,

29.58, 29.62, 29.63, 31.9, 36.5, 68.8, 121.8, 125.2 ppm.
NMR data is in agreement with published data.[173]
3-(2,3,3-Trimethylcycloprop-1-en-1-yl)pentan-3-ol 319m
Following general procedure A, cyclopropane 318 (1.0307 g, 3.21 mmol)
was dissolved in Et2O (6 mL) and n-BuLi (2.5 M in hexanes, 2.6 mL,
6.50 mmol) and pentan-3-one (0.51 mL, 4.81 mmol) were added stepwise. Once complete
the reaction was worked-up and flash column chromatography gave the title compound
319m as a colourless oil (447.8 mg, 2.66 mmol) in 83% yield. 1H NMR (400 MHz,
CDCl3): 𝛿 = 0.91 (t, 6H, J = 7.5 Hz, 2CH3), 1.12 (s, 6H, 2CH3), 1.65 (q, 4H, J = 7.5 Hz,
2CH2), 2.00 (s, 3H, CH3) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 8.2, 8.6, 21.2, 25.9,
32.2, 76.6, 121.8, 126.7 ppm; HRMS (ESI): m/z calcd for C11H20NaO [M + Na]+
191.1406, found 191.1420; IR (ATR): 3467 (br), 2964, 2929, 2880, 2854, 1458, 1439,
1362, 1128, 953 cm-1.
4.3.1.3.

Preparation of Cyclopropenyl Allyl Ethers 320

1-((Allyloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)-2-bromobenzene 320a
Following general procedure B, cyclopropenyl alcohol 319a
(822.3 mg, 3.08 mmol) was dissolved in THF (30 mL) and NaH (60%
w/w dispersion on mineral oil, 259.0 mg, 6.48 mmol) and allyl
bromide (0.54 mL, 6.24 mmol) were added stepwise. The reaction was stirred overnight
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at rt and once complete, flash column chromatography gave the title compound 320a as
an oil (867.6 mg, 2.82 mmol) in 92% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.99 (s,
3H, CH3), 1.03 (s, 3H, CH3), 1.94 (s, 3H, CH3), 4.06 (dd, 1H, J = 13.0, 5.5 Hz, CHaHb),
4.12 (dd, 1H, J = 13.0, 5.5 Hz, CHaHb), 5.20 (d, 1H, J = 10.5 Hz, CHaHb), 5.33 (dd, 1H,
J = 17.0, 2.0 Hz, CHaHb), 5.68 (s, 1H, CH), 5.92-6.02 (m, 1H, CH), 7.09-7.14 (m, 1H,
CHAr), 7.30 (t, 1H, J = 7.5 Hz, CHAr), 7.50 (d, 1H, J = 8.0 Hz, CHAr), 7.56 (d, 1H,
J = 8.0 Hz, CHAr) ppm; 13C NMR (125 MHz, CDCl3): 8.9, 21.9, 25.3, 25.6, 69.8, 75.8,
116.8, 122.4, 122.7, 124.5, 127.5, 128.6, 128.8, 132.4, 134.7, 139.7 ppm; HRMS (ESI):
m/z calcd for C16H19(79Br)NaO [M + Na]+ 329.0511, found 329.0519; IR (ATR): 2925,
2858, 1437, 1363, 1120, 1070, 1067, 1065, 1064, 1025, 923, 748 cm-1
(E)-1-Bromo-2-((pent-2-en-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)
benzene 320b
Following general procedure B, cyclopropenyl alcohol 319a
(274.8 mg, 1.03 mmol) was dissolved in THF (10.3 mL) and NaH
(60% w/w dispersion on mineral oil, 112.1 mg, 2.80 mmol) and
(E)-1-bromopent-2-ene (0.24 mL, 2.03 mmol) were added stepwise. The reaction was
stirred at rt for 18 h. Flash column chromatography gave the title compound 320b as a
pale yellow oil (295.6 mg, 0.882 mmol) in 86% yield. 1H NMR (500 MHz, CDCl3):
𝛿 = 0.96-1.05 (m, 9H, 3CH3), 1.94 (s, 3H, CH3), 2.07 (p, 2H, J = 7.0 Hz, CH2), 3.96-4.13
(m, 2H, CH2), 5.54-5.66 (m, 1H, CH), 5.68 (s, 1H, CH), 5.71-5.82 (m, 1H, CH), 7.10 (t,
1H, J = 7.5 Hz, CHAr), 7.29 (t, 1H, J = 7.5 Hz, CHAr), 7.50 (d, 1H, J = 8.0 Hz, CHAr),
7.56 (d, 1H, J = 7.5 Hz, CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.9, 13.3, 21.8,
25.2, 25.3, 25.6, 69.7, 75.3, 122.4, 122.7, 124.1, 125.1, 127.4, 128.69, 128.73, 132.4,
136.3, 139.7 ppm; HRMS (ASAP): m/z calcd for C18H24(79Br)O [M + H]+ 335.1005,
found 335.1001; IR (ATR): 2961, 2911, 2853, 1464, 1437, 1024, 966, 748 cm-1.
242

4.3.1.4.

Preparation of Cyclopropenyl Propargyl Ethers 342

1-Bromo-2-((prop-2-yn-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)benzene
342a
Following general procedure B, cyclopropenyl alcohol 319a
(448.0 mg, 1.68 mmol) was dissolved in THF (16.7 mL) and NaH
(60% w/w dispersion on mineral oil, 138.4 mg, 3.46 mmol) and
propargyl bromide (80% w/v in toluene, 0.30 mL, 2.69 mmol) were added stepwise. The
reaction was left for 6 h at rt. Flash column chromatography gave the title compound 342a
as a colourless oil (463.7 mg, 1.52 mmol) in 90% yield. 1H NMR (500 MHz, CDCl3):
𝛿 = 1.00 (s, 3H, CH3), 1.02 (s, 3H, CH3), 1.96 (s, 3H, CH3), 2.46 (t, 1H, J = 2.5 Hz, CH),
4.26 (d, 2H, J = 1.5 Hz, CH2), 5.91 (s, 1H, CH), 7.13 (td, 1H, J = 7.5, 2.0 Hz, CHAr), 7.30
(t, 1H, J = 7.5 Hz, CHAr), 7.49-7.55 (m, 2H, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3):
𝛿 = 9.0, 22.0, 25.2, 25.6, 55.9, 74.6, 75.2, 79.5, 121.9, 122.4, 125.4, 127.5, 128.5, 129.0,
132.5, 138.8 ppm; HRMS (ASAP): m/z calcd for C16H18(79Br)O [M + H]+ 305.0536,
found 305.0545; IR (ATR): 3297, 2854, 1069, 749 cm-1.
1-Bromo-2-((pent-2-yn-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)benzene
342b
Following general procedure B, cyclopropenyl alcohol 319a
(229.9 mg, 0.860 mmol) was dissolved in THF (8.6 mL) and NaH
(60% w/w dispersion on mineral oil, 100.6 mg, 2.52 mmol) and
1-bromopent-2-yne (0.13 mL, 1.27 mmol) were added stepwise. The reaction was left for
18 h at rt. Flash column chromatography gave the title compound 342b as a colourless oil
243

(228.5 mg, 0.686 mmol) in 80% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.98 (s, 3H,
CH3), 1.02 (s, 3H, CH3), 1.15 (t, 3H, J = 7.5 Hz, CH3), 1.95 (d, 3H, J = 1.5 Hz, CH3),
2.24 (qt, 2H, J = 7.5, 2.0 Hz, CH2), 4.23 (appar. q, 2H, J = 2.0 Hz, CH2), 5.91 (s, 1H,
CH), 7.12 (td, 1H, J = 7.5, 2.0 Hz, CHAr), 7.30 (t, 1H, J = 7.5 Hz, CHAr), 7.50-7.55 (m,
2H, 2CHAr) ppm;
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C NMR (125 MHz, CDCl3): 𝛿 = 8.8, 12.5, 13.7, 21.9, 25.2, 25.5,

56.6, 74.8, 75.1, 88.6, 122.3, 122.4, 124.8, 127.4, 128.7, 128.8, 132.4, 139.2 ppm; HRMS
(ASAP): m/z calcd for C18H22(79Br)O [M + H]+ 333.0849, found 333.0843; IR (ATR):
2957, 2914, 2854, 1466, 1438, 1068, 1059, 1022, 749 cm-1.
(3-((2-Bromophenyl)(2,3,3-trimethylcycloprop-1-en-1-yl)methoxy)prop-1-yn-1yl)
trimethylsilane 342c
Following general procedure B, cyclopropenyl alcohol 319a
(210.0 mg, 0.786 mmol) was dissolved in THF (8 mL) and NaH
(60% w/w dispersion on mineral oil, 99.0 mg, 2.48 mmol) was
added. Following 1 h of stirring (3-bromoprop-1-yn-1-yl)trimethylsilane (0.32 mL,
1.96 mmol) was added rapidly and the reaction mixture was heated to 60 °C. Deviating
from the general method, after 2 h the solvent was removed under reduced pressure and
flash column chromatography was used to give the title compounds 342c as an oil
(70.8 mg, 0.188 mmol) in 24% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.18 (s, 9H,
Si(CH3)3), 0.99 (s, 3H, CH3), 1.03 (s, 3H, CH3), 1.95 (s, 3H, CH3), 4.27 (s, 2H, CH2),
5.96 (s, 1H, CH), 7.12 (td, 1H, J = 7.5, 2.0 Hz, CHAr), 7.30 (t, 1H, J = 7.5 Hz, CHAr),
7.49-7.55 (m, 2H, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = -0.2, 9.0, 22.0, 25.2,
25.6, 56.8, 74.9, 91.9, 101.3, 122.1, 122.5, 125.2, 127.5, 128.7, 129.0, 132.5, 139.0 ppm;
HRMS (ASAP): m/z calcd for C19H26(79Br)OSi [M + H]+ 377.0931, found 377.0937; IR
(ATR): 2958, 2855, 1439, 1250, 1067, 1022, 992, 841 cm-1.
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1-Chloro-2-((pent-2-yn-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)benzene
342d
Following general procedure B, cyclopropenyl alcohol 319b
(204.6 mg, 0.919 mmol) was dissolved in THF (9.2 mL) and NaH
(60% w/w dispersion on mineral oil, 115.9 mg, 2.90 mmol) and
1-bromopent-2-yne (0.14 mL, 1.37 mmol) were added stepwise. The reaction was left for
16 h at rt. Flash column chromatography gave the title compound 342d as a pale yellow
oil (212.4 mg, 0.735 mmol) in 80% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.98 (s, 3H,
CH3), 1.03 (s, 3H, CH3), 1.14 (t, 3H, J = 7.5 Hz, CH3), 1.95 (s, 3H, CH3), 2.22 (qt, 2H,
J = 7.5, 2.0 Hz, CH2), 4.20-4.28 (m, 2H, CH2), 5.96 (s, 1H, CH), 7.16-7.21 (m, 1H, CHAr),
7.24 (t, 1H, J = 7.5 Hz, CHAr), 7.32 (d, 1H, J = 7.9 Hz, CHAr), 7.55 (d, 1H, J = 7.7 Hz,
CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.8, 12.5, 13.7, 21.9, 25.2, 25.5, 56.6, 72.3,
75.1, 88.6, 122.2, 124.8, 126.8, 128.5, 128.6, 129.2, 132.4, 137.6 ppm; HRMS (ASAP):
m/z calcd for C18H22(35Cl)O [M + H]+ 289.1354, found 289.1364; IR (ATR): 2912, 2854,
1442, 1363, 1069, 1045, 750 cm-1.
tert-Butyl(3-((2-chlorophenyl)(2,3,3-trimethylcycloprop-1-en-1-yl)methoxy)prop-1-yn1-yl)dimethylsilane 342e

Following general procedure B, cyclopropenyl alcohol 319b (185.3 mg,
0.832 mmol) was dissolved in THF (8.2 mL) and NaH (60% w/w dispersion on mineral
oil, 103.8 mg, 2.60 mmol) and propargyl bromide (80% w/v in toluene, 0.14 mL,
1.26 mmol) were added stepwise. The reaction was left for 15.5 h at rt. Flash column
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chromatography gave the cyclopropenyl propargyl ether 342s as a colourless oil
(170.6 mg, 0.654 mmol) in 79% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.99 (s, 3H,
CH3), 1.03 (s, 3H, CH3), 1.96 (s, 3H, CH3), 2.44 (t, 1H, J = 2.5 Hz, CH), 4.26 (bs, 2H,
CH2), 5.95 (s, 1H, CH), 7.20 (t, 1H, J = 7.0 Hz, CHAr), 7.25 (t, 1H, J = 7.5 Hz, CHAr),
7.33 (d, 1H, J = 7.5 Hz, CHAr), 7.54 (d, 1H, J = 7.5 Hz, CHAr) ppm; 13C NMR (125 MHz,
CDCl3): 𝛿 = 8.8, 22.0, 25.2, 25.5, 56.0, 72.7, 74.5, 79.6, 122.0, 125.3, 126.9, 128.4, 128.7,
129.2, 132.4, 137.3 ppm.
Using a modified literature procedure for closely related compounds, [183]
cyclopropenyl propargyl ether 342s (150.3 mg, 0.576 mmol) was dissolved in dry THF
(5.8 mL) under a nitrogen atmosphere and was cooled to –78 °C. A solution of n-BuLi
(1.10 M solution in hexanes, 0.58 mL, 0.638 mmol) was added dropwise and the reaction
was left to stir for 30 min. While still at –78 °C, tert-butylchlorodimethylsilane (TBSCl,
120.7 mg, 0.801 mmol) was added and the reaction was stirred at this temperature before
being warmed to rt. After 3.5 h an additional portion of n-BuLi (1.10 M solution in
hexanes, 0.21 mL, 0.231 mmol) was added followed by an additional portion of TBSCl
(31.5 mg, 0.209 mmol) after 5.5 h. The reaction was left for 14 h at rt and was quenched
with NaHCO3 before the THF solvent was removed under reduced pressure. The aqueous
layer was extracted (3x) with Et2O and the combined organic extracts were washed with
brine, dried over Na2SO4, filtered and concentrated under reduced pressure. Flash column
chromatography (2:98 EtOAC:hex) gave the title compound 342e as a colourless oil
(86.1 mg, 0.230 mmol) in 40% yield. Based on the 1H NMR spectrum of the crude
residue, the conversion of the reaction was ~60%. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.12
(s, 6H, Si(CH3)2), 0.95 (s, 9H, C(CH3)3), 0.99 (s, 3H, CH3), 1.03 (s, 3H, CH3), 1.95 (s,
3H, CH3), 4.27-4.30 (m, 2H, CH2), 6.06 (s, 1H, CH), 7.20 (td, 1H, J = 7.5, 2.0 Hz, CHAr),
7.23-727 (m, 1H, CHAr), 7.33 (d, 1H, J = 8.0 Hz, CHAr), 7.54 (d, 1H, J = 7.5 Hz, CHAr)
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ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = -4.7, 8.8, 16.5, 22.0, 25.2, 25.6, 26.1, 56.7, 72.0,
90.2, 101.9, 122.1, 125.2 (Cq), 126.9, 128.5, 128.6, 129.2, 132.5, 137.5 ppm; HRMS
(ASAP): m/z calcd for C22H32(35Cl)OSi [M + H]+ 375.1905, found 375.1895; IR (ATR):
2954, 2929, 2856, 1472, 1442, 1250, 1070, 1048, 992, 838, 825, 810, 775, 750 cm-1.
1-Chloro-4-((pent-2-yn-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)benzene
342f
Following general procedure B, cyclopropenyl alcohol 319c
(256.2 mg, 1.15 mmol) was dissolved in THF (12 mL) and NaH
(60% w/w dispersion on mineral oil, 94.2 mg, 2.36 mmol) and
1-bromopent-2-yne (0.17 mL, 1.66 mmol) were added. The reaction was left for 16.5 h
at rt. Flash column chromatography gave the title compound 342f as an oil (151.1 mg,
0.523 mmol) in 45% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.02 (s, 3H, CH3), 1.06 (s,
3H, CH3), 1.15 (t, 3H, J = 7.5 Hz, CH3), 1.98 (s, 3H, CH3), 2.23 (q, 2H, J = 7.5 Hz, CH2),
4.18 (s, 2H, CH2), 5.50 (s, 1H, CH), 7.25-7.35 (m, 4H, 4CHAr) ppm; 13C NMR (125 MHz,
CDCl3): 𝛿 = 8.8, 12.5, 13.8, 21.6, 25.4, 25.6, 56.2, 74.8, 75.0, 88.6, 122.6, 125.0, 128.4,
128.7, 133.4, 138.3 ppm; HRMS (ASAP): m/z calcd for C18H22(35Cl)O [M + H]+
289.1354, found 289.1369; IR (ATR): 2937, 2854, 1490, 1439, 1088, 1054, 1014,
816 cm-1.
((Prop-2-yn-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)benzene 342g
Following general procedure B, cyclopropenyl alcohol 319d (187.2 mg,
0.994 mmol) was dissolved in THF (9.9 mL) and NaH (60% w/w
dispersion on mineral oil, 101.2 mg, 2.53 mmol) and propargyl bromide
(80% w/v in toluene, 0.17 mL, 1.53 mmol) were added stepwise. After 4 h another portion
of NaH (60% w/w dispersion on mineral oil, 40.9 mg, 1.02 mmol) was added and the
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reaction was left overnight at rt. After 20 h a third portion of NaH (60% w/w dispersion
on mineral oil, 82.4 mg, 2.06 mmol) was added followed by propargyl bromide (80% w/v
in toluene, 0.11 mL, 0.988 mmol) and the reaction was left to stir for a further 6 h. Flash
column chromatography gave the title compound 342g as a colourless oil (79.6 mg,
0.352 mmol) in 35% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.03 (s, 3H, CH3), 1.07 (s,
3H, CH3), 1.98 (s, 3H, CH3), 2.44 (t, 1H, J = 2.5 Hz, CH), 4.21 (dd, 2H, J = 4.5, 2.5 Hz,
CH2), 5.54 (s, 1H, CH), 7.28 (t, 1H, J = 7.0 Hz, CHAr), 7.34 (t, 2H, J = 7.5 Hz, 2CHAr),
7.38 (d, 2H, J = 7.0 Hz, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.9, 21.6, 25.4,
25.7, 55.5, 74.4, 75.8, 79.8, 122.7, 124.9, 127.4, 127.9, 128.3, 139.3 ppm; HRMS
(ASAP): m/z calcd for C16H19O [M + H]+ 227.1430, found 227.1445; IR (ATR): 3292,
2931, 2854, 1450, 1363, 1063, 746 cm-1.
((Pent-2-yn-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)benzene 342h
Following general procedure B, cyclopropenyl alcohol 319d (314.9 mg,
1.67 mmol) was dissolved in THF (16 mL) and NaH (60% w/w
dispersion on mineral oil, 270.3 mg, 6.76 mmol) and 1-bromopent-2yne (0.26 mL, 2.54 mmol) were added stepwise. The reaction was left at rt for 16 h. Flash
column chromatography gave the title compound 342h as an oil (210.9 mg, 0.829 mmol)
in 50% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.02 (s, 3H, CH3), 1.07 (s, 3H, CH3),
1.15 (t, 3H, J = 7.5 Hz, CH3), 1.98 (s, 3H, CH3), 2.24 (qt, 2H, J = 7.5, 2.5 Hz, CH2), 4.19
(bs, 2H, CH2), 5.52 (s, 1H, CH), 7.25-7.30 (m, 1H, CHAr), 7.33 (t, 2H, J = 7.5 Hz, 2CHAr),
7.39 (d, 2H, J = 7.0 Hz, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.9, 12.5, 13.8,
21.5, 25.4, 25.7, 56.1, 75.3, 75.6, 88.3, 122.8, 124.5, 127.4, 127.7, 128.2, 139.6 ppm;
HRMS (ASAP): m/z calcd for C18H23O [M + H]+ 255.1743, found 255.1756; IR (ATR):
2978, 2937, 1450, 1363, 1054, 759, 699 cm-1.
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1-Bromo-3-((pent-2-yn-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)benzene
342i
Following general procedure B, cyclopropenyl alcohol 319e
(82.1 mg, 0.307 mmol) was dissolved in THF (3.1 mL) and NaH
(60% w/w dispersion on mineral oil, 51.4 mg, 1.29 mmol) and
1-bromopent-2-yne (50 μL, 0.489 mmol) were added stepwise. The reaction was left for
16 h at rt. Flash column chromatography gave the title compound 342i as a colourless oil
(21.3 mg, 63.9 µmol) in 21% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.03 (s, 3H, CH3),
1.07 (s, 3H, CH3), 1.15 (t, 3H, J = 7.5 Hz, CH3), 1.98 (s, 3H, CH3), 2.24 (qt, 2H, J = 7.5,
2.0 Hz, CH2), 4.20 (s, 2H, CH2), 5.49 (s, 1H, CH), 7.20 (t, 1H, J = 8.0 Hz, CHAr), 7.31
(d, 1H, J = 7.6 Hz, CHAr), 7.41 (d, 1H, J = 7.9 Hz, CHAr), 7.55 (s, 1H, CHAr) ppm; 13C
NMR (125 MHz, CDCl3): 𝛿 = 8.9, 12.5, 13.8, 21.7, 25.4, 25.6, 56.4, 74.8, 75.0, 88.7,
122.3, 122.4, 125.3, 125.9, 129.8, 130.4, 130.7, 142.1 ppm; HRMS (ASAP): m/z calcd
for C18H22(79Br)O [M + H]+ 333.0849, found 333.0869; IR (ATR): 2975, 2937, 2855,
1570, 1426, 1068, 781 cm-1.
1-Bromo-4-((pent-2-yn-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)benzene
342j
Following general procedure B, cyclopropenyl alcohol 319f
(259.4 mg, 0.971 mmol) was dissolved in THF (9.8 mL) and NaH
(60% w/w dispersion on mineral oil, 99.1 mg, 2.48 mmol) and
1-bromopent-2-yne (0.15 mL, 1.47 mmol) were added stepwise. The reaction was left for
16 h at rt. Flash column chromatography gave the title compound 342j as an oil
(109.8 mg, 0.329 mmol) in 34% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.02 (s, 3H,
CH3), 1.06 (s, 3H, CH3), 1.14 (t, 3H, J = 7.5 Hz, CH3), 1.97 (s, 3H, CH3), 2.20-2.27 (m,
249

2H, CH2), 4.18 (s, 2H, CH2), 5.48 (s, 1H, CH), 7.27 (d, 2H, J = 8.0 Hz, 2CHAr), 7.46 (d,
2H, J = 8.0 Hz, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.8, 12.5, 13.8, 21.6,
25.4, 25.6, 56.2, 74.8, 75.0, 88.6, 121.6, 122.5, 125.0, 129.0, 131.3, 138.8 ppm; HRMS
(ASAP): m/z calcd for C18H22(79Br)O [M + H]+ 333.0849, found 333.0867; IR (ATR):
2976, 2936, 1585, 1486, 1265, 1069, 1011, 736 cm-1.
1-Fluoro-2-((pent-2-yn-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)benzene
342k
Following general procedure B, cyclopropenyl alcohol 319g
(263.0 mg, 1.28 mmol) was dissolved in THF (13 mL) and NaH
(60% w/w dispersion on mineral oil, 103.3 mg, 2.58 mmol) and
1-bromopent-2-yne (0.19 mL, 1.86 mmol) were added stepwise. The reaction was left for
17 h at rt. Flash column chromatography gave the title compound 342k as a colourless oil
(229.9 mg, 0.844 mmol) in 66% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.01 (s, 3H,
CH3), 1.06 (s, 3H, CH3), 1.14 (t, 3H, J = 7.5 Hz, CH3), 1.97 (s, 3H, CH3), 2.23 (q, 2H,
J = 7.5 Hz, CH2), 4.21-4.25 (m, 2H, CH2), 5.86 (s, 1H, CH), 7.02 (t, 1H, J = 9.0 Hz,
CHAr), 7.12 (t, 1H, J = 7.5 Hz, CHAr) 7.22-7.28 (m, 1H, CHAr), 7.47 (t, 1H, J = 7.5 Hz,
CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.8, 12.5, 13.7, 21.8, 25.2, 25.6, 56.5, 68.8
(d, J = 3.9 Hz), 75.0, 88.5, 115.1 (d, J = 21.7 Hz), 122.2, 124.1 (d, J = 2.9 Hz), 124.8,
127.0 (d, J = 13.5 Hz), 128.8 (d, J = 3.9 Hz), 129.1 (d, J = 8.6 Hz), 159.9 (d,
J = 247.0 Hz) ppm; HRMS (ASAP): m/z calcd for C18H22FO [M + H]+ 273.1649, found
273.1658; IR (ATR): 2937, 2855, 1489, 1457, 1229, 1054, 755 cm-1.

250

1-Fluoro-4-((pent-2-yn-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)benzene
342l
Following general procedure B, cyclopropenyl alcohol 319h
(143.8 mg, 0.697 mmol) was dissolved in THF (7 mL) and NaH
(60% w/w dispersion on mineral oil, 74.2 mg, 1.86 mmol) and
1-bromopent-2-yne (0.14 mL, 1.37 mmol) were added stepwise. The reaction was left for
20 h at rt. Flash column chromatography gave the title compound 342l as a colourless oil
(100.1 mg, 0.368 mmol) in 53% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.02 (s, 3H,
CH3), 1.06 (s, 3H, CH3), 1.15 (t, 3H, J = 7.5 Hz, CH3), 1.98 (s, 3H, CH3), 2.24 (q, 2H,
J = 7.5 Hz, CH2), 4.18 (bs, 2H, CH2), 5.50 (s, 1H, CH), 7.02 (t, 2H, J = 8.5 Hz, 2CHAr),
7.35 (dd, 2H, J = 8.5, 5.5 Hz, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.8, 12.5,
13.8, 21.6, 25.3, 25.6, 56.2, 74.9, 75.2, 88.5, 115.0 (d, J = 21.4 Hz), 122.8, 124.7, 129.0
(d, J = 8.4 Hz), 135.6 (d, J = 3.7 Hz), 162.4 (d, J = 246.3 Hz) ppm; HRMS (ASAP): m/z
calcd for C18H22FO [M + H]+ 273.1649, found 273.1666; IR (ATR): 2979, 2940, 1597,
1507, 1227, 1153, 838 cm-1.
1-Methyl-2-((pent-2-yn-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)benzene
342m
Following general procedure B, cyclopropenyl alcohol 319i
(207.0 mg, 1.02 mmol) was dissolved in THF (10 mL) and NaH
(60% w/w dispersion on mineral oil, 64.2 mg, 1.61 mmol) and
1-bromopent-2-yne (0.15 mL, 1.47 mmol) were added stepwise. After 5 h a second
portion of NaH (60% w/w dispersion on mineral oil, 49.0 mg, 1.23 mmol) was added.
The reaction was left for an additional 20 h at rt. Flash column chromatography gave the
title compound 342m as a colourless oil (196.0 mg, 0.730 mmol) in 71% yield. 1H NMR
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(500 MHz, CDCl3): 𝛿 = 0.98 (d, 3H, J = 2.0 Hz, CH3), 1.05 (d, 3H, J = 2.0 Hz, CH3), 1.14
(td, 3H, J = 7.5, 1.5 Hz, CH3), 1.96 (s, 3H, CH3), 2.20-2.27 (m, 2H, CH2), 2.39 (s, 3H,
CH3), 4.16-4.24 (m, 2H, CH2), 5.73 (s, 1H, CH), 7.10-7.20 (m, 3H, 3CHAr), 7.37-7.41 (m,
1H, CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.8, 12.5, 13.8, 18.9, 21.5, 25.1, 25.6,
56.0, 72.8, 75.3, 88.2, 122.4, 123.9, 125.9, 127.3, 127.5, 130.2, 135.5, 137.5 ppm; HRMS
(ASAP): m/z calcd for C19H25O [M + H]+ 269.1900, found 269.1897; IR (ATR): 2911,
2853, 1458, 1436, 1048, 746 cm-1.
1-Methyl-4-((pent-2-yn-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)benzene
342n
Following general procedure B, cyclopropenyl alcohol 319j
(66.7 mg, 0.330 mmol) was dissolved in THF (3.2 mL) and NaH
(60% w/w dispersion on mineral oil, 44.3 mg, 1.11 mmol) and
1-bromopent-2-yne (50 μL, 0.489 mmol) were added stepwise. The reaction was left for
21 h at rt after which additional portions of NaH (60% w/w dispersion on mineral oil,
13.6 mg, 3.40 mmol) and 1-bromopent-2-yne (20 μL, 0.196 mmol) were added. A third
portion of NaH (60% w/w dispersion on mineral oil, 18.1 mg, 0.453 mmol) was added
after another 4 h and the mixture was heated to 60 °C for 2.5 h before being worked up.
Flash column chromatography gave the title compound 342n as an oil (37.0 mg,
0.137 mmol) in 42% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.03 (s, 3H, CH3), 1.07 (s,
3H, CH3), 1.15 (t, 3H, J = 7.5 Hz, CH3), 1.98 (s, 3H, CH3), 2.23 (q, 2H, J = 7.5 Hz, CH2),
2.33 (s, 3H, CH3), 4.14-4.18 (m, 2H, CH2), 5.48 (s, 1H, CH), 7.13 (d, 2H, J = 7.5 Hz,
2CHAr), 7.26 (d, 2H, J = 7.5 Hz, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.8,
12.5, 13.8, 21.2, 21.5, 25.4, 25.7, 56.0, 75.4, 75.5, 88.2, 123.0, 124.2, 127.4, 128.9, 136.7,
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137.4 ppm; HRMS (ASAP): m/z calcd for C19H25O [M + H]+ 269.1900, found 269.1899;
IR (ATR): 2979, 2922, 1458, 1374, 1363, 1051, 814 cm-1.
1-Nitro-2-((pent-2-yn-1-yloxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)benzene
342o

Following general procedure C, cyclopropenyl alcohol 319k (112.5 mg,
0.482 mmol), Cs2CO3 (394.2 mg, 1.21 mmol) and MeCN (2.5 mL) were stirred at 50 °C
for 30 min and to this was added 1-bromopent-2-yne (70 μL, 0.685 mmol). After 5.5 h
the reaction was filtered and purified by flash column chromatography (4:96 EtOAc:hex)
to give the title compound 342o as a yellow oil (93.4 mg, 0.312 mmol) in 65% yield. 1H
NMR (500 MHz, CDCl3): 𝛿 = 0.98 (s, 6H, 2CH3), 1.13 (t, 3H, J = 7.5 Hz, CH3), 1.93 (s,
3H, CH3), 2.22 (q, 2H, J = 7.5 Hz, CH2), 4.23-4.27 (m, 2H, CH2), 6.28 (s, 1H, CH), 7.41
(t, 1H, J = 7.5 Hz, CHAr), 7.61 (t, 1H, J = 7.5 Hz, CHAr), 7.85 (d, 1H, J = 8.0 Hz, CHAr),
7.93 (d, 1H, J = 8.0 Hz, CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.8, 12.4, 13.6,
22.3, 25.2, 25.4, 56.9, 70.8, 74.6, 89.1, 122.4, 124.3, 126.0, 128.0, 128.8, 133.2, 135.7,
147.6 ppm; HRMS (ASAP): m/z calcd for C18H21NO3 [M]+ 299.1516, found 299.1513;
IR (ATR): 2913, 2855, 1527, 1349, 1054, 786, 731 cm-1.
1-(1-(But-2-yn-1-yloxy)dodecyl)-2,3,3-trimethylcycloprop-1-ene 342p
Following general procedure B, cyclopropenyl alcohol 319l
(278.2 mg, 1.04 mmol) was dissolved in THF (10 mL) and NaH
(60% w/w dispersion on mineral oil, 124.9 mg, 3.12 mmol) and
1-bromobut-2-yne (0.14 mL, 1.60 mmol) were added stepwise. The reaction was left
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overnight at rt. After 17 h additional portions of NaH (60% w/w dispersion on mineral
oil, 112.6 mg, 2.82 mmol) and 1-bromobut-2-yne (50 μL, 0.571 mmol) were added and
the reaction was left at rt for an another 73 h. Flash column chromatography gave the title
compound 342p as a colourless oil (118.6 mg, 0.372 mmol) in 36% yield. 1H NMR
(500 MHz, CDCl3): 𝛿 = 0.88 (s, 3H, J = 7.0 Hz, CH3), 1.10 (s, 3H, CH3), 1.11 (s, 3H,
CH3), 1.21-1.48 (m, 18H, 9CH2), 1.58-1.73 (m, 2H, CH2), 1.85 (t, 3H, J = 2.5 Hz, CH3),
2.00 (s, 3H, CH3), 4.01 (dd, 1H, J = 15.0, 2.0 Hz, CHaHb), 4.19 (dd, 1H, J = 15.0, 2.0 Hz,
CHaHb), 4.42 (t, 1H, J = 6.5 Hz, CH) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 3.6, 9.0,
14.1, 20.8, 22.7, 25.5, 25.8, 25.9, 29.3, 29.55, 29.57, 29.62 , 29.63, 31.9, 34.5, 56.4, 74.2,
75.6, 81.7, 122.9, 123.3 ppm; HRMS (ASAP): m/z calcd for C22H39O [M + H]+ 319.2995,
found 319.2995; IR (ATR): 2922, 2853, 1458, 1442, 1137, 1071 cm-1.
1,3,3-Trimethyl-2-(3-(pent-2-yn-1-yloxy)pentan-3-yl)cycloprop-1-ene 342q
Following general procedure B, cyclopropenyl alcohol 319m
(162.7 mg, 0.967 mmol) was dissolved in THF (8.5 mL) and NaH (60%
w/w dispersion on mineral oil, 156.7 mg, 3.92 mmol) and 1-bromopent2-yne (0.16 mL, 1.57 mmol) were added stepwise. The reaction was left overnight at rt.
After 17 h the reaction was heated to reflux for 8 h and then left stirring at 60 °C overnight.
After 2 d the reaction was worked-up and flash column chromatography gave the title
compound 342q as a yellow oil (96.6 mg, 0.412 mmol) in 43% yield. 1H NMR
(500 MHz, CDCl3): 𝛿 = 0.87 (t, 6H, J = 7.5 Hz, 2CH3), 1.11 (s, 6H, 2CH3), 1.13 (t, 3H,
J = 7.5 Hz, CH3), 1.64-1.71 (m, 4H, 2CH2), 2.01 (s, 3H, CH3), 2.22 (qt, 2H, J = 7.5,
2.0 Hz, CH2), 4.00 (t, 2H, J = 2.0 Hz, CH2) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 7.8,
9.0, 12.6, 13.7, 21.1, 25.9, 28.1, 52.0, 81.6, 86.7, 124.2, 124.6 ppm; HRMS (ESI): m/z
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calcd for C16H26NaO [M + Na]+ 257.1876, found 257.1892; IR (ATR): 2967, 2936, 2855,
1456, 1438, 1363, 1149, 1050 cm-1
1-Bromo-2-(((3-phenylprop-2-yn-1-yl)oxy)(2,3,3-trimethylcycloprop-1-en-1-yl)methyl)
benzene 342r

Using a slightly altered literature procedure, [184] to a solution of 3-phenylprop-2yn-1-ol (527.8 mg, 3.99 mmol) and Et3N (1.11 mL, 7.96 mmol) in dry THF (4 mL) under
a nitrogen atmosphere at 0 °C, was added methanesulfonyl chloride (MsCl, 0.46 mL,
5.94 mmol). The reaction was stirred for 1.5 h and was then diluted with Et 2O. The
organic layer was washed with 1 M HCl, brine and saturated NaHCO3 before being dried
over Na2SO4. The crude residue was filtered and concentrated under reduced pressure to
give 3-phenylprop-2-yn-1-yl methanesulfonate as a yellow oil (726.3 mg, 3.45 mmol)
which was used without further purification. 1H NMR (500 MHz, CDCl3): 𝛿 = 3.16 (s,
3H, CH3), 5.09 (s, 2H, CH2), 7.32-7.41 (m, 3H, 3CHAr), 7.45-7.49 (m, 2H, 2CHAr) ppm.
NMR data is in agreement with published data.[185]
Following general procedure B, cyclopropenyl alcohol 319a (428.6 mg,
1.60 mmol) was dissolved in THF (16 mL), and NaH (60% w/w dispersion on mineral
oil, 122.8 mg, 3.07 mmol) was added. Using a cannula, 3-phenylprop-2-yn-1-ylmethane
sulfonate (670.8 mg, 3.19 mmol) in Et2O (0.4 mL) was added followed by a quantitative
transfer (2×0.3 mL). The reaction was left for 21 h at rt. Flash column chromatography
gave the title compound 342r as an oil (231.1 mg, 0.606 mmol) in 38% yield. 1H NMR
(500 MHz, CDCl3): 𝛿 = 1.01 (s, 3H, CH3), 1.05 (s, 3H, CH3), 1.97 (d, 3H, J = 1.5 Hz,
CH3), 4.49 (s, 2H, CH2), 6.03 (s, 1H, CH), 7.13 (td, 1H, J = 7.5, 1.5 Hz, CHAr), 7.28-7.34
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(m, 4H, 4CHAr), 7.43-7.47 (m, 2H, 2CHAr), 7.52 (d, 1H, J = 8.0 Hz, CHAr), 7.57 (dd, 1H,
J = 8.0, 1.5 Hz, CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 9.0, 22.0, 25.3, 25.6, 56.8,
75.1, 85.0, 86.5, 122.1, 122.6, 122.7, 125.3, 127.5, 128.2, 128.3, 128.8, 129.0, 131.8,
132.5, 139.0 ppm; HRMS (ASAP): m/z calcd for C22H22(79Br)O [M + H]+ 381.0849,
found 381.0865; IR (ATR): 2945, 1697, 1067, 1026, 734 cm-1.

4.3.2. Reactions of Cyclopropenyl Allyl Ethers 320 with Gold(I) Catalysts and
Further Reactivity
2-Allyl-1-(2-bromophenyl)-3,4-dimethylpent-3-en-1-one 322a

Cyclopropenyl allyl ether 320a (179.6 mg, 0.585 mmol) was dissolved in PhMe
(5.8 mL) and to this was added Ph3PAuNTf2 (24.4 mg, 33.0 µmol). The mixture was
heated to 50 °C and its progress was monitored by TLC. Following the disappearance of
the starting material 320a, the mixture was heated to reflux and was left stirring overnight.
The solvent was then removed under reduced pressure and the crude residue was purified
by flash column chromatography (4:96 EtOAc:hex) to give the title compound 322a as a
yellow oil (129.1 mg, 0.420 mmol) in 72% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.44
(s, 3H, CH3), 1.55 (s, 3H, CH3), 1.59 (s, 3H, CH3), 2.38-2.46 (m, 1H, CHaHb), 2.66-2.73
(m, 1H, CHaHb), 4.40 (dd, 1H, J = 8.5, 6.0 Hz, CH), 4.99 (d, 1H, J = 10.0 Hz, CHaHb),
5.10 (dd, 1H, J = 17.0, 2.0 Hz, CHaHb), 5.71-5.81 (m, 1H, CH), 7.14 (dd, 1H, J = 7.5, 2.0
Hz, CHAr), 7.22 (td, 1H, J = 7.5, 2.0 Hz, CHAr), 7.28 (t, 1H, J = 7.5 Hz, CHAr), 7.54 (d,
1H, J = 8.0 Hz, CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 13.5, 20.6, 21.2, 32.2,
54.6, 116.1, 118.4, 122.4, 126.8, 128.0, 130.7, 131.4, 133.1, 136.1, 142.1, 203.3 ppm;
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HRMS (ESI): m/z calcd for C16H20(79Br)O [M + H]+ 307.0692, found 307.0705; IR
(ATR): 2979, 2920, 2863, 1700, 1437, 1028, 910, 748 cm-1.
3-(2-Bromobenzoyl)-4,5-dimethylhex-4-enal 323a23

To a solution of dienyl ketone 322a (29.5 mg, 96.0 µmol) in 1,4-dioxane/water
(ratio 3:1, 0.9 mL) was added OsO4 (4% w/v in H2O, 12.0 µL, 1.96 µmol), 2,6-lutidine
(30 μL, 0.259 mmol) and sodium periodate (84.3 mg, 0.394 mmol) with stirring at rt.
After 3 h 45 mins, an additional portion of OsO4 (4% w/v in H2O, 15.0 µL, 2.45 µmol)
was added to push the reaction to completion. After 1 h, water and DCM were added to
the reaction and the mixture was separated. The aqueous phase was extracted with DCM
and the combined organics were washed with brine and dried over Na2SO4. The organic
phase was filtered, concentrated under reduced pressure and purified by flash column
chromatography (20:80 EtOAc:hex) to give to the title compound 323a as a clear oil
(17.0 mg, 54.8 µmol) in 57% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.51 (s, 3H, CH3),
1.55 (s, 3H, CH3), 1.59 (s, 3H, CH3), 2.56 (dd, 1H, J = 18.0, 4.5 Hz, CHaHb), 3.35 (dd,
1H, J = 18.0, 8.8 Hz, CHaHb), 4.88 (dd, 1H, J = 8.7, 5.0 Hz, CH), 7.25 (t, 1H, J = 8.5 Hz,
CHAr), 7.34 (t, 1H, J = 7.5 Hz, CHAr), 7.51 (d, 1H, J = 7.5 Hz, CHAr), 7.56 (d, 1H,
J = 8.0 Hz, CHAr), 9.85 (s, 1H, CHO) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 14.2, 20.7,
21.3, 42.8, 48.6, 119.1, 121.2, 126.9, 128.5, 131.1, 132.0, 133.5, 141.1, 200.7, 201.4 ppm;
HRMS (ASAP): m/z calcd for C15H18(79Br)O2 [M + H]+ 309.0485, found 309.0493; IR
(ATR): 2918, 1719, 1700, 1427, 1378, 1223, 1050, 1027, 971, 756 cm-1.

23

Results were obtained by the Honour’s student, Jack Rimington
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1-(2-Bromophenyl)-2-(2-hydroxyethyl)-3,4-dimethylpent-3-en-1-one 325

Sodium borohydride (NaBH4, 3.6 mg, 95.1 µmol) was added to a solution of
3-(2-bromobenzoyl)-4,5-dimethylhex-4-enal 323a (26.0 mg, 84.1 µmol) in dry EtOH
(1 mL) that had been cooled to 0 °C, under nitrogen. After 15 minutes at rt, the the reaction
was complete and water was added. The organics were extracted using DCM and the
combined organics extracts were washed with brine and dried over Na2SO4. The solution
was filtered, concentrated under reduced pressure and purified by flash column
chromatography (8:92 EtOAc:hex, <1% MeOH) to give to the title compound 325 as an
oil (14.3 mg, 45.9 µmol) in 55% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.49 (s, 3H,
CH3), 1.55 (s, 3H, CH3), 1.60 (s, 3H, CH3), 1.81-1.90 (m, 1H, CHaHb), 2.23-2.31 (m, 1H,
CHaHb), 3.61-3.67 (m, 1H, CHaHb), 3.69-3.76 (m, 1H, CHaHb), 4.56 (t, 1H, J = 7.0 Hz,
CH), 7.18-7.25 (m, 2H, 2CHAr), 7.29 (dd, overlapped with CHCl3, 1H, J = 7.5, 2.0 Hz,
CHAr) 7.55 (d, 1H, J = 8.0 Hz, CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 13.8, 20.6,
21.2, 30.9, 51.5, 60.9, 118.4, 122.5, 126.9, 128.1, 130.8, 131.7, 133.2, 142.0, 203.9 ppm;
LRMS (EI): m/z 311 C15H20BrO2 [79M + H]+, m/z 313 C15H20BrO2 [81M + H]+, m/z 310
C15H19BrO2 [79M]+, m/z 312 C15H19BrO2 [81M]+; IR (ATR): 3385 (br), 2922, 1697, 1428,
1268, 1214, 1043, 1028, 751 cm-1.
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2-Allyl-1-(2-bromophenyl)-3,4-dimethylpent-3-en-1-ol 329a

Dienyl ketone 322a (108.7 mg, 0.354 mmol) was dissolved in dry EtOH (3.6 mL)
under nitrogen and the solution was cooled to 0 °C. NaBH4 (33.8 mg, 0.893 mmol) was
added slowly and the reaction was warmed to rt and left overnight. After 19 h, a second
portion of NaBH4 (5.7 mg, 0.151 mmol) was added and the reaction was left stirring at rt
for another 3 h, after which the reaction was quenched with 2 M HCl (0.5 mL). Water
was added and the aqueous phase was extracted (3x) with DCM. The combined organic
extracts were dried over Na2SO4, filtered and were concentrated under reduced pressure.
Flash column chromatography (4:96 EtOAc:hex) gave the title compound 329a as an oil
(77.2 mg, 0.250 mmol) in 71% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.708 (s, 3H,
CH3), 1.712 (s, 3H, CH3), 1.75 (s, 3H, CH3), 1.77-1.84 (m, 1H, CHaHb), 2.16 (s, 1H, OH),
2.20-2.29 (m, 1H, CHaHb), 2.98-2.06 (m, 1H, CH), 4.82 (d, 1H, J = 10.0 Hz, CHaHb),
4.87 (dd, 1H, J = 17.0, 2.0 Hz, CHaHb), 5.03 (d, 1H, J = 9.0 Hz, CH), 5.43-5.53 (m, 1H,
CH), 7.13 (td, 1H, J = 7.5, 2.0 Hz, CHAr), 7.34 (t, 1H, J = 7.5 Hz, CHAr), 7.51 (d, 2H,
J = 8.0 Hz, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 12.8, 20.5, 21.3, 32.8, 50.4,
73.4, 115.2, 123.8, 125.4, 127.7, 128.7, 128.9, 131.7, 132.4, 136.6, 142.0 ppm; HRMS
(ASAP): m/z calcd for C16H21(79Br)O [M]+ 308.0776, found 308.0769; IR (ATR): 3468
(br), 3067, 1639, 1466, 1439, 1018, 991, 908, 756 cm-1.
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5-Allyl-2-(2-bromophenyl)-3-(3-methylbut-2-en-2-yl)tetrahydrofuran 331a

To a solution of dienyl alcohol 329a (42.9 mg, 0.139 mmol) in 1,4-dioxane/water
(ratio 3:1, 1.39 mL) was added 2,6-lutidine (16.1 µL, 0.139 mmol), OsO4 (4% w/v in
H2O, 44.1 µL, 6.94 µmol) and sodium periodate (30% NaIO4 absorbed to silica,
394.6 mg, 0.553 mmol) with stirring at rt. The reaction was monitored by TLC and after
1.5 h, a second portion of OsO4 (4% w/v in H2O, 17.6 µL, 2.77 µmol) was added. After
a total reaction time of 2.5 h, water was added and the mixture was filtered to remove the
silica gel. The mixture was extracted (3x) with DCM and the combined organics were
washed with brine and dried over Na2SO4. The solution was filtered and concentrated
under reduced pressure to give the crude lactol intermediate 330a which was used
immediately in the next step.
Using a slightly altered literature procedure, [114a] the crude lactol 330a was
dissolved in dry DCM (1.5 mL) under a nitrogen atmosphere and to this was added
allyltrimethylsilane (50 μL, 0.315 mmol) before the mixture was cooled to –78 °C. Boron
trifluoride diethyl etherate (BF3·Et2O, 50 μL, 0.405 mmol) was added and the reaction
was allowed to warm to rt. After 1 h, water was added and the reaction was stirred
vigorously for several minutes. The aqueous phase was extracted (3x) with ether and the
combined organics were washed with brine and dried over Na2SO4. The crude residue
was filtered, concentrated under reduced pressure and purified by flash column
chromatography (4:96 EtOAc:hex) using silica that had been pre-treated with the eluent
and 1% Et3N. The title compound 331a was obtained as a clear oil (16.2 mg, 48.3 µmol)
in 35% yield over two-steps. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.24 (s, 3H, CH3), 1.41
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(s, 3H, CH3), 1.61 (s, 3H, CH3), 1.94 (ddd, 1H, J = 13.0, 8.0, 5.0 Hz, CHaHb), 2.20 (ddd,
1H, J = 13.0, 8.0, 5.5 Hz, CHaHb), 2.29-2.36 (m, 1H, CHaHb), 2.45-2.52 (m, 1H, CHaHb),
3.91 (dd, 1H, J = 13.5, 7.0 Hz, CH), 4.53-4.59 (m, 1H, CH), 5.11 (d, 1H, J = 10.0 Hz,
CHaHb), 5.15 (dd, 1H, J = 17.0, 2.0 Hz, CHaHb), 5.37 (d, 1H, J = 6.5 Hz, CH), 5.84-5.93
(m, 1H, CH), 7.04 (td, 1H, J = 7.5, 2.0 Hz, CHAr), 7.22 (t, 1H, J = 7.5 Hz, CHAr), 7.42
(dd, 1H, J = 8.0, 1.5 Hz, CHAr), 7.46 (dd, 1H, J = 8.0, 1.5 Hz, CHAr) ppm;

13

C NMR

(125 MHz, CDCl3): 𝛿 = 15.3, 20.87, 20.92, 35.1, 41.3, 44.6, 78.4, 82.4, 117.2, 122.1,
125.2, 126.5, 128.20, 128.21, 128.3, 132.1, 134.9, 140.0 ppm; LRMS (EI): m/z 334
C18H23BrO [79M]+, m/z 336 C18H23BrO [80M]+; IR (ATR): 2918, 1066, 1022, 748 cm-1.

4.3.3. Gold(I)-Catalysed Rearrangements of Cyclopropenyl Propargyl Ethers 342

2-(2-Bromophenyl)-5-methyl-3-(3-methylbut-2-en-2-yl)furan 343a
Following general procedure D, cyclopropenyl propargyl ether 342a
(59.2 mg, 0.194 mmol) was dissolved in DCE (2 mL) and Ph3PAuCl
(5.2 mg, 10.5 µmol) and AgBF4 (1.9 mg, 9.78 µmol) were added. The
reaction was heated for 1.25 h and flash column chromatography gave the title compound
343a as a colourless oil (25.0 mg, 81.9 µmol) in 42% yield. 1H NMR (500 MHz, CDCl3):
𝛿 = 1.41 (s, 3H, CH3), 1.66 (s, 3H, CH3), 1.81 (s, 3H, CH3), 2.34 (s, 3H, CH3), 5.97 (s,
1H, CHHet), 7.10-7.16 (m, 1H, CHAr), 7.21-7.32 (m, 2H, 2CHAr), 7.61 (d, 1H, J = 8.0 Hz,
CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 13.7, 19.6, 20.4, 22.1, 108.9, 121.0, 122.8,
126.9, 127.1, 128.9, 129.3, 131.5, 133.4, 133.6, 145.7, 151.1 ppm; HRMS (ASAP): m/z
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calcd for C16H18(79Br)O [M + H]+ 305.0536 found 305.0528; IR (ATR): 2986, 2918,
2857, 1564, 1465, 1456, 1435, 1371, 756 cm-1.
2-(2-Bromophenyl)-4-ethyl-5-methyl-3-(3-methylbut-2-en-2-yl)furan 343b
Following general procedure D, cyclopropenyl propargy ether 342b
(89.4 mg, 0.268 mmol) was dissolved in DCE (2.6 mL) and Ph3PAuCl
(7.5 mg, 15.2 µmol) and AgBF4 (2.6 mg, 13.4 µmol) were added. The
reaction was heated for 30 min and flash column chromatography gave the title compound
343b as a colourless oil (71.2 mg, 0.214 mmol) in 80% yield. 1H NMR (500 MHz,
CDCl3): 𝛿 = 1.06 (t, 3H, J = 7.5 Hz, CH3), 1.47 (s, 3H, CH3), 1.68 (s, 3H, CH3), 1.79 (s,
3H, CH3), 2.23-2.33 (m, 2H, CH2), 2.29 (s, 3H, CH3), 7.11 (ddd, 1H, J = 8.0, 6.5, 2.5 Hz,
CHAr), 7.21-7.26 (m, 2H, 2CHAr), 7.59 (d, 1H, J = 8.0 Hz, CHAr) ppm;
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C NMR

(125 MHz, CDCl3): 𝛿 = 11.9, 14.8, 17.4, 19.87, 19.94, 22.2, 120.6, 121.6, 122.8, 126.7,
127.5, 128.8, 130.4, 131.3, 133.3, 133.4, 144.4, 146.5 ppm; HRMS (ASAP): m/z calcd
for C18H22(79Br)O [M + H]+ 333.0849, found 333.0863; IR (ATR): 2966, 2918, 2857,
1568, 1462, 1433, 1370, 1131, 1026, 755 cm-1.
(5-(2-Bromophenyl)-2-methyl-4-(3-methylbut-2-en-2-yl)furan-3-yl)trimethylsilane 343c
Following general procedure D, cyclopropenyl propargyl ether 342c
(60.1 mg, 0.159 mmol) was dissolved in DCE (1.6 mL) and Ph3PAuCl
(4.4 mg, 8.89 µmol) and AgBF4 (1.5 mg, 7.70 µmol) were added with
stirring. The reaction was heated for 2 h and flash column chromatography gave the title
compound 343c as a colourless oil (44.0 mg, 0.117 mmol) in 73% yield. The sample
contained approximately 7% of the desilyated derivative which could not be removed. 1H
NMR (500 MHz, CDCl3): 𝛿 = 0.21 (s, 9H, Si(CH3)3), 1.49 (s, 3H, CH3), 1.61 (s, 3H,
CH3), 1.76 (s, 3H, CH3), 2.39 (s, 3H, CH3), 7.11-7.16 (m, 1H, CHAr), 7.21-7.28 (m, 2H,
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2CHAr), 7.59 (d, 1H, J = 8.0 Hz, CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 0.1, 14.9,
19.8, 21.1, 22.6, 113.2, 122.2, 123.4, 126.7, 129.1, 130.4, 131.4, 131.5, 133.16, 133.18,
145.1, 156.7 ppm; HRMS (ASAP): m/z calcd for C19H26(79Br)OSi [M + H]+ 377.0931,
found 377.0917; IR (ATR): 2955, 2911, 2857, 1544, 1464, 1432, 1248, 1027, 835,
755 cm-1.
2-(2-Chlorophenyl)-4-ethyl-5-methyl-3-(3-methylbut-2-en-2-yl)furan 343d
Following general procedure D, cyclopropenyl propargyl ether 342d
(176.5 mg, 0.611 mmol) was dissolved in DCE (6.2 mL) and Ph3PAuCl
(15.8 mg, 31.9 µmol) and AgBF4 (5.9 mg, 30.3 µmol) were added with
stirring. The reaction was heated for 2 h and flash column chromatography gave the title
compound 343d as a pale yellow oil (108.9 mg, 0.377 mmol) in 62% yield. 1H NMR
(500 MHz, CDCl3): 𝛿 = 1.06 (t, 3H, J = 7.5 Hz, CH3), 1.45 (s, 3H, CH3), 1.68 (s, 3H,
CH3), 1.80 (s, 3H, CH3), 2.23-2.33 (m, 2H, CH2), 2.29 (s, 3H, CH3), 7.16-7.19 (m, 2H,
2CHAr), 7.27-7.30 (m, 1H, CHAr), 7.34-7.40 (m, 1H, CHAr) ppm; 13C NMR (125 MHz,
CDCl3): 𝛿 = 12.0, 14.9, 17.5, 19.9, 20.1, 22.2, 121.0, 121.9, 126.4, 128.0, 128.6, 130.2,
130.5, 131.0, 131.6, 133.2, 143.5, 146.9 ppm; HRMS (ASAP): m/z calcd for
C18H22(35Cl)O [M + H]+ 289.1354, found 289.1355; IR (ATR): 2967, 2921, 2857, 1572,
1467, 1435, 1371, 1054, 1035, 958, 756 cm-1.
tert-Butyl(5-(2-chlorophenyl)-2-methyl-4-(3-methylbut-2-en-2-yl)furan-3-yl)dimethyl
silane 343e
Following general procedure D, cyclopropenyl propargyl ether 342e
(76.7 mg, 0.205 mmol) was dissolved in DCE (2 mL) and Ph3PAuCl
(5.5 mg, 11.1 µmol) and AgBF4 (2.0 mg, 10.3 µmol) were added with
stirring. The reaction was heated for 2.5 h and flash column chromatography gave the
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title compound 343e as a colourless oil (40.2 mg, 0.107 mmol) in 52% yield. 1H NMR
(500 MHz, CDCl3): 𝛿 = 0.15 (s, 3H, SiCH3), 0.22 (s, 3H, CH3, SiCH3), 0.93 (s, 9H,
C(CH3)3), 1.42 (s, 3H, CH3), 1.57 (s, 3H, CH3), 1.80 (s, 3H, CH3), 2.41 (s, 3H, CH3),
7.14-7.26 (m, 3H, 3CHAr), 7.39 (dd, 1H, J = 7.5, 1.5 Hz, CHAr) ppm;
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(125 MHz, CDCl3): 𝛿 = -4.8, -3.8, 15.9, 18.8, 19.8, 21.5, 22.6, 27.3, 110.8, 122.1, 126.0,
128.8, 129.9, 130.8, 131.18, 131.23, 132.2, 134.0, 144.4, 158.0 ppm; HRMS (ASAP):
m/z calcd for C22H32(35Cl)OSi [M + H]+ 375.1905, found 375.1908; IR (ATR): 2927,
2856, 1539, 1463, 1435, 1257, 1249, 1098, 832, 821, 809, 756 cm-1.
2-(4-Chlorophenyl)-4-ethyl-5-methyl-3-(3-methylbut-2-en-2-yl)furan 343f, 3-(4-chloro
phenyl)-4-ethyl-5-methyl-2-(3-methylbut-2-en-2-yl)furan 343f’

and (E)-1-chloro-4-

(3,4-dimethyl-1-(pent-2-yn-1-yloxy)penta-1,3-dien-2-yl)benzene 344f
Following general procedure D, cyclopropenyl propargyl ether 342f (100.8 mg,
0.349 mmol) was dissolved in DCE (3.4 mL) and Ph3PAuCl (8.7 mg, 17.6 µmol) and
AgBF4 (3.4 mg, 17.4 µmol) were added with stirring. The reaction was heated for 50 min
and flash column chromatography gave the title compound 343f as an oil (2.9 mg,
10.0 µmol) in 3% yield. In addition to the desired furan 343f, rearranged furan 343f’
(9.0 mg, 31.2 µmol) was obtained in 9% yield and enol ether 344f (9.1 mg, 31.5 µmol)
was obtained in 9% yield.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.03 (t, 3H, J = 7.5 Hz, CH3),

1.52 (s, 3H, CH3), 1.84 (s, 3H, CH3), 1.85 (s, 3H, CH3), 2.21 (q,
2H, J = 7.5 Hz, CH2), 2.28 (s, 3H, CH3), 7.23-7.28 (m, overlapped
with CHCl3, 2H, 2CHAr), 7.53 (d, 2H, J = 8.5 Hz, 2CHAr) ppm;
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C NMR (125 MHz,

CDCl3): 𝛿 = 11.9, 14.9, 17.0, 19.2, 19.9, 21.9, 121.6, 123.0, 124.7, 126.5, 128.5, 130.8,
130.9, 131.2, 143.0, 146.5 ppm; HRMS (ASAP): m/z calcd for C18H22(35Cl)O [M + H]+
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289.1354, found 289.1350; IR (ATR): 2963, 2926, 1593, 1488, 1374, 1090, 1013,
800 cm-1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 0.96 (t, 3H, J = 7.5 Hz, CH3), 1.36

(s, 3H, CH3), 1.67 (s, 3H, CH3), 1.84 (s, 3H, CH3), 2.26 (s, 3H, CH3),
2.37 (q, 2H, J = 7.5 Hz, CH2), 7.13 (d, 2H, J = 8.5 Hz, 2CHAr), 7.29 (d,
2H, J = 8.5 Hz, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 11.7,
15.0, 16.9, 18.2, 20.4, 22.5, 119.4, 120.2, 121.6, 128.4, 130.1, 131.9, 133.6, 133.7, 145.6,
150.0 ppm; HRMS (ASAP): m/z calcd for C18H22(35Cl)O [M + H]+ 289.1354, found
289.1350; IR (ATR): 2964, 2921, 2865, 1490, 1446, 1373, 1090, 827 cm-1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.13 (t, 3H, J = 7.5 Hz, CH3),

1.68 (s, 3H, CH3), 1.73 (s, 3H, CH3), 1.79 (s, 3H, CH3), 2.23 (q,
2H, J = 7.5 Hz, CH2), 4.44 (s, 2H, CH2), 6.17 (s, 1H, CH), 7.24
(d, 2H, J = 9.0 Hz, 2CHAr), 7.44 (d, 2H, J = 8.5 Hz, 2CHAr) ppm;
13

C NMR (125 MHz, CDCl3): 𝛿 = 12.4, 13.6, 19.6, 20.2, 22.0, 60.1, 74.6, 89.4, 120.2,

126.8, 128.0, 129.8, 130.4, 131.4, 135.0, 143.3 ppm; HRMS (ASAP): m/z calcd for
C18H22(35Cl)O [M + H]+ 289.1354, found 289.1353; IR (ATR): 2977, 2916, 2859, 1630,
1489, 1169, 1097, 1032, 833 cm-1.
5-Methyl-3-(3-methylbut-2-en-2-yl)-2-phenylfuran 343g and (E)-(3,4-dimethyl-1-(prop2-yn-1-yloxy) penta-1,3-dien-2-yl)benzene 344g
Following general procedure D, cyclopropenyl propargyl ether 342g (59.0 mg,
0.261 mmol) was dissolved in DCE (2.6 mL) and Ph3PAuCl (6.7 mg, 13.5 µmol) and
AgBF4 (2.5 mg, 12.8 µmol) were added with stirring. The reaction was heated for 45 min
and flash column chromatography gave the title compound 343g as an oil (3.1 mg,
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13.7 µmol) in 5% yield. In addition to the desired furan 343g, enol ether 344g (5.7 mg,
25.2 µmol) was also obtained in 10% yield.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.55 (s, overlapped with H2O, 3H,

CH3), 1.80 (s, 3H, CH3), 1.88 (s, 3H, CH3), 2.33 (s, 3H, CH3), 5.86 (s,
1H, CHHet), 7.16 (t, 1H, J = 7.5 Hz, CHAr), 7.31 (t, 2H, J = 7.7 Hz,
2CHAr), 7.60 (d, 2H, J = 7.9 Hz, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 13.6,
19.4, 20.1, 21.9, 110.1, 122.2, 123.9, 125.4, 126.0, 128.3, 129.5, 132.2, 145.3, 150.4 ppm;
HRMS (ASAP): m/z calcd for C16H19O [M + H]+ 227.1430, found 227.1431; IR (ATR):
2919, 1598, 1490, 1446, 1371, 1064, 764 cm-1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.69 (s, 3H, CH3), 1.76 (s, 3H,

CH3), 1.79 (s, 3H, CH3), 2.49 (t, 1H, J = 2.5 Hz, CH), 4.46 (d, 2H,
J = 2.5 Hz, CH2), 6.16 (s, 1H, CH), 7.17 (t, 1H, J = 7.5 Hz, CHAr),
7.30 (t, 2H, J = 7.5 Hz, 2CHAr), 7.49 (d, 2H, J = 7.5 Hz, 2CHAr) ppm; 13C NMR
(125 MHz, CDCl3): 𝛿 = 19.7, 20.2, 22.1, 59.3, 75.2, 79.0, 122.1, 126.2, 127.1, 127.9,
128.6, 130.0, 136.3, 142.4 ppm; HRMS (ASAP): m/z calcd for C16H19O [M + H]+
227.1430, found 227.1434; IR (ATR): 3296, 2981, 2916, 2862, 1671, 1444, 1168, 1099,
1040, 773 cm-1.
3-Ethyl-2-methyl-4-(3-methylbut-2-en-2-yl)-5-phenylfuran 343h, 3-ethyl-2-methyl-5(3-methylbut-2-en-2-yl)-4-phenylfuran 343h’ and (E)-(3,4-dimethyl-1-(pent-2-yn-1yloxy)penta-1,3-dien-2-yl)benzene 344h
Following general procedure D, cyclopropenyl propargyl ether 342h (192.5 mg,
0.757 mmol) was dissolved in DCE (7.6 mL) and Ph3PAuCl (19.0 mg, 38.4 µmol) and
AgBF4 (7.4 mg, 38.0 µmol) were added with stirring. The reaction was heated for 1 h and
flash column chromatography gave the title compound 343h as an oil (7.9 mg, 31.1 µmol)
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in 4% yield. In addition to the desired furan 343h, rearranged furan 343h’ (4.0 mg,
15.7 µmol) was also obtained in 2% yield and enol ether 344h (22.7 mg, 89.2 µmol) was
obtained in 12% yield. Other complex side products also occurred which could not be
isolated or characterised.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.03 (t, 3H, J = 7.5 Hz, CH3), 1.54 (s,

overlapped with H2O, 3H, CH3), 1.84 (s, 3H, CH3), 1.87 (s, 3H, CH3),
2.22 (q, 2H, J = 7.5 Hz, CH2), 2.29 (s, 3H, CH3), 7.14 (t, 1H, J = 7.5 Hz,
CHAr), 7.29 (t, 2H, J = 7.5 Hz, 2CHAr), 7.61 (d, 2H, J = 7.5 Hz, 2CHAr) ppm; 13C NMR
(125 MHz, CDCl3): 𝛿 = 11.9, 15.0, 17.0, 19.2, 19.9, 22.0, 121.8, 122.8, 123.5, 125.7,
126.0, 128.4, 130.5, 132.3, 143.9, 146.1 ppm; HRMS (ASAP): m/z calcd for C18H23O
[M + H]+ 255.1743, found 255.1740; IR (ATR): 2981, 2926, 1449, 1374, 1069, 1025,
770, 693 cm-1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 0.97 (t, 3H, J = 7.5 Hz, CH3), 1.36

(s, 3H, CH3), 1.67 (s, 3H, CH3), 1.84 (s, 3H, CH3), 2.27 (s, 3H, CH3),
2.39 (q, 2H, J = 7.5 Hz, CH2), 7.18-7.25 (m, 3H, 3CHAr), 7.32 (t, 2H,
J = 7.5 Hz, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 11.7, 15.1, 16.9, 18.2, 20.4,
22.4, 119.6, 120.4, 122.7, 126.0, 128.1, 128.9, 133.3, 135.2, 145.3, 149.8 ppm; HRMS
(ASAP): m/z calcd for C18H23O [M + H]+ 255.1743, found 255.1743; IR (ATR): 2975,
2933, 1445, 1374, 1067, 735, 700 cm-1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.14 (t, 3H, J = 7.5 Hz, CH3),

1.70 (s, 3H, CH3), 1.77 (s, 3H, CH3), 1.80 (s, 3H, CH3), 2.20-2.26
(m, 2H, CH2), 4.44 (s, 2H, CH2), 6.17 (s, 1H, CH), 7.16 (t, 1H,
J = 7.5 Hz, CHAr), 7.29 (t, 2H, J = 7.5 Hz, 2CHAr), 7.50 (d, 2H, J = 7.5 Hz, 2CHAr) ppm;
13

C NMR (100 MHz, CDCl3): 𝛿 = 12.5, 13.6, 19.7, 20.2, 22.1, 60.0, 74.8, 89.2, 121.4,
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126.0, 127.3, 127.9, 128.6, 129.8, 136.6, 142.9 ppm; HRMS (ASAP): m/z calcd for
C18H23O [M + H]+ 255.1743, found 255.1744; IR (ATR): 2979, 2916, 2859, 1632, 1493,
1444, 1169, 1099, 1036, 772, 694 cm-1.
2-(3-Bromophenyl)-4-ethyl-5-methyl-3-(3-methylbut-2-en-2-yl)furan 343i and (E)-1bromo-3-(3,4-dimethyl-1-(pent-2-yn-1-yloxy)penta-1,3-dien-2-yl)benzene 344i
Following general procedure D, cyclopropenyl propargyl ether 342i (50.7 mg,
0.152 mmol) was dissolved in DCE (1.5 mL) and Ph3PAuCl (3.8 mg, 7.68 µmol) and
AgBF4 (1.5 mg, 7.71 µmol) were added with stirring. The reaction was heated for 1 h and
flash column chromatography gave the title compound 343i as an oil (4.6 mg, 13.8 µmol)
in 9% yield. In addition to the desired furan 343i, enol ether 344i (1.7 mg, 5.10 µmol)
was also obtained in 3% yield. Other complex side products also occurred that could not
be isolated or characterised.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.03 (t, 3H, J = 7.5 Hz, CH3), 1.53

(s, overlapped with H2O, 3H, CH3), 1.85 (s, 3H, CH3), 1.86 (s, 3H,
CH3), 2.22 (q, 2H, J = 7.5 Hz, CH2), 2.29 (s, 3H, CH3), 7.14 (t, 1H,
J = 8.0 Hz, CHAr), 7.22-7.26 (m, overlapped with CHCl3, 1H, CHAr),
7.50 (d, 1H, J = 8.0 Hz, CHAr), 7.77 (s, 1H, CHAr) ppm; 13C NMR (100 MHz, CDCl3):
𝛿 = 11.9, 14.9, 16.9, 19.2, 19.9, 21.9, 121.4, 121.8, 122.6, 123.1, 126.4, 127.3, 128.4,
129.9, 131.0, 134.2, 142.4, 146.9 ppm; HRMS (ASAP): m/z calcd for C18H22(79Br)O
[M + H]+ 333.0849, found 333.0847; IR (ATR): 2972, 2920, 1592, 1548, 1476, 1374,
1067, 782, 687 cm-1.
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1

H NMR (500 MHz, CDCl3): 𝛿 = 1.14 (t, 3H, J = 7.5 Hz, CH3),

1.68 (s, 3H, CH3), 1.74 (s, 3H, CH3), 1.80 (s, 3H, CH3), 2.23 (qt,
2H, J = 7.5, 2.0 Hz, CH2), 4.46 (t, 2H, J = 2.0 Hz, CH2), 6.20 (s,
1H, CH), 7.15 (t, 1H, J = 8.0 Hz, CHAr), 7.24-7.31 (m, overlapped with CHCl3, 1H, CHAr),
7.42 (d, 1H, J = 7.5 Hz, CHAr), 7.65 (s, 1H, CHAr) ppm; 13C NMR (125 MHz, CDCl3):
𝛿 = 12.5, 13.6, 19.7, 20.3, 22.1, 60.2, 74.6, 89.6, 120.1, 122.2, 126.7, 127.1, 128.9, 129.4,
130.6, 131.3, 138.8, 143.9 ppm; HRMS (ASAP): m/z calcd for C18H22(79Br)O [M + H]+
333.0849, found 333.0870; IR (ATR): 2976, 2920, 2855, 1630, 1588, 1473, 1373, 1168,
1103, 1031, 888, 786, 694 cm-1.
2-(4-Bromophenyl)-4-ethyl-5-methyl-3-(3-methylbut-2-en-2-yl)furan 343j, 3-(4-bromo
phenyl)-4-ethyl-5-methyl-2-(3-methylbut-2-en-2-yl)furan 343j’ and (E)-1-bromo-4-(3,4dimethyl-1-(pent-2-yn-1-yloxy)penta-1,3-dien-2-yl)benzene 344j
Following general procedure D, cyclopropenyl propargyl ether 342j (84.6 mg,
0.254 mmol) was dissolved in DCE (2.5 mL) and Ph3PAuCl (6.7 mg, 13.5 µmol) and
AgBF4 (2.5 mg, 12.8 µmol) were added with stirring. The reaction was heated for 2 h and
flash column chromatography gave the title compound 343j as an oil (4.1 mg, 12.3 μmol)
in 5% yield with minor impurities that could not be separated. In addition to the desired
furan 343j, rearranged furan 343j’ (1.7 mg, 5.10 µmol) was obtained in 2% yield and enol
ether 344j (4.9 mg, 14.7 µmol) was obtained in 6% yield. Other complex side products
also occurred which could not be isolated or characterised.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.03 (t, 3H, J = 7.5 Hz, CH3),

1.52 (s, 3H, CH3), 1.83 (s, 3H, CH3), 1.85 (s, 3H, CH3), 2.21 (q,
2H, J = 7.5 Hz, CH2), 2.28 (s, 3H, CH3), 7.40 (d, 2H, J = 8.5 Hz,
2CHAr), 7.47 (d, 2H, J = 8.5 Hz, 2CHAr) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 11.9,
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14.9, 16.9, 19.2, 19.9, 21.9, 119.3, 121.6, 123.0, 125.0, 126.7, 130.9, 131.2, 131.4, 143.0,
146.6 ppm; HRMS (ASAP): m/z calcd for C18H22(79Br)O [M + H]+ 333.0849, found
333.0841; IR (ATR): 2967, 2917, 2856, 1592, 1550, 1484, 1394, 1372, 1093, 1071,
1009, 825 cm-1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 0.96 (t, 3H, J = 7.5 Hz, CH3), 1.36

(s, 3H, CH3), 1.68 (s, 3H, CH3), 1.84 (s, 3H, CH3), 2.26 (s, 3H, CH3),
2.37 (q, 2H, J = 7.5 Hz, CH2), 7.07 (d, 2H, J = 8.0 Hz, 2CHAr), 7.44 (d,
2H, J = 8.0 Hz, 2CHAr) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 11.7,
15.0, 16.9, 18.2, 20.5, 22.5, 119.4, 120.0, 120.2, 121.6, 130.5, 131.4, 133.7, 134.2, 145.6,
150.0 ppm; HRMS (ASAP): m/z calcd for C18H22(79Br)O [M + H]+ 333.0849, found
333.0838; IR (ATR): 2924, 2857, 1489, 1458, 1374, 1072, 1011, 826 cm-1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.13 (t, 3H, J = 7.5 Hz, CH3),

1.68 (s, 3H, CH3), 1.73 (s, 3H, CH3), 1.79 (s, 3H, CH3), 2.23 (q,
2H, J = 7.5 Hz, CH2), 4.45 (s, 2H, CH2), 6.18 (s, 1H, CH), 7.367.42 (m, 4H, 4CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 12.4,
13.6, 19.7, 20.2, 22.0, 60.2, 74.6, 89.5, 119.6, 120.2, 126.7, 130.2, 130.4, 131.0, 135.4,
143.4 ppm; HRMS (ASAP): m/z calcd for C18H22(79Br)O [M + H]+ 333.0849, found
333.0865; IR (ATR): 2974, 2920, 1677, 1584, 1486, 1396, 1070, 1009, 823 cm-1.
3-Ethyl-5-(2-fluorophenyl)-2-methyl-4-(3-methylbut-2-en-2-yl)furan 343k, 3-ethyl-4(2-fluorophenyl)-2-methyl-5-(3-methylbut-2-en-2-yl)furan 343k’, (Z)-1-(3,4-dimethyl1-(pent-2-yn-1-yloxy)penta-1,3-dien-2-yl)-2-fluorobenzene (Z)-344k and (E)-1-(3,4dimethyl-1-(pent-2-yn-1-yloxy)penta-1,3-dien-2-yl)-2-fluorobenzene (E)-344k
Following general procedure D, cyclopropenyl propargyl ether 342k (71.1 mg,
0.261 mmol) was dissolved in DCE (2.6 mL) and Ph3PAuCl (6.5 mg, 13.1 µmol) and
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AgBF4 (2.5 mg, 12.8 µmol) were added with stirring. The reaction was heated for 1.5 h
and flash column chromatography gave the desired furan 343k and the rearranged furan
343k’ as an oil (15.4 mg, 56.5 µmol) in 22% combined yield. From the 1H NMR, the ratio
of 343:343’ was calculated to be 6.1:1 and the individual yields were calculated to be
19% and 3%, respectively. Further purification resulted in the isolation of the desired
furan 343k (2.3 mg, 8.44 μmol) which was used for characterisation. In addition to the
desired furan 343k, enol ethers (Z)-344k and (E)-344k were obtained as an inseparable
yellow oil (17.7 mg, 65.0 µmol) in 25% combined yield. From the 1H NMR, the Z:E ratio
was 78:22.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.04 (t, 3H,

J = 7.5 Hz, CH3), 1.45 (s, 3H, CH3), 1.75 (s, 3H, CH3),
1.83 (s, 3H, CH3), 2.22-2.30 (m, 2H, CH2), 2.30 (s, 3H,
CH3), 7.00-7.10 (m, 2H, 2CHAr), 7.14-7.20 (m, 1H,
CHAr), 7.43 (td, 1H, J = 7.5, 2.0 Hz, CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 11.9,
14.8, 17.2, 19.5, 19.9, 21.9, 116.0 (d, J = 22.3 Hz), 120.3 (d, J = 13.4 Hz), 121.2, 122.3,
123.7 (d, J = 3.5 Hz), 128.0 (d, J = 7.9 Hz), 128.1, 128.5 (d, J = 3.6 Hz), 129.9, 140.6,
147.1, 158.9 (d, J = 249.8 Hz) ppm; HRMS (ASAP): m/z calcd for C18H22FO [M + H]+
273.1649, found 273.1653; IR (ATR): 2966, 2920, 2857, 1581, 1493, 1455, 1372, 1221,
1110, 958, 756 cm-1.
1

H NMR (500 MHz, CDCl3) (mixture of

isomers): 𝛿 = 1.14 (t, 3H, J = 7.5 Hz, CH3,
for each isomer), 1.62 (s, 3H, CH3, for each
isomer), 1.75 (s, 3H, CH3, for each isomer),
1.80 (s, 3H, CH3, minor isomer), 1.88 (s, 3H, CH3, major isomer), 2.22 (q, 2H,
J = 7.5 Hz, CH2, for each isomer), 4.39 (s, 2H, CH2, major isomer), 4.47 (s, 2H, CH2,
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minor isomer), 6.23 (s, 1H, CH, major isomer), 6.69 (s, 1H, CH, minor isomer), 6.987.22 (m, 4H, 4CHAr, for each isomer) ppm;

13

C NMR (100 MHz, CDCl3) (mixture of

isomers, minor isomer indicated by asterisk): 𝛿 = 12.4, 13.6, 18.3*, 18.8, 20.0*, 20.6,
22.0*, 22.3, 59.7, 60.1*, 74.6*, 74.7, 89.3, 89.4*, 115.4 (d, J = 22.7 Hz), 115.8 (d,
J = 23.4 Hz)*, 116.3, 117.9 (d, J = 2.4 Hz)*, 123.4 (d, J = 3.5 Hz), 123.9 (d, J = 3.3 Hz)*,
124.1*, 125.2 (d, J = 15.8 Hz), 126.4 (d, J = 12.7 Hz)*, 126.79 (d, J = 8.3 Hz)*, 126.80,
128.0 (d, J = 8.1 Hz), 129.0, 129.7*, 129.8 (d, J = 4.1 Hz)*, 131.1 (d, J = 4.4 Hz), 143.7,
144.8 (d, J = 10.2 Hz)*, 160.2 (d, J = 246.8 Hz), 160.4 (d, J = 245.5 Hz)* ppm; HRMS
(ASAP): m/z calcd for C18H22FO [M + H]+ 273.1649, found 273.1646; IR (ATR): 2979,
2913, 2860, 1642, 1489, 1449, 1263, 1169, 1116, 1090, 1034, 754 cm -1.
3-Ethyl-5-(4-fluorophenyl)-2-methyl-4-(3-methylbut-2-en-2-yl)furan 343l, 2-ethyl-5-(4fluorophenyl)-3-methyl-4-(3-methylbut-2-en-2-yl)furan 343l’ and (E)-1-(3,4-dimethyl1-(pent-2-yn-1-yloxy)penta-1,3-dien-2-yl)-4-fluorobenzene 344l
Following general procedure D, cyclopropenyl propargyl ether 342l (81.4 mg,
0.299 mmol) was dissolved in DCE (3 mL) and Ph3PAuCl (7.6 mg, 15.4 µmol) and
AgBF4 (2.9 mg, 14.9 µmol) were added with stirring. The reaction was heated for 1 h and
flash column chromatography gave the title compound 343l as a pale yellow oil (4.2 mg,
15.4 µmol) in 5% yield. In addition to the desired furan 343l, rearranged furan 343l’
(9.2 mg, 33.8 µmol) was obtained in 11% yield and enol ether 344l (17.8 mg, 65.4 µmol)
was obtained in 22% yield.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.03 (t, 3H, J = 7.5 Hz, CH3), 1.53

(s, overlapped with H2O, 3H, CH3), 1.84 (s, 3H, CH3), 1.85 (s, 3H,
CH3), 2.21 (q, 2H, J = 7.5 Hz, CH2), 2.28 (s, 3H, CH3), 6.98 (appar.
t, 2H, J = 8.5 Hz, 2CHAr), 7.56 (dd, 2H, J = 8.5, 5.5 Hz, 2CHAr) ppm;

13

C NMR
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(125 MHz, CDCl3): 𝛿 = 11.8, 14.9, 17.0, 19.2, 19.9, 21.9, 115.2 (d, J = 21.3 Hz), 121.7,
122.8, 125.1 (d, J = 7.9 Hz), 125.5, 128.7, 130.8, 143.2, 146.0, 161.1 (d, J = 244.0 Hz)
ppm; HRMS (ASAP): m/z calcd for C18H22FO [M + H]+ 273.1649, found 273.1657; IR
(ATR): 2978, 2931, 1604, 1507, 1232, 1158, 855, 839 cm-1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 0.96 (t, 3H, J = 7.5 Hz, CH3), 1.36

(s, 3H, CH3), 1.67 (s, 3H, CH3), 1.83 (s, 3H, CH3), 2.26 (s, 3H, CH3),
2.36 (q, 2H, J = 7.5 Hz, CH2), 7.01 (appar. t, 2H, J = 8.5 Hz, 2CHAr),
7.12-7.19 (m, 2H, 2CHAr) ppm;

13

C NMR (125 MHz, CDCl3):

𝛿 = 11.7, 15.0, 16.9, 18.2, 20.4, 22.4, 115.0 (d, J = 21.0 Hz), 119.5, 120.3, 121.8, 130.3
(d, J = 7.6 Hz), 131.1 (d, J = 3.4 Hz), 133.4, 145.4, 149.8, 161.4 (d, J = 243.4 Hz) ppm;
HRMS (ASAP): m/z calcd for C18H22FO [M + H]+ 273.1649, found 273.1649; IR
(ATR): 2966, 2922, 2871, 1568, 1506, 1448, 1373, 1221, 1156, 1097, 955, 832 cm-1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.13 (t, 3H, J = 7.5 Hz, CH3),

1.68 (s, 3H, CH3), 1.75 (s, 3H, CH3), 1.79 (s, 3H, CH3), 2.23 (q,
2H, J = 7.0 Hz, CH2), 4.44 (s, 2H, CH2), 6.14 (s, 1H, CH), 6.97
(appar. t, 2H, J = 8.5 Hz, 2CHAr), 7.47 (dd, 2H, J = 8.5, 5.5 Hz,
2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 12.4, 13.6, 19.6, 20.2, 22.0, 60.0, 74.7,
89.3, 114.6 (d, J = 20.9 Hz), 120.4, 127.1, 130.10, 130.11 (d, J = 7.6 Hz), 132.5, 142.6,
161.1 (d, J = 243.5 Hz) ppm; HRMS (ASAP): m/z calcd for C18H22FO [M + H]+
273.1649, found 273.1668; IR (ATR): 2981, 2912, 2860, 1633, 1506, 1448, 1373, 1223,
1168, 1159, 1096, 838 cm-1.
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3-Ethyl-2-methyl-4-(3-methylbut-2-en-2-yl)-5-(o-tolyl)furan 343m, 3-ethyl-2-methyl-5(3-methylbut-2-en-2-yl)-4-(o-tolyl)furan 343m’, (Z)-1-(3,4-dimethyl-1-(pent-2-yn-1yloxy)penta-1,3-dien-2-yl)-2-methylbenzene (Z)-344m and (E)-1-(3,4-dimethyl-1-(pent2-yn-1-yloxy)penta-1,3-dien-2-yl)-2-methylbenzene (E)-344m
Following general procedure D, cyclopropenyl propargyl ether 342m (93.9 mg,
0.350 mmol) was dissolved in DCE (3.4 mL) and Ph3PAuCl (8.8 mg, 17.8 µmol) and
AgBF4 (3.4 mg, 17.5 µmol) were added with stirring. The reaction was heated for 40 mins
and flash column chromatography gave the desired furan 343m and the rearranged furan
343m’ as an inseparable colourless oil (21.0 mg, 78.2 µmol) in 22% combined yield.
From the 1H NMR, the ratio of 343:343’ was 2.1:1 and the individual yields were
calculated to be 15% and 7%, respectively. In addition to furans 343m and 343m’, enol
ethers (Z)-344m and (E)-344m were obtained as an inseparable yellow oil (22.2 mg,
82.7 µmol) in 24% combined yield. From the 1H NMR, the Z:E ratio was 75:25.
1

H NMR (500 MHz, CDCl3) (mixture of isomers):

𝛿 = 0.83 (t, 3H, J = 7.5 Hz, CH3, minor isomer), 1.05
(t, 3H, J = 7.5 Hz, CH3, major isomer), 1.45-1.49 (m,
3H, CH3, for each isomer), 1.65 (s, 3H, CH3, minor
isomer), 1.70 (s, 3H, CH3, major isomer), 1.72 (s, 3H, CH3, minor isomer), 1.77 (s, 3H,
CH3, major isomer), 2.11 (s, 3H, CH3, minor isomer), 2.12-2.19 (m, 2H, CH2, minor
isomer), 2.21-2.32 (m, 2H, CH2, major isomer), 2.27 (s, 3H, CH3, minor isomer), 2.35 (s,
3H, CH3, major isomer), 7.07-7.21 (m, 3H, 3CHAr, major isomer, 4H, 4CHAr, minor
isomer), 7.24 (d, 1H, J = 7.0 Hz, CHAr, major isomer) ppm; 13C NMR (125 MHz, CDCl3)
(mixture of isomers, minor isomer indicated by asterisk): 𝛿 = 11.8*, 11.9, 14.8*, 14.9,
17.0*, 17.3, 17.8*, 19.86, 19.93, 20.6*, 20.8, 22.1, 22.7*, 120.2*, 121.4, 121.5*, 121.7,
122.1*, 125.2, 125.3*, 126.4, 126.7*, 127.2, 128.8, 129.7*, 129.9, 130.5, 130.7*, 131.8,
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132.7*, 134.4*, 136.5, 137.1*, 144.7*, 145.8, 146.0, 149.5* ppm (one carbon for minor
isomer missing); HRMS (ASAP): m/z calcd for C19H25O [M + H]+ 269.1900, found
269.1894; IR (ATR): 2964, 2920, 2859, 1455, 1371, 1131, 1044, 761, 736 cm-1.
1

H NMR (500 MHz, CDCl3) (mixture of

isomers): 𝛿 = 1.13 (t, 3H, J = 7.5 Hz, CH3,
for each isomer), 1.52 (s, 3H, CH3, major
isomer), 1.59 (s, 3H, CH3, minor isomer), 1.73 (s, 3H, CH3, minor isomer), 1.75 (s, 3H,
CH3, major isomer), 1.76 (s, 3H, CH3, minor isomer), 1.96 (s, 3H, CH3, major isomer),
2.22 (q, 2H, J = 7.5 Hz, CH2, for each isomer), 2.27 (s, 3H, CH3, for each isomer), 4.34
(s, 2H, CH2, major isomer), 4.43 (s, 2H, CH2, minor isomer), 6.11 (s, 1H, CH, minor
isomer), 6.15 (s, 1H, CH, major isomer), 7.05-7.19 (m, 4H, 4CHAr, for each isomer) ppm;
13

C NMR (100 MHz, CDCl3) (mixture of isomers, minor isomer indicated by asterisk):

𝛿 = 12.4, 13.7, 17.9*, 18.1, 20.0, 20.2*, 20.4*, 20.7, 22.5, 22.8*, 59.5, 59.7*, 74.8*, 75.0,
89.0, 89.1*, 120.9, 122.9*, 124.3*, 125.1, 125.5*, 126.4*, 126.6, 127.5, 127.9, 129.4*,
129.5, 129.8, 130.28*, 130.31*, 136.9*, 137.1, 137.2, 139.4*, 142.51*, 142.54 ppm (two
carbons for minor isomer missing); HRMS (ASAP): m/z calcd for C19H25O [M + H]+
269.1900, found 269.1916; IR (ATR): 2975, 2919, 2857, 1644, 1490, 1455, 1269, 1166,
1132, 1121, 1091, 1033, 753, 729 cm-1.
3-Ethyl-2-methyl-4-(3-methylbut-2-en-2-yl)-5-(p-tolyl)furan 343n
Following general procedure D, cyclopropenyl propargyl ether
342n (30.0 mg, 0.112 mmol) was dissolved in DCE (1.1 mL) and
Ph3PAuCl (2.7 mg, 5.46 µmol) and AgBF4 (1.1 mg, 5.65 µmol)
were added with stirring. The reaction was heated for 3.5 h and flash column
chromatography gave the title compound 343n in trace amounts (> 0.5 mg). No further
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characterisation was performed due to the small amount of product obtained. 1H NMR
(500 MHz, CDCl3): 𝛿 = 1.03 (t, 3H, J = 7.5 Hz, CH3), 1.83 (s, 3H, CH3), 1.86 (s, 3H,
CH3), 2.21 (q, 2H, J = 7.5 Hz, CH2), 2.28 (s, 3H, CH3), 2.32 (s, 3H, CH3), 7.10 (d, 2H,
J = 8.0 Hz, 2CHAr), 7.50 (d, 2H, J = 8.0 Hz, 2CHAr) ppm.
3-Ethyl-2-methyl-4-(3-methylbut-2-en-2-yl)-5-(2-nitrophenyl)furan 343o
Following general procedure D, cyclopropenyl propargyl ether 342o
(84.5 mg, 0.282 mmol) was dissolved in DCE (2.8 mL) and Ph3PAuCl
(7.3 mg, 14.8 µmol) and AgBF4 (2.7 mg, 13.9 µmol) were added with
stirring. The reaction was heated for 2 h and flash column chromatography gave the title
compound 343o as a yellow oil (19.4 mg, 64.8 µmol) in 23% yield. Analysis of the 1H
NMR of the crude reaction indicated a side product was formed but this decomposed on
the column and could not be isolated. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.04 (t, 3H,
J = 7.5 Hz, CH3), 1.43-1.45 (m, 3H, CH3), 1.73 (s, 3H, CH3), 1.82-1.84 (m, 3H, CH3),
2.23 (s, 3H, CH3), 2.24-2.29 (m, 2H, CH2), 7.30 (ddd, 1H, J = 8.0, 5.5, 3.5 Hz, CHAr),
7.46 (d, 1H, J = 1.0 Hz, CHAr), 7.46-7.48 (m, 1H, CHAr), 7.66-7.69 (m, 1H, CHAr) ppm;
13

C NMR (125 MHz, CDCl3): 𝛿 = 11.8, 14.7, 17.2, 19.2, 19.9, 21.9, 120.1, 122.6, 124.1,

125.8, 127.0, 128.7, 129.0, 131.5, 131.6, 140.5, 147.6, 148.4 ppm; HRMS (ESI): m/z
calcd for C18H21NNaO3 [M + Na]+ 322.1414, found 322.1430; IR (ATR): 2972, 2931,
1468, 1433, 1379, 1261, 1092, 1027, 748 cm-1.
2,3-Dimethyl-4-(3-methylbut-2-en-2-yl)-5-undecylfuran 343p and 4-ethylidene-3-(3methylbut-3-en-2-ylidene)-2-undecyltetrahydrofuran 371
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Following general procedure D, cyclopropenyl propargyl ether 342p (109.0 mg,
0.342 mmol) was dissolved in DCE (3.4 mL) and Ph3PAuCl (9.0 mg, 18.2 µmol) and
AgBF4 (3.3 mg, 17.0 µmol) were added with stirring. The reaction was heated for 2 h and
flash column chromatography gave the title compound 343p as a colourless oil (50.8 mg,
0.159 mmol) in 47% yield and tetrahydrofuran 371 (41.3 mg, 0.°mmol) was obtained in
38% yield.
1

H NMR (500 MHz, CDCl3): 𝛿 = 0.88 (t, 3H, J = 7.0 Hz, CH3), 1.20-

1.33 (m, 16H, 8CH2), 1.49-1.58 (m, 5H, CH2, CH3), 1.73 (s, 3H, CH3),
1.77 (s, 6H, 2CH3), 2.16 (s, 3H, CH3), 2.35 (t, 2H, J = 7.5 Hz, CH2)
ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 8.7, 11.5, 14.1, 19.88, 19.91, 21.9, 22.7, 26.7,
28.3, 29.35, 29.38, 29.41, 29.58, 29.64, 29.67, 31.9, 114.3, 121.2, 124.3, 129.4, 144.2,
147.5 ppm; HRMS (ASAP): m/z calcd for C22H39O [M + H]+ 319.2995, found 319.2986;
IR (ATR): 2921, 2854, 1590, 1455, 1370, 1132, 1039 cm-1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 0.88 (t, 3H, J = 7.0 Hz, CH3), 1.22-

1.53 (m, 20H, 10CH2), 1.60 (d, 3H, J = 7.0 Hz, CH3), 1.78 (s, 3H,
CH3), 1.84 (s, 3H, CH3), 4.47 (s, 2H, CH2), 4.66 (d, 1H, J = 9.0 Hz,
CH), 4.77 (s, 1H, CHaHb), 4.94 (s, 1H, CHaHb), 5.90 (appar. q, 1H, J = 7.0 Hz, CH) ppm;
13

C NMR (125 MHz, CDCl3): 𝛿 = 14.1, 15.3, 20.4, 22.1, 22.7, 25.8, 29.3, 29.60, 29.62,

29.63, 29.64, 29.7, 31.9, 33.7, 69.3, 82.2, 112.7, 117.4, 130.3, 132.8, 136.0, 147.7 ppm;
HRMS (ASAP): m/z calcd for C22H39O [M + H]+ 319.2995, found 319.2994; IR (ATR):
3076, 2955, 2922, 2853, 1466, 1455, 1369, 1083, 1066, 892, 720 cm -1.
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2-(2-Bromophenyl)-5-methyl-3-(3-methylbut-2-en-2-yl)-4-phenylfuran

343r,

1-(2-

bromophenyl)-5,5,6-trimethyl-4-phenyl-3,5-dihydro-1H-cyclopenta[c]furan 382 and 1(2-bromo phenyl)-6,7-dimethyl-4-phenyl-1,3,4,5-tetrahydroisobenzofuran 383

Following general procedure D, cyclopropenyl propargyl ether 342r (30.8 mg,
80.8 µmol) was dissolved in DCE (0.8 mL) and Ph3PAuCl (2.3 mg, 4.65 µmol) and
AgBF4 (0.8 mg, 4.11 µmol) were added with stirring. The reaction was heated at 50 °C
for 19 h before additional portions of Ph3PAuCl (2.4 mg, 4.85 µmol) and AgBF4
(0.8 mg, 4.11 µmol) were added. The reaction was stopped after 23 h and flash column
chromatography gave the title compound 343r as a colourless oil (3.8 mg, 9.97 µmol) in
12% yield, 382 as a yellow oil (10.9 mg, 28.6 µmol) in 35% yield and 383 as a yellow oil
(7.8 mg, 20.5 µmol) in 25% yield.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.37 (s, 3H, CH3), 1.60 (s, 3H, CH3),

1.61 (s, 3H, CH3), 2.42 (s, 3H, CH3), 7.16 (ddd, 1H, J = 9.0, 6.0,
3.0 Hz, CHAr), 7.23-7.31 (m, overlapped with CHCl3, 5H, 5CHAr), 7.35
(t, 2H, J = 7.5 Hz, 2CHAr), 7.64 (d, 1H, J = 8.0 Hz, CHAr) ppm; 13C NMR (100 MHz,
CDCl3): 𝛿 = 12.7, 19.6, 20.0, 22.1, 120.1, 122.2, 123.0, 126.2, 126.7, 126.9, 128.1, 128.7,
129.1, 131.1, 131.6, 133.2, 133.4, 134.1, 145.4, 147.9 ppm; HRMS (ASAP): m/z calcd
for C22H22(79Br)O [M + H]+ 381.0849, found 381.0872; IR (ATR): 2984, 2920, 2855,
1604, 1568, 1492, 1464, 1435, 1088, 1026, 754, 698 cm-1.
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1

H NMR (500 MHz, CDCl3): 𝛿 = 1.33 (s, 3H, CH3), 1.34 (s, 3H, CH3),

1.60 (s, 3H, CH3), 4.92 (d, 1H, J = 14.0 Hz, CHaHb), 5.00 (d, 1H,
J = 14.0 Hz, CHaHb), 6.06 (s, 1H, CH), 7.14-7.22 (m, 2H, 2CHAr),
7.26-7.33 (m, 4H, 4CHAr), 7.38 (t, 2H, J = 7.5 Hz, 2CHAr), 7.59 (d,
1H, J = 8.0 Hz, CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 10.1, 22.5, 23.0, 62.5,
67.5, 77.0, 123.8, 125.7, 126.4, 127.7, 128.6, 129.4, 129.5, 133.0, 135.3, 138.9, 139.5,
142.6, 142.9, 144.8 ppm; HRMS (ASAP): m/z calcd for C22H22(79Br)O [M + H]+
381.0849, found 381.0859; IR (ATR): 3056, 2976, 2924, 1591, 1498, 1468, 1442, 1024,
733, 701 cm-1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.44 (s, 3H, CH3), 1.68 (s, 3H,

CH3), 2.43 (dd, 1H, J = 17.0, 6.0 Hz, CHaHb), 2.90 (dd, 1H, J = 17.0,
10.5 Hz, CHaHb), 3.66 (dd, 1H, J = 10.0, 6.0 Hz, CH), 4.53 (d, 1H,
J = 13.0 Hz, CHaHb), 4.68 (dd, 1H, J = 13.5, 5.5 Hz, CHaHb), 6.37 (t,
1H, J = 4.5 Hz, CH), 7.15 (t, 1H, J = 8.0 Hz, CHAr), 7.23 (t, 4H, J = 7.5 Hz, 4CHAr), 7.30
(t, 3H, J = 7.5 Hz, 3CHAr), 7.58 (d, 1H, J = 8.0 Hz, CHAr) ppm; 13C NMR (125 MHz,
CDCl3): 𝛿 = 14.1, 19.0, 38.2, 40.1, 75.4, 86.3, 120.5, 124.5, 126.7, 127.3, 127.8, 128.0,
128.6, 129.3, 129.6, 133.1, 133.5, 135.8, 140.1, 143.1 ppm; HRMS (ASAP): m/z calcd
for C22H22(79Br)O [M + H]+ 381.0849, found 381.0854; IR (ATR): 2925, 2856, 1493,
1466, 1444, 1023, 736, 699 cm-1.
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4.3.4. Reaction of Cyclopropenyl Propargyl Ethers 342 with Ag(I)-Catalysts
1-(2-Bromophenyl)-2-(3-methylbut-2-en-2-yl)penta-3,4-dien-1-ol 345 and (Z)-1-bromo2-(3,4-dimethyl-1-(prop-2-yn-1-yloxy)penta-1,3-dien-2-yl)benzene 344a

Cyclopropenyl propargyl ether 342a (44.6 mg, 0.146 mmol) was dissolved in
DCE (1.5 mL) under a nitrogen atmosphere and to this was added AgBF 4 (1.4 mg,
7.19 µmol). The reaction was left stirring at reflux and after 1.5 h a second portion of
AgBF4 (1.4 mg, 7.19 µmol) was added. The reaction was left at reflux overnight before a
third portion of AgBF4 (2.8 mg, 14.4 µmol) was added. After a total of 28 h, the mixture
was concentrated under reduced pressure, redissolved in dry EtOH (1.4 mL) and cooled
to 0 °C. To this was added NaBH4 (10.0 mg, 0.264 mmol) and the reaction was warmed
to rt and left stirring overnight. Once complete, the reaction was quenched with 2 M HCl
(2 mL) and the mixture was allowed to stir for several minutes. Water was added and the
aqueous phase was extracted (3x) with DCM. The combined organics were dried over
Na2SO4 before the crude residue was filtered, concentrated under reduced pressure and
purified by flash column chromatography (4:96 EtOAc:hex). Allenyl alcohol 345 was
obtained as a yellow oil (8.5 mg, 27.7 µmol) in 19% yield in addition to enol ether 344a
which was obtained as pale yellow oil (15.5 mg, 50.8 µmol) in 35% yield.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.69 (s, 3H, CH3), 1.74 (s, 3H,

CH3), 1.77 (s, 3H, CH3), 2.15 (d, 1H, J = 2.0 Hz, OH), 3.70 (tt, 1H,
J = 8.5, 2.5 Hz, CH), 4.38 (ddd, 1H, J = 10.5, 6.5, 2.5 Hz, CHaHb),
4.53 (ddd, 1H, J = 10.5, 6.5, 2.5 Hz, CHaHb), 5.08 (q, 1H, J = 7.0 Hz, CH), 5.19 (d, 1H,
J = 8.5 Hz, CH), 7.12 (td, 1H, J = 7.5, 2.0 Hz, CHAr), 7.32 (t, 1H, J = 7.5 Hz, CHAr), 7.49280

7.53 (m, 2H, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 14.1, 20.4, 21.3, 50.2, 73.6,
74.9, 88.3, 123.8, 125.4, 127.5, 128.87, 128.88, 130.9, 132.4, 141.4, 208.8 ppm: HRMS
(ASAP): m/z calcd for C16H20(79Br)O [M]+ 306.0614, found 306.0609; IR (ATR): 3429
(br), 2918, 2859, 1954, 1468, 1435, 1020, 750 cm-1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 1.63 (s, 3H, CH3), 1.71 (s,

3H, CH3), 1.76 (s, 3H, CH3), 2.49 (t, 1H, J = 2.5 Hz, CH), 4.49
(d, 2H, J = 2.5 Hz, CH2), 6.27 (s, 1H, CH), 7.03-7.08 (m, 1H,
CHAr), 7.17-7.26 (m, 2H, 2CHAr), 7.54 (dd, 1H, J = 8.0 Hz, CHAr) ppm;
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C NMR

(125 MHz, CDCl3): 𝛿 = 18.0, 20.4, 23.0, 59.2, 75.4, 78.8, 122.7, 123.6, 123.8, 127.0,
127.9, 130.7, 131.7, 133.3, 140.1, 143.7 ppm; HRMS (ASAP): m/z calcd for
C16H18(79Br)O [M + H]+ 305.0536, found 305.0550; IR (ATR): 3292, 2924, 2862, 1465,
1431, 1107, 1024, 746 cm-1.

4.4.

Gold(I)-Catalysed Synthesis of Substituted Heterocycles from
Cyclopropenyl Sulfonamides

4.4.1. Synthesis of Starting Materials
4.4.1.1.

Synthesis of Alkynes

tert-Butyldimethyl(non-2-yn-1-yloxy)silane

Following a literature procedure,[186] 1-octyne (3.2 mL, 21.7 mmol) was dissolved
in dry THF (17.5 mL) under a nitrogen atomsphere and the reaction was cooled to
–78 °C. A solution of n-BuLi (2.5 M in hexanes, 11 mL, 27.5 mmol) was added dropwise
to the reaction and the mixture was allowed to warm to rt and stir for 1 h. The reaction
was again cooled to –78 °C and paraformaldehyde (781.4 mg, 26.0 mmol) was added
before the reaction was stirred for 16 h at rt. Following completion of the reaction
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according to TLC analysis, saturated NH4Cl was added and the aqueous layer was
extracted (3x) with Et2O. The combined organic layer was dried over Na2SO4 and the
crude residue of the alkynol was concentrated under reduced pressure to be used directly
in the next step without further purification. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.89 (t,
3H, J = 7.0 Hz, CH3), 1.24-1.42 (m, 6H, 3CH2), 1.50 (p, 2H, J = 7.2 Hz, CH2), 2.20 (tt,
2H, J = 7.2, 2.3 Hz, CH2), 4.21-4.24 (m, 2H, CH2) ppm.
In accordance with the literature procedure,[187] the crude alkynol was dissolved
in dry DCM (44 mL) under nitrogen at rt. This was treated with Et3N (3 mL, 21.5 mmol),
imidazole (148.4 mg, 2.18 mmol) and TBSCl (3.5399 g, 23.5 mmol) and was left to stir
the 3.5 h. Once complete, H2O was added and the two phases were separated. The organic
layer was washed (3x) with H2O and dried over Na2SO4. The crude residue was then
filtered, concentrated under reduced pressure and purified by flash column
chromatography (100% hex) to give the title compound tert-butyldimethyl(non-2-yn-1yloxy)silane as a colourless oil (3.7690 g, 14.8 mmol) in 68% yield over two steps. 1H
NMR (400 MHz, CDCl3): 𝛿 = 0.12 (s, 6H, Si(CH3)2), 0.87-0.92 (m, 12H, 4CH3), 1.241.42 (m, 6H, 3CH2), 1.45-1.54 (m, 2H, CH2), 2.19 (tt, 2H, J = 7.2, 2.2 Hz, CH2), 4.30 (t,
2H, J = 2.2 Hz, CH2) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = -5.1, 14.0, 18.3, 18.8, 22.5,
25.8, 28.5, 28.6, 31.3, 52.0, 78.6, 85.5 ppm; MS: m/z signal could not be detected by ESI
or EI methods; IR (ATR): 2958, 2929, 2857, 1471, 1256, 1080, 834, 775 cm-1.
tert-Butyldimethyl(pent-4-yn-1-yloxy)silane

In accordance with the literature,[188] imidazole (1.7028 g, 25.0 mmol), pent-4-yn1-ol (1.50 mL, 16.1 mmol) and DCM (16 mL) were added to a round bottom flask which
was cooled to 0 °C, under nitrogen. To this was added TBSCl (2.7893 g, 18.5 mmol) and
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the reaction was warmed to rt and stirred for 1 h. The mixture was filtered through a plug
of silica gel (EtOAc used to wash through) and the filtrate was concentrated under
reduced pressure. Flash column chromatography (10:90 EtOAc: hex) gave the title
compound tert-butyldimethyl(pent-4-yn-1-yloxy)silane as a colourless oil (3.0744 g,
15.5 mmol) in 96% yield. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.06 (s, 6H, Si(CH3)2), 0.90
(s, 9H, C(CH3)3), 1.72 (tt, 2H, J = 7.2, 6.1 Hz, CH2), 1.92 (t, 1H, J = 2.8 Hz, CH), 2.27
(td, 2H, J = 7.2, 2.8 Hz, CH2), 3.70 (t, 2H, J = 6.0 Hz, CH2) ppm; 13C NMR (100 MHz,
CDCl3): 𝛿 = -5.4, 14.8, 18.3, 25.9, 31.5, 61.4, 68.2, 84.2 ppm.
NMR data is in agreement with published data.[188]
tert-Butyldimethyl(5-methylhex-1-yn-1-yl)silane

A solution of 5-methylhex-1-yne (0.69 mL, 5.22 mmol) in THF (1.8 mL) was
cooled to –78 °C and to this was added a solution of n-BuLi (2.1 M in hexanes, 3.0 mL,
6.30 mmol), dropwise. The reaction mixture was stirred for 30 min at –78 °C before a
solution TBSCl (3 M solution in THF, 2.9 mL, 8.70 mmol) was added. The reaction was
allowed to gradually warm to rt and was left stirring overnight. Once complete, H 2O and
pentane were added and the two phases were separated. The organic layer was dried over
Na2SO4, filtered and concentrated under reduced pressure. The crude residue was purified
by Kugelrohr distillation (120 °C at 10 mbar) to give the title compound tertbutyldimethyl(5-methylhex-1-yn-1-yl)silane as a colourless oil (521.8 mg, 2.48 mmol) in
48% yield. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.07 (s, 6H, Si(CH3)2), 0.89 (d, 6H,
J = 6.6 Hz, 2CH3), 0.92 (s, 9H, C(CH3)3), 1.42 (q, 2H, J = 7.3 Hz, CH2), 1.68 (nonet, 1H,
J = 6.7 Hz, CH), 2.23 (t, 2H, J = 7.4 Hz, CH2) ppm;
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C NMR (100 MHz, CDCl3):

𝛿 = -4.4, 16.5, 17.9, 22.2, 26.1, 27.3, 37.7, 82.2, 108.3 ppm; MS: m/z signal could not be
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detected by ESI or EI methods; IR (ATR): 2955, 2929, 2857, 2174, 1472, 1463, 1249,
836, 824, 808, 773 cm-1.
4.4.1.2.

Preparation of Cyclopropenyl Carboxylates 435

Ethyl 2,3-dibutylcycloprop-2-ene-1-carboxylate 435a
Following general procedure E, 5-decyne (5.50 mL, 30.5 mmol)
Rh2(OAc)4·2H2O (44.8 mg, 93.7 μmol) and DCM (10 mL) were added to
a round bottom flask. Ethyl diazoacetate (87% solution in DCM, 2.5 mL, 20.7 mmol) in
DCM (5 mL) was added and after the completion of the reaction, the crude residue was
purified to give the title compound 435a as a colourless oil (4.2628 g, 19.0 mmol) in 92%
yield. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.91 (t, 6H, J = 7.3 Hz, 2CH3), 1.24 (t, 3H,
J = 7.2 Hz, CH3), 1.29-1.45 (m, 4H, 2CH2), 1.46-1.60 (m, 4H, 2CH2), 2.03 (s, 1H, CH),
2.41 (t, 4H, J = 7.2 Hz, 2CH2), 4.11 (q, 2H, J = 7.2 Hz, CH2) ppm; 13C NMR (100 MHz,
CDCl3): 𝛿 = 13.6, 14.3, 22.16, 22.20, 24.1, 29.0, 59.6, 105.6, 176.9 ppm.
NMR data is in agreement with published data.[80]
Ethyl 2,3-dipropylcycloprop-2-ene-1-carboxylate 435b
Following general procedure E, 4-octyne (5.8 mL, 39.5 mmol), Rh2(OAc)4
(58.9 mg, 0.133 mmol) and DCM (13 mL) were added to a round bottom
flask. Ethyl diazoacetate (87% solution in DCM, 3.2 mL, 26.5 mmol) in DCM (6.6 mL)
was added and after the completion of the reaction, the crude residue was purified to give
the title compound 435b as a yellow oil (3.2278 g, 16.4 mmol) in 62% yield. 1H NMR
(500 MHz, CDCl3): 𝛿 = 0.96 (t, 6H, J = 7.5 Hz, 2CH3), 1.24 (t, 3H, J = 7.0 Hz, CH3),
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1.53-1.64 (m, 4H, 2CH2), 2.03 (s, 1H, CH), 2.39 (t, 4H, J = 7.5 Hz, 2CH2), 4.11 (q, 2H,
J = 7.0 Hz, CH2) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 13.8, 14.4, 20.4, 22.2, 26.5,
59.7, 105.7, 177.1 ppm; HRMS (ESI): m/z calcd for C12H20NaO2 [M + Na]+ 219.1356,
found 219.1355; IR (ATR): 2961, 2935, 2874, 1719, 1461, 1334, 1173, 1039 cm-1.
Ethyl

2-(((tert-butyldimethylsilyl)oxy)methyl)-3-hexylcycloprop-2-ene-1-carboxylate

435c
Following general procedure E, tert-butyldimethyl(non-2-yn-1yloxy)silane (3.1599 g, 12.4 mmol), Rh2(OAc)4 (18.5 mg,
41.9 μmol) and DCM (4 mL) were added to a round bottom flask. Ethyl diazoacetate
(87% solution in DCM, 1 mL, 8.27 mmol) in DCM (2 mL) was added and after the
completion of the reaction, the crude residue was purified to give the title compound 435c
as an oil (1.1490 g, 3.37 mmol) in 41% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.09 (s,
6H, Si(CH3)2), 0.86-0.90 (m, 3H, CH3), 0.91 (s, 9H, C(CH3)3), 1.24 (t, 3H, J = 7.0 Hz,
CH3), 1.26-1.37 (m, 6H, 3CH2), 1.53-1.59 (m, overlapped with H2O, 2H, CH2), 2.18 (s,
1H, CH), 2.44 (tt, 2H, J = 7.5, 1.5 Hz, CH2), 4.07-4.14 (m, 2H, CH2), 4.53 (dt, 1H,
J = 15.5, 1.5 Hz, CHaHb), 4.61 (dt, 1H, J = 15.5, 1.5 Hz, CHaHb) ppm;

13

C NMR

(125 MHz, CDCl3): 𝛿 = -5.5, -5.4, 14.0, 14.4, 18.3, 22.5, 22.8, 24.4, 25.8, 26.9, 28.9, 31.5,
57.5, 59.9, 104.6, 108.2, 176.1 ppm; HRMS (ESI): m/z calcd for C19H37O3Si [M + H]+
341.2506, found 341.2500; IR (ATR): 2929, 2856, 1723, 1463, 1254, 1180, 1085,
834 cm-1.
Ethyl 2-(3-((tert-butyldimethylsilyl)oxy)propyl)cycloprop-2-ene-1-carboxylate 435d
Following general procedure E, tert-butyldimethyl(pent-4-yn-1yloxy)silane (2.4836 g, 12.5 mmol), Rh2(OAc)4 (20.9 mg, 47.3 μmol)
and DCM (4 mL) were added to a round bottom flask. Ethyl
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diazoacetate (87% solution in DCM, 1 mL, 8.27 mmol) in DCM (2 mL) was added and
after the completion of the reaction, the crude residue was purified to give the title
compound 435d as a yellow oil (1.6501 g, 5.80 mmol) in 70% yield. 1H NMR (500 MHz,
CDCl3): 𝛿 = 0.05 (s, 6H, Si(CH3)2), 0.89 (s, 9H, C(CH3)3), 1.25 (t, 3H, J = 7.0 Hz, CH3),
1.76-1.83 (m, 2H, CH2), 2.13 (d, 1H, J = 1.5 Hz, CH), 2.58 (tt, 2H, J = 7.0, 1.5 Hz, CH2),
3.61-3.70 (m, 2H, CH2), 4.09-4.17 (m, 2H, CH2), 6.34 (appar. q, 1H, J = 1.5 Hz, CH)
ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = -5.4, 14.3, 18.3, 19.7, 21.5, 25.9, 29.8, 60.1, 61.9,
94.3, 115.3, 176.5 ppm; HRMS (ESI): m/z calcd for C15H28NaO3Si [M + Na]+ 307.1700,
found 307.1716; IR (ATR): 2954, 2930, 2857, 1723, 1251, 1178, 109, 833 cm-1.
Ethyl 2-isopentylcycloprop-2-ene-1-carboxylate 435e
Following general procedure E, 5-methylhex-1-yne (0.87 mL,
6.59 mmol), Rh2(OAc)4 (10.0 mg, 22.6 μmol) and DCM (2.2 mL)
were added to a round bottom flask. Ethyl diazoacetate (87% solution
in DCM, 0.5 mL, 4.14 mmol) in DCM (1.1 mL) was added and after the completion of
the reaction, the crude residue was purified to give the title compound 435e as a pale
yellow oil (445.1 mg, 2.44 mmol) in 59% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.91
(d, 6H, J = 6.5 Hz, 2CH3), 1.25 (t, 3H, J = 7.0 Hz, CH3), 1.48 (q, 2H, J = 7.5 Hz, CH2),
1.63 (nonet, 1H, J = 6.5 Hz, CH), 2.12 (d, 1H, J = 1.5 Hz, CH), 2.50 (t, 2H, J = 7.5 Hz,
CH2), 4.09-4.18 (m, 2H, CH2), 6.32 (m, 1H, CH) ppm;
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C NMR (125 MHz, CDCl3):

𝛿 = 14.3, 19.3, 22.16, 22.25, 22.9, 27.4, 35.5, 60.1, 93.8, 115.7, 176.6 ppm; HRMS (ESI):
m/z calcd for C11H19O2 [M + H]+ 183.1380, found 183.1389; IR (ATR): 2958, 2871,
1725, 1468, 1368, 1251, 1177, 1030 cm-1.

286

Ethyl 2-(tert-butyl)cycloprop-2-ene-1-carboxylate 435f
Following general procedure E, 3,3-dimethylbut-1-yne (2.2 mL,
17.9 mmol), Rh2(OAc)4 (41.8 mg, 94.6 μmol) and DCM (6 mL) were added
to a round bottom flask. Ethyl diazoacetate (87% solution in DCM, 1.5 mL, 12.4 mmol)
in DCM (3 mL) was added and after the completion of the reaction, the crude residue was
purified to give the title compound 435f as an oil (1.2854 g, 7.64 mmol) in 62% yield. 1H
NMR (400 MHz, CDCl3): 𝛿 = 1.18 (m, 9H, C(CH3)3), 1.24 (t, 3H, J = 7.2 Hz, CH3), 2.162.18 (m, 1H, CH), 4.07-4.19 (m, 2H, CH2), 6.21 (d, 1H, J = 1.4 Hz, CH) ppm; 13C NMR
(100 MHz, CDCl3): 𝛿 = 14.3, 19.7, 27.7, 31.1, 60.0, 91.1, 123.3, 176.5 ppm.
NMR data is in agreement with published data.[189]
tert-Butyldimethyl(5-methylhex-1-yn-1-yl)silane 435i
Following general procedure E, tert-butyldimethyl(5-methylhex-1yn-1-yl)silane (521.8 mg, 2.48 mmol), Rh2(OAc)4 (4.0 mg,
9.05 μmol) and DCM (3.8 mL) were added to a round bottom flask.
Ethyl diazoacetate (87% solution in DCM, 0.23 mL, 1.90 mmol) in DCM (0.5 mL) was
added and after the completion of the reaction, the crude residue was purified to give the
title compound 435i as a colourless oil (182.7 mg, 0.616 mmol) in 32% yield. 1H NMR
(400 MHz, CDCl3): 𝛿 = 0.12 (s, 3H, SiCH3), 0.13 (s, 3H, SiCH3), 0.90 (d, 3H, J = 2.8 Hz,
CH3), 0.91 (d, 3H, J = 2.8 Hz, CH3), 0.93 (s, 9H, C(CH3)3), 1.22 (t, 3H, J = 7.2 Hz, CH3),
1.44-1.51 (m, 2H, CH2), 1.57-1.67 (m, overlapped with H2O, 1H, CH), 1.97 (s, 1H, CH),
2.54 (td, 2H, J = 7.3, 1.6 Hz, CH2), 4.09 (qd, 2H, J = 7.2, 0.8 Hz, CH2) ppm; 13C NMR
(125 MHz, CDCl3): 𝛿 = -5.8, -5.7, 14.4, 16.9, 21.2, 22.2, 22.3, 24.4, 26.2, 27.5, 35.8, 59.7,
101.8, 128.0, 177.1 ppm; HRMS (ESI): m/z calcd for C17H33O2Si [M + H]+ 297.2244,
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found 297.2263; IR (ATR): 2956, 2929, 2858, 1719, 1471, 1249, 1176, 836, 822, 808,
775 cm-1.
4.4.1.3.

Preparation of Cyclopropenyl Alcohols 436

(2,3-Dibutylcycloprop-2-en-1-yl)methanol 436a
Following general procedure F, cyclopropenyl carboxylate 435a
(500.0 mg, 2.23 mmol) was dissolved in THF (12.5 mL) and to this was
added DIBAL-H (1 M solution in THF, 6.75 mL, 6.75 mmol). After 30 mins –78 °C, the
reaction was worked-up to give the title compound 436a as a colourless oil (399.0 mg,
2.19 mmol) in 98% yield. Cyclopropenyl alcohol 436a was used directly without
purification. 1H NMR (300 MHz, CDCl3): 𝛿 = 0.92 (t, 6H, J = 7.5 Hz, 2CH3), 1.28-1.44
(m, 4H, 2CH2), 1.45-1.60 (m, 5H, 2CH2, CH), 2.40 (t, 4H, J = 7.3 Hz, 2CH2), 3.52 (d,
2H, J = 4.5 Hz, CH2) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 13.8, 22.5, 22.6, 25.3, 29.8,
69.1, 114.1 ppm.
NMR data is in agreement with published data.[80]
(2,3-Dipropylcycloprop-2-en-1-yl)methanol 436b
Following general procedure F, cyclopropenyl carboxylate 435b
(1.0017 g, 5.10 mmol) was dissolved in THF (26 mL) and to this was added
DIBAL-H (1 M solution in THF, 15.5 mL, 15.5 mmol). After 30 mins at –78 °C, the
reaction was worked-up and purified to give the title compound 436b as a colourless oil
(646.8 mg, 4.19 mmol) in 82% yield. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.95 (t, 6H,
J = 7.4 Hz, 2CH3), 1.26 (bs, 1H, OH), 1.52-1.62 (m, 5H, 2CH2, CH), 2.39 (td, 4H,
J = 7.2, 1.4 Hz, 2CH2), 3.52 (d, 2H, J = 4.4 Hz, CH2) ppm; 13C NMR (100 MHz, CDCl3):
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𝛿 = 14.0, 21.0, 22.6, 27.7, 69.1, 114.1 ppm; HRMS (ESI): m/z calcd for C10H19O
[M + H]+ 155.1430, found 155.1429; IR (ATR): 3335 (br), 2959, 2929, 2902, 2872 1457,
1009 cm-1.
(2-(((tert-Butyldimethylsilyl)oxy)methyl)-3-hexylcycloprop-2-en-1-yl)methanol 436c
Following general procedure F, cyclopropenyl carboxylate 435c
(969.5 mg, 2.85 mmol) was dissolved in THF (14 mL) and to this
was added DIBAL-H (1 M solution in THF, 8.5 mL, 8.50 mmol). Following completion,
the reaction was worked-up give the title compound 436c as a colourless oil (694.5 mg,
2.33 mmol) in 82% yield. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.115 (s, 3H, SiCH3), 0.121
(s, 3H, SiCH3), 0.86-0.91 (m, 3H, CH3), 0.93 (s, 9H, C(CH3)3), 1.26-1.36 (m, 6H, 3CH2),
1.49-1.58 (m, 2H, CH2), 1.80 (dd, 1H, J = 5.8, 3.8 Hz, CH), 1.91 (bs, 1H, OH), 2.41 (tq
2H, J = 7.6, 2.0 Hz, CH2), 3.19 (dd, 1H, J = 10.8, 6.0 Hz, CHaHb), 3.75 (dd, 1H, J = 10.8,
3.6 Hz, CHaHb), 4.46 (dtd, 1H, J = 14.0, 2.0, 0.8 Hz, CHaHb), 4.65 (dt, 1H, J = 14.0,
1.2 Hz, CHaHb) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = -5.4, 14.0, 18.3, 22.5, 23.9, 25.6,
25.8, 27.4, 29.0, 31.5, 57.6, 68.4, 112.7, 117.0 ppm; HRMS (ESI): m/z calcd for
C17H34NaO2Si [M + Na]+ 321.2220, found 321.2239; IR (ATR): 3359 (br), 2928, 2856,
1463, 1253, 1087, 1005, 833, 775 cm-1.
(2-(3-((tert-Butyldimethylsilyl)oxy)propyl)cycloprop-2-en-1-yl)methanol 436d
Following general procedure F, cyclopropenyl carboxylate 435d
(1.1591 g, 4.07 mmol) was dissolved in THF (20 mL) and to this was
added DIBAL-H (1 M solution in THF, 10.4 mL, 10.4 mmol). Once
complete, the reaction was worked-up and purified to give the title compound 436d as a
colourless oil (799.3 mg, 3.30 mmol) in 81% yield. 1H NMR (500 MHz, CDCl3):
𝛿 = 0.05 (s, 6H, Si(CH3)2), 0.90 (m, 9H, C(CH3)3), 1.71 (td, 1H, J = 4.5, 1.5 Hz, CH),
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1.80 (tt, 2H, J = 7.0, 6.0 Hz, CH2), 2.57 (td, 2H, J = 7.0, 1.5 Hz, CH2), 3.50 (ddd, 1H,
J = 10.5, 4.5, 1.0 Hz, CHaHb), 3.55 (dd, 1H, J = 10.5, 4.5 Hz, CHaHb), 3.65-3.71 (m, 2H,
CH2), 6.65 (s, 1H, CH) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = -5.3, 18.3, 20.5, 22.6,
25.9, 30.2, 62.1, 68.7, 102.0, 125.4 ppm; HRMS (ESI): m/z calcd for C13H26NaO2Si
[M + Na]+ 265.1594, found 265.1607; IR (ATR): 3344 (br), 2928, 2856, 1471, 1253,
1100, 1006, 832, 773 cm-1.
(2,3-Diphenylcycloprop-2-en-1-yl)methanol 436g

In accordance with the literature procedure,[80] a round bottom flask was charged
with diphenylacetylene (1.0039 g, 5.63 mmol), Cu(CH3CN)4PF6 (22.8 mg, 61.2 μmol)
and DCM (7 mL), under nitrogen. Ethyl diazoacetate (87% solution in DCM, 3.4 mL,
28.1 mmol) in DCM (3.4 mL) was added via syringe pump at a rate of 1.9 mL/h. After
the complete addition of the ethyl diazoacetate, the reaction was left stirring at rt
overnight. The solvent was removed under reduced pressure and the crude residue was
purified to give cyclopropenyl carboxylate 435g (922.3 mg). 1H NMR confirmed the
desired product 435g had been obtained but also showed impurities believed to be from
dimerization of the ethyl diazoacetate. Cyclopropenyl carboxylate 435g was employed in
the next reaction step without further purification. 1H NMR (300 MHz, CDCl3): 𝛿 = 1.24
(t, 3H, J = 7.2 Hz, CH3), 2.82 (s, 1H, CH), 4.19 (q, 2H, J = 7.2 Hz, CH2), 7.36-7.43 (m,
2H, 2CHAr), 7.44-7.51 (m, 4H, 4CHAr), 7.66-7.71 (m, 4H, 4CHAr) ppm.
NMR data is in agreement with published data.[80]
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Following general procedure F, cyclopropenyl carboxylate 435g (922.3 mg) was
dissolved in THF (14 mL) and to this was added DIBAL-H (1 M solution in THF, 10 mL,
10.0 mmol). Once complete, the reaction was worked-up and purified to give the title
compound 436g as a white solid (607.6 mg, 2.73 mmol) in 48% yield over two steps. 1H
NMR (300 MHz, CDCl3): 𝛿 = 2.41 (t, 1H, J = 4.7 Hz, CH), 3.88 (appar. t, 2H,
J = 5.1 Hz, CH2), 7.33-7.40 (m, 2H, 2CHAr), 7.44-7.51 (m, 4H, 4CHAr), 7.71-7.76 (m,
4H, 4CHAr) ppm.
NMR data is in agreement with published data. [80]
(2-(tert-Butyl)-3-propylcycloprop-2-en-1-yl)methanol 436j

Following general procedure F, cyclopropenyl carboxylate 435f (1.1156 g,
6.63 mmol) was dissolved in THF (33 mL) and to this was added DIBAL-H (1 M solution
in THF, 20 mL, 20.0 mmol). After 50 mins at –78 °C, the reaction was worked-up give
cyclopropenyl alcohol 436f, which was used in the next step without purification.
Following a modified literature procedure,[190] to a dry round bottom was added
the crude residue of cyclopropenyl alcohol 436f and THF (26.5 mL). The flask was cooled
to –78 °C and to this was added n-BuLi (2.5 M in hexanes, 5.2 mL, 13.0 mmol), dropwise
by syringe. The reaction was allowed to warm rt and was stirred for 1 h. To this was then
added iodopropane (0.72 mL, 7.38 mmol) and the reaction was stirred for 3 h. The
reaction was quenched with 2 M HCl, extracted (3x) with Et2O and the combined organic
layer was washed with brine and dried over Na2SO4. The crude residue was filtered,
concentrated under reduced pressure and analysised by 1H NMR which revealed the
reaction had only gone to ~35% completion so the crude residue was resubjected to the
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reaction conditions until complete. Flash column chromatography (20:80 Et2O:hex) using
silica gel that had been pre-treated with 1% TEA, gave the title compound 436j as a pale
yellow oil (349.5 mg, 2.08 mmol) in 31% yield over two steps with some minor
impurities. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.94 (t, 3H, J = 7.5 Hz, CH3), 1.14 (s, 9H,
C(CH3)3), 1.56 (qd, 2H, J = 7.5, 1.0 Hz, CH2), 1.62 (t, 1H, J = 4.5 Hz, CH), 2.39 (td, 2H,
J = 7.5, 4.0 Hz, CH2), 3.47 (dd, 1H, J = 10.5, 5.0 Hz, CHaHb), 3.57 (dd, 1H, J = 10.5,
4.5 Hz, CHaHb) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 14.0, 21.3, 22.5, 27.3, 28.6, 30.9,
69.5, 111.3, 122.5 ppm; HRMS (ESI): m/z calcd for C11H20NaO [M + Na]+ 191.1406,
found 191.1405; IR (ATR): 3329 (br), 2961, 2869, 1459, 1361, 1009 cm-1.
4.4.1.4.

Methylation of 1H-Indole-2-Carboxylates

Ethyl 5-bromo-1-methyl-1H-indole-2-carboxylate
Following general procedure C, ethyl 5-bromo-1H-indole-2carboxylate (1.0099 g, 3.77 mmol), Cs2CO3 (3.0674 g, 9.41 mmol)
and MeCN (18.5 mL) were added to a flask and after 30 mins of heating, MeI (0.59 mL,
9.48 mmol) was injected. The reaction was heated for 15 h after which a second portion
of MeI (0.59 mL, 9.48 mmol) was injected. The reaction was stirred for a further 2 h
before being worked up to give the title compound ethyl 5-bromo-1-methyl-1H-indole2-carboxylate as a white solid (1.0557 g, 3.74 mmol) in 99% yield. 1H NMR (400 MHz,
CDCl3): 𝛿 = 1.41 (t, 3H, J = 7.2 Hz, CH3), 4.06 (s, 3H, CH3), 4.38 (q, 2H, J = 7.2 Hz,
CH2), 7.21 (s, 1H, CHAr), 7.26 (d, overlapped with CHCl3, 1H, J = 8.9 HZ, CHAr), 7.42
(dd, 1H, J = 8.8, 2.0 Hz, CHAr), 7.80 (d, 1H, J = 2.0 Hz, CHAr) ppm; 13C NMR (100 MHz,
CDCl3): 𝛿 = 14.3, 31.8, 60.7, 109.2, 111.8, 113.7, 124.8, 127.4, 127.8, 129.0, 138.1,
161.9 ppm.
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NMR data is in agreement with published data.[191]
Ethyl 5-chloro-1-methyl-1H-indole-2-carboxylate
Following general procedure C, ethyl 5-chloro-1H-indole-2carboxylate (920.7 mg, 4.12 mmol), Cs2CO3 (3.3937 g,
10.4 mmol) and MeCN (20 mL) were added to a flask and after 30 mins of heating, MeI
(0.64 mL, 10.3 mmol) was injected. The reaction was heated for 15 h after which a second
portion of MeI (0.64 mL, 10.3 mmol) was injected. The reaction was stirred for a further
2 h before being worked up to give the title compound ethyl 5-chloro-1-methyl-1Hindole-2-carboxylate as an orange solid (969.7 mg, 4.08 mmol) in 99% yield. 1H NMR
(400 MHz, CDCl3): 𝛿 = 1.41 (t, 3H, J = 7.2 Hz, CH3), 4.06 (s, 3H, CH3), 4.38 (q, 2H,
J = 7.2 Hz, CH2), 7.22 (s, 1H, CHAr), 7.29-7.31 (m, 2H, 2CHAr), 7.62-7.64 (m, 1H, CHAr)
ppm;

13

C NMR (100 MHz, CDCl3): 𝛿 = 14.3, 31.8, 60.7, 109.3, 111.4, 121.6, 125.3,

126.2, 126.6, 129.2, 137.9, 161.9 ppm.
NMR data is in agreement with published data.[181]
4.4.1.5.

Preparation of 1H-indole-2-Carbaldehydes

5-Bromo-1-methyl-1H-indole-2-carbaldehyde
Following general procedure F, ethyl 5-bromo-1-methyl-1Hindole-2-carboxylate (966.5 mg, 3.43 mmol) was dissolved in
DCM (17 mL) and to this was added DIBAL-H (1 M solution in hexanes, 8.5 mL,
8.50 mmol) and the reaction was warmed to rt. After 30 mins the reaction was worked up
to give (5-bromo-1-methyl-1H-indol-2-yl)methanol as a solid (821.0 mg). The crude
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residue of (5-bromo-1-methyl-1H-indol-2-yl)methanol was used in the next step without
further purification. 1H NMR (400 MHz, CDCl3): 𝛿 = 3.78 (s, 3H, CH3), 4.79 (d, 2H,
J = 5.6 Hz, CH2), 6.39 (s, 1H, CHAr), 7.18 (d, 1H, J = 8.8 Hz, CHAr), 7.30 (dd, 1H,
J = 8.7, 2.0 Hz, CHAr), 7.70 (dd, 1H, J = 2.0 Hz, CHAr) ppm;

13

C NMR (100 MHz,

CDCl3): 𝛿 = 30.0, 57.4, 100.9, 110.6, 112.8, 123.2, 124.8, 128.8, 136.8, 139.8 ppm.
NMR data is in agreement with published data.[192]
Following general procedure G, (5-bromo-1-methyl-1H-indol-2yl)methanol (770.7 mg, 3.21 mmol) was dissolved in DCM
(8.4 mL) and to this was added activated MnO2 (2.8423 g, 27.8 mmol). After 4 h the
reaction was worked up and purified to give the title compound 5-bromo-1-methyl-1Hindole-2-carbaldehyde as an off white solid (657.0 mg, 2.76 mmol) in 86% yield. 1H
NMR (400 MHz, CDCl3): 𝛿 = 4.08 (s, 3H, CH3), 7.17 (s, 1H, CHHet), 7.24-7.31 (m,
overlapped with CHCl3, 1H, CHHet), 7.48 (d, 1H, J = 8.8 Hz, CHHet), 7.86 (s, 1H, CHHet),
9.89 (s, 1H, CHO) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 31.7, 111.9, 114.1, 116.1,
125.5, 127.7, 129.7, 136.3, 139.3, 182.8 ppm; HRMS (ESI): m/z calcd for
C10H9(79Br)NO [M + H]+ 237.9862, found 237.9873; IR (ATR): 1663, 1473, 1401, 1126,
859, 795, 728 cm-1; MP: 136.8–137.5 °C.
5-Chloro-1-methyl-1H-indole-2-carbaldehyde
Following general procedure F, ethyl 5-chloro-1-methyl-1Hindole-2-carboxylate (496.4 mg, 2.09 mmol) was dissolved in
DCM (10.5 mL) and to this was added DIBAL-H (1 M solution in hexanes, 2.8 mL,
2.80 mmol). After 1 h at –78 °C an additional portion of DIBAL-H (1 M solution in
hexanes, 2.8 mL, 2.80 mmol) was added and the reaction was warmed to rt. After
30 mins, the reaction was worked up to give (5-chloro-1-methyl-1H-indol-2-yl)methanol
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as a solid (430.8 mg). The crude residue of (5-chloro-1-methyl-1H-indol-2-yl)methanol
was used in the next step without further purification. 1H NMR (400 MHz, CDCl3):
𝛿 = 3.76-3.80 (m, 3H, CH3), 4.79 (d, 2H, J = 4.0 Hz, CH2), 6.39 (d, 1H, J = 2.8 Hz, CHAr),
7.17 (dd, 1H, J = 8.8, 2.0 Hz, CHAr), 7.19-7.24 (m, 1H, CHAr), 7.52-7.55 (m, 1H, CHAr)
ppm;

13

C NMR (100 MHz, CDCl3): 𝛿 = 30.0, 57.4, 100.9, 110.2, 120.1, 122.3, 125.2,

128.1, 136.5, 139.9 ppm.
NMR data is in agreement with published data.[181]
Following general procedure G, (5-chloro-1-methyl-1H-indol-2yl)methanol (202.0 mg, 1.03 mmol) was dissolved in DCM
(1.8 mL) and to this was added activated MnO2 (879.0 mg, 8.59 mmol). After 21 h the
reaction was worked up and purified to give the title compound 5-chloro-1-methyl-1Hindole-2-carbaldehyde as a light yellow solid (171.2 mg, 0.884 mmol) in 86% yield. 1H
NMR (400 MHz, CDCl3): 𝛿 = 4.08 (s, 3H, CH3), 7.18 (s, 1H, CHAr), 7.33 (d, 1H,
J = 8.8 Hz, CHAr), 7.37 (dd, 1H, J = 8.8, 2.0 Hz, CHAr), 7.71 (d, 1H, J = 2.0 Hz, CHAr),
9.89 (s, 1H, CHO) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 31.8, 111.6, 116.2, 122.4,
126.7, 127.0, 127.3, 136.5, 139.1, 182.9 ppm.
NMR data is in agreement with published data. [181]
5-Bromo-1H-indole-2-carbaldehyde
Following general procedure F, ethyl 5-bromo-1H-indole-2carboxylate (1.0124 g, 3.78 mmol) was dissolved in THF (19 mL)
and to this was added DIBAL-H (1 M solution in THF, 9.5 mL, 9.50 mmol) and the
reaction was warmed to rt. After 3.5 h an additional portion of DIBAL-H (1 M solution
of THF, 3 mL, 3.00 mmol) was added. After another 2 h the reaction was worked up and
run through a short column to give (5-bromo-1H-indol-2-yl)methanol as a solid
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(780.5 mg, 3.45 mmol) in 91% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.83 (bs, 1H,
OH), 4.83 (s, 3H, CH3), 6.33-6.35 (m, 1H, CHAr), 7.21 (d, 1H, J = 8.5 Hz, CHAr), 7.26
(dd, overlap with CHCl3, 1H, J = 8.5, 2.0 Hz, CHAr), 7.69 (m, 1H, CHAr), 8.40 (bs, 1H,
NH) ppm;

13

C NMR (125 MHz, CDCl3): 𝛿 = 58.6, 99.9, 112.3, 113.1, 123.1, 124.9,

129.9, 134.8, 138.8 ppm.
NMR data is in agreement with published data.[193]
Following general procedure G, (5-bromo-1H-indol-2-yl)methanol
(780.5 mg, 3.45 mmol) was dissolved in DCM (12 mL) and to this
was added activated MnO2 (3.2881 g, 32.1 mmol). After 16 h the reaction was worked up
and purified to give the title compound 5-bromo-1H-indole-2-carbaldehyde as a yellow
powder (178.8 mg, 0.798 mmol) in 23% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 7.21
(dd, 1H, J = 2.0, 1.0 Hz, CHAr), 7.34 (dt, 1H, J = 9.0, 1.0 Hz, CHAr), 7.48 (dd, 1H,
J = 9.0, 2.0 Hz, CHAr), 7.90 (m, 1H, CHAr), 9.03 (bs, 1H, NH), 9.86 (s, 1H, CHO) ppm;
13

C NMR (125 MHz, CDCl3): 𝛿 = 113.4, 113.9, 114.4, 125.7, 128.9, 130.2, 136.2, 136.6,

181.9 ppm.
NMR data is in agreement with published data.[194]
1-Benzyl-5-bromo-1H-indole-2-carbaldehyde
Following general procedure C, 5-bromo-1H-indole-2-carbaldehyde
(176.5 mg, 0.788 mmol), Cs2CO3 (681.5 mg, 2.09 mmol) and MeCN
(8.4 mL) were added to a flask and after 30 mins of heating, benzyl bromide (0.15 mL,
1.26 mmol) was injected. The reaction was heated for 20 h after which the reation was
worked up to give the title compound 1-benzyl-5-bromo-1H-indole-2-carbaldehyde as a
solid (173.6 mg, 0.553 mmol) in 70% yield. 1H NMR (400 MHz, CDCl3): 𝛿 = 5.80 (s,
2H, CH2), 7.02-7.07 (m, 2H, 2CHAr), 7.19-7.28 (m, overlapped with CHCl3, 5H, 3CHAr,
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2CHHet), 7.43 (dd, 1H, J = 9.2, 2.0 Hz, CHHet), 7.89 (d, 1H, J = 2.0 Hz, CHHet), 9.90 (s,
1H, CHO) ppm;

13

C NMR (100 MHz, CDCl3): 𝛿 = 48.1, 112.6, 114.4, 117.0, 125.7,

126.5, 127.5, 128.0, 128.7, 130.0, 136.0, 137.2, 139.1, 182.6 ppm; IR (ATR): 1745,
1668, 1454, 1243, 1125, 801, 720, 697 cm-1; MP: 113.1–116.7 °C.
4.4.1.6.

Preparation of Sulfonamides 438

4-Methyl-N-((5-methylfuran-2-yl)methyl)benzenesulfonamide 438a
Following general procedure H, 5-methylfuran-2-carbaldehyde
(2.6 mL, 26.1 mmol), tosyl amide (4.4767 g, 26.1 mmol) and
Si(OEt)4 (6.4 mL, 28.7 mmol) were heated overnight to obtain the corresponding imine
437a. Imine 437a was dissolved in THF (105 mL) and MeOH (22 mL) and reacted with
NaBH4 (507.7 mg, 13.4 mmol). The crude residue was purified to give the title compound
438a as a yellow solid (4.5903 g, 17.3 mmol) in 66% yield over two steps. 1H NMR
(400 MHz, CDCl3): 𝛿 = 2.13 (s, 3H, CH3), 2.42 (s, 3H, CH3), 4.11 (d, 2H, J = 6.0 Hz,
CH2), 4.65-4.75 (m, 1H, NH), 5.776-5.79 (m, 1H, CHHet), 5.96 (d, 1H, J = 3.2 Hz, CHHet),
7.26-7.29 (m, overlapped with CHCl3, 2H, 2CHAr), 7.69-7.74 (m, 2H, 2CHAr) ppm; 13C
NMR (100 MHz, CDCl3): 𝛿 = 13.3, 21.5, 40.3, 106.2, 109.1, 127.2, 129.5, 137.0, 143.3,
147.5, 152.2 ppm.
NMR data is in agreement with published data.[195]
N-(Furan-2-ylmethyl)-4-methylbenzenesulfonamide 438b
Following general procedure H, furan-2-carbaldehyde (3.40 mL,
41.0 mmol), tosyl amide (2.0007 g, 11.7 mmol) and Si(OEt) 4
(2.90 mL, 13.0 mmol) were heated overnight to obtain the corresponding imine 437b.
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Imine 437b was dissolved in THF (50 mL) and MeOH (10 mL) and reacted with NaBH4
(455.0 mg, 12.0 mmol). The crude residue was purified to give the title compound 438b
as an off-white solid (1.4551 g, 5.79 mmol) in 49% yield over two steps. 1H NMR
(300 MHz, CDCl3): 𝛿 = 2.42 (s, 3H, CH3), 4.18 (d, 2H, J = 6.0 Hz, CH2), 4.66 (bs, 1H,
NH), 6.09 (dd, 1H, J = 3.2, 0.8 Hz, CHHet), 6.22 (dd, 1H, J = 3.3, 2.1 Hz, CHHet), 7.237.25 (m, 1H, CHHet), 7.28 (d, overlapped with CHCl3, 2H, J = 8.0 Hz, 2CHAr), 7.69-7.74
(m, 2H, 2CHAr) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 21.5, 40.1, 108.2, 110.4, 127.1,
129.6, 136.9, 142.5, 143.5, 149.5 ppm.
NMR data is in agreement with published data.[182]
N-((5-(Ethoxymethyl)furan-2-yl)methyl)-4-methylbenzenesulfonamide 438c
Following general procedure H, 5-(ethoxymethyl)furan-2carbaldehyde (0.45 mL, 3.21 mmol), tosyl amide (499.5 mg,
2.92 mmol) and Si(OEt)4 (0.72 mL, 3.22 mmol) were heated overnight to obtain the
corresponding imine 437c. Imine 437c was dissolved in THF (12.5 mL) and MeOH
(2.5 mL) and reacted with NaBH4 (61.8 mg, 1.63 mmol). The crude residue was purified
to give the title compound 438c as a fluffy, yellow solid (93.7 mg, 0.303 mmol) in 10%
yield over two steps. 1H NMR (400 MHz, CDCl3): 𝛿 = 1.20 (t, 3H, J = 7.0 Hz, CH3), 2.42
(s, 3H, CH3), 3.48 (q, 2H, J = 7.0 Hz, CH2), 4.16 (d, 2H, J = 6.0 Hz, CH2), 4.28 (s, 2H,
CH2), 4.72 (t, 1H, J = 6.0 Hz, NH), 6.05 (d, 1H, J = 3.0 Hz, CHHet), 6.14 (d, 1H,
J = 3.0 Hz, CHHet), 7.26-7.29 (m, overlapped with CHCl3, 2H, 2CHAr), 7.69-7.74 (m, 2H,
2CHAr) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 15.1, 21.5, 40.3, 64.4, 65.7, 108.8, 109.8,
127.2, 129.6, 136.9, 143.5, 149.7, 152.0 ppm; HRMS (ESI): m/z calcd for
C15H19NNaO4S [M + Na]+ 332.0927, found 332.0942; IR (ATR): 3304, 3184, 2973,
2866, 1378, 1327, 1160, 1093, 1048 cm-1; MP: 79.6–82.1 °C.
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N-((5-Bromofuran-2-yl)methyl)-4-methylbenzenesulfonamide 438d
Following general procedure H, 5-bromofuran-2-carbaldehyde
(547.2 mg, 3.13 mmol), tosyl amide (538.7 mg, 3.16 mmol) and
Si(OEt)4 (0.77 mL, 3.45 mmol) were heated overnight to obtain the corresponding imine
437d. Imine 437d was dissolved in THF (13 mL) and MeOH (2.6 mL) and reacted with
NaBH4 (59.8 mg, 1.58 mmol). The crude residue was purified to give the title compound
438d as an off-white solid (144.9 mg, 0.311 mmol) in 10% yield over two steps. Another
fraction of the title compound 438d (340.9 mg) was also collected that had a purity of
approximately 80% (contaminant was tosyl amide). 1H NMR (400 MHz, CDCl3):
𝛿 = 2.42 (s, 3H, CH3), 4.16 (d, 2H, J = 6.0 Hz, CH2), 4.74 (t, 1H, J = 5.8 Hz, NH), 6.08
(dt, 1H, J = 3.2, 0.8 Hz, CHHet), 6.11 (d, 1H, J = 3.2 Hz, CHHet), 7.26-7.30 (m, overlapped
with CHCl3, 2H, 2CHAr), 7.67-7.71 (m, 2H, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3):
𝛿 = 21.5, 40.1, 111.1, 112.0, 121.8, 127.1, 129.6, 136.8, 143.6, 151.5 ppm.
NMR data is in agreement with published data.[182]
4-Methyl-N-((5-phenylfuran-2-yl)methyl)benzenesulfonamide 438e

Sulfonamide 438d (80% purity, 142.1 mg, 0.344 mmol), phenyl boronic acid
(63.8 mg, 0.523 mmol), K2CO3 (95.0 mg, 0.687 mmol), Pd(dppf)Cl2·CH2Cl2 (28.3 mg,
34.7 μmol) and a solution of dioxane:H2O (ratio 4:1, 3 mL) were added to a round bottom
flask, which was heated to 105 °C for 4.5 h. The reaction was diluted with H 2O and
separated before the aqueous phase was extracted (3x) with DCM. The combined organic
extracts were washed with brine, dried over Na2SO4, filtered and concentrated under
reduced pressure. The crude residue was purified by flash column chromatorgraphy
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(20:80 EtOAc:hex) to give the title compound 438e as a white solid (65.3 mg,
0.199 mmol) in 58% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 2.30 (s, 3H, CH3), 4.25 (d,
2H, J = 6.0 Hz, CH2), 4.89 (bs, 1H, NH), 6.17 (d, 1H, J = 3.0 Hz, CHHet), 6.44 (d, 1H,
J = 3.5 Hz, CHHet), 7.20 (d, 2H, J = 8.0 Hz, 2CHAr), 7.22-7.27 (m, overlapped with CHCl3,
1H, CHAr), 7.34 (t, 2H, J = 8.0 Hz, 2CHAr), 7.45-7.49 (m, 2H, 2CHAr), 7.69-7.73 (m, 2H,
2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 21.4, 40.3, 105.5, 110.4, 123.6, 127.0,
127.5, 128.6, 129.6, 130.2, 136.9, 143.4, 148.9, 154.0 ppm.
NMR data is in agreement with published data.[195].5 °C
4-Methyl-N-((1-methyl-1H-indol-2-yl)methyl)benzenesulfonamide 438f
Following general procedure H, 1-methyl-1H-indole-2-carbaldehyde (312.4 mg, 1.96 mmol), tosyl amide (340.1 mg, 1.99 mmol)
and Si(OEt)4 (0.96 mL, 4.30 mmol) were heated overnight to obtain the corresponding
imine 437f. Imine 437f was dissolved in THF (8.5 mL) and MeOH (1.6 mL) and reacted
with NaBH4 (39.5 mg, 1.04 mmol). The crude residue was purified to give the title
compound 438f as a yellow solid (331.0 mg, 1.05 mmol) in 54% yield over two steps. 1H
NMR (500 MHz, CDCl3): 𝛿 = 2.44 (s, 3H, CH3), 3.72 (s, 3H, CH3), 4.28 (d, 2H,
J = 6.0 Hz, CH2), 4.43 (t, 1H, J = 6.0 Hz, NH), 6.30 (s, 1H, CHHet), 7.08 (ddd, 1H,
J = 8.0, 7.0, 1.0 Hz, CHHet), 7.22 (ddd, 1H, J = 8.2, 7.0, 1.0 Hz, CHHet), 7.28 (dd,
overlapped with CHCl3, 1H, J = 8.3, 1.0 Hz, CHHet), 7.32 (d, 2H, J = 7.5 Hz, 2CHAr), 7.52
(dt, 1H, J = 8.0, 1.0 Hz, CHHet), 7.76-7.79 (m, 2H, 2CHAr) ppm; 13C NMR (100 MHz,
CDCl3): 𝛿 = 21.5, 29.8, 40.0, 102.4, 109.2, 119.8, 120.6, 122.2, 126.9, 127.2, 129.8,
133.3, 136.3, 138.1, 143.9 ppm.
NMR data is in agreement with published data.[196]
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N-((5-Bromo-1-methyl-1H-indol-2-yl)methyl)-4-methylbenzenesulfonamide 438g
Following general procedure H, 5-bromo-1-methyl-1H-indole-2carbaldehyde (531.5 mg, 2.23 mmol), tosyl amide (346.4 mg,
2.02 mmol) and Si(OEt)4 (2 mL, 8.96 mmol) were heated
overnight to obtain the corresponding imine 437g. Imine 437g was dissolved in THF
(9.5 mL) and MeOH (2 mL) and reacted with NaBH4 (47.0 mg, 1.24 mmol). The crude
residue was purified to give the title compound 438g as a yellow solid (236.0 mg,
0.600 mmol) in 27% yield over two steps. 1H NMR (500 MHz, CDCl3): 𝛿 = 2.44 (s, 3H,
CH3), 3.70 (s, 3H, CH3), 4.26 (d, 2H, J = 6.0 Hz, CH2), 4.47 (t, 1H, J = 6.0 Hz, NH), 6.23
(s, 1H, CHHet), 7.13 (d, 1H, J = 8.5 Hz, CHHet), 7.29 (dd, 1H, J = 8.5, 2.0 Hz, CHHet), 7.31
(d, 2H, J = 8.0, 2CHAr), 7.63 (d, 1H, J = 1.5 Hz, CHHet), 7.74-7.77 (m, 2H, 2CHAr) ppm;
13

C NMR (125 MHz, CDCl3): 𝛿 = 21.5, 30.0, 39.9, 101.9, 110.7, 113.0, 123.0, 125.0,

127.1, 128.5, 129.9, 134.6, 136.2, 136.7, 144.0 ppm; HRMS (ESI): m/z calcd for
C17H18(79Br)N2O2S [M + H]+ 393.0267, found 393.0279; IR (ATR): 3357, 3256, 2920,
2852, 1471, 1423, 1319, 1306, 1153, 1089, 1031 cm-1; MP: 195 °C decomp.
N-((5-Chloro-1-methyl-1H-indol-2-yl)methyl)-4-methylbenzenesulfonamide 438h
Following general procedure H, 5-chloro-1-methyl-1H-indole-2carbaldehyde (149.1 mg, 0.770 mmol), tosyl amide (116.6 mg,
0.681 mmol) and Si(OEt)4 (0.70 mL, 3.13 mmol) were heated
overnight to obtain the corresponding imine 437h. Imine 437h was dissolved in THF
(3.5 mL) and MeOH (0.75 mL) and reacted with NaBH4 (22.4 mg, 0.592 mmol). The
crude residue was purified to give the title compound 438h as a yellow solid (135.6 mg,
0.389 mmol) in 51% yield over two steps. 1H NMR (500 MHz, CDCl3): 𝛿 = 2.43 (s, 3H,
CH3), 3.69 (s, 3H, CH3), 4.25 (d, 2H, J = 6.0 Hz, CH2), 4.50 (t, 1H, J = 6.0 Hz, NH), 6.23
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(s, 1H, CHHet), 7.16-7.17 (m, 2H, 2CHHet), 7.31 (d, 2H, J = 8.0 Hz, 2CHAr), 7.47 (dd, 1H,
J = 2.0, 1.0 Hz, CHHet), 7.73-7.77 (m, 2H, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3):
𝛿 = 21.5, 30.0, 39.9, 102.0, 110.2, 119.9, 122.5, 125.4, 127.1, 127.8, 129.8, 134.7, 136.2,
136.4, 144.0 ppm.
NMR data is in agreement with published data.[196].4–1
N-((1-Benzyl-5-bromo-1H-indol-2-yl)methyl)-4-methylbenzenesulfonamide 438i
Following general procedure H, 1-benzyl-5-bromo-1H-indole-2carbaldehyde (147.7 mg, 0.470 mmol), tosyl amide (79.8 mg,
0.466 mmol) and Si(OEt)4 (0.24 mL, 1.07 mmol) were heated for
44 h to obtain the corresponding imine 437i. Imine 437i was dissolved in THF (2 mL)
and MeOH (0.4 mL) and reacted with NaBH4 (11.2 mg, 0.296 mmol). The reaction was
worked up to give the title compound 438i as a brown solid (223.3 mg, 0.476 mmol) in
quantitative yield over two steps. Sulfonamide 438i was used in the next reaction without
further purification. 1H NMR (500 MHz, CDCl3): 𝛿 = 2.42 (s, 3H, CH3), 4.16 (d, 2H,
J = 6.5 Hz, CH2), 4.47 (bs, 1H, NH), 5.31 (s, 2H, CH2), 6.32 (s, 1H, CHHet), 6.84-6.88
(m, 2H, 2CHAr), 7.08 (d, 1H, J = 8.5 Hz, CHHet), 7.22-7.28 (m, overlapped with CHCl3,
6H, 5CHAr, CHHet), 7.64-7.68 (m, 3H, 2CHAr, CHHet) ppm; 13C NMR (125 MHz, CDCl3):
𝛿 = 21.5, 39.8, 46.7, 102.8, 111.2, 113.2, 123.2, 125.3, 125.9, 127.2, 127.6, 128.8, 128.9,
129.8, 134.7, 136.1, 136.5, 137.0, 143.9 ppm; HRMS (ESI): m/z calcd for
C23H21(79Br)N2NaO2S [M + Na]+ 491.0399, found 491.0417; IR (ATR): 3278, 1429,
1313, 1149, 1090, 1049, 884 cm-1; MP: 142.8 °C decomp.
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4-Methyl-N-((1-methyl-1H-pyrrol-2-yl)methyl)benzenesulfonamide 438j
Following general procedure H, 1-methyl-1H-pyrrole-2-carbaldehyde[197] (976.7 mg, 8.95 mmol), tosyl amide (1.5393 g, 8.99 mmol) and
Si(OEt)4 (2.20 mL, 9.85 mmol) were heated overnight to obtain the corresponding imine
437j. Imine 437j was dissolved in THF (37.5 mL) and MeOH (7.5 mL) and reacted with
NaBH4 (174.5 mg, 4.61 mmol). The crude residue was purified to give the title compound
438j as solid (230.9 mg, 0.873 mmol) in 10% yield over two steps. 1H NMR (400 MHz,
CDCl3): 𝛿 = 2.44 (s, 3H, CH3), 3.57 (s, 3H, CH3), 4.04 (d, 2H, J = 5.8 Hz, CH2), 4.43 (t,
1H, J = 5.8 Hz, NH), 5.92 (dd, 1H, J = 3.6, 1.8 Hz, CHHet), 5.97 (dd, 1H, J = 3.6, 2.8 Hz,
CHHet), 6.57 (dd, 1H, J = 2.8, 1.8 Hz, CHAr), 7.33 (d, 2H, J = 8.6 Hz, 2CHAr), 7.72-7.77
(m, 2H, 2CHAr) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 21.5, 33.7, 39.3, 106.8, 109.5,
123.7, 126.0, 127.1, 129.8, 136.4, 143.6 ppm.
NMR data is in agreement with published data.[197]
4-Methyl-N-((1-tosyl-1H-pyrrol-2-yl)methyl)benzenesulfonamide 438k
Following general procedure H, 1-tosyl-1H-pyrrole-2-carbaldehyde[198]
(698.8 mg, 2.80 mmol), tosyl amide (481.9 mg, 2.81 mmol) and
Si(OEt)4 (1.38 mL, 6.18 mmol) were heated overnight to obtain the corresponding imine
437k. Imine 437k was dissolved in THF (11.5 mL) and MeOH (2.4 mL) and reacted with
NaBH4 (53.5 mg, 1.41 mmol). The crude residue was purified to give the title compound
438k as an off-white solid (738.4 mg, 1.83 mmol) in 65% yield over two steps. 1H NMR
(500 MHz, CDCl3): 𝛿 = 2.40 (s, 3H, CH3), 2.42 (s, 3H, CH3), 4.14 (d, 2H, J = 6.6 Hz,
CH2), 5.28 (t, 1H, J = 6.6 Hz, NH), 6.04-6.06 (m, 1H, CHAr), 6.07 (t, 1H, J = 3.5 Hz,
CHAr), 7.13 (dd, 1H, J = 3.5, 2.0 Hz, CHAr), 7.22-7.26 (m, overlapped with CHCl3, 4H,
4CHAr), 7.48 (d, 2H, J = 8.5 Hz, 2CHAr), 7.65 (d, 2H, J = 8.5 Hz, 2CHAr) ppm; 13C NMR
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(100 MHz, CDCl3): 𝛿 = 21.5, 21.6, 39.7, 111.8, 116.3, 123.7 (CHAr), 126.5, 127.1, 129.3,
129.5, 130.2, 135.6, 137.3, 143.1, 145.4 ppm.
NMR data is in agreement with published data.[150]
4-Methyl-N-((5-methylthiophen-2-yl)methyl)benzenesulfonamide 438l
Following general procedure H, 5-methyl-2-thiophenecarboxaldehyde (0.60 mL, 5.56 mmol), tosyl amide (954.5 mg, 5.57 mmol)
and Si(OEt)4 (1.37 mL, 6.14 mmol) were heated overnight to obtain the corresponding
imine 437l. Imine 437l was dissolved in THF (23.2 mL) and MeOH (4.6 mL) and reacted
with NaBH4 (107.6 mg, 2.84 mmol). The crude residue was purified to give the title
compound 438l as a yellow solid (1.3034 g, 4.63 mmol) in 83% yield over two steps. 1H
NMR (400 MHz, CDCl3): 𝛿 = 2.40 (s, 3H, CH3), 2.44 (s, 3H, CH3), 4.23 (d, 2H,
J = 6.0 Hz, CH2), 4.71 (bs, 1H, NH), 6.49-6.52 (m, 1H, CHHet), 6.62 (d, 1H, J = 3.4 Hz,
CHHet), 7.30 (d, 2H, J = 8.0 Hz, 2CHAr), 7.73-7.77 (m, 2H, 2CHAr) ppm;

13

C NMR

(100 MHz, CDCl3): 𝛿 = 15.3, 21.5, 42.4, 124.8, 126.5, 127.2, 129.7, 136.3, 136.8, 140.7,
143.6 ppm; HRMS (ESI): m/z calcd for C13H15NNaO2S2 [M + Na]+ 304.0436, found
304.0436; IR (ATR): 3280, 1416, 1324, 1165, 1092, 1057, 1041, 861, 809 cm-1; MP:
114.4–117.0 °C.
N-(Benzofuran-2-ylmethyl)-4-methylbenzenesulfonamide 438m
Following general procedure H, benzofuran-2-carbaldehyde
(0.41 mL, 3.38 mmol), tosyl amide (525.2 mg, 3.07 mmol) and
Si(OEt)4 (0.76 mL, 3.40 mmol) were heated overnight to obtain the corresponding imine
437m. Imine 437m was dissolved in THF (12.5 mL) and MeOH (2.5 mL) and reacted
with NaBH4 (60.2 mg, 1.59 mmol). The crude residue was purified to give the title
compound 438m as an off-white solid (706.0 mg, 2.34 mmol) in 76% yield over two304

steps. 1H NMR (500 MHz, CDCl3): 𝛿 = 2.31 (s, 3H, CH3), 4.33 (d, 2H, J = 6.5 Hz, CH2),
4.99 (bs, 1H, NH), 6.45 (s, 1H, CHHet), 7.13-7.19 (m, 3H, 2CHAr, CHHet), 7.22 (td, 1H,
J = 7.5, 1.5 Hz, CHHet), 7.28 (d, 1H, J = 8.0 Hz, CHHet), 7.43 (d, 1H, J = 7.5 Hz, CHHet),
7.67-7.71 (m, 2H, 2CHAr) ppm;

13

C NMR (125 MHz, CDCl3): 𝛿 = 21.4, 40.6, 105.0,

111.0, 121.0, 122.9, 124.3, 127.1, 127.8, 129.5, 136.7, 143.5, 152.0, 154.8 ppm; HRMS
(ESI): m/z calcd for C16H15NNaO3S [M + Na]+ 324.0665, found 324.0676; IR (ATR):
3276, 1597, 1492, 1452, 1327, 1254, 1162, 1089, 940, 851, 811, 760 cm-1; MP: 103.0–
106.7 °C.
N-(Benzo[b]thiophen-2-ylmethyl)-4-methylbenzenesulfonamide 438n
Following general procedure H, benzo[b]thiophene-2-carbaldehyde (309.7 mg, 1.91 mmol), tosyl amide (327.1 mg, 1.91 mmol)
and Si(OEt)4 (0.94 mL, 4.21 mmol) were heated overnight to obtain the corresponding
imine 437n. Imine 437n was dissolved in THF (8 mL) and MeOH (1.6 mL) and reacted
with NaBH4 (36.3 mg, 0.959 mmol). The crude residue was purified to give the title
compound 438n as a yellow solid (479.4 mg, 1.51 mmol) in 79% yield over two steps.
1

H NMR (400 MHz, CDCl3): 𝛿 = 2.40 (s, 3H, CH3), 4.42 (d, 2H, J = 6.3 Hz, CH2), 4.73-

4.78 (m, 1H, NH), 7.06 (s, 1H, CHHet), 7.26-7.34 (m, overlapped with CHCl3, 4H, 2CHAr,
2CHHet), 7.63-7.66 (m, 1H, CHAr), 7.72-7.78 (m, 3H, CHHet, 2CHAr) ppm;

13

C NMR

(100 MHz, CDCl3): 𝛿 = 21.5, 42.9, 122.3, 123.0, 123.5, 124.47, 124.53, 127.2, 129.7,
136.8, 139.3, 139.8, 139.9, 143.7 ppm; HRMS (ESI): m/z calcd for C16H15NNaO2S2
[M + Na]+ 340.0436, found 340.0435; IR (ATR): 3288, 1414, 1329, 1163, 1151, 1025,
812, 692, 666 cm-1; MP: 162.4–164.6 °C.
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4.4.1.7.

Preparation of Cyclopropenyl Sulfonamides 439

N-((2,3-Dibutylcycloprop-2-en-1-yl)methyl)-4-methyl-N-((5-methylfuran-2-yl)methyl)
benzenesulfonamide 439aa
Following the general procedure I, cyclopropenyl alcohol 436a
(204.1 mg, 1.12 mmol), furyl sulfonamide 438a (309.3 mg,
1.17 mmol), PPh3 (392.7 mg, 1.50 mmol) and THF (11 mL) were
added to a flask. DIAD (0.29 mL, 1.47 mmol) was added with
stirring at rt. Following purification the title compound 439aa was obtained as an oil
(330.0 mg, 0.768 mmol) in 69% yield with a purity of 95%. The contaminant was the
cyclobutene isomer of the title compound 439aa which has the same mass and Rf as 439aa
and could not be separated. 1H NMR (300 MHz, CDCl3): 𝛿 = 0.90 (t, 6H, J = 7.3 Hz,
2CH3), 1.25-1.39 (m, 4H, 2CH2), 1.40-1.54 (m, 5H, 2CH2, CH), 2.10 (s, 3H, CH3), 2.302.44 (m, 7H, 2CH2, CH3), 3.08 (d, 2H, J = 4.9 Hz, CH2), 4.44 (s, 2H, CH2), 5.78 (dd, 1H,
J = 3.1, 1.1 Hz, CHHet), 5.96 (d, 1H, J = 3.1 Hz, CHHet), 7.21 (d, 2H, J = 8.1 Hz, 2CHAr),
7.63 (d, 2H, J = 8.3 Hz, 2CHAr) ppm; 13C NMR (75 MHz, CDCl3): 𝛿 = 13.3, 13.8, 18.9,
21.4, 22.5, 25.1, 29.7, 43.1, 54.1, 106.0, 109.7, 114.5, 127.2, 129.1, 138.0, 142.4, 148.4,
151.6 ppm; HRMS (ESI): m/z calcd for C25H35NNaO3S [M + Na]+ 452.2230, found
452.2232; IR (ATR): 2956, 2928, 2872, 1599, 1563, 1455, 1344, 1220, 1158, 1093,
1020 cm-1.
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N-((2,3-Dibutylcycloprop-2-en-1-yl)methyl)-N-(furan-2-ylmethyl)-4-methylbenzene
sulfonamide 439ab
Following general procedure I, cyclopropenyl alcohol 436a
(404.5 mg, 2.22 mmol), furyl sulfonamide 438b (557.9 mg,
2.22 mmol), PPh3 (754.1 mg, 2.88 mmol) and THF (22 mL) were
added to a flask. DIAD (0.57 mL, 2.89 mmol) was added with stirring at rt. Following
purification the title compound 439ab was obtained as a colourless oil (614.1 mg,
1.48 mmol) in 67% yield with a purity of 94%. The contaminant was the cyclobutene
isomer of the title compound 439ab which has the same mass and Rf as 439ab and could
not be separated. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.89 (t, 6H, J = 7.3 Hz, 2CH3), 1.251.36 (m, 4H, 2CH2), 1.40 (t, 1H, J = 5.0 Hz, CH), 1.42-1.51 (m, 4H, 2CH2), 2.25-2.37
(m, 4H, 2CH2), 2.38 (s, 3H, CH3), 3.09 (d, 2H, J = 5.0 Hz, CH2), 4.49 (s, 2H, CH2), 6.10
(d, 1H, J = 3.1 Hz, CHHet), 6.22-6.25 (m, 1H, CHHet), 7.18-7.23 (m, 3H, 2CHAr, CHHet),
7.61 (d, 2H, J = 8.4 Hz, 2CHAr) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 13.8, 18.8, 21.4,
22.4, 25.1, 29.6, 43.0, 54.4, 108.7, 110.2, 114.4, 127.1, 129.3, 137.8, 141.9, 142.6, 150.6
ppm; HRMS (ESI): m/z calcd for C24H33NNaO3S [M + Na]+ 438.2073, found 438.2072;
IR (ATR): 2957, 2929, 2872, 1599, 1465, 1344, 1159, 1094, 1012 cm-1.
N-((2,3-Dipropylcycloprop-2-en-1-yl)methyl)-4-methyl-N-((5-methylfuran-2-yl)methyl)
benzenesulfonamide 439ac
Following general procedure I, cyclopropenyl alcohol 436b
(155.1 mg, 1.01 mmol), furyl sulfonamide 438a (278.1 mg,
1.05 mmol), PPh3 (343.0 mg, 1.31 mmol) and THF (10 mL) were
added to a flask. DIAD (0.26 mL, 1.32 mmol) was added with stirring at rt. Following
purification the title compound 439ac was obtained as a yellow oil (266.5 mg,
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0.664 mmol) in 66% yield with a purity of 93%. The contaminant was the cyclobutene
isomer of the title compound 439ac which has the same mass and Rf as 439ac and could
not be separated. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.92 (t, 6H, J = 7.5 Hz, 2CH3), 1.44
(t, 1H, J = 5.0 Hz, CH), 1.50-1.56 (m, 4H, 2CH2), 2.10 (d, 3H, J = 1.0 Hz, CH3), 2.302.36 (m, 4H, 2CH2), 2.39 (s, 3H, CH3), 3.08 (d, 2H, J = 5.0 Hz, CH2), 4.44 (s, 2H, CH2),
5.77-5.79 (m, 1H, CHHet), 5.96 (d, 1H, J = 3.0 Hz, CHHet), 7.19-7.23 (m, 2H, 2CHAr),
7.61-7.64 (m, 2H, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 13.3, 14.0, 18.9, 20.9,
21.4, 27.5, 43.1, 54.0, 106.0, 109.7, 114.5, 127.2, 129.1, 137.9, 142.4, 148.4, 151.6 ppm;
HRMS (ESI): m/z calcd for C23H32NO3S [M + H]+ 402.2097, found 402.2098; IR
(ATR): 2960, 2930, 2872, 1699, 1335, 1155, 1090, 814 cm-1.
N-((2,3-Dipropylcycloprop-2-en-1-yl)methyl)-N-((5-(ethoxymethyl)furan-2-yl)methyl)4-methylbenzenesulfonamide 439ad
Following general procedure I, cyclopropenyl alcohol 436b
(40.6 mg, 0.263 mmol), furyl sulfonamide 438c (84.1 mg,
0.272 mmol), PPh3 (90.4 mg, 0.345 mmol) and THF (2.6 mL)
were added to a flask. DIAD (70 μL, 0.356 mmol) was added
with stirring at rt. Following purification the title compound 439ad was obtained as a pale
yellow oil (75.2 mg, 0.169 mmol) in 64% yield with a purity of 95%. The contaminant
was the cyclobutene isomer of the title compound 439ad which has the same mass and
Rf as 439ad and could not be separated. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.91 (t, 6H,
J = 7.4 Hz, 2CH3), 1.18 (t, 3H, J = 7.0 Hz, CH3), 1.42 (t, 1H, J = 4.8 Hz, CH), 1.46-1.57
(m, 4H, 2CH2), 2.28-2.35 (m, 4H, 2CH2), 2.39 (s, 3H, CH3), 3.10 (d, 2H, J = 4.8 Hz,
CH2), 3.44 (q, 2H, J = 7.0 Hz, CH2), 4.26 (s, 2H, CH2), 4.48 (s, 2H, CH2), 6.04 (d, 1H,
J = 3.2 Hz, CHHet), 6.15 (d, 1H, J = 3.2 Hz, CHHet), 7.21 (d, 2H, J = 8.0 Hz 2CHAr), 7.61-
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7.65 (m, 2H, 2CHAr) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 14.0, 15.1, 18.8, 20.9, 21.4,
27.5, 43.2, 54.4, 64.4, 65.5, 109.4, 109.7, 114.5, 127.2, 129.3, 137.8, 142.5, 150.6, 151.6
ppm; HRMS (ESI): m/z calcd for C25H35NNaO4S [M + Na]+ 468.2179, found 468.2191;
IR (ATR): 2959, 2931, 2871, 1344, 1156, 1090, 1019 cm-1.
N-((5-Bromofuran-2-yl)methyl)-N-((2,3-dipropylcycloprop-2-en-1-yl)methyl)-4-methyl
benzenesulfonamide 439ae
Following general procedure I, cyclopropenyl alcohol 436b
(66.9 mg, 0.434 mmol), furyl sulfonamide 438d (140.8 mg,
0.426 mmol), PPh3 (147.2 mg, 0.561 mmol) and THF (4.4 mL)
were added to a flask. DIAD (0.11 mL, 0.559 mmol) was added with stirring at rt.
Following purification the title compound 439ae was obtained as an oil (124.8 mg,
0.268 mmol) in 63% yield with a purity of 88%. The contaminant was the cyclobutene
isomer of the title compound 439ae which has the same mass and Rf as 439ae and could
not be separated. 1H NMR (500 MHz, CDCl3) (mixture of isomers): 𝛿 = 0.81 (t, 3H,
J = 7.5 Hz, CH3, cyclobutene), 0.87 (t, 3H, J = 7.5 Hz, CH3, cyclobutene), 0.92 (t, 6H,
J = 7.5 Hz, 2CH3, cyclopropene), 1.38 (appar. q, 2H, J = 7.5 Hz, CH2, cyclobutene), 1.43
(t, 1H, J = 5.0 Hz, CH, cyclopropene), 1.48-1.58 (m, 4H, 2CH2, cyclopropene), 2.29-2.36
(m, 4H, 2CH2, cyclopropene), 2.40 (s, 3H, CH3, cyclopropene), 2.41 (s, 3H, CH3,
cyclobutene), 3.10 (d, 2H, J = 5.0 Hz, CH2, cyclopropene), 4.14 (d, 1H, J = 16.5 Hz,
CHaHb, cyclobutene), 4.20 (d, 1H, J = 16.5 Hz, CHaHb, cyclobutene), 4.45 (s, 2H, CH2,
cyclopropene), 4.75-4.79 (m, 1H, CH, cyclobutene), 6.10 (d, 1H, J = 3.0 Hz, CHHet,
cyclopropene), 6.13 (d, 1H, J = 3.0 Hz, CHHet, cyclopropene), 6.18 (d, 1H, J = 3.0 Hz,
CHHet, cyclobutene), 6.27 (d, 1H, J = 3.0 Hz, CHHet, cyclobutene), 7.23 (d, 2H,
J = 8.0 Hz, 2CHAr, cyclopropene and cyclobutene), 7.59-7.63 (m, 2H, 2CHAr,
cyclopropene and cyclobutene) ppm; 13C NMR (125 MHz, CDCl3) (mixture of isomers,
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minor isomer indicated by asterisk): 𝛿 = 13.99, 14.03*, 14.1*, 18.8, 20.4*, 20.6*, 20.9,
21.4, 27.5, 28.4*, 30.0*, 34.8*, 38.9*, 43.0, 54.5, 54.6*, 111.5, 111.6*, 111.9, 112.1*,
114.4, 120.5*, 121.0, 126.9*, 127.0, 129.35, 129.41*, 137.4, 140.3*, 142.8, 143.0*,
144.0*, 152.5, 153.8* ppm; HRMS (ESI): m/z calcd for C22H28(79Br)NNaO3S [M + Na]+
488.0865, found 488.0863; IR (ATR): 2959, 2929, 2871, 1496, 1455, 1338, 1156, 1091,
1012 cm-1.
4-Bromo-N-((2,3-dipropylcycloprop-2-en-1-yl)methyl)-N-((5-methylfuran-2-yl)methyl)
benzenesulfonamide 439af
Following general procedure I, cyclopropenyl alcohol 436b
(70.6 mg, 0.458 mmol), 4-bromo-N-((5-methylfuran-2-yl)methyl)
benzenesulfonamide (152.3 mg, 0.461 mmol), PPh3 (154.7 mg,
0.590 mmol) and THF (4.6 mL) were added to a flask. DIAD (0.12 mL, 0.609 mmol) was
added with stirring at rt. Following purification the title compound 439af was obtained
as a colourless oil (82.3 mg, 0.176 mmol) in 39% yield with a purity of 83%. The
contaminant was the cyclobutene isomer of the title compound 439af which has the same
mass and Rf as 439af and could not be separated. 1H NMR (500 MHz, CDCl3) (mixture
of isomers): 𝛿 = 0.84 (t, 3H, J = 7.5 Hz, CH3, cyclobutene), 0.88 (t, 3H, J = 7.5 Hz, CH3,
cyclobutene), 0.93 (t, 6H, J = 7.5 Hz, 2CH3, cyclopropene), 1.26-1.34 (m, 2H, CH2,
cyclobutene), 1.39 (appar. q, 2H, J = 7.5 Hz, CH2, cyclobutene), 1.47 (t, 1H, J = 5.0 Hz,
CH, cyclopropene), 1.51-1.58 (m, 4H, 2CH2, cyclopropene), 1.66-1.74 (m, 1H, CHaHb,
cyclobutene), 1.86-2.04 (m, 3H, CH2, CHaHb, cyclobutene), 2.07 (d, 3H, J = 1.0 Hz, CH3,
cyclopropene), 2.11 (d, 3H, J = 1.0 Hz, CH3, cyclobutene), 2.12-2.16 (m, 1H, CHaHb,
cyclobutene), 2.31-2.39 (m, 4H, 2CH2, cyclopropene), 2.42-2.48 (m, 1H, CHaHb,
cyclobutene), 3.10 (d, 2H, J = 5.0 Hz, CH2, cyclopropene), 4.12 (d, 1H, J = 16.0 Hz,
CHaHb, cyclobutene), 4.27 (d, 1H, J = 16.0 Hz, CHaHb, cyclobutene), 4.45 (s, 2H, CH2,
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cyclopropene), 4.77-4.80 (m, 1H, CH, cyclobutene), 5.78 (dq, 1H, J = 3.0, 1.0 Hz, CHHet,
cyclopropene), 5.81 (dq, 1H, J = 3.0, 1.0 Hz, CHHet, cyclobutene), 5.98 (d, 1H,
J = 3.0 Hz, CHHet, cyclopropene), 6.10 (d, 1H, J = 3.0 Hz, CHHet, cyclobutene), 7.52-7.59
(m, 4H, 4CHAr, cyclopropene and cyclobutene) ppm;
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C NMR (125 MHz, CDCl3)

(mixture of isomers, minor isomer indicated by asterisk): 𝛿 = 13.3, 14.02, 14.05*, 14.2*,
18.9, 20.4*, 20.6*, 20.9, 27.5, 28.5*, 30.0*, 35.0*, 39.1*, 42.9, 54.1, 54.7*, 106.0,
106.2*, 110.1, 110.3*, 114.4, 126.58, 126.65*, 128.5*, 128.7, 131.70, 131.73*, 139.9,
140.2*, 140.3*, 143.9*, 147.9, 148.9*, 151.5*, 151.9 ppm; HRMS (ESI): m/z calcd for
C22H28(79Br)NNaO3S [M + Na]+ 488.0865, found 488.0873; IR (ATR): 2958, 2928,
2871, 1574, 1470, 1341, 1158, 1090, 1067, 1009 cm-1.
N-((2,3-Dipropylcycloprop-2-en-1-yl)methyl)-N-((5-methylfuran-2-yl)methyl)-4-nitro
benzenesulfonamide 439ag
Following general procedure I, cyclopropenyl alcohol 436b
(103.3 mg, 0.670 mmol), N-((5-methylfuran-2-yl)methyl)-4-nitro
benzenesulfonamide (200.4 mg, 0.676 mmol), PPh3 (230.9 mg,
0.880 mmol) and THF (6.8 mL) were added to a flask. DIAD (0.17 mL, 0.863 mmol) was
added with stirring at rt. Following purification the title compound 439ag was obtained
as a yellow oil (110.2 mg, 0.255 mmol) in 38% yield with a purity of 64%. The
contaminant was the cyclobutene isomer of the title compound 439ag which has the same
mass and Rf as 439ag and could not be separated. 1H NMR (500 MHz, CDCl3) (mixture
of isomers): 𝛿 = 0.88 (appar. dt, 6H, J = 13.2, 7.5 Hz, 2CH3, cyclobutene), 0.94 (t, 6H,
J = 7.5 Hz, 2CH3, cyclopropene), 1.36-1.44 (m, 4H, 2CH2, cyclobutene), 1.51 (t, 1H,
J = 5.0 Hz, CH, cyclopropene), 1.53-1.59 (m, 4H, 2CH2, cyclopropene), 1.73-1.81 (m,
1H, CHaHb, cyclobutene), 1.92-2.09 (m, 6H, CH2, CHaHb, CH3, cyclobutene, 3H, CH3,
cyclopropene), 2.19-2.24 (m, 1H, CHaHb, cyclobutene), 2.33-2.41 (m, 4H, 2CH2,
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cyclopropene), 2.48-2.53 (m, 1H, CHaHb, cyclobutene), 3.15 (d, 2H, J = 5.0 Hz, CH2,
cyclopropene), 4.15 (d, 1H, J = 16.0 Hz, CHaHb, cyclobutene), 4.34 (d, 1H, J = 16.0 Hz,
CHaHb, cyclobutene), 4.50 (s, 2H, CH2, cyclopropene), 4.83-4.86 (m, 1H, CH,
cyclobutene), 5.76 (dq, 1H, J = 3.0, 1.0 Hz, CHHet, cyclopropene), 5.80 (dq, 1H,
J = 3.0, 1.0 Hz, CHHet, cyclobutene), 5.99 (d, 1H, J = 3.0 Hz, CHHet, cyclopropene), 6.12
(d, 1H, J = 3.0 Hz, CHHet, cyclobutene), 7.77-7.81 (m, 2H, 2CHAr, cyclobutene), 7.857.89 (m, 2H, 2CHAr, cyclopropene), 8.19-8.22 (m, 2H, 2CHAr, cyclobutene), 8.22-8.25
(m, 2H, 2CHAr, cyclopropene) ppm; 13C NMR (125 MHz, CDCl3) (mixture of isomers,
minor isomer indicated by asterisk): 𝛿 = 13.28*, 13.29, 14.01, 14.04*, 14.1*, 18.9, 20.4*,
20.6*, 20.9, 27.5, 28.4*, 30.0*, 35.2*, 39.1*, 43.0, 54.4, 54.8*, 106.1, 106.3*, 110.5,
110.9*, 114.3, 123.6*, 123.7, 128.0*, 128.3, 140.0*, 144.3*, 146.7, 147.0*, 147.5,
148.3*, 149.4*, 149.5, 151.7*, 152.0 ppm; HRMS (ESI): m/z calcd for C22H28N2NaO5S
[M + Na]+ 455.1611, found 455.1634; IR (ATR): 2959, 2931, 2871, 1606, 1528, 1347,
1310, 1159, 1090, 1020, 771 cm-1.
N-((2-(((tert-Butyldimethylsilyl)oxy)methyl)-3-hexylcycloprop-2-en-1-yl)methyl)-4methyl-N-((5-methylfuran-2-yl)methyl)benzenesulfonamide 439ah
Following general procedure I, cyclopropenyl alcohol 436c
(219.4 mg, 0.735 mmol), furyl sulfonamide 438a (198.6 mg,
0.749 mmol), PPh3 (256.9 mg, 0.979 mmol) and THF (7.5 mL)
were added to a flask. DIAD (0.19 mL, 0.965 mmol) was added with stirring at rt.
Following purification the title compound 439ah was obtained as an oil (311.0 mg,
0.570 mmol) in 78% yield. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.06 (s, 6H, Si(CH3)2), 0.850.91 (m, 3H, CH3), 0.89 (s, 9H, C(CH3)3), 1.23-1.35 (m, 6H, 3CH2), 1.48-1.57 (m, 2H,
CH2), 1.60 (t, 1H, J = 4.8 Hz, CH), 2.09 (s, 3H, CH3), 2.31-2.47 (m, 2H, CH2), 2.39 (s,
3H, CH3), 3.05 (dd, 1H, J = 14.1, 5.2 Hz, CHaHb), 3.17 (dd, 1H, J = 14.1, 4.6 Hz, CHaHb),
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4.45 (d, 2H, J = 3.2 Hz, CH2), 4.48-4.55 (m, 1H, CHaHb), 4.58 (dt, 1H, J = 15.4, 1.7 Hz,
CHaHb), 5.78 (dq, 1H, J = 3.1, 1.2 Hz, CHHet), 5.97 (d, 1H, J = 3.2 Hz, CHHet), 7.20 (d,
2H, J = 8.2 Hz, 2CHAr), 7.59-7.63 (m, 2H, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3):
𝛿 = -5.43, -5.41, 13.3, 14.0, 18.3, 20.3, 21.4, 22.6, 25.4, 25.8, 27.5, 29.1, 31.5, 43.2, 53.7,
58.7, 106.0, 109.8, 113.8, 116.7, 127.2, 129.2, 137.8, 142.5, 148.4, 151.7 ppm; HRMS
(ESI): m/z calcd for C30H47NNaO4SSi [M + Na]+ 568.2887, found 568.2889; IR (ATR):
2927, 2855, 1343, 1253, 1157, 1093, 1021, 835, 776 cm-1.
N-((2-(3-((tert-Butyldimethylsilyl)oxy)propyl)cycloprop-2-en-1-yl)methyl)-4-methylN-((5-methylfuran-2-yl)methyl)benzenesulfonamide 439ai
Following general procedure I, cycloropenyl alcohol 436d
(410.6 mg, 1.69 mmol), furyl sulfonamide 438a (451.1 mg,
1.70 mmol), PPh3 (586.7 mg, 2.24 mmol) and THF (17 mL) were
added to a flask. DIAD (0.43 mL, 2.18 mmol) was added with
stirring at rt. Following purification the title compound 439ai was obtained as a colourless
oil (545.4 mg, 1.11 mmol) in 66% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.03 (s, 6H,
Si(CH3)2), 0.88 (s, 9H, C(CH3)3), 1.54 (ddd, 1H, J = 5.5, 4.5, 1.5 Hz, CH), 1.72-1.78 (m,
2H, CH2), 2.11 (d, 3H, J = 1.0 Hz, CH3), 2.39 (s, 3H, CH3), 2.45-2.55 (m, 2H, CH2), 2.92
(dd, 1H, J = 14.0, 5.5 Hz, CHaHb), 3.23 (dd, 1H, J = 14.0, 4.5 Hz, CHaHb), 3.60-3.66 (m,
2H, CH2), 4.40 (d, 1H, J = 16.0 Hz, CHaHb), 4.48 (d, 1H, J = 16.0 Hz, CHaHb), 5.79 (dq,
1H, J = 3.0, 1.0 Hz, CHHet), 5.97 (d, 1H, J = 3.0 Hz, CHHet), 6.52-6.54 (m, 1H, CH), 7.22
(d, 2H, J = 7.9 Hz, 2CHAr), 7.62-7.66 (m, 2H, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3):
𝛿 = -5.3, 13.4, 17.0, 18.3, 21.4, 22.4, 25.9, 30.2, 43.5, 53.9, 62.2, 103.4, 106.0, 109.9,
124.7, 127.2, 129.2, 137.8, 142.5, 148.1, 151.8 ppm; HRMS (ESI): m/z calcd for
C26H39NNaO4SSi [M + Na]+ 512.2261, found 512.2257; IR (ATR): 2928, 2856, 1342,
1253, 1159, 1092, 1000, 834 cm-1.
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N-((2-Isopentylcycloprop-2-en-1-yl)methyl)-4-methyl-N-((5-methylfuran-2-yl)methyl)
benzenesulfonamide 439aj

Following general procedure F, cyclopropenyl carboxylate 435e (351.9 mg,
1.93 mmol) was dissolved in THF (10 mL) and to this was added DIBAL-H (1 M solution
in cyclohexanes, 7.7 mL, 7.70 mmol), portionwise. After 1.5 h at –78 °C, the reaction
was worked-up and purified to give cyclopropenyl alcohol 436e as an oil (89.6 mg,
0.639 mmol) in 33% yield. Cyclopropenyl alcohol 436e was used immediately in the next
step. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.90 (d, 3H, J = 2.0 Hz, CH3), 0.92 (d, 3H,
J = 2.0 Hz, CH3), 1.42-1.50 (m, 2H, CH2), 1.57-1.66 (m, 1H, CH), 1.70 (td, 1H, J = 4.4,
1.6 Hz, CH), 2.45-2.53 (m, 2H, CH2), 3.47 (dd, 1H, J = 10.7, 4.7 Hz, CHaHb), 3.58 (dd,
1H, J = 10.6, 4.2 Hz, CHaHb), 6.61-6.63 (m, 1H, CH) ppm; 13C NMR (100 MHz, CDCl3):
𝛿 = 20.5, 22.3, 22.4, 24.3, 27.6, 36.1, 68.7, 101.5, 125.9 ppm.
Following general procedure I, cyclopropenyl alcohol 436e (84.5 mg,
0.603 mmol), furyl sulfonamide 438a (168.9 mg, 0.637 mmol), PPh3 (209.3 mg,
0.798 mmol) and THF (6 mL) were added to a flask. DIAD (0.15 mL, 0.762 mmol) was
added with stirring at rt. After 39 h the reaction was worked up and following purification,
the title compound 439aj was obtained as an oil (145.2 mg, 0.375 mmol) in 62% yield.
1

H NMR (500 MHz, CDCl3): 𝛿 = 0.88 (d, 3H, J = 6.5, CH3), 0.89 (d, 3H, J = 6.5, CH3),

1.39-1.44 (m, 2H, CH2), 1.52 (ddd, 1H, J = 5.5, 4.5, 1.5 Hz, CH), 1.54-1.62 (m,
overlapped with H2O, 1H, CH), 2.11 (d, 3H, J = 1.0 Hz, CH3), 2.36-2.48 (m, 2H, CH2),
2.39 (s, 3H, CH3), 2.94 (dd, 1H, J = 14.0, 5.5 Hz, CHaHb), 3.22 (dd, 1H, J = 14.0, 4.5 Hz,
CHaHb), 4.40 (d, 1H, J = 16.0 Hz, CHaHb), 4.49 (d, 1H, J = 16.0 Hz, CHaHb), 5.78-5.81
314

(m, 1H, CHHet), 5.97 (d, 1H, J = 3.0 Hz, CHHet), 6.50 (m, 1H, CH), 7.22 (d, 2H,
J = 7.9 Hz, 2CHAr), 7.63-7.66 (m, 2H, 2CHAr) ppm;

13

C NMR (125 MHz, CDCl3):

𝛿 = 13.4, 17.0, 21.4, 22.2, 22.4, 23.9, 27.5, 36.0, 43.4, 54.0, 102.9, 106.0, 109.9, 125.2,
127.2, 129.2, 137.8, 142.5, 148.1, 151.8 ppm; HRMS (ESI): m/z calcd for C22H30NO3S
[M + H]+ 388.1941, found 388.1937; IR (ATR): 2953, 2922, 2868, 1340, 1156, 1092,
1019 cm-1.
N-((2-(tert-Butyl)cycloprop-2-en-1-yl)methyl)-4-methyl-N-((5-methylfuran-2-yl)meth
yl)benzenesulfonamide 439ak

Following general procedure F, cyclopropenyl carboxylate 435f (1.1870 g,
7.06 mmol) was dissolved in THF (35 mL) and to this was added DIBAL-H (1 M solution
in THF, 21 mL, 21.0 mmol). After 1 h at –78 °C, the reaction was worked-up and purified
to give cyclopropenyl alcohol 436f as an oil (579.0 mg, 4.59 mmol) in 65% yield.
Cyclopropenyl alcohol 436f was used immediately in the next step. 1H NMR (500 MHz,
CDCl3): 𝛿 = 1.15-1.17 (m, 9H, C(CH3)3), 1.76-1.79 (m, 1H, CH), 3.40 (dd, 1H, J = 10.5,
5.0 Hz, CHaHb), 3.63 (dd, 1H, J = 10.5, 4.0 Hz, CHaHb), 6.52 (d, 1H, J = 1.5 Hz, CH)
ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 20.9, 28.0, 31.1, 69.1, 98.7, 133.9 ppm.
Following general procedure I, cyclopropenyl alcohol 436f (536.2 mg,
4.25 mmol), furyl sulfonamide 438a (1.1543 g, 4.35 mmol), PPh3 (1.4505 g, 5.53 mmol)
and THF (42 mL) were added to a flask. DIAD (1.09 mL, 5.54 mmol) was added with
stirring at rt. Following purification the title compound 439ak was obtained as a
colourless oil (400.2 mg, 1.07 mmol) in 25% yield. A second fraction of the title
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compound 439ak (645.2 mg) was obtained with an estimated purity of 75% and was not
included in the product yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.11 (s, 9H, C(CH3)3),
1.61 (ddd, 1H, J = 7.5, 3.0, 1.5 Hz, CH), 2.11 (d, 3H, J = 1.0 Hz, CH3), 2.40 (s, 3H, CH3),
2.52 (dd, 1H, J = 14.0, 7.5 Hz, CHaHb), 3.65 (dd, 1H, J = 14.0, 3.0 Hz, CHaHb), 4.48 (s,
2H, CH2), 5.79 (dq, 1H, J = 3.0, 1.0 Hz, CHHet), 5.98 (d, 1H, J = 3.0 Hz, CHHet), 6.40 (d,
1H, J = 1.5 Hz, CH), 7.23 (d, 2H, J = 7.9 Hz, 2CHAr), 7.64-7.67 (m, 2H, 2CHAr) ppm;
13

C NMR (125 MHz, CDCl3): 𝛿 = 13.4, 17.4, 21.4, 28.1, 31.2, 43.3, 54.5, 100.9, 106.0,

109.9, 127.3, 129.2, 132.2, 137.7, 142.5, 148.1, 151.8 ppm; HRMS (ESI): m/z calcd for
C21H27NNaO3S [M + Na]+ 396.1604, found 396.1625; IR (ATR): 2964, 2917, 2868,
1340, 1323, 1157, 1092, 801 cm-1; MP: 56.6–58.8 °C.
N-((2,3-Diphenylcycloprop-2-en-1-yl)methyl)-4-methyl-N-((5-methylfuran-2yl)methyl) benzenesulfonamide 439al
Following general procedure I, cyclopropenyl alcohol 436g
(249.1 mg, 1.12 mmol), furyl sulfonamide 438a (297.0 mg,
1.12 mmol), PPh3 (387.5 mg, 1.48 mmol) and THF (11 mL) were
added to a flask. DIAD (0.29 mL, 1.47 mmol) was added with stirring at rt. Following
purification the title compound 439al was obtained as a yellow, viscous oil (422.3 mg,
0.899 mmol) in 80% yield. 1H NMR (500 MHz, CDCl3): 𝛿 = 2.02 (d, 3H, J = 1.0 Hz,
CH3), 2.36-2.39 (m, 4H, CH, CH3), 3.37 (d, 2H, J = 5.0 Hz, CH2), 4.47 (s, 2H, CH2), 5.71
(dt, 1H, J = 3.0, 1.0 Hz, CHHet), 5.84 (d, 1H, J = 3.0 Hz, CHHet), 7.20 (d, 2H, J = 8.0 Hz,
2CHAr), 7.32-7.37 (m, 2H, 2CHAr), 7.43-7.48 (m, 4H, 4CHAr), 7.65-7.69 (m, 6H, 6CHAr)
ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 13.3, 19.4, 21.4, 44.5, 52.7, 106.0, 110.4, 116.0,
127.4, 128.6, 128.8, 129.2, 129.3, 129.6, 137.4, 142.7, 147.7, 152.0 ppm; HRMS (ESI):
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m/z calcd for C29H27NNaO3S [M + Na]+ 492.1604, found 492.1603; IR (ATR): 2920,
1597, 1562, 1493, 1445, 1339, 1154, 1092, 1020, 754, 737 cm -1.
4-Methyl-N-((2-methyl-3-phenylcycloprop-2-en-1-yl)methyl)-N-((5-methylfuran-2-yl)
methyl)benzenesulfonamide 439am

Following a variation of general procedure E, prop-1-yn-1-ylbenzene[199]
(136.0 mg, 1.17 mmol), Rh2(OAc)4 (5.6 mg, 12.7 μmol) and DCM (1.2 mL) were added
to a round bottom flask. Ethyl diazoacetate (87% solution in DCM, 1.4 mL, 11.6 mmol)
in DCM (1.6 mL) was added and following the complete addition of the ethyl
diazoacetate, an additional portion of Rh2(OAc)4 (5.0 mg, 11.3 μmol) was added causing
the reaction to fizz. Flash column chromatography (15:85 EtOAc:hex) gave
cyclopropenyl carboxylate 435h (428.8 mg) with significant impurities from the
dimerization of ethyl diazoacetate. The residue was subjected to the next step without
further purification. In a separate case, to a mixture of prop-1-yn-1-ylbenzene (357.3 mg,
3.08 mmol), Rh2(OAc)4 (4.5 mg, 10.2 μmol) and DCM (1 mL) was added ethyl
diazoacetate (87% solution in DCM, 0.25 mL, 2.07 mmol) in DCM (0.5 mL). Flash
column chromatography gave cyclopropenyl carboxylate 435h as a colourless oil
(53.8 mg, 0.266 mmol) in 13% yield. 1H NMR (400 MHz, CDCl3): 𝛿 = 1.24 (t, 3H,
J = 7.1 Hz, CH3), 2.32 (s, 3H, CH3), 2.43 (s, 1H, CH), 4.11-4.20 (m, 2H, CH2), 7.27-7.33
(m, 1H, CHAr), 7.35-7.41 (m, 2H, 2CHAr), 7.44-7.48 (m, 2H, 2CHAr) ppm;

13

C NMR

(100 MHz, CDCl3): 𝛿 = 10.6, 14.4, 22.5, 60.1, 105.2, 106.3, 127.1, 128.50, 128.54, 129.2,
175.7 ppm.
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NMR data is in agreement with published data.[200]
Following general procedure F, cyclopropenyl carboxylate 435h (428.8 mg) was
dissolved in THF (6 mL) and to this was added DIBAL-H (1 M solution in THF, 4.2 mL,
4.20 mmol). Following completion, the reaction was worked-up and purified to give the
cyclopropenyl alcohol 436h as a yellow oil (30.8 mg). No yield was determined due to
impurities and cyclopropenyl alcohol 436h was used immediately in the next step. 1H
NMR (400 MHz, CDCl3): 𝛿 = 2.00 (t, 1H, J = 4.4 Hz, CH), 2.34 (s, 3H, CH3), 3.66-3.76
(m, 2H, CH2), 7.26-7.30 (m, overlapped with CHCl3, 1H, CHAr), 7.36-7.41 (m, 2H,
2CHAr), 7.47-7.51 (m, 2H, 2CHAr) ppm.
Following general procedure I, cyclopropenyl alcohol 436h (30.8 mg, ~0.192
mmol), furyl sulfonamide 438a (51.1 mg, 0.193 mmol), PPh3 (68.9 mg, 0.263 mmol) and
THF (2 mL) were added to a flask. DIAD (50 μL, 0.254 mmol) was added with stirring
at rt. Following purification the title compound 439am was obtained as an oil (13.2 mg,
32.4 μmol) in 3% yield over 3 steps. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.87 (dd, 1H,
J = 6.0, 3.5 Hz, CH), 2.07 (d, 3H, J = 1.0 Hz, CH3), 2.30 (s, 3H, CH3), 2.38 (s, 3H, CH3),
2.96 (dd, 1H, J = 14.0, 6.0 Hz, CHaHb), 3.55 (ddd, 1H, J = 14.0, 3.5, 1.0 Hz, CHaHb), 4.39
(d, 1H, J = 16.0 Hz, CHaHb), 4.51 (d, 1H, J = 16.0 Hz, CHaHb), 5.76 (dq, 1H, J = 3.0,
1.0 Hz, CHHet), 5.92 (d, 1H, J = 3.0 Hz, CHHet), 7.21 (d, 2H, J = 7.8 Hz, 2CHAr), 7.257.29 (m, overlapped with CHCl3, 1H, CHAr), 7.35-7.39 (m, 2H, 2CHAr), 7.41-7.44 (m,
2H, 2CHAr), 7.63-7.66 (m, 2H, 2CHAr) ppm;

13

C NMR (125 MHz, CDCl3): 𝛿 = 11.5,

13.3, 19.7, 21.4, 43.7, 52.8, 106.0, 110.0, 112.7, 116.0, 127.3, 127.8, 128.5, 128.8, 129.2,
129.4, 137.7, 142.6, 148.0, 151.8 ppm; HRMS (ESI): m/z calcd for C24H26NO3S
[M + H]+ 408.1628, found 408.1628.
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N-((2-(tert-Butyldimethylsilyl)-3-isopentylcycloprop-2-en-1-yl)methyl)-4-methyl-N((5-methylfuran-2-yl)methyl)benzenesulfonamide 439an

Following general procedure F, cyclopropenyl carboxylate 435i (171.8 mg,
0.579 mmol) was dissolved in THF (2.9 mL) and to this was added DIBAL-H (1 M
solution in THF, 2.1 mL, 2.10 mmol) portionwise. Following completion, the reaction
was worked-up to give cyclopropenyl alcohol 436i as an oil. No further purification or
characterisation was performed and cyclopropenyl alcohol 436i was used immediately in
the next step. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.11 (s, 3H, SiCH3), 0.13 (s, 3H, SiCH3),
0.91-0.93 (m, 15H, C(CH3)3, 2CH3), 1.42-62 (m, overlapped with other impurities, 4H,
CH2, 2CH), 2.54-2.60 (m, 2H, CH2), 3.45 (dd, 1H, J = 10.6, 4.6 Hz, CHaHb), 3.53 (dd,
1H, J = 10.6, 4.6 Hz, CHaHb) ppm.
Following the general procedure I, the crude residue of cyclopropenyl alcohol
436i, furyl sulfonamide 438a (188.0 mg, 0.708 mmol), PPh3 (199.0 mg, 0.759 mmol) and
THF (5.8 mL) were added to a flask. DIAD (0.15 mL, 0.762 mmol) was added with
stirring at rt. Following purification the title compound 439an was obtained as a
colourless oil (152.0 mg, 0.303 mmol) in 52% yield over 2 steps, with a purity of 79%.
The contaminant was allene 467 which has the same mass and Rf as 439an and could not
be separated. 1H NMR (500 MHz, CDCl3) (mixture of isomers): 𝛿 = 0.026 (s, 3H, SiCH3,
allene), 0.030 (s, 3H, SiCH3, allene), 0.08 (s, 3H, SiCH3, cyclopropene), 0.10 (s, 3H,
SiCH3, cyclopropene), 0.87-0.91 (m, 15H, C(CH3)3, 2CH3, cyclopropene and allene),
1.27-1.36 (m, 2H, CH2, allene), 1.37 (dd, 1H, J = 7.0, 3.0 Hz, CH, cyclopropene), 1.391.45 (m, 2H, CH2, cyclopropene), 1.49-1.56 (m, overlapped with H2O, 1H, CH,
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cyclopropene), 1.91-1.98 (m, 2H, CH2, allene), 2.10 (d, 3H, J = 1.0 Hz, CH3,
cyclopropene), 2.11 (d, 3H, J = 1.0 Hz, CH3, allene), 2.39 (s, 3H, CH3, cyclopropene),
2.40 (s, 3H, CH3, allene), 2.49 (t, 1H, J = 7.5 Hz, CHaHb, cyclopropene), 2.53 (t, 1H,
J = 8.0 Hz, CHaHb, cyclopropene), 2.55-2.61 (m, 1H, CHaHb, cyclopropene), 3.51 (ddd,
1H, J = 14.0, 3.0, 1.0 Hz, CHaHb, cyclopropene), 3.66 (dd, 1H, J = 8.0 Hz, 14.5 Hz,
CHaHb, allene), 3.94 (ddd, 1H, J = 14.5, 6.0, 1.0 Hz, CHaHb, allene), 4.34-4.39 (m, 1H,
CHaHb, cyclopropene and allene), 4.50 (d, 1H, J = 16.0 Hz, CHaHb, allene), 4.54 (d, 1H,
J = 16.0 Hz, CHaHb, cyclopropene), 4.68-4.74 (m, 1H, CH, allene), 5.78-5.81 (m, 1H,
CHHet, cyclopropene and allene), 5.97 (d, 1H, J = 3.0 Hz, CHHet, cyclopropene), 6.00 (d,
1H, J = 3.0 Hz, CHHet, allene), 7.20-7.24 (m, 2H, 2CHAr, cyclopropene and allene), 7.617.64 (m, 2H, 2CHAr, cyclopropene), 7.64-7.66 (m, 2H, 2CHAr, allene) ppm;
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C NMR

(125 MHz, CDCl3) (mixture of isomers, minor isomer indicated by asterisk):
𝛿 = -6.1*, -5.9*, -5.2, -5.1, 13.36, 13.38*, 16.9, 17.8*, 18.1, 21.42, 21.45*, 22.2, 22.5,
22.6*, 25.7, 26.4, 26.7*, 27.7, 27.76*, 27.78*, 36.2, 38.4*, 42.2*, 43.2, 46.6*, 55.0,
81.7*, 96.2*, 106.0*, 106.1, 108.4, 109.8, 109.9*, 127.2, 129.2, 129.3*, 137.8, 141.6,
142.5, 142.8*, 148.1*, 148.3, 151.7, 151.9*, 206.7* ppm; HRMS (ESI): m/z calcd for
C28H43NNaO3SSi [M + Na]+ 524.2625, found 524.2626; IR (ATR): 2953, 2927, 1340,
1156, 808, 773, 661 cm-1.
N-((2,3-Dipropylcycloprop-2-en-1-yl)methyl)-4-methyl-N-((5-phenylfuran-2-yl)methyl)
benzenesulfonamide 439ao
Following general procedure I, cyclopropenyl alcohol 436b
(29.3 mg, 0.190 mmol), furyl sulfonamide 438e (63.6 mg,
0.194 mmol), PPh3 (66.8 mg, 0.255 mmol) and THF (2 mL) were
added to a flask. DIAD (50 μL, 0.254 mmol) was added with stirring at rt. Following
purification the title compound 439ao was obtained as a colourless oil (55.6 mg,
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0.120 mmol) in 63% yield with a purity of 93%. The contaminant was the cyclobutene
isomer of the title compound 439ao which has the same mass and Rf as 439ao and could
not be separated. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.91 (t, 6H, J = 7.5 Hz, 2CH3), 1.491.58 (m, 5H, 2CH2,CH), 2.25 (s, 3H, CH3), 2.31-2.40 (m, 4H, 2CH2), 3.19 (d, 2H,
J = 5.0 Hz, CH2), 4.57 (s, 2H, CH2), 6.19 (d, 1H, J = 3.5 Hz, CHHet), 6.47 (d, 1H,
J = 3.5 Hz, CHHet), 7.13 (d, 2H, J = 7.5 Hz, 2CHAr), 7.22 (tt, 1H, J = 7.0, 1.0 Hz, CHAr),
7.29-7.34 (m, 2H, 2CHAr), 7.41-7.44 (m, 2H, 2CHAr), 7.60-7.63 (m, 2H, 2CHAr) ppm; 13C
NMR (125 MHz, CDCl3): 𝛿 = 14.0, 18.9, 20.9, 21.3, 27.5, 43.0, 54.5, 105.4, 110.9, 114.5,
123.5, 126.9, 127.2, 128.5, 129.3, 130.4, 137.6, 142.6, 149.9, 153.4 ppm; HRMS (ESI):
m/z calcd for C28H33NNaO3S [M + Na]+ 486.2073, found 486.2072; IR (ATR): 2959,
2928, 2871, 1597, 1449, 1338, 1155, 1092, 1019, 759, 654 cm-1.cm-1
N-((2,3-Dipropylcycloprop-2-en-1-yl)methyl)-4-methyl-N-((1-methyl-1H-indol-2-yl)
methyl)benzenesulfonamide 439ba
Following general procedure I, cyclopropenyl alcohol 436b
(99.5 mg, 0.645 mmol), 1H-indolyl sulfonamide 438f
(204.8 mg, 0.651 mmol), PPh3 (221.9 mg, 0.846 mmol) and
THF (6.5 mL) were added to a flask. DIAD (0.17 mL, 0.863 mmol) was added with
stirring at rt. Following purification the title compound 439ba was obtained as a yellow
solid (185.5 mg, 0.412 mmol) in 64% yield with a purity of 94%. The contaminant was
the cyclobutene isomer of the title compound 439ba which has the same mass and Rf as
439ba and could not be separated. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.81 (t, 6H,
J = 7.4 Hz, 2CH3), 1.09 (t, 1H, J = 4.8 Hz, CH), 1.34-1.44 (m, 4H, 2CH2), 2.10-2.17 (m,
4H, 2CH2), 2.42 (s, 3H, CH3), 2.99 (d, 2H, J = 4.8 Hz, CH2), 3.84 (s, 3H, CH3), 4.50 (s,
2H, CH2), 6.27 (s, 1H, CHHet), 7.07 (ddd, 1H, J = 8.0, 7.0, 1.2 Hz, CHHet), 7.20 (ddd, 1H,
J = 8.0, 7.0, 1.2 Hz, CHHet), 7.27-7.32 (m, 3H, 2CHAr, CHHet), 7.51 (d, 1H, J = 8.0 Hz,
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CHHet), 7.71 (d, 2H, J = 8.3 Hz, 2CHAr); 13C NMR (100 MHz, CDCl3): 𝛿 = 13.9, 19.0,
20.8, 21.5, 27.3, 30.0, 45.3, 55.0, 103.3, 109.2, 114.6, 119.4, 120.4, 121.7, 127.1, 127.3,
129.6, 133.7, 136.6, 138.2, 143.1 ppm; HRMS (ESI): m/z calcd for C27H35N2O2S
[M + H]+ 451.2414, found 451.2434; IR (ATR): 2956, 2930, 2869, 1468, 1337, 1307,
1162, 1088, 878, 813, 733 cm-1; MP: 63.4–65.1 °C.
N-((2-(3-((tert-Butyldimethylsilyl)oxy)propyl)cycloprop-2-en-1-yl)methyl)-4-methylN-((1-methyl-1H-indol-2-yl)methyl)benzenesulfonamide 439bb
Following general procedure I, cyclopropenyl alcohol
436d (63.4 mg, 0.262 mmol), 1H-indolyl sulfonamide
438f (75.5 mg, 0.240 mmol), PPh3 (84.3 mg, 0.321 mmol)
and THF (2.5 mL) were added to a flask. DIAD (60 μL,
0.305 mmol) was added with stirring at rt. After 7.5 h the reaction was worked up and
following purification, the title compound 439bb was obtained as an oil (57.1 mg,
0.106 mmol) in 44% yield. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.01 (s, overlapped with
TMS, 6H, Si(CH3)2), 0.88 (s, 9H, C(CH3)3), 1.22-1.26 (m, 1H, CH), 1.57-1.66 (m, 2H,
CH2), 2.27-2.33 (m, 2H, CH2), 2.45 (s, 3H, CH3), 2.70 (dd, 1H, J = 14.8, 6.0 Hz, CHaHb),
3.28 (dd, 1H, J = 14.6, 3.6 Hz, CHaHb), 3.48-3.54 (m, 2H, CH2), 3.89 (s, 3H, CH3), 4.43
(d, 1H, J = 14.2 Hz, CHaHb), 4.62 (d, 1H, J = 14.2 Hz, CHaHb), 6.02 (appar. q, 1H,
J = 1.6 Hz, CH), 6.31 (s, 1H, CHHet), 7.10 (ddd, 1H, J = 8.0, 7.0, 1.0 Hz, CHHet), 7.23
(ddd, 1H, J = 8.2, 7.0, 1.2 Hz, CHHet), 7.30-7.36 (m, 3H, 2CHAr, CHHet), 7.54 (dt, 1H,
J = 8.0, 1.0 Hz, CHHet), 7.73-7.77 (m, 2H, 2CHAr);
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C NMR (100 MHz, CDCl3):

𝛿 = -5.4, 17.2, 18.3, 21.5, 22.1, 25.9, 30.10, 30.12, 45.5, 54.8, 62.1, 103.4, 103.6, 109.2,
119.5, 120.4, 121.8, 124.1, 127.0, 127.3, 129.7, 133.4, 136.4, 138.2, 143.2 ppm; HRMS
(ESI): m/z calcd for C30H43N2O3SSi [M + H]+ 539.2758, found 539.2758; IR (ATR):
2950, 2855, 1470, 1339, 1252, 1158, 1092, 834, 773, 747 cm-1.
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N-((5-Bromo-1-methyl-1H-indol-2-yl)methyl)-N-((2,3-dipropylcycloprop-2-en-1yl)methyl)-4-methylbenzenesulfonamide 439bc
Following general procedure I, cyclopropenyl alcohol
436b (32.1 mg, 0.208 mmol), 1H-indolyl sulfonamide
438g (69.9 mg, 0.178 mmol), PPh3 (62.3 mg, 0.238 mmol)
and THF (1.8 mL) were added to a flask. DIAD (50 μL, 0.254 mmol) was added with
stirring at rt. Following purification the title compound 439bc was obtained as a white
gum-like solid (59.6 mg, 0.113 mmol) in 63% yield with a purity of 89%. The
contaminant was the cyclobutene isomer of the title compound 439bc which has the same
mass and Rf as 439bc and could not be separated. 1H NMR (500 MHz, CDCl3) (mixture
of isomers): 𝛿 = 0.63 (t, 3H, J = 7.0 Hz, CH3, cyclobutene), 0.81 (t, 6H, J = 7.7 Hz, 2CH3,
cyclopropene, 3H, CH3, cyclobutene), 1.05 (t, 1H, J = 5.0 Hz, CH, cyclopropene), 1.341.44 (m, 4H, 2CH2, cyclopropene), 1.78-1.89 (m, 3H, CH2, CHaHb, cyclobutene), 2.072.19 (m, 4H, 2CH2,cyclopropene), 2.21-2.25 (m, 1H, CHaHb, cyclobutene), 2.41 (s, 3H,
CH3, cyclopropene), 2.42 (s, 3H, CH3, cyclobutene), 2.98 (d, 2H, J = 5.0 Hz, CH2,
cyclopropene), 3.80 (s, 3H, CH3, cyclobutene), 3.82 (s, 3H, CH3, cyclopropene), 4.37 (d,
1H, J = 15.5 Hz, CHaHb, cyclobutene), 4.46 (s, 2H, CH2, cyclopropene), 4.53 (d, 1H,
J = 15.5 Hz, CHaHb, cyclobutene), 4.76-4.79 (m, 1H, CH, cyclobutene), 6.21 (s, 1H,
CHHet, cyclopropene), 6.25 (s, 1H, CHHet, cyclobutene), 7.16 (d, 1H, J = 8.5 Hz, CHHet,
cyclopropene and cyclobutene), 7.25-7.30 (m, overlapped with CHCl3, 3H, 2CHAr, CHHet,
cyclopropene and cyclobutene), 7.60 (d, 1H, J = 2.0 Hz, CHHet, cyclobutene), 7.62 (d,
1H, J = 2.0 Hz, CHHet, cyclopropene), 7.69 (d, 2H, J = 8.5 Hz, 2CHAr, cyclopropene),
7.72 (d, 2H, J = 8.5 Hz, 2CHAr, cyclobutene) ppm; 13C NMR (125 MHz, CDCl3) (mixture
of isomers, minor isomer indicated by asterisk): 𝛿 = 13.88, 13.94*, 14.1*, 18.9, 20.2*,
20.5*, 20.8, 21.4, 21.5*, 27.3, 28.4*, 29.9*, 30.2, 33.5*, 40.2*, 45.2, 54.8*, 55.3, 102.5*,
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102.6, 110.5*, 110.6, 112.7, 114.5, 122.6*, 122.8, 124.1*, 124.5, 127.15*, 127.23, 128.7,
128.9*, 129.59, 129.63*, 135.1, 136.3, 136.7, 137.0*, 140.6*, 142.9*, 143.2, 143.4* ppm;
HRMS (ESI): m/z calcd for C27H33(79Br)N2NaO2S [M + Na]+ 551.1338, found 551.1340;
IR (ATR): 2956, 2927, 2870, 1470, 1338, 1160, 1089, 793, 773, 714 cm-1.
N-((5-Chloro-1-methyl-1H-indol-2-yl)methyl)-N-((2,3-dipropylcycloprop-2-en-1yl)meth yl)-4-methylbenzenesulfonamide 438bd
Following general procedure I, cyclopropenyl alcohol
436b (39.6 mg, 0.257 mmol), 1H-indolyl sulfonamide
438h (67.8 mg, 0.194 mmol), PPh3 (66.1 mg, 0.252 mmol)
and THF (2 mL) were added to a flask. DIAD (50 μL, 0.254 mmol) was added with
stirring at rt. Following purification the title compound 439bd was obtained as a white
gum-like solid (68.9 mg, 0.142 mmol) in 73% yield with a purity of 90%. The
contaminant was the cyclobutene isomer of the title compound 439bd which has the same
mass and Rf as 439bd and could not be separated. 1H NMR (500 MHz, CDCl3):
𝛿 = 0.81 (t, 6H, J = 7.5 Hz, 2CH3), 1.06 (t, 1H, J = 5.0 Hz, CH), 1.34-1.43 (m, 4H, 2CH2),
2.07-2.19 (m, 4H, 2CH2), 2.41 (s, 3H, CH3), 2.98 (d, 2H, J = 5.0 Hz, CH2), 3.82 (s, 3H,
CH3), 4.46 (s, 2H, CH2), 6.22 (s, 1H, CHHet), 7.14 (dd, 1H, J = 8.5, 2.0 Hz, CHHet), 7.20
(d, 1H, J = 8.5 Hz, CHHet), 7.28 (d, 2H, J = 8.0 Hz, 2CHAr), 7.46 (d, 1H, J = 2.0 Hz,
CHHet), 7.67-7.71 (m, 2H, 2CHAr) ppm;
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C NMR (125 MHz, CDCl3): 𝛿 = 13.9, 18.9,

20.7, 21.4, 27.3, 30.2, 45.2, 55.2, 102.7, 110.1, 114.5, 119.7, 121.9, 125.1, 127.2, 128.0,
129.6, 135.2, 136.3, 136.5, 143.2 ppm; HRMS (ESI): m/z calcd for C27H34(35Cl)N2O2S
[M + H]+ 485.2024, found 485.2034; IR (ATR): 2957, 2926, 2871, 1475, 1336, 1159,
1089, 1061, 793, 772, 743, 716 cm-1; MP: 65.4–67.8 °C. 63.4–65.1 °
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N-((1-Benzyl-5-bromo-1H-indol-2-yl)methyl)-N-((2,3-dipropylcycloprop-2-en-1yl)meth yl)-4-methylbenzenesulfonamide 439be
Following general procedure I, cyclopropenyl alcohol
436b (26.3 mg, 0.171 mmol), 1H-indolyl sulfonamide 438i
(69.9 mg, 0.149 mmol), PPh3 (51.3 mg, 0.196 mmol) and
THF (1.5 mL) were added to a flask. DIAD (40 μL, 0.203 mmol) was added with stirring
at rt. Following purification the title compound 439be was obtained as a yellow oil
(50.7 mg, 83.7 μmol) in 56% yield. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.82 (t, 6H,
J = 7.4 Hz, 2CH3), 1.12 (t, 1H, J = 4.8 Hz, CH), 1.34-1.44 (m, 4H, 2CH2), 2.07-2.19 (m,
4H, 2CH2), 2.38 (s, 3H, CH3), 3.02 (d, 2H, J = 5.0 Hz, CH2), 4.38 (s, 2H, CH2), 5.49 (s,
2H, CH2), 6.30 (s, 1H, CHHet), 6.94 (dd, 2H, J = 7.7, 1.8 Hz, 2CHAr), 7.10 (d, 1H,
J = 8.8 Hz, CHHet), 7.19-7.27 (m, overlapped with CHCl3, 6H, 5CHAr, CHHet), 7.61 (d,
2H, J = 8.3 Hz, 2CHAr), 7.67 (d, 1H, J = 1.9 Hz, CHHet) ppm;
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C NMR (100 MHz,

CDCl3): 𝛿 = 13.9, 18.8, 20.8, 21.4, 27.3, 44.6, 46.6, 55.1, 103.5, 111.3, 113.0, 114.5,
123.0, 124.9, 126.0, 127.3, 127.4, 128.7, 129.0, 129.5, 135.2, 136.5, 136.6, 137.4, 143.1
ppm; HRMS (ESI): m/z calcd for C33H38(79Br)N2O2S [M + H]+ 605.1832, found
605.1833; IR (ATR): 2958, 2928, 2870, 1495, 1451, 1332, 1156, 1090, 899, 729 cm-1.
N-((2,3-Dipropylcycloprop-2-en-1-yl)methyl)-4-methyl-N-((1-methyl-1H-pyrrol-2-yl)
methyl)benzenesulfonamide 439ca
Following general procedure I, cyclopropenyl alcohol 436b
(118.7 mg, 0.770 mmol), 1H-pyrrolyl sulfonamide 438j (200.4 mg,
0.758 mmol), PPh3 (256.3 mg, 0.977 mmol) and THF (7.6 mL) were
added to a flask. DIAD (0.19 mL, 0.965 mmol) was added with stirring at rt. Following
purification the title compound 439ca was obtained as an oil (166.0 mg, 0.414 mmol) in
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54% yield with a purity of 95%. The contaminant was the cyclobutene isomer of the title
compound 439ca which has the same mass and Rf as 439ca and could not be separated.
1

H NMR (400 MHz, CDCl3): 𝛿 = 0.87 (t, 6H, J = 7.4 Hz, 2CH3), 1.04 (t, 1H, J = 4.9 Hz,

CH), 1.40-1.51 (m, 4H, 2CH2), 2.15-2.30 (m, 4H, 2CH2), 2.42 (s, 3H, CH3), 2.92 (d, 2H,
J = 4.9 Hz, CH2), 3.70 (s, 3H, CH3), 4.29 (s, 2H, CH2), 5.91 (dd, 1H, J = 3.6, 2.0 Hz,
CHHet), 5.98 (dd, 1H, J = 3.6, 2.8 Hz, CHHet), 6.59 (dd, 1H, J = 2.8, 2.0 Hz, CHHet), 7.28
(d, 2H, J = 8.0 Hz, 2CHAr), 7.64-7.68 (m, 2H, 2CHAr);
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C NMR (100 MHz, CDCl3):

𝛿 = 14.0, 18.9, 20.8, 21.5, 27.4, 34.1, 44.6, 54.6, 106.6, 110.5, 114.7, 123.4, 126.0, 127.2,
129.5, 136.8, 142.8 ppm; HRMS (ESI): m/z calcd for C23H32N2NaO2S [M + Na]+
423.2077, found 423.2066; IR (ATR): 2958, 2871, 1453, 1336, 1302, 1156, 1091, 900,
814 cm-1.
N-((2,3-Dipropylcycloprop-2-en-1-yl)methyl)-4-methyl-N-((5-methylthiophen-2-yl)
methyl)benzenesulfonamide 439d
Following general procedure I, cyclopropenyl alcohol 436b
(160.1 mg, 1.04 mmol), thiophenyl sulfonamide 438l (306.9 mg,
1.09 mmol), PPh3 (361.7 mg, 1.38 mmol) and THF (10 mL) were
added to a flask. DIAD (0.27 mL, 1.37 mmol) was added with stirring at rt. Following
purification the title compound 439d was obtained as a colourless oil (344.8 mg,
0.826 mmol) in 80% yield with a purity of 93%. The contaminant was the cyclobutene
isomer of the title compound 439d which has the same mass and Rf as 439d and could
not be separated. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.90 (t, 6H, J = 7.5 Hz, 2CH3), 1.39
(t, 1H, J = 5.0 Hz, CH), 1.45-1.55 (m, 4H, 2CH2), 2.26-2.32 (m, 4H, 2CH2), 2.39 (d, 3H,
J = 1.0 Hz, CH3), 2.40 (s, 3H, CH3), 3.11 (d, 2H, J = 5.0 Hz, CH2), 4.55 (s, 2H, CH2),
6.52 (appar. dq, 1H, J = 3.5, 1.0 Hz, CHHet), 6.65 (d, 1H, J = 3.5 Hz, CHHet), 7.23 (d, 2H,
J = 7.9 Hz, 2CHAr), 7.63-7.67 (m, 2H, 2CHAr) ppm;
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C NMR (125 MHz, CDCl3):
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𝛿 = 14.0, 15.3, 18.8, 20.9, 21.4, 27.5, 45.4, 54.0, 114.5, 124.5, 126.8, 127.2, 129.4, 137.2,
138.0, 140.0, 142.7 ppm; HRMS (ESI): m/z calcd for C23H31NNaO2S2 [M + Na]+
440.1688, found 440.1687; IR (ATR): 2958, 2926, 2871, 1452, 1337, 1154, 1091, 902,
801, 761, 742 cm-1.
N-(Benzofuran-2-ylmethyl)-N-((2,3-dipropylcycloprop-2-en-1-yl)methyl)-4methylbenzene sulfonamide 439e
Following general procedure I, cyclopropenyl alcohol 436b
(56.6 mg, 0.367 mmol), benzofuranyl sulfonamide 438m
(117.7 mg, 0.391 mmol), PPh3 (122.1 mg, 0.466 mmol) and
THF (3.8 mL) were added to a flask. DIAD (90 μL, 0.457 mmol) was added with stirring
at rt. Following purification the title compound 439e was obtained as a pale yellow oil
(69.6 mg, 0.159 mmol) in 43% yield with a purity of 86%. The contaminant was the
cyclobutene isomer of the title compound 439e which has the same mass and Rf as 439e
and could not be separated. 1H NMR (400 MHz, CDCl3) (mixture of isomers): 𝛿 = 0.77
(t, 3H, J = 7.4 Hz, CH3, cyclobutene), 0.89 (t, 6H, J = 7.2 Hz, 2CH3, cyclopropene, 3H,
CH3, cyclobutene), 1.37 (appar. q, 2H, J = 7.4 Hz, CH2, cyclobutene), 1.45-1.55 (m, 5H,
2CH2, CH, cyclopropene), 1.77-1.87 (m, 1H, CHaHb, cyclobutene), 1.90-2.03 (m, 2H,
CH2, cyclobutene), 2.03-2.09 (m, 1H, CHaHb, cyclobutene), 2.27-2.33 (m, 4H, 2CH2,
cyclopropene), 2.34 (s, 3H, CH3, cyclopropene), 2.35 (s, 3H, CH3, cyclobutene), 2.402.26 (m. 1H, CHaHb, cyclobutene), 3.20 (d, 2H, J = 5.0 Hz, CH2, cyclopropene), 4.30 (d,
1H, J = 16.8 Hz, CHaHb, cyclobutene), 4.38 (d, 1H, J = 16.8 Hz, CHaHb, cyclobutene),
4.64 (s, 2H, CH2, cyclopropene), 4.81-4.85 (m, 1H, CH, cyclobutene), 6.49 (appar. q, 1H,
J = 0.8 Hz, CHHet, cyclopropene), 6.67 (appar. q, 1H, J = 0.8 Hz, CHHet, cyclobutene),
7.13-7.23 (m, 4H, 2CHAr, 2CHHet, cyclopropene and cyclobutene), 7.24-7.28 (m,
overlapped with CHCl3, 1H, CHHet, cyclopropene), 7.30-7.33 (m, 1H, CHHet,
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cyclobutene), 7.44-7.47 (m, 1H, CHHet, cyclopropene), 7.47-7.50 (m, 1H, CHHet,
cyclobutene), 7.64 (d, 2H, J = 8.3 Hz, 2CHAr, cyclopropene and cyclobutene); 13C NMR
(100 MHz, CDCl3) (mixture of isomers, minor isomer indicated by asterisk): 𝛿 = 13.98,
14.03*, 14.1*, 18.9, 20.4*, 20.6*, 20.9, 21.38, 21.41*, 27.5, 28.5*, 30.0*, 34.9*, 39.6*,
43.7, 54.87*, 54.90, 105.36*, 105.45, 110.9, 114.5, 120.8, 120.9*, 122.6*, 122.7, 123.8*,
124.0, 127.09*, 127.14, 128.1, 129.2, 129.3*, 137.5, 142.7, 153.3, 154.69*, 154.74 ppm;
HRMS (ESI): m/z calcd for C26H31NNaO3S [M + Na]+ 460.1917, found 460.1942; IR
(ATR): 2959, 2930, 2871, 1453, 1340, 1156, 1090, 950, 905, 813 cm-1.
N-(Benzo[b]thiophen-2-ylmethyl)-N-((2,3-dipropylcycloprop-2-en-1-yl)methyl)-4methyl benzenesulfonamide 439f
Following general procedure I, cyclopropenyl alcohol 436b
(56.5 mg, 0.366 mmol), benzo[b]thiophenyl sulfonamide 438n
(117.9 mg, 0.371 mmol), PPh3 (128.9 mg, 0.491 mmol) and
THF (3.8 mL) were added to a flask. DIAD (90 μL, 0.457 mmol) was added with stirring
at rt. Following purification the title compound 439f was obtained as an oil (110.5 mg,
0.244 mmol) in 66% yield with a purity of 91%. The contaminant was the cyclobutene
isomer of the title compound 439f which has the same mass and Rf as 439f and could not
be separated. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.88 (t, 6H, J = 7.4 Hz, 2CH3), 1.41 (t,
1H, J = 5.0 Hz, CH), 1.44-1.51 (m, 4H, 2CH2), 2.23-2.32 (m, 4H, 2CH2), 2.38 (s, 3H,
CH3), 3.18 (d, 2H, J = 5.0 Hz, CH2), 4.72 (s, 2H, CH2), 7.11 (d, 1H, J = 1.0 Hz, CHHet),
7.22 (d, 2H, J = 7.8 Hz, 2CHAr), 7.26-7.33 (m, overlapped with CHCl3, 2H, 2CHHet), 7.647.75 (m, 4H, 2CHAr, 2CHHet); 13C NMR (125 MHz, CDCl3): 𝛿 = 14.0, 18.7, 20.8, 21.4,
27.5, 46.1, 54.7, 114.5, 122.2, 123.1, 123.3, 124.1, 124.2, 127.2, 129.4, 137.7, 139.4,
140.0, 141.0, 142.9 ppm; HRMS (ESI): m/z calcd for C26H32NO2S2 [M + H]+ 454.1869,
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found 454.1889; IR (ATR): 2958, 2927, 2870, 1457, 1435, 1337, 1154, 1090, 903, 813,
745 cm-1.

4.4.2. Gold(I)-Catalysed Reactions of Cyclopropenyl Sulfonamides 439
4.4.2.1.

Gold(I)-Catalysed Reactions of Cyclopropenyl Furyl Sulfonamides 439a

7,8-Dibutyl-6-methyl-2-tosyl-2,3,6,8a-tetrahydro-1H-3a,6-epoxycyclohepta[c]pyrrole
448a
Following general procedure J, cyclopropenyl furyl sulfonamide
439aa (53.7 mg, 0.125 mmol) was dissolved in DCE (1.25 mL)
and IPrAuCl (3.8 mg, 6.12 µmol) and AgBF4 (1.2 mg, 6.16 µmol)
were added at 0 °C and the reaction was complete after 1 h. Purification gave the title
compound 439aa as a yellow oil (38.1 mg, 88.7 µmol) in 75% yield (yield has been
corrected for the presence of cyclobutene in the starting material). 1H NMR (300 MHz,
CDCl3): 𝛿 = 0.84-0.93 (m, 6H, 2CH3), 1.10-1.33 (m, 8H, 4CH2), 1.34 (s, 3H, CH3), 1.661.78 (m, 1H, CHaHb), 1.90-2.18 (m, 4H, CH2, CHaHb, CH), 2.41 (s, 3H, CH3), 2.97 (dd,
1H, J = 11.0, 9.0 Hz, CHaHb), 3.33 (d, 1H, J = 12.0 Hz, CHaHb), 3.80 (d, 1H, J = 12.0 Hz,
CHaHb), 3.92 (dd, 1H, J = 9.0, 7.7 Hz, CHaHb), 5.70 (d, 1H, J = 5.7 Hz, CH), 6.18 (d, 1H,
J = 5.7 Hz, CH), 7.30 (d, 2H, J = 8.1 Hz, 2CHAr), 7.72 (d, 2H, J = 8.1 Hz, 2CHAr) ppm;
13

C NMR (75 MHz, CDCl3): 𝛿 = 13.8, 13.9, 19.9, 21.5, 22.8, 22.9, 27.2, 30.6, 31.1, 32.4,

43.5, 51.8, 54.6, 85.1, 90.2, 126.9, 127.5, 128.0, 129.6, 134.3, 139.3, 143.1, 143.3 ppm;
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HRMS (ESI): m/z calcd for C25H35NNaO3S [M + Na]+ 452.2230, found 452.2232; IR
(ATR): 2957, 2931, 2871, 1458, 1346, 1164, 1117, 1092, 815, 716 cm-1.
7,8-Dibutyl-2-tosyl-2,3,6,8a-tetrahydro-1H-3a,6-epoxycyclohepta[c]pyrrole 448b
Following general procedure J, cyclopropenyl furyl sulfonamide
439ab (300.4 mg, 0.723 mmol) was dissolved in DCE (7.09 mL)
and IPrAuCl (22.1 mg, 35.6 µmol) and AgBF4 (7.0 mg, 36.0 µmol) were added at 0 °C
and the reaction was complete after 1 h. Purification by column gave the title compound
448b as a white solid (201.1 mg, 0.484 mmol) in 71% yield with minor impurities (yield
has been corrected for the presence of cyclobutene in the starting material).
Recrystallisation from pentane at 0 °C, overnight gave the title compound 448b as pure,
white crystals (58.2 mg, 0.140 mmol) in 21% yield (yield has been corrected for the
presence of cyclobutene in the starting material). 1H NMR (400 MHz, CDCl3): 𝛿 = 0.850.91 (m, 6H, 2CH3), 1.10-1.33 (m, 8H, 4CH2), 1.64-1.74 (m, 1H, CHaHb), 1.96-2.12 (m,
4H, CH2, CHaHb, CH), 2.42 (s, 3H, CH3), 2.93 (dd, 1H, J = 11.0, 8.8 Hz, CHaHb), 3.33
(d, 1H, J = 11.8 Hz, CHaHb), 3.86 (d, 1H, J = 11.8 Hz, CHaHb), 3.93 (dd, 1H, J = 8.8,
7.6 Hz, CHaHb), 4.49 (d, 1H, J = 1.8 Hz, CH), 5.82 (d, 1H, J = 5.6 Hz, CH), 6.42 (dd, 1H,
J = 5.6, 1.8 Hz, CH), 7.33 (d, 2H, J = 8.0 Hz, 2CHAr), 7.72 (d, 2H, J = 8.3 Hz, 2CHAr)
ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 13.91, 13.94, 21.5, 22.60, 22.62, 29.2, 30.3, 30.4,
30.8, 42.0, 51.8, 54.3, 80.4, 90.3, 127.3, 127.5, 127.8, 129.7, 134.0, 136.9, 139.0, 143.4
ppm; HRMS (DART): m/z calcd for C24H34NO3S [M + H]+ 416.2254, found 416.2260;
IR (ATR): 2956, 2929, 2871, 2859, 1598, 1466, 1346, 1165, 1092, 1014, 816 cm-1; MP:
76.3–78.4 °C.
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6-Methyl-7,8-dipropyl-2-tosyl-2,3,6,8a-tetrahydro-1H-3a,6-epoxycyclohepta[c]pyrrole
448c24
Following general procedure J, cyclopropenyl furyl sulfonamide
439ac (20.0 mg, 49.8 μmol) was dissolved in DCE (0.5 mL) and
IPrAuCl (1.6 mg, 2.50 µmol) and AgBF4 (0.5 mg, 2.57 µmol) were
added at 0 °C and the reaction was complete after 1 h. Purification gave the title
compound 448c as a yellow oil (12.0 mg, 29.9 µmol) in 65% yield (yield has been
corrected for the presence of cyclobutene in the starting material). 1H NMR (500 MHz,
CDCl3): 𝛿 = 0.83 (t, 3H, J = 7.5 Hz, CH3), 0.89 (t, 3H, J = 7.5 Hz, CH3), 1.16-1.24 (m,
2H, 2CHaHb), 1.28-1.36 (m, 2H, 2CHaHb), 1.35 (s, 3H, CH3), 1.70-1.78 (m, 1H, CHaHb),
1.95-2.05 (m, 2H, 2CHaHb), 2.05-2.14 (m, 2H, CHaHb, CH), 2.42 (s, 3H, CH3), 2.97 (dd,
1H, J = 11.0, 9.0 Hz, CHaHb), 3.33 (d, 1H, J = 11.5 Hz, CHaHb), 3.81 (d, 1H, J = 11.5 Hz,
CHaHb), 3.92 (dd, 1H, J = 9.0, 7.5 Hz, CHaHb), 5.72 (d, 1H, J = 5.5 Hz, CH), 6.18 (d, 1H,
J = 5.5 Hz, CH), 7.31 (d, 2H, J = 8.0 Hz, 2CHAr), 7.71-7.74 (m, 2H, 2CHAr) ppm; 13C
NMR (125 MHz, CDCl3): 𝛿 = 14.1, 14.3, 19.9, 21.5, 21.7, 23.4, 29.6, 33.4, 43.5, 51.8,
54.6, 85.1, 90.2, 127.0, 127.5, 128.0, 129.7, 134.3, 139.4, 143.1, 143.3 ppm; HRMS
(ESI): m/z calcd for C23H31NNaO3S [M + Na]+ 424.1917, found 424.1916; IR (ATR):
2959, 2930, 2871, 1456, 1341, 1160, 1091, 813 cm-1.
6-(Ethoxymethyl)-7,8-dipropyl-2-tosyl-2,3,6,8a-tetrahydro-1H-3a,6-epoxycyclohepta[c]
pyrrole 448d
Following general procedure J, cyclopropenyl furyl sulfonamide
439ad (44.8 mg, 0.101 mmol) was dissolved in DCE (1 mL) and
IPrAuCl (3.2 mg, 5.15 µmol) and AgBF4 (1.0 mg, 5.14 µmol) were added at 0 °C and the

24

Results were obtained by our collaborator, Dr Sebastian Arndt
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reaction was complete after 1 h. Purification gave the title compound 448d as a yellow
oil (23.5 mg, 52.7 µmol) in 55% yield (yield has been corrected for the presence of
cyclobutene in the starting material). 1H NMR (400 MHz, CDCl3): 𝛿 = 0.83 (t, 3H,
J = 7.2 Hz, CH3), 0.89 (t, 3H, J = 7.2 Hz, CH3), 1.14 (t, 3H, J = 7.0 Hz, CH3), 1.17-1.40
(m, 4H, 2CH2), 1.69-1.78 (m, 1H, CHaHb), 1.92-2.10 (m, 3H, 2CHaHb, CH), 2.12-2.21
(m, 1H, CHaHb), 2.42 (s, 3H, CH3), 3.02 (dd, 1H, J = 11.0, 9.0 Hz, CHaHb), 3.40 (d, 1H,
J = 12.0 Hz, CHaHb), 3.43-3.51 (m, 2H, CH2), 3.60 (d, 1H, J = 11.0 Hz, CHaHb), 3.66 (d,
1H, J = 11.0 Hz, CHaHb), 3.83 (d, 1H, J = 12.0 Hz, CHaHb), 3.93 (dd, 1H, J = 9.0, 7.7 Hz,
CHaHb), 5.76 (d, 1H, J = 5.6 Hz, CH), 6.23 (d, 1H, J = 5.6 Hz, CH), 7.30 (d, 2H,
J = 7.7 Hz, 2CHAr), 7.70-7.74 (m, 2H, 2CHAr) ppm;

13

C NMR (100 MHz, CDCl3):

𝛿 = 14.1, 14.4, 14.9, 21.5, 21.6, 23.7, 29.4, 33.2, 43.3, 51.8, 54.5, 67.2, 70.7, 87.9, 90.6,
127.5, 127.6, 129.1, 129.6, 134.3, 138.0, 140.1, 143.3 ppm; HRMS (ESI): m/z calcd for
C25H35NNaO4S [M + Na]+ 468.2179, found 468.2181; IR (ATR): 2959, 2871, 1456,
1341, 1163, 1092, 908, 813 cm-1.
6-Bromo-7,8-dipropyl-2-tosyl-2,3,6,8a-tetrahydro-1H-3a,6-epoxycyclohepta[c]pyrrole
448e
Following general procedure J, cyclopropenyl furyl sulfonamide
439ae (63.3 mg, 0.136 mmol) was dissolved in DCE (1.36 mL) and
IPrAuCl (4.3 mg, 6.92 µmol) and AgBF4 (1.3 mg, 6.68 µmol) were
added at 0 °C with stirring. After 3 days at 0 °C, TLC and 1H NMR indicated the reaction
had only gone to ~50% completion so an additional portion of IPrAuCl (8.7 mg,
14.0 µmol) and AgBF4 (2.5 mg, 12.8 µmol) were added. After another 18 h at 0 °C, the
reaction was complete and purification gave the title compound 448e as a pale yellow
solid (7.9 mg, 16.9 µmol) in 14% yield (yield has been corrected for the presence of
cyclobutene in the starting material). 1H NMR (500 MHz, CDCl3): 𝛿 = 0.85 (t, 3H,
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J = 7.5 Hz, CH3), 0.91 (t, 3H, J = 7.5 Hz, CH3), 1.20-1.36 (m, 3H, CH2, CHaHb), 1.441.51 (m, 1H, CHaHb), 1.77-1.84 (m, 1H, CHaHb), 2.00-2.08 (m, 1H, CHaHb), 2.12 (dd,
1H, J = 11.0, 7.5 Hz, CH), 2.16-2.24 (m, 1H, CHaHb), 2.28-2.35 (m, 1H, CHaHb), 2.43 (s,
3H, CH3), 2.98 (dd, 1H, J = 11.0, 9.0 Hz, CHaHb), 3.40 (d, 1H, J = 12.0 Hz, CHaHb), 3.89
(d, 1H, J = 12.0 Hz, CHaHb), 3.96 (dd, 1H, J = 9.0, 7.5 Hz, CHaHb), 5.82 (d, 1H,
J = 5.5 Hz, CH), 6.52 (d, 1H, J = 5.5 Hz, CH), 7.32 (d, 2H, J = 8.0 Hz, 2CHAr), 7.71 (d,
2H, J = 8.0 Hz, 2CHAr) ppm;

13

C NMR (125 MHz, CDCl3): 𝛿 = 14.06, 14.13, 21.48,

21.55, 23.0, 32.2, 34.1, 44.4, 51.3, 53.8, 93.3, 97.5, 126.5, 127.5, 129.1, 129.8, 133.7,
138.3, 143.4, 143.8 ppm; HRMS (ESI): m/z calcd for C22H29(79Br)NO3S [M + H]+
466.1046, found 466.1062; IR (ATR): 2952, 2927, 2870, 1454, 1333, 1164, 1096, 1061,
975 cm-1; MP: 119.7–121.8 °C.
2-((4-Bromophenyl)sulfonyl)-6-methyl-7,8-dipropyl-2,3,6,8a-tetrahydro-1H-3a,6epoxycyclohepta[c]pyrrole 448f
Following general procedure J, cyclopropenyl furyl sulfonamide
439af (64.9 mg, 0.139 mmol) was dissolved in DCE (1.39 mL) and
IPrAuCl (4.3 mg, 6.92 µmol) and AgBF4 (1.4 mg, 7.19 µmol) were added at 0 °C and the
reaction was stirred for 2.5 h. Purification gave the title compound 448f as a white solid
(32.9 mg, 70.5 µmol) in 61% yield (yield has been corrected for the presence of
cyclobutene in the starting material). 1H NMR (400 MHz, CDCl3): 𝛿 = 0.84 (t, 3H,
J = 7.2 Hz, CH3), 0.90 (t, 3H, J = 7.2 Hz, CH3), 1.16-1.38 (m, 4H, 2CH2), 1.34 (s, 3H,
CH3), 1.69-1.78 (m, 1H, CHaHb), 1.92-2.16 (m, 4H, CH, CH2, CHaHb), 2.96 (dd, 1H,
J = 11.0, 8.8 Hz, CHaHb), 3.35 (d, 1H, J = 11.8 Hz, CHaHb), 3.80 (d, 1H, J = 11.8 Hz,
CHaHb), 3.92 (dd, 1H, J = 8.8, 7.8 Hz, CHaHb), 5.72 (d, 1H, J = 5.6 Hz, CH), 6.21 (d, 1H,
J = 5.6 Hz, CH), 7.63-7.72 (m, 4H, 4CHAr) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 14.1,
14.3, 19.9, 21.6, 23.4, 29.6, 33.4, 43.4, 52.0, 54.7, 85.2, 90.1, 126.6, 127.6, 127.9, 129.0,
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132.3, 136.3, 139.6, 143.4 ppm; HRMS (ESI): m/z calcd for C22H29(79Br)NO3S [M + H]+
466.1046, found 466.1064; IR (ATR): 2958, 2931, 2869, 1574, 1454, 1337, 1159, 1110,
1070, 1008, 814 cm-1; MP: 136.6–138.5 °C.
6-Methyl-2-((4-nitrophenyl)sulfonyl)-7,8-dipropyl-2,3,6,8a-tetrahydro-1H-3a,6epoxycyclohepta[c]pyrrole 448g
Following general procedure J, cyclopropenyl furyl sulfonamide
439ag (57.2 mg, 0.132 mmol) was dissolved in DCE (1.32 mL)
and IPrAuCl (4.1 mg, 6.60 µmol) and AgBF4 (1.3 mg, 6.68 µmol)
were added at 0 °C and the reaction was stirred for 2.5 h. Purification gave the title
compound 448g as a white solid (17.0 mg, 39.3 µmol) in 46% yield (yield has been
corrected for the presence of cyclobutene in the starting material). 1H NMR (400 MHz,
CDCl3): 𝛿 = 0.84 (t, 3H, J = 7.2 Hz, CH3), 0.89 (t, 3H, J = 7.2 Hz, CH3), 1.16-1.38 (m,
4H, 2CH2), 1.29 (s, 3H, CH3), 1.69-1.78 (m, 1H, CHaHb), 1.91-2.14 (m, 3H, CH2, CHaHb),
2.20 (dd, 1H, J = 11.0, 8.0 Hz, CH), 2.99 (dd, 1H, J = 10.8, 8.8 Hz, CHaHb ), 3.40 (d, 1H,
J = 11.8 Hz, CHaHb), 3.84 (d, 1H, J = 11.8 Hz, CHaHb), 3.97 (dd, 1H, J = 8.8, 8.0 Hz,
CHaHb), 5.72 (d, 1H, J = 5.6 Hz, CH), 6.23 (d, 1H, J = 5.6 Hz, CH), 8.00-8.04 (m, 2H,
2CHAr), 8.34-8.38 (m, 2H, 2CHAr) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = 14.1, 14.3,
19.8, 21.6, 23.4, 29.6, 33.4, 43.3, 52.2, 54.9, 85.3, 90.0, 124.2, 126.2, 127.8, 128.6, 139.7,
143.2, 143.8, 150.1 ppm; HRMS (ESI): m/z calcd for C22H28N2NaO5S [M + Na]+
455.1611, found 455.1639; IR (ATR): 2959, 2934, 2864, 1527, 1343, 1315, 1156, 1090,
1061, 853, 810, 737 cm-1; MP: 146.9–148.0 °C.
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7-(((tert-Butyldimethylsilyl)oxy)methyl)-8-hexyl-6-methyl-2-tosyl-2,3,6,8a-tetrahydro1H-3a,6-epoxycyclohepta[c]pyrrole 448h and N-(3-(2-((tert-butyldimethylsilyl)oxy)vinyl)non-2-en-1-yl)-4-methyl-N-((5-methylfuran-2-yl)methyl)benzenesulfonamide 459ah
Following general procedure J, cyclopropenyl furyl sulfonamide 439ah
(111.4 mg, 0.204 mmol) was dissolved in DCE (2.04 mL) and IPrAuCl (6.3 mg,
10.1 µmol) and AgBF4 (2.0 mg, 10.3 µmol) were added at 0 °C and the reaction was
stirred for 2 h. Purification gave the 5,7-fused heterocycle 448h as an off-white crystal
(3.0 mg, 5.50 µmol) in 3% yield and a mixture of diene 459ah as a colourless oil
(36.8 mg, 67.4 µmol) in 33% yield. All four possible isomers were obtained as a mixture
and were assigned as isomer a, b, c and d based on their abundance in the 1H NMR. The
ration of ab:c:d was 4.4:2.1:1.6:1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 0.03 (s, 3H, SiCH3), 0.05 (s,

3H, SiCH3), 0.87-0.89 (m, 12H, C(CH3)3, CH3), 1.18-1.32 (m,
8H, 4CH2), 1.43 (s, 3H, CH3), 1.74-1.82 (m, 1H, CHaHb), 1.992.07 (m, 2H, CHaHb, CH), 2.42 (s, 3H, CH3), 2.98 (dd, 1H, J = 11.0, 9.0 Hz, CHaHb), 3.36
(d, 1H, J = 12.0 Hz, CHaHb), 3.82 (d, 1H, J = 12.0 Hz, CHaHb), 3.92 (dd, 1H, J = 9.0,
8.0 Hz, CHaHb), 4.03 (d, 1H, J = 11.5 Hz, CHaHb), 4.23 (d, 1H, J = 11.5 Hz, CHaHb), 5.67
(d, 1H, J = 5.5 Hz, CH), 6.22 (d, 1H, J = 5.5 Hz, CH), 7.30 (d, 2H, J = 8.0 Hz, 2CHAr),
7.71-7.74 (m, 2H, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = -5.6, -5.4, 14.0, 18.1,
19.3, 21.5, 22.5, 25.8, 28.9, 29.2, 31.4, 31.6, 43.2, 51.6, 54.6, 57.3, 84.8, 90.2, 126.0,
127.5, 129.7, 130.7, 134.3, 138.6, 143.4, 144.3 ppm; HRMS (ESI): m/z calcd for
C30H47NNaO4SSi [M + Na]+ 568.2887, found 568.2885; IR (ATR): 2927, 2857, 1470,
1338, 1250, 1164, 1123, 1058, 834, 773 cm-1.
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1

H NMR (400 MHz, CDCl3): 𝛿 = 0.10-0.16 (m, 6H, Si(CH3)2,

for all isomers), 0.86-0.93 (m, 12H, C(CH3)3, CH3, for all
isomers), 1.20-1.37 (m, 8H, 4CH2, for all isomers), 2.05 (t, 2H,
J = 7.6 Hz, CH2, for isomers a, c, d), 2.12 (s, 3H, CH3, for all
isomers), 2.17-2.23 (m, 2H, CH2, for isomer b), 2.39-2.43 (m, 3H, CH3, for all isomers),
3.78 (d, 2H, J = 7.0 Hz, CH2, for isomer c), 3.84-3.90 (m, 2H, CH2, for isomer a, b, d),
4.30 (appar. d, 2H, J = 2.5 Hz, CH2, for all isomers), 4.69 (d, 1H, J = 7.0 Hz, CH, for
isomer d), 4.86 (d, 1H, J = 6.7 Hz, CH, for isomer c), 4.90-5.02 (m, 1H, CH, for isomers
a, b, c), 5.38 (t, 1H, J = 7.0 Hz, CH, for isomer d), 5.52 (d, 1H, J = 12.1 Hz, CH, for
isomer b), 5.77-5.84 (m, 1H, CHHet, for all isomers, CH for isomer a), 5.98-6.02 (m, 1H,
CHHet, for all isomers), 6.10 (d, 1H, J = 6.7 Hz, CH, for isomer d), 6.14 (dd, 1H,
J = 6.8, 1.0 Hz, CH, isomer C), 6.52 (d, 1H, J = 12.1 Hz, CH, for isomer b), 6.58 (d, 1H,
J = 12.0 Hz, CH, for isomer a), 7.21-7.26 (m, 2H, 2CHAr, for all isomers), 7.65 (d, 2H,
J = 8.3 Hz, 2CHAr, for all isomers) ppm; 13C NMR (125 MHz, CDCl3) (only carbons for
major isomer reported: 𝛿 = -5.3, 13.4, 14.1, 18.3, 21.4, 22.6, 25.6, 28.7, 29.2, 31.7, 34.4,
42.6, 44.1, 106.0, 109.0, 110.2, 118.7, 127.3, 129.2, 137.6, 138.9, 142.7, 143.4, 147.9,
152.0 ppm; HRMS (ESI): m/z calcd for C30H47NNaO4SSi [M + Na]+ 568.2887, found
568.2894; IR (ATR): 2928, 2856, 1463, 1340, 1157, 1091, 835, 781, 733 cm-1.
8-(3-((tert-Butyldimethylsilyl)oxy)propyl)-6-methyl-2-tosyl-2,3,6,8a-tetrahydro-1H3a,6-epoxycyclohepta[c]pyrrole 448i and 8-(3-((tert-butyldimethylsilyl)oxy)propyl)-6methyl-2-tosyl-2,3-dihydrocyclohepta[c]pyrrol-4(1H)-one 462
Following general procedure J, cyclopropenyl furyl sulfonamide 439ai (133.0 mg,
0.272 mmol) was dissolved in DCE (2.90 mL) and IPrAuCl (8.5 mg, 13.7 µmol) and
AgBF4 (2.6 mg, 13.4 µmol) were added at 0 °C and the reaction was complete after 1 h.
Purification gave the title compound 448i as an off-white crystal (31.3 mg, 63.9 µmol) in
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24% yield. In addition to the desired heterocycle 448i, tropone 462 was also obtained as
an oil (12.2 mg, 25.0 µmol) in 9% yield. Other complex side products were also obtained
from the reaction which could not be isolated or identified.
1

H NMR (500 MHz, CDCl3): 𝛿 = 0.03 (s, 6H, Si(CH3)2), 0.89 (m,

9H, C(CH3)3), 1.31 (s, 3H, CH3), 1.46-1.58 (m, overlapped with
H2O, 2H, CH2), 1.82-1.96 (m, 2H, CH2), 2.03 (dd, 1H, J = 10.5,
8.5 Hz, CH), 2.42 (s, 3H, CH3), 2.96 (dd, 1H, J = 11.0, 9.0 Hz, CHaHb), 3.38 (d, 1H,
J = 12.0 Hz, CHaHb), 3.48-3.56 (m, 2H, CH2), 3.83 (d, 1H, J = 12.0 Hz, CHaHb), 3.93
(dd, 1H, J = 9.0, 8.0 Hz, CHaHb), 5.66 (q, 1H, J = 1.5 Hz, CH), 5.75 (d, 1H, J = 5.5 Hz,
CH), 6.22 (d, 1H, J = 5.5 Hz, CH), 7.31 (d, 2H, J = 8.0 Hz, 2CHAr), 7.71-7.74 (m, 2H,
2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = -5.3, 18.3, 21.51, 21.53, 25.9, 29.9, 31.2,
43.4, 51.2, 54.4, 62.3, 82.3, 90.5, 127.3, 127.5, 129.1, 129.7, 134.1, 135.3, 142.8, 143.4
ppm; HRMS (ESI): m/z calcd for C26H39NNaO4SSi [M + Na]+ 512.2261, found
512.2254; IR (ATR): 2927, 2855, 1338, 1252, 1164, 1115, 1084, 832, 815 cm-1; MP:
104.4–105.4 °C.
1

H NMR (500 MHz, CDCl3): 𝛿 = 0.09 (s, 6H, Si(CH3)2), 0.94 (s,

9H, C(CH3)3), 1.74-1.81 (m, 2H, CH2), 2.30 (s, 3H, CH3), 2.38 (s,
3H, CH3), 2.66-2.71 (m, 2H, CH2), 3.66 (t, 2H, J = 6.0 Hz, CH2),
3.99 (s, 2H, CH2), 4.48 (s, 2H, CH2), 7.21-7.24 (m, 3H, 3CHAr),
7.56 (bs, 1H, CHAr), 7.59-7.62 (m, 2H, 2CHAr) ppm;

13

C NMR (125 MHz, CDCl3):

𝛿 = -5.3, 18.3, 20.9, 21.5, 26.0, 28.6, 33.0, 44.9, 53.8, 62.0, 125.2, 127.6, 129.8, 130.2,
133.3, 133.7, 136.1, 137.3, 138.6, 144.1, 191.5 ppm; HRMS (ESI): m/z calcd for
C26H37NNaO4SSi [M + Na]+ 510.2105, found 510.2111; IR (ATR): 2928, 2856, 1694,
1351, 1160, 1091, 834 cm-1.
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8-Isopentyl-6-methyl-2-tosyl-2,3,6,8a-tetrahydro-1H-3a,6-epoxycyclohepta[c]pyrrole
448j
Following general procedure J, cyclopropenyl furyl sulfonamide
439aj (64.8 mg, 0.167 mmol) was dissolved in DCE (1.67 mL)
and IPrAuCl (5.2 mg, 8.37 µmol) and AgBF4 (1.6 mg, 8.22 µmol)
were added at 0 °C and the reaction was complete after 45 min. Purification gave the title
compound 448j as an off-white crystal (21.5 mg, 55.5 µmol) in 33% yield. 1H NMR
(400 MHz, CDCl3): 𝛿 = 0.85 (d, 6H, J = 6.6 Hz, 2CH3), 1.14-1.21 (m, 2H, CH2), 1.31 (s,
3H, CH3), 1.38-1.49 (m, 1H, CH), 1.74-1.92 (m, 2H, CH2), 2.03 (dd, 1H, J = 10.6,
8.3 Hz, CH), 2.42 (s, 3H, CH3), 2.96 (dd, 1H, J = 11.0, 9.0 Hz, CHaHb), 3.37 (d, 1H,
J = 11.8 Hz, CHaHb), 3.84 (d, 1H, J = 11.8 Hz, CHaHb), 3.93 (dd, 1H, J = 9.0, 7.8 Hz,
CHaHb), 5.65 (q, 1H, J = 1.6 Hz, CH), 5.74 (d, 1H, J = 5.6 Hz, CH), 6.22 (d, 1H,
J = 5.6 Hz, CH), 7.31 (d, 2H, J = 7.9 Hz, 2CHAr), 7.71-7.75 (m, 2H, 2CHAr) ppm; 13C
NMR (100 MHz, CDCl3): 𝛿 = 21.50, 21.55, 22.2, 22.6, 27.7, 32.9, 35.9, 43.4, 51.2, 54.5,
82.4, 90.5, 127.2, 127.5, 128.7, 129.7, 134.2, 136.0, 142.8, 143.4 ppm; HRMS (ESI):
m/z calcd for C22H29NNaO3S [M + Na]+ 410.1760, found 410.1781; IR (ATR): 2956,
2928, 2872, 2860, 1465, 1338, 1162, 1111, 1096, 816, 807, 731, 724 cm-1; MP: 93.5–
96.5 °C.
8-(tert-Butyl)-6-methyl-2-tosyl-2,3,6,8a-tetrahydro-1H-3a,6-epoxycyclohepta[c]pyrrole
448k
Following general procedure J, cyclopropenyl furyl sulfonamide
439ak (115.2 mg, 0.308 mmol) was dissolved in DCE (3.00 mL)
and IPrAuCl (9.8 mg, 15.8 µmol) and AgBF4 (3.0 mg, 15.4 µmol)
were added at 0 °C and the reaction was complete after 1 h. Purification gave the title
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compound 448k as a white crystal (19.8 mg, 53.0 µmol) in 17% yield. Other complex
side products were also obtained which could not be isolated or identified. 1H NMR
(500 MHz, CDCl3): 𝛿 = 0.94 (s, 9H, C(CH3)3), 1.32 (s, 3H, CH3), 2.10 (ddd, 1H,
J = 11.0, 7.5, 1.0 Hz, CH), 2.42 (s, 3H, CH3), 3.07 (dd, 1H, J = 11.0, 9.5 Hz, CHaHb),
3.39 (d, 1H, J = 12.0 Hz, CHaHb), 3.78 (d, 1H, J = 12.0 Hz, CHaHb), 4.07 (dd, 1H,
J = 9.5, 7.5 Hz, CHaHb), 5.66 (d, 1H, J = 5.5 Hz, CH), 5.74 (d, 1H, J = 1.0 Hz, CH), 6.26
(d, 1H, J = 5.5 Hz, CH), 7.31 (d, 2H, J = 8.0 Hz, 2CHAr), 7.72-7.76 (m, 2H, 2CHAr) ppm;
13

C NMR (125 MHz, CDCl3): 𝛿 = 21.46, 21.50, 29.4, 34.9, 41.2, 52.8, 53.9, 82.4, 91.3,

126.6, 127.48, 127.55, 129.7, 134.4, 142.9, 143.4, 143.6 ppm; HRMS (ESI): m/z calcd
for C21H27NNaO3S [M + Na]+ 396.1604, found 396.1623; IR (ATR): 2955, 2863, 1340,
1159, 1108, 1026, 1016 cm-1; MP: 173.2–174.9 °C.
4-Methyl-N-((5-phenylfuran-2-yl)methyl)-N-(3-propylhepta-2,4-dien-1-yl)benzene
sulfonamide 459ao
Following general procedure J, cyclopropenyl furyl sulfonamide
439ao (40.9 mg, 88.2 µmol) was dissolved in DCE (0.88 mL)
and IPrAuCl (2.8 mg, 4.51 µmol) and AgBF4 (0.9 mg,
4.62 µmol) were added at 0 °C with stirring. After 18 h at 0 °C,
the reaction was complete and purification gave the title compound 459ao as a yellow oil
(24.2 mg, 52.2 µmol) in 59% yield with a purity of 87%. The contaminant was the
cyclobutene isomer from the Mitsunobu reaction which has the same mass and Rf as the
title compound 459ao and could not be separated. The 2Z,4E -diene was identified as the
major isomer; however, two other diene isomers could also be seen which could not be
conclusively identified. The ratio of diene isomers was estimated to be 16:3:1. Other
complex side products were also obtained from the reaction which could not be isolated
or identified. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.86 (t, 3H, J = 7.5 Hz, CH3), 0.93 (t, 3H,
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J = 7.5 Hz, CH3), 1.37-1.42 (m, 2H, CH2), 2.00-2.07 (m, 2H, CH2), 2.09-2.14 (m, 2H,
CH2), 2.28 (s, 3H, CH3), 4.03 (d, 2H, J = 7.3 Hz, CH2), 4.44 (s, 2H, CH2), 5.14 (t, 1H,
J = 7.2 Hz, CH), 5.77 (dt, 1H, J = 15.5, 6.5 Hz, CH), 6.16 (dq, 1H, J = 15.5, 1.5 Hz, CH),
6.22 (d, 1H, J = 3.5 Hz, CHHet), 6.49 (d, 1H, J = 3.5 Hz, CHHet), 7.17 (d, 2H, J = 8.0 Hz,
2CHAr), 7.22-7.26 (m, overlapped with CHCl3, 1H, CHAr), 7.33 (t, 2H, J = 7.5 Hz, 2CHAr),
7.43-7.47 (m, 2H, 2CHAr), 7.66 (d, 2H, J = 8.3 Hz, 2CHAr) ppm; 13C NMR (125 MHz,
CDCl3): 𝛿 = 13.6, 14.0, 21.3, 21.8, 26.3, 36.2, 42.7, 44.1, 105.4, 111.4, 120.7, 123.6,
124.1, 127.1, 127.3, 128.5, 129.4, 130.4, 134.3, 137.4, 141.3, 142.9, 149.6, 153.8 ppm;
HRMS (ESI): m/z calcd for C28H33NNaO3S [M + Na]+ 486.2073, found 486.2071; IR
(ATR): 2960, 2930, 2870, 1597, 1449, 1346, 1156, 1117, 1092, 813, 759, 655 cm -1.
4.4.2.2.

Gold(I)-Catalysed Reactions of Cyclopropenyl Indolyl Sulfonamides 439b
and Cyclopropenyl Pyrrolyl Sulfonamides 439c

(E)-9-Methyl-4-(oct-4-en-4-yl)-2-tosyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole 457a
and N-(2,3-dipropylcyclobut-2-en-1-yl)-4-methyl-N-((1-methyl-1H-indol-2-yl)methyl)
benzenesulfonamide 440ba
Following general procedure J, cyclopropenyl indolyl sulfonamide 439ba
(98.1 mg, 0.218 mmol) was dissolved in DCE (2.20 mL) and IPrAuCl (6.8 mg, 10.9 µmol)
and AgBF4 (2.1 mg, 10.8 µmol) were added at 0 °C and the reaction was complete after
17 h. Purification gave the title compound 457a as a yellow solid (88.4 mg, 0.196 mmol)
in 96% yield (yield has been corrected for the presence of cyclobutene in the starting
material). The E-isomer was the major product and the ratio of E:Z isomers was estimated
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to be 8:1. In addition to the desired heterocycle 457a, the cyclobutene isomer 440ba
(4.7 mg, 10.4 μmol) was also isolated.
1

H NMR (500 MHz, CDCl3) (mixture of isomers): 𝛿 = 0.72 (t, 3H,

J = 7.5 Hz, CH3, minor isomer), 0.83 (t, 3H, J = 7.5 Hz, CH3, major
isomer), 0.88 (t, 3H, J = 6.9 Hz, CH3, minor isomer), 0.94 (t, 3H,
J = 7.5 Hz, CH3, major isomer), 1.24-1.30 (m, 2H, CH2, for each
isomer), 1.42-1.56 (m, 2H, CH2, for each isomer), 1.86-1.92 (m, 1H, CHaHb, major
isomer), 1.98 (appar. q, 2H, J = 7.5 Hz, CH2, major isomer), 2.20-2.28 (m, 1H, CHaHb,
major isomer), 2.39 (s, 3H, CH3, minor isomer), 2.41 (s, 3H, CH3, major isomer), 2.91
(dd, 1H, J = 12.0, 9.0 Hz, CHaHb, minor isomer), 3.13 (dd, 1H, J = 12.0, 6.5 Hz, CHaHb,
major isomer), 3.54 (dd, 1H, J = 12.0, 5.0 Hz, CHaHb, major isomer), 3.59 (s, 3H, CH3,
major isomer), 3.61 (s, 3H, CH3, minor isomer), 3.66 (t, 1H, J = 6.0 Hz, CH, major
isomer), 3.70 (dd, 1H, J = 12.0, 5.5 Hz, CHaHb, minor isomer), 4.11-4.15 (m, 1H, CH2
CHaHb, minor isomer), 4.15-4.20 (m, 1H, CH, minor isomer), 4.27 (dd, 1H, J = 14.5,
1.5 Hz, CHaHb, major isomer), 4.36 (d, 1H, J = 14.5 Hz, CHaHb, major isomer), 4.64 (d,
1H, J = 14.5 Hz, CHaHb, minor isomer), 5.09 (t, 1H, J = 7.5 Hz, CH, major isomer), 5.44
(t, 1H, J = 7.5 Hz, CH, minor isomer), 6.98-7.03 (m, 1H, CHAr, for each isomer), 7.137.17 (m, 1H, CHAr, for each isomer), 7.24 (d, 1H, J = 8.0 Hz, CHAr, for each isomer), 7.31
(d, 2H, J = 8.0 Hz, 2CHAr, for each isomer), 7.35 (d, 1H, J = 8.0 Hz, CHAr, major isomer),
7.37 (d, 1H, J = 8.0 Hz, CHAr, minor isomer), 7.71-7.76 (m, 2H, 2CHAr, for each isomer)
ppm;

13

C NMR (125 MHz, CDCl3) (mixture of isomers, minor isomer indicated by

asterisk): 𝛿 = 13.9, 14.0*, 14.1*, 14.5, 21.48, 21.54*, 22.6*, 22.7, 22.9, 23.2*, 29.41,
29.45*, 29.8*, 30.1, 31.6*, 32.1, 35.4*, 40.7, 42.6*, 42.7, 48.3*, 49.7, 108.6, 109.3*,
109.8, 118.9, 119.12*, 119.15*, 119.7, 121.2, 121.3 *, 126.0, 126.2*, 127.5*, 127.6,
129.2, 129.68, 129.70*, 131.0, 133.9, 134.1*, 137.1*, 137.3, 137.7, 143.6, 143.7* ppm;
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HRMS (ESI): m/z calcd for C27H35N2O2S [M + H]+ 451.2414, found 451.2439; IR
(ATR): 2958, 2926, 2857, 1471, 1457, 1387, 1377, 1164, 1089, 948, 811, 743 cm -1.
1

H NMR (500 MHz, CDCl3): 𝛿 = 0.62 (t, 3H, J = 7.0 Hz, CH3),

0.81 (t, 3H, J = 7.5 Hz, CH3), 1.03-1.10 (m, 2H, 2CHaHb), 1.121.19 (m, 1H, CHaHb), 1.25-1.30 (m, 2H, overlapped with grease,
CH2), 1.45-1.50 (m, 1H, CHaHb), 1.79-1.89 (m, 3H, CH2,
CHaHb), 2.21-2.26 (m, 1H, CHaHb), 2.43 (s, 3H, CH3), 3.84 (s, 3H, CH3), 4.45 (d, 1H,
J = 15.5 Hz, CHaHb), 4.54 (d, 1H, J = 15.5 Hz, CHaHb), 4.75-4.78 (m, 1H, CH), 6.31 (d,
1H, J = 1.0 Hz, CHHet), 7.06 (ddd, 1H, J = 8.0, 7.0, 1.0 Hz, CHHet), 7.19 (ddd, 1H,
J = 8.0, 7.0, 1.0 Hz, CHAr), 7.29 (appar. d, 3H, J = 8.0 Hz, 2CHAr, CHHet), 7.49 (dt, 1H,
J = 8.0, 1.0 Hz, CHHet), 7.72-7.75 (m, 2H, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3):
𝛿 = 14.0, 14.2, 20.3, 20.5, 21.5, 28.6, 30.0, 30.1, 33.7, 40.5, 54.9, 103.1, 109.0, 119.3,
120.3, 121.4, 127.2, 127.3, 129.6, 135.6, 137.1, 137.7, 140.6, 142.7, 143.3 ppm; HRMS
(ESI): m/z calcd for C27H34N2NaO2S [M + Na]+ 473.2233, found 473.2247; IR (ATR):
2957, 2871, 1466, 1335, 1265, 1159, 1090, 814 cm-1.
4-(5-((tert-Butyldimethylsilyl)oxy)pent-1-en-2-yl)-9-methyl-2-tosyl-2,3,4,9-tetrahydro1H-pyrido[3,4-b]indole 457b
Following general procedure J, cyclopropenyl indolyl sulfonamide
439bb (42.0 mg, 77.9 μmol) was dissolved in DCE (0.78 mL) and
IPrAuCl (2.5 mg, 4.03 µmol) and AgBF4 (0.8 mg, 4.11 µmol) were
added at –10 °C and the reaction was complete after 15 min. Purification gave the title
compound 457b as a yellow solid (28.5 mg, 52.9 mmol) in 68% yield. 1H NMR
(400 MHz, CDCl3): 𝛿 = 0.01 (s, 3H, Si(CH3)2), 0.02 (s, 3H, Si(CH3)2), 0.86 (s, 9H,
C(CH3)3), 1.63-1.82 (m, 2H, CH2), 2.09 (t, 2H, J = 8.0 Hz, CH2), 2.41 (s, 3H, CH3), 3.27
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(dd, 1H, J = 12.0, 6.2 Hz, CHaHb), 3.48 (dd, 1H, J = 12.0, 5.0 Hz, CHaHb), 3.54-3.66 (m,
2H, CH2), 3.60 (s, 3H, CH3), 3.75 (t, 1H, J = 5.6 Hz, CH), 4.32 (d, 2H, J = 1.5 Hz, CH2),
4.81 (bs, 1H, CHaHb), 4.95 (appar. q, 1H, J = 1.6 Hz, CHaHb), 7.02 (ddd, 1H, J = 8.0, 7.0,
1.2 Hz, CHAr), 7.16 (ddd, 1H, J = 8.0, 7.0, 1.2 Hz, CHAr), 7.22-7.26 (m, overlapped with
CHCl3, 1H, CHAr), 7.32 (d, 2H, J = 8.0 Hz, 2CHAr), 7.37 (dt, 1H, J = 7.8, 1.0 Hz, CHAr),
7.72-7.76 (m, 2H, 2CHAr) ppm; 13C NMR (100 MHz, CDCl3): 𝛿 = -5.3, 18.3, 21.5, 25.9,
29.4, 29.8, 31.3, 40.7, 42.7, 49.0, 62.8, 108.7, 109.1, 112.9, 119.20, 119.22, 121.4, 126.0,
127.6, 129.7, 130.8, 133.8, 137.3, 143.7, 148.0 ppm; HRMS (ESI): m/z calcd for
C30H42N2NaO3SSi [M + Na]+ 561.2578, found 561.2576; IR (ATR): 2926, 2893, 2853,
1461, 1348, 1251, 1164, 1100, 1073, 938, 835, 774, 735 cm -1; MP: 125.9–127.0 °C.
(E)-6-Bromo-9-methyl-4-(oct-4-en-4-yl)-2-tosyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]
indole 457c
Following general procedure J, cyclopropenyl indolyl sulfonamide
439bc (45.4 mg, 85.7 μmol) was dissolved in DCE (0.86 mL) and
IPrAuCl (2.5 mg, 4.03 µmol) and AgBF4 (0.8 mg, 4.11 µmol) were
added at 0 °C and the reactions was complete after 1 h. Purification
gave the title compound 457c as a yellow solid (35.4 mg, 66.9 μmol) in 88% yield (yield
has been corrected for the presence of cyclobutene in the starting material). The E-isomer
was the major product and the ratio of E:Z isomers was estimated to be 6:1. 1H NMR
(400 MHz, CDCl3) (mixture of isomers): 𝛿 = 0.74 (t, 3H, J = 7.2 Hz, CH3, minor isomer),
0.86 (t, 3H, J= 7.3 Hz, CH3, major isomer), 0.94 (t, 3H, J = 7.3 Hz, CH3, major isomer),
1.30 (appar. q, 2H, J = 7.4 Hz, CH2, for each isomer), 1.40-1.52 (m, 2H, CH2, for each
isomer), 1.82-1.91 (m, 1H, CHaHb, major isomer), 1.99 (appar. qd, 2H, J = 7.2, 3.2 Hz,
CH2, major isomer), 2.17-2.27 (m, 1H, CHaHb, major isomer), 2.41 (s, 3H, CH3, minor
isomer), 2.42 (s, 3H, CH3, major isomer), 2.88 (dd, 1H, J = 12.0, 9.2 Hz, CHaHb, minor
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isomer), 3.06 (dd, 1H, J = 11.2, 6.3 Hz, CHaHb, major isomer), 3.54-3.64 (m, 5H, CH3,
CH, CHaHb, major isomer, 3H, CH3, minor isomer), 3.70 (dd, 1H, J = 11.6, 5.5 Hz,
CHaHb, minor isomer), 4.08-4.14 (m, 2H, CH, CHaHb, minor isomer), 4.22 (dd, 1H,
J = 14.8, 1.6 Hz, CHaHb, major isomer), 4.38 (d, 1H, J = 14.8 Hz, CHaHb, major isomer),
4.64 (d, 1H, J = 14.8 Hz, CHaHb, minor isomer), 5.08 (t, 1H, J = 7.2 Hz, CH, major
isomer), 5.46 (t, 1H, J = 7.2 Hz, CH, minor isomer), 7.10 (d, 1H, J = 8.7 Hz, CHAr, for
each isomer), 7.22 (dd, 1H, J = 8.8, 2.0 Hz, CHAr, for each isomer), 7.28-7.34 (m, 2H,
2CHAr, for each isomer), 7.45 (d, 1H, J = 2.0 Hz, CHAr, major isomer), 7.47 (d, 1H,
J = 2.0 Hz, CHAr, minor isomer), 7.73 (m, 2H, 2CHAr, for each isomer) ppm; 13C NMR
(100 MHz, CDCl3): 𝛿 = 13.9, 14.5, 21.5, 22.8, 22.9, 29.6, 30.1, 32.2, 40.7, 42.7, 49.7,
109.6, 110.1, 112.4, 122.3, 124.0, 127.5, 127.6, 129.6, 129.7, 132.3, 133.9, 136.0, 137.4,
143.8 ppm; HRMS (ESI): m/z calcd for C27H34(79Br)N2O2S [M + H]+ 529.1519, found
529.1522; IR (ATR): 2952, 2923, 2858, 1473, 1341, 1161, 953, 814, 798, 712 cm-1.
(E)-6-Chloro-9-methyl-4-(oct-4-en-4-yl)-2-tosyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]
indole 457d
Following general procedure J, cyclopropenyl indolyl sulfonamide
439bd (60.3 mg, 0.124 mmol) was dissolved in DCE (1.24 mL) and
IPrAuCl (4.2 mg, 6.76 µmol) and AgBF4 (1.2 mg, 6.16 µmol) were
added at 0 °C and the reaction was complete after 1 h. Purification
gave the title compound 457d as a yellow solid (49.1 mg, 0.101 mmol) in 90% yield
(yield has been corrected for the presence of cyclobutene in the starting material). The
E-isomer was the major product and the ratio of E:Z isomers was estimated to be 7:1. 1H
NMR (400 MHz, CDCl3) (mixture of isomers): 𝛿 = 0.74 (t, 3H, J = 7.3 Hz, CH3, minor
isomer), 0.85 (t, 3H, J = 7.4 Hz, CH3, major isomer), 0.87-0.91 (m, 3H, CH3, minor
isomer), 0.94 (t, 3H, J = 7.3 Hz, CH3, major isomer), 1.26-1.33 (m, 2H, CH2, major
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isomer), 1.41-1.52 (m, 2H, CH2, for each isomer), 1.82-1.92 (m, 1H, CHaHb, major
isomer), 1.99 (qd, 2H, J = 7.2, 2.0 Hz, CH2, major isomer), 2.18-2.27 (m, 1H, CHaHb,
major isomer), 2.41 (s, 3H, CH3, minor isomer), 2.42 (s, 3H, CH3, major isomer), 2.88
(dd, 1H, J = 12.0, 9.2 Hz, CHaHb, minor isomer), 3.07 (dd, 1H, J = 11.5, 6.5 Hz, CHaHb,
major isomer), 3.54-3.63 (m, 5H, CH3, CH, CHaHb, major isomer, 3H, CH3, minor
isomer), 3.70 (dd, 1H, J = 12.0, 5.6 Hz, CHaHb, minor isomer), 4.08-4.14 (m, 2H, CH,
CHaHb, minor isomer), 4.23 (dd, 1H, J = 14.6, 1.5 Hz, CHaHb, major isomer), 4.37 (d,
1H, J = 14.6 Hz, CHaHb, major isomer), 4.64 (d, 1H, J = 14.8 Hz, CHaHb, minor isomer),
5.07 (t, 1H, J = 7.3 Hz, CH, major isomer), 5.46 (t, 1H, J = 7.2 Hz, CH, minor
isomer),7.09 (dd, 1H, J = 8.7, 2.0 Hz, CHAr, for each isomer), 7.15 (d, 1H, J = 8.6 Hz,
CHAr, for each isomer), 7.29 (d, 1H, J = 1.7 Hz, CHAr, for each isomer), 7.32 (d, 2H,
J = 8.0 Hz, 2CHAr, for each isomer), 7.71-7.75 (m, 2H, 2CHAr, for each isomer) ppm; 13C
NMR (100 MHz, CDCl3) (mixture of isomers, minor isomer indicated by asterisk):
𝛿 = 13.9, 13.97*, 14.03*, 14.5, 21.5, 22.8, 22.9, 29.6, 29.8*, 30.1, 32.2, 40.6, 42.6*, 42.7,
48.2*, 49.7, 109.61, 109.65, 119.2, 121.5, 124.8, 127.5*, 126.9, 127.6, 129.5, 129.7,
132.5,

133.9,

135.7,

137.4,

143.7

ppm;

HRMS

(ESI):

m/z

calcd

for

C27H33(35Cl)N2NaO2S [M + Na]+ 507.1843, found 507.1846; IR (ATR): 2951, 2923,
2859, 1475, 1341, 1305, 1161, 1139, 954, 814, 799, 714 cm -1.
(E)-9-Benzyl-6-bromo-4-(oct-4-en-4-yl)-2-tosyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]
indole 457e
Following general procedure J, cyclopropenyl indolyl sulfonamide
439be (44.2 mg, 73.0 μmol) was dissolved in DCE (0.73 mL) and
IPrAuCl (2.5 mg, 4.03 µmol) and AgBF4 (0.7 mg, 3.60 µmol) were
added at 0 °C and the reaction was complete after 1 h. Purification
gave the title compound 457e as a white solid (38.5 mg, 63.6 μmol) in 87% yield. The
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E-isomer was the major product and the ratio of E:Z isomers was estimated to be 6:1. 1H
NMR (500 MHz, CDCl3) (mixture of isomers): 𝛿 = 0.77 (t, 3H, J = 7.3 Hz, CH3, minor
isomer),0.87 (t, 3H, J = 7.4 Hz, CH3, major isomer), 0.95 (t, 3H, J = 7.3 Hz, CH3, major
isomer), 1.29-1.35 (m, 2H, CH2, for each isomer), 1.39-1.53 (m, 2H, CH2, for each
isomer), 1.84-1.92 (m, 1H, CHaHb, major isomer), 2.00 (qd, 2H, J = 7.2, 3.5 Hz, CH2,
major isomer), 2.19-2.27 (m, 1H, CHaHb, major isomer), 2.39 (s, 3H, CH3, minor isomer),
2.40 (s, 3H, CH3, major isomer), 2.91 (dd, 1H, J = 12.4, 9.2 Hz, CHaHb, minor isomer),
3.09 (dd, 1H, J = 12.0, 6.7 Hz, CHaHb, major isomer), 3.56 (dd, 1H, J = 12.0, 4.9 Hz,
CHaHb, major isomer), 3.62 (t, 1H, J = 5.8 Hz, CH, major isomer), 3.72 (dd, 1H, J = 12.4,
5.4 Hz, CHaHb, minor isomer), 4.03 (dd, 1H, J = 15.2, 2.0 Hz, CHaHb, minor isomer),
4.06-4.12 (m, 1H, CH, minor isomer), 4.15 (dd, 1H, J = 14.8, 1.6 Hz, CHaHb, major
isomer), 4.26 (d, 1H, J = 14.8 Hz, CHaHb, major isomer), 4.55 (d, 1H, J = 15.2 Hz, CHaHb,
minor isomer), 5.09 (t, 1H, J = 7.3 Hz, CH, major isomer), 5.19 (s, 2H, CH2, major
isomer), 5.20 (s, 2H, CH2, minor isomer), 5.46 (t, 1H, J = 7.3 Hz, CH, minor isomer),
6.89-6.94 (m, 2H, 2CHAr, for each isomer), 7.06 (d, 1H, J = 8.7 Hz, CHAr, for each
isomer), 7.16-7.19 (m, 1H, CHAr, for each isomer), 7.24-7.29 (m, overlapped with CHCl3,
5H, 5CHAr, for each isomer), 7.49 (d, 1H, J = 2.0 Hz, CHAr, major isomer), 7.50 (d, 1H,
J = 2.0 Hz, CHAr, minor isomer), 7.60 (d, 2H, J = 8.6 Hz, 2CHAr, minor isomer), 7.62 (m,
2H, J = 8.3 Hz, 2CHAr, major isomer) ppm; 13C NMR (125 MHz, CDCl3) (mixture of
isomers, minor isomer indicated by asterisk): 𝛿 = 13.9, 14.0*, 14.1*, 14.6, 21.5, 21.6*,
22.8, 22.9, 23.2*, 29.8*, 30.0, 32.1, 40.4, 42.5*, 42.6, 46.78*, 46.81, 48.0*, 49.5, 110.2,
110.7, 112.5, 112.7*, 121.8*, 122.4, 124.3, 124.4*, 125.88*, 125.93, 127.3*, 127.5,
127.7, 127.8, 128.9, 129.5, 129.66, 129.69*, 132.3, 133.7, 134.1*, 135.5*, 135.7, 136.5,
137.3, 143.67, 143.73* ppm; HRMS (ESI): m/z calcd for C33H38(79Br)N2O2S
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[M + H]+ 605.1832, found 605.1830; IR (ATR): 2954, 2928, 2868, 1598, 1453, 1340,
1158, 1094, 937, 810, 783 cm-1.
(E)-1-Methyl-4-(oct-4-en-4-yl)-6-tosyl-4,5,6,7-tetrahydro-1H-pyrrolo[2,3-c]pyridine
458
Following general procedure J, cyclopropenyl pyrrolyl sulfonamide
439ca (112.7 mg, 0.281 mmol) was dissolved in DCE (2.77 mL) and
IPrAuCl (8.6 mg, 13.8 µmol) and AgBF4 (2.7 mg, 13.9 µmol) were
added at 0 °C and the reaction was complete after 17.5 h. Purification
gave the title compound 458 as a colourless oil (79.0 mg, 0.197 mmol) in 74% yield (yield
has been corrected for the presence of cyclobutene in the starting material). The E-isomer
was the major product and the ratio of E:Z isomers was estimated to be 6:1. 1H NMR
(400 MHz, CDCl3) (mixture of isomers): 𝛿 = 0.80 (t, 3H, J = 7.2 Hz, CH3, minor isomer),
0.85-0.92 (m, 6H, 2CH3, major isomer, 3H, CH3, minor isomer) 1.29-1.44 (m, 4H, 2CH2,
for each isomer), 1.79-1.88 (m, 1H, CHaHb, for each isomer), 1.94-2.01 (m, 2H, CH2, for
each isomer), 2.08-2.17 (m, 1H, CHaHb, for each isomer), 2.42 (s, 3H, CH3, for each
isomer), 2.67-2.72 (m, 1H, CHaHb, minor isomer), 2.75 (dd, 1H, J = 11.6, 8.2 Hz, CHaHb,
major isomer), 3.39 (dd, 1H, J = 8.0, 5.0 Hz, CH, major isomer), 3.45 (s, 3H, CH3, major
isomer), 3.46 (s, 3H, CH3, minor isomer), 3.61 (dd, 1H, J = 11.6, 4.8 Hz, CHaHb, major
isomer), 3.66 (dd, 1H, J = 12.4, 5.2 Hz, CHaHb, minor isomer), 3.84-3.89 (m, 2H, CH,
CHaHb, minor isomer), 3.93 (dd, 1H, J = 13.6, 1.6 Hz, CHaHb, major isomer), 4.31 (d,
1H, J = 13.5 Hz, CHaHb, major isomer), 4.50 (d, 1H, J = 13.4 Hz, CHaHb, minor isomer),
5.17 (t, 1H, J = 7.2 Hz, CH, major isomer), 5.32 (t, 1H, J = 7.4 Hz, CH, minor isomer),
5.72 (d, 1H, J = 2.8 Hz, CHHet, minor isomer), 5.77 (d, 1H, J = 2.8 Hz, CHHet, major
isomer), 6.44 (d, 1H, J = 2.8 Hz, CHHet, minor isomer), 6.46 (d, 1H, J = 2.8 Hz, CHHet,
major isomer), 7.31 (d, 2H, J = 8.0 Hz, 2CHAr, for each isomer), 7.69-7.73 (m, 2H, 2CHAr,
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for each isomer) ppm; 13C NMR (100 MHz, CDCl3) (mixture of isomers, minor isomer
indicated by asterisk): 𝛿 = 13.8, 14.0*, 14.3, 21.5, 21.8*, 22.6, 23.0, 23.3*, 29.6*, 29.9,
32.1, 33.2, 34.7*, 36.2*, 41.7, 42.65*, 42.70, 48.0*, 49.8, 105.6*, 106.0, 118.4*, 119.0,
120.96*, 120.99, 123.2, 127.57*, 127.60, 128.5, 129.59, 129.62, 134.0, 137.8*, 139.0,
143.4 ppm; HRMS (ESI): m/z calcd for C23H33N2O2S [M + H]+ 401.2257, found
401.2267; IR (ATR): 2955, 2928, 2869, 1499, 1456, 1345, 1314, 1162, 1090, 941, 814
cm-1.
4.4.2.3.

Gold(I)-Catalysed Rearranges of Other Cyclopropene–Heterocycle Systems

4-Methyl-N-((5-methylthiophen-2-yl)methyl)-N-(3-propylhepta-2,4-dien-1-yl)benzene
sulfonamide 459d
Following general procedure J, cyclopropenyl thiophenyl
sulfonamide 439d (206.7 mg, 0.495 mmol) was dissolved in DCE
(5.02 mL) and IPrAuCl (15.2 mg, 24.5 µmol) and AgBF4 (4.8 mg,
24.7 µmol) were added at 0 °C. The reaction was stirred at this temperature for 2.5 h and
was then warmed to rt. After 23 h, the reaction was complete and purification gave the
title compound 459d as a yellow oil (175.9 mg, 0.421 mmol) in 85% yield with a purity
of 93%. The contaminant was the cyclobutene isomer from the Mitsunobu reaction which
has the same mass and Rf as the title compound 459d and could not be separated. The
2Z,4E -diene was identified as the major isomer; however, two other diene isomers could
also be seen which could not be conclusively identified. The ratio of diene isomers was
estimated to be 16:3:1. 1H NMR (400 MHz, CDCl3): 𝛿 = 0.84 (t, 3H, J = 7.4 Hz, CH3),
0.98 (t, 3H, J = 7.4 Hz, CH3), 1.29-1.39 (m, 2H, CH2), 2.03-2.10 (m, 4H, 2CH2), 2.41 (d,
3H, J = 1.2 Hz, CH3), 2.42 (s, 3H, CH3), 3.95 (d, 2H, J = 7.2 Hz, CH2), 4.43 (s, 2H, CH2),
4.98 (t, 1H, J = 7.2 Hz, CH), 5.75 (dt, 1H, J = 15.6, 6.4 Hz, CH), 6.03 (dq, 1H, J = 15.8,
1.4 Hz, CH), 6.50-6.52 (m, 1H, CHHet), 6.63 (d, 1H, J = 3.4 Hz, CHHet), 7.26-7.29 (m,
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overlapped with CHCl3, 2H, 2CHAr), 7.68-7.72 (m, 2H, 2CHAr) ppm;

13

C NMR (100

MHz, CDCl3): 𝛿 = 13.5, 13.9, 15.3, 21.4, 21.6, 26.2, 36.1, 43.1, 44.8, 120.3, 124.2, 124.4,
127.2, 127.3, 129.5, 134.0, 136.6, 137.7, 140.5, 140.9, 143.0 ppm; HRMS (ESI): m/z
calcd for C23H31NNaO2S2 [M + Na]+ 440.1688, found 440.1686; IR (ATR): 2958, 2927,
2870, 1598, 1453, 1339, 1155, 1091, 906, 799, 738 cm-1.
4-Methyl-N-((5-methylthiophen-2-yl)methyl)-N-(3-propylhepta-2,4-dien-1-yl)benzene
sulfonamide 459e
Following general procedure J, cyclopropenyl benzofuryl
sulfonamide 439e (40.9 mg, 93.5 μmol) was dissolved in DCE
(0.93 mL) and IPrAuCl (2.9 mg, 4.67 µmol) and AgBF4 (0.9 mg,
4.62 µmol) were added at 0 °C and the reaction was left for 22 h. Purification gave the
title compound 459e as an oil (33.2 mg, 75.9 mmol) in 81% yield with a purity of 83%.
The contaminant was the cyclobutene isomer from the Mitsunobu reaction which has the
same mass and Rf as the title compound 459e and could not be separated. The 2Z,4Ediene was identified as the major isomer; however, two other diene isomers could also be
seen which could not be conclusively identified. The ratio of diene isomers was estimated
to be 15:4:1. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.84 (t, 3H, J = 7.5 Hz, CH3), 0.94 (t, 3H,
J = 7.5 Hz, CH3), 1.33-1.39 (m, 2H, CH2), 2.01-2.05 (m, 2H, CH2), 2.05-2.10 (m, 2H,
CH2), 2.36 (s, 3H, CH3), 4.02 (d, 2H, J = 7.5 Hz, CH2), 4.51 (s, 2H, CH2), 5.09 (t, 1H,
J = 7.5 Hz, CH), 5.77 (dt, 1H, J = 15.5, 6.5 Hz, CH), 6.12 (dd, 1H, J = 15.5, 1.0 Hz, CH),
6.51 (d, 1H, J = 1.0 Hz, CHHet), 7.14-7.24 (m, 4H, 2CHAr, 2CHHet), 7.26-7.29 (m, 1H,
CHHet), 7.45-7.48 (m, 1H, CHHet), 7.67-7.71 (m, 2H, 2CHAr) ppm; 13C NMR (125 MHz,
CDCl3): 𝛿 = 13.5, 14.0, 21.4, 21.7, 26.2, 36.1, 43.0, 44.1, 106.0, 111.0, 120.2, 120.8,
122.7, 124.06, 124.14, 127.3, 127.9, 129.3, 134.4, 137.3, 141.6, 143.1, 152.7, 154.9 ppm;
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HRMS (ESI): m/z calcd for C26H32NO3S [M + H]+ 438.2097, found 438.2106; IR
(ATR): 2959, 2930, 2871, 1598, 1453, 1341, 1158, 1091, 909, 813, 731 cm-1.
N-(Benzo[b]thiophen-2-ylmethyl)-4-methyl-N-3-propylhepta-2,4-dien-1-yl)benzene
sulfonamide 459f
Following general procedure J, cyclopropenyl benzo[b]thiophenyl
sulfonamide 439f (52.0 mg, 0.115 mmol) was dissolved in DCE
(1.15 mL) and IPrAuCl (3.6 mg, 5.80 µmol) and AgBF4 (1.1 mg,
5.65 µmol) were added at 0 °C and the reaction was stirred for 18 h. Purification gave the
title compound 459f as a colourless oil (46.2 mg, 0.102 mmol) in 89% yield with a purity
of 91%. The contaminant was the cyclobutene isomer from the Mitsunobu reaction which
has the same mass and Rf as the title compound 459f and could not be separated. The
2Z,4E -diene was identified as the major isomer; however, two other diene isomers could
also be seen which could not be conclusively identified. The ratio of diene isomers was
estimated to be 16:3:1. 1H NMR (500 MHz, CDCl3): 𝛿 = 0.82 (t, 3H, J = 7.4 Hz, CH3),
0.90 (t, 3H, J = 7.5 Hz, CH3), 1.27-1.36 (m, 2H, CH2), 1.96-2.00 (m, 2H, CH2), 2.02-2.07
(m, 2H, CH2), 2.42 (s, 3H, CH3), 4.00 (d, 2H, J = 7.5 Hz, CH2), 4.60 (s, 2H, CH2), 5.01
(t, 1H, J = 7.5 Hz, CH), 5.74 (dt, 1H, J = 15.5, 6.5 Hz, CH), 5.99 (dq, 1H, J = 15.5,
1.5 Hz, CH), 7.07 (d, 1H, J = 1.0 Hz, CHHet), 7.26-7.33 (m, overlapped with CHCl3, 4H,
2CHAr, 2CHHet), 7.63-7.65 (m, 1H, CHHet), 7.73-7.76 (m, 3H, 2CHAr, CHHet) ppm; 13C
NMR (125 MHz, CDCl3): 𝛿 = 13.5, 14.0, 21.5, 21.7, 26.2, 36.1, 43.5, 45.5, 119.9, 122.3,
123.3, 123.8, 124.0, 124.21, 124.24, 127.3, 129.6, 134.4, 137.5, 139.3, 140.3, 140.4,
141.5, 143.3 ppm; HRMS (ESI): m/z calcd for C26H31NNaO2S2 [M + Na]+ 476.1688,
found 476.1713; IR (ATR): 2958, 2929, 2870, 1598, 1458, 1436, 1339, 1155, 1090, 907,
813, 726 cm-1.
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4.4.3. Chemical Transformations on Heterocycles 448 and 457
3-(6-Methyl-2-tosyl-2,3,6,8a-tetrahydro-1H-3a,6-epoxycyclohepta[c]pyrrol-8yl)propan-1-ol 494

In accordance with the literature procedure,[201] heterocycle 448i (21.5 mg,
43.9 μmol) was dissolved in dry THF (1.10 mL) under a nitrogen atmosphere and to this
was added tetrabutylammonium fluoride (TBAF, 1 M solution in THF, 0.10 mL,
0.100 mmol) with stirring. The reaction was left at rt for 1.5 h until TLC indicated the
reaction had gone to completion. The solvent was removed under reduced pressure and
the crude residue was purified by flash column chromatography (50:50 EtOAc:hex) to
obtained the title compound 494 as a colourless oil (solid in fridge) (14.4 mg, 38.4 μmol)
in 87% yield. 1H NMR (500 MHz, CDCl3) = δ 1.32 (s, 3H, CH3), 1.55-1.64 (m, 2H, CH2),
1.88-2.01 (m, 2H, CH2), 2.04-2.09 (m, 1H, CH), 2.43 (s, 3H, CH3), 2.97 (dd, 1H, J = 11.1,
9.0 Hz, CHaHb), 3.39 (d, 1H, J = 11.8 Hz, CHaHb), 3.58 (td, 2H, J = 6.4, 1.3 Hz, CH2),
3.83 (d, 1H, J = 11.8 Hz, CHaHb), 3.94 (dd, 1H, J = 9.0, 7.9 Hz, CHaHb), 5.70 (q, 1H,
J = 1.5 Hz, CH), 5.76 (d, 1H, J = 5.6 Hz, CH), 6.23 (d, 1H, J = 5.6 Hz, CH), 7.31 (d, 2H,
J = 7.7 Hz, 2CHAr), 7.71-7.74 (m, 2H, 2CHAr) ppm;

13

C NMR (125 MHz, CDCl3):

δ = 21.50, 21.52, 29.7, 31.4, 43.3, 51.1, 54.4, 62.2, 82.3, 90.5, 127.3, 127.5, 129.4, 129.7,
134.1, 135.1, 142.7, 143.5 ppm; HRMS (ESI): m/z calcd for C20H25NNaO4S [M + Na]+
398.1397, found 398.1396; IR (ATR): 3361 (br), 2929, 2860, 1334, 1161, 1111, 1026,
808 cm-1.
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(E)-9-Methyl-4-(oct-4-en-4-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole 495

To a dry round bottom flask was added heterocycle 457a (20.0 mg, 44.4 μmol)
and powdered Mg solid (54.4 mg, 2.24 mmol) and the reaction was sealed with a new
rubber septum. The flask was evacuated under vacuum and was refilled with argon. To
the reaction flask was added dry THF (0.36 mL) and the reaction was swirled until the
starting material appeared to be dissolved. Dry MeOH (1.10 mL) was subsequently added
and the reaction was shaken vigouously before been sonicated for 45 mins (sonication
was paused roughly every 2 mins for the first 10 mins to shake the reaction flask). Once
finished, the reaction was diluted with EtOAc and filtered over celite and the crude
residue was concentrated under reduced pressure. Flash column chromatography (95:4:1
DCM:MeOH:Et3N) gave the title compound 495 as a yellow solid (10.0 mg, 33.7 μmol)
in 76% yield with minor impurities. A second column was performed first using 100%
EtOAc to remove impurities and then 10:90 MeOH:DCM to obtain title compound 495
(7.2 mg, 24.3 μmol) in 55% yield. 1H NMR (400 MHz, CDCl3): δ = 0.80 (t, 3H,
J = 7.4 Hz, CH3), 1.00 (t, 3H, J = 7.3 Hz, CH3), 1.19-1.28 (m, 2H, CH2), 1.48-1.57 (m,
1H, CHaHb), 1.58-1.69 (m, 1H, CHaHb), 1.85-1.94 (m, 1H, CHaHb), 1.93-2.02 (m, 2H,
CH2), 2.24-2.34 (m, 1H CHaHb), 3.07 (dd, 1H, J = 13.0, 3.7 Hz, CHaHb), 3.19 (dd, 1H,
J = 13.0, 4.9 Hz, CHaHb), 3.61 (s, 3H, CH3), 3.64-3.69 (m, 1H, CH), 4.14 (s, 2H, CH2),
4.99 (t, 1H, J = 7.2 Hz, CH), 7.03 (ddd, 1H, J = 7.9, 7.0, 1.0 Hz, CHAr), 7.17 (ddd, 1H,
J = 8.2, 7.0, 1.2 Hz, CHAr), 7.25-7.29 (m, overlapped with CHCl3, 2H, CHAr), 7.35 (dt,
1H, J = 7.9, 1.0 Hz, CHAr) ppm; 13C NMR (125 MHz, CDCl3): δ = 13.9, 14.5, 22.7, 23.0,
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29.4, 30.0, 32.3, 39.1, 41.8, 48.0, 108.6, 109.5, 119.0, 119.1, 121.2, 126.4, 129.0, 132.9,
137.1, 138.9 ppm; HRMS (ESI): m/z calcd for C20H29N2 [M + H]+ 297.2325, found
297.2332; IR (ATR): 3381, 2955, 2928, 2869, 1467, 1013 cm-1 MP: decomp > 150 °C.
9-Methyl-4-(oct-4-en-4-yl)-6-phenyl-2-tosyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole
457f

To a Schlenk flask was added heterocycle 457c (20.5 mg, 38.7 μmol), K2CO3
(10.8 mg, 78.1 μmol) and phenylboronic acid (7.9 mg, 64.8 μmol). Dioxane:H2O (4:1,
0.5 mL) was added and the mixture was (3x) subjected to a freeze-pump-thaw process
before the reaction was put under a nitrogen atmosphere. Once at rt, Pd(dppf)Cl2·CH2Cl2
(3.4 mg, 4.16 μmol) was added and the reaction was heated to 85-90 °C for 21 h.
Following a short column (30:70 Et2O:hex) and analysis by 1H NMR, title compound
457f (17.8 mg) was obtained but ~5% starting material remained. The residue was
resubjected to the reaction conditions using K2CO3 (1.6 mg, 11.6 μmol), phenylboronic
acid (1.4 mg, 11.5 μmol), Pd(dppf)Cl2·CH2Cl2 (0.3 mg, 0.367 μmol) and a mixture of
dioxane:H2O (4:1, 0.5 mL) and was heated for 6 h at 90-95 °C. Flash column
chromatography (30:70 Et2O:hex) gave the title compound 457f as a pale yellow solid
(16.4 mg, 31.1 μmol) in 80% yield. The E-isomer was the major product and the ratio of
E:Z isomers was estimated to be 5.7:1. 1H NMR (500 MHz, CDCl3) (mixture of isomers):
δ = 0.73 (t, 3H, J = 7.3 Hz, CH3, minor isomer), 0.83 (t, 3H, J = 7.4 Hz, CH3, major
isomer), 0.94 (t, 3H, J = 7.3 Hz, CH3, major isomer), 1.26-1.33 (m, 2H, CH2, for each
isomer), 1.44-1.54 (m, 2H, CH2, for each isomer), 1.86-1.94 (m, 1H, CHaHb, major
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isomer), 2.00 (qd, 2H, J = 7.2, 2.5 Hz, CH2, major isomer), 2.21-2.29 (m, 1H, CHaHb,
major isomer), 2.40 (s, 3H, CH3, minor isomer), 2.42 (s, 3H, CH3, major isomer), 2.94
(dd, 1H, J = 12.1, 9.1 Hz, CHaHb, minor isomer), 3.14 (dd, 1H, J = 11.9, 6.7 Hz, CHaHb,
major isomer), 3.57 (dd, 1H, J = 12.0, 5.0 Hz, CHaHb, major isomer), 3.63 (s, 3H, CH3,
major isomer), 3.65 (s, 3H, CH3, minor isomer), 3.70 (t, J = 5.8 Hz, 1H, CH, major
isomer), 3.71-3.74 (m, 1H, CHaHb, minor isomer), 4.15 (dd, 1H, J = 14.7, 2.1 Hz, CHaHb,
minor isomer), 4.18-4.24 (m, 1H, CH, minor isomer), 4.28 (dd, 1H, J = 14.5, 1.6 Hz,
CHaHb, major isomer), 4.38 (d, 1H, J = 14.4 Hz, CHaHb, major isomer), 4.65 (d, 1H,
J = 14.9 Hz, CHaHb, minor isomer), 5.17 (t, 6H, J = 7.3 Hz, CH, major isomer), 5.46 (t,
1H, J = 7.3 Hz, CH, minor isomer), 7.26-7.34 (m, 4H, 4CHAr, for each isomer), 7.38-7.44
(m, 3H, 3CHAr, for each isomer), 7.54-7.59 (m, 3H, 3CHAr, major isomer, 2H, 2CHAr,
minor isomer), 7.60 (d, 1H, J = 1.4 Hz, CHAr, minor isomer), 7.72-7.77 (m, 2H, 2CHAr,
for each isomer) ppm; 13C NMR (125 MHz, CDCl3) (mixture of diastereoisomer, minor
isomer indicated by asterisk): δ = 13.9, 14.0*, 14.1*, 14.5, 21.5, 22.8, 23.0, 23.2*, 29.59,
29.62*, 30.1, 32.1, 35.4*, 40.8, 42.6*, 42.8, 48.3*, 49.7, 108.9, 110.2, 117.6*, 118.2,
121.0, 121.1*, 126.2, 126.5, 126.7*, 127.2, 127.5*, 127.6, 128.59, 128.62*, 129.4,
129.71, 129.73*, 131.7, 132.5, 132.6*, 134.0, 134.1*, 136.7*, 136.9, 137.7*, 137.8,
142.5, 143.67, 143.74* ppm; HRMS (ESI): m/z calcd for C33H39N2O2S [M + H]+
527.2727, found 527.2738; IR (ATR): 2952, 2925, 2866, 1599, 1473, 1455, 1341, 1314,
1157, 1095, 938, 807, 752 cm-1.
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7,8-Dibutyl-2-tosyl-2,3,4,5,6,8a-hexahydro-1H-3a,6-epoxycyclohepta[c]pyrrol-4-ol 497
and 7,8-dibutyl-2-tosyl-2,3,4,5,6,8a-hexahydro-1H-3a,6-epoxycyclohepta[c]pyrrol-5-ol
498

Following a modified literature procedure,[168] to a stirring solution of heterocycle
448b (57.9 mg, 0.139 mmol) in dry THF (1.4 mL) under a nitrogen atmosphere was added
BH3·Me2S (2 M solution in THF, 70 μL, 0.140 mmol) at 0 °C. After 2 h, another portion
of BH3·Me2S (2 M solution in THF, 35 μL, 70 μmol) was added, followed by a third
portion of BH3·Me2S (2 M solution in THF, 50 μL, 0.100 mmol) after another 2 h. After
a total time of 6.5 h at 0 °C, NaBO3·4H2O (109.4 mg, 0.711 mmol) in H2O was added
and the reaction was left stirring at rt for 24 h. The suspension was quenched with NH4Cl
and the phases were separated before the aqueous layer was extracted (3x) with EtOAc.
The combined organic layer was dried over Na2SO4, filtered and concentrated under
reduced pressure. Flash column chromatography (30:70 EtOAc:hex) gave regioisomers
497 (26.3 mg, 60.7 μmol) and 498 (8.3 mg, 19.1 μmol) as colourless oils in 44% and 14%
yield, respectively. In each case, the ratio of the major diastereoisomer to the minor
diastereoisomer was estimated to be 1.5:1 for 497 and 2.3:1 for 498.
1

H NMR (500 MHz, CDCl3) (mixture of diastereoisomers): δ = 0.85-

0.92 (m, 6H, 2CH3, for each isomer), 1.19-1.37 (m, 8H, 4CH2, for
each isomer), 1.53 (dd, 1H, J = 12.7, 2.5 Hz, CHaHb, major isomer),
1.59-1.71 (m, 1H, CHaHb, for each isomer), 1.73-1.84 (m, 1H,
CHaHb, for each isomer), 1.88 (ddd, 1H, J = 13.0, 7.2, 3.1 Hz, CHaHb, minor isomer),
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2.01-2.10 (m, 1H, CHaHb, for each isomer), 2.10-2.17 (m, 1H, CHaHb, major isomer, 1H,
CH, minor isomer), 2.33 (dd, 1H, J = 12.9, 7.5 Hz, CHaHb, minor isomer), 2.37-2.46 (m,
4H, CH3, CHaHb, major isomer, 3H, CH3, minor isomer), 2.78 (dd, 1H, J = 11.2, 7.7 Hz,
CH, major isomer), 2.92-3.00 (m, 1H, CHaHb, for each isomer), 3.29 (d, 1H, J = 12.3 Hz,
CHaHb, minor isomer), 3.33 (d, 1H, J = 11.5 Hz, CHaHb, major isomer), 3.73 (d, 1H,
J = 11.6 Hz, CHaHb, major isomer), 3.81-389 (m, 2H, CHaHb, for each isomer), 3.97 (d,
1H, J = 12.4 Hz, CHaHb, minor isomer), 4.05 (d, 1H, J = 7.5 Hz, CH, for each isomer),
4.23 (d, 1H, J = 7.2 Hz, CH, minor isomer), 4.28 (dd, 1H, J = 9.9, 2.9 Hz, CH, major
isomer), 7.32 (appar. dd, 2H, J = 8.2, 2.4 Hz, 2CHAr, for each isomer), 7.69-7.75 (m, 2H,
2CHAr, for each isomer) ppm; 13C NMR (125 MHz, CDCl3) (mixture of diastereoisomer,
minor isomer indicated by asterisk): δ = 13.89*, 13.91, 13.94*, 14.0, 21.5, 22.6*, 22.7,
22.76*, 22.78, 28.88, 28.89*, 29.4*, 29.7, 30.4*, 30.48*, 30.52, 40.0, 41.4, 45.0*, 46.0*,
52.3, 52.6*, 53.2*, 54.8, 73.2, 74.7*, 75.9, 76.1*, 88.2, 90.2*, 125.6*, 127.3, 127.4,
127.5*, 129.69, 129.72*, 133.9*, 134.1, 138.2, 138.5*, 143.40, 143.44* ppm; HRMS
(ESI): m/z calcd for C24H36NO4S [M + H]+ 434.2360, found 434.2373; IR (ATR): 3506
(br), 2954, 2928, 2858, 1457, 1335, 1160, 1092, 1016, 813 cm-1.
1

H NMR (500 MHz, CDCl3) (mixture of diastereoisomers): δ = 0.85-

0.94 (m, 6H, 2CH3, for each isomer), 1.20-1.36 (m, 8H, 4CH2, for
each isomer), 1.45 (dd, 1H, J = 13.4, 4.0 Hz, CHaHb, minor isomer),
1.63-1.71 (m, 1H, CHaHb, for each isomer), 1.75 (dt, 1H, J = 14.0, 1.4 Hz, CHaHb, major
isomer), 1.79-1.86 (m, 1H, CHaHb, for each isomer), 2.03-2.13 (m, 1H, CHaHb, for each
isomer, 1H, CH, major isomer), 2.19 (dd, 1H, J = 13.7, 6.4 Hz, CHaHb, major isomer),
2.22-2.31 (m, 1H, CHaHb, major isomer, 1H, CH, minor isomer), 2.38 (dd, 1H,
J = 13.6, 9.9 Hz, CHaHb, minor isomer), 2.43 (s, 3H, CH3, for each isomer), 2.92-2.98
(m, 1H, CHaHb, for each isomer), 3.32 (d, 1H, J = 11.7 Hz, CHaHb, minor isomer), 3.47
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(d, 2H, J = 11.6 Hz, CHaHb, major isomer), 3.57 (d, 1H, J = 11.7 Hz, CHaHb, minor
isomer), 3.66 (d, 1H, J = 11.6 Hz, CHaHb, major isomer), 3.77-3.84 (m, 1H, CHaHb, for
each isomer), 4.04 (s, 1H, CH, major isomer), 4.17 (d, 2H, J = 6.5 Hz, CH, major isomer),
4.20 (d, 1H, J = 6.2 Hz, CH, minor isomer), 4.52 (m, 1H, CH, minor isomer), 7.28-7.34
(m, 2H, 2CHAr, for each isomer), 7.69-7.74 (m, 2H, 2CHAr, for each isomer) ppm;

13

C

NMR (126 MHz, CDCl3) (mixture of diastereoisomer, minor isomer indicated by
asterisk): δ = 13.92, 13.94, 14.0*, 21.5, 22.6, 22.7*, 22.76*, 22.81, 28.9, 29.8, 30.2*,
30.4*, 30.5, 30.60*, 30.64, 41.4*, 43.0, 47.9, 48.6*, 52.2, 52.7*, 55.5, 55.9*, 75.7*, 76.8,
77.6*, 84.6, 85.1*, 86.3, 127.4, 128.2, 129.69*, 129.71, 130.3*, 133.7, 134.1*, 134.2*,
134.3, 143.38, 143.42* ppm; HRMS (ESI): m/z calcd for C24H36NO4S [M + H]+
434.2360, found 434.2374; IR (ATR): 3486 (br), 2955, 2929, 2860, 1336, 1159, 1093,
1037, 813 cm-1.
5-((tert-Butyldimethylsilyl)oxy)-2-(9-methyl-2-tosyl-2,3,4,9-tetrahydro-1H-pyrido[3,4b]indol-4-yl)pentan-1-ol 499

Following a modified literature procedure,[168] to a stirring solution of heterocycle
457b (15.8 mg, 29.3 μmol) in dry THF (0.30 mL) under a nitrogen atmosphere was added
BH3·Me2S (2 M solution in THF, 16.0 μL, 32.0 μmol) at 0 °C. After 1 h, another portion
of BH3·Me2S (2 M solution in THF, 16.0 μL, 32.0 μmol) and the reaction was warmed to
rt after another 1.5 h. After 1 h, a third portion of BH3·Me2S (2 M solution in THF,
16.0 μL, 32.0 μmol) was added, followed by a fourth portion of BH3·Me2S (2 M solution
in THF, 32.0 μL, 64.0 μmol) 2 h later and the reaction was left overnight. After a total
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time of 21.5 h, NaBO3·4H2O in H2O was added and the reaction was left stirring at rt for
4 h. The suspension was quenched with NH4Cl and the phases were separated before the
aqueous layer was extracted (3x) with EtOAc. The combined organic layer was dried over
Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography
(30:70 EtOAc:hex) gave the title compound 499 as a white semi-solid (7.4 mg, 13.3 μmol)
in 45% yield as a mixture of diastereoisomers (ratio 2.6:1). 1H NMR (500 MHz, CDCl3)
(mixture of diastereoisomers): δ = 0.02 (s, 3H, SiCH3, minor isomer), 0.026 (s, 3H,
SiCH3, minor isomer), 0.030 (s, 3H, SiCH3, major isomer), 0.04 (s, 3H, SiCH3, major
isomer), 0.87 (s, 9H, C(CH3)3, minor isomer), 0.88 (s, 9H, C(CH3)3, major isomer), 1.471.75 (m, overlapped with H2O, 4H, 2CH2, for both isomers), 2.09-2.18 (m, 1H, CH, for
each isomer), 2.426 (s, 3H, CH3, minor isomer), 2.434 (s, 3H, CH3, major isomer), 2.67
(dd, 1H, J = 12.0, 4.2 Hz, CHaHb, major isomer), 2.76 (dd, 1H, J = 11.9, 3.9 Hz, CHaHb,
minor isomer), 3.20-3.27 (m, 1H, CH, for each isomer), 3.55-3.61 (m, 3H, CH3, major
isomer, 5H, CH3, CH2, minor isomer), 3.63 (t, 2H, J = 6.3 Hz, CH2, major isomer), 3.70
(dd, 3H, J = 11.5, 4.3 Hz, CHaHb, major isomer), 3.76 (dd, 1H, J = 11.1, 5.0 Hz, CHaHb,
major isomer, 2H, CH2, minor isomer), 3.80 (dd, 1H, J = 14.3, 1.2 Hz, CHaHb, major
isomer), 3.86 (d, 1H, J = 14.4 Hz, CHaHb, minor isomer), 4.00 (dd, 1H, J = 11.9, 2.6 Hz,
CHaHb, minor isomer), 4.08 (dd, 1H, J = 12.0, 2.2 Hz, CHaHb, major isomer), 4.67 (d,
1H, J = 14.4 Hz, CHaHb, minor isomer), 4.71 (d, 1H, J = 14.3 Hz, CHaHb, major isomer),
7.05-7.10 (m, 1H, CHHet, for each isomer), 7.16-7.20 (m, 1H, CHHet, for each isomer),
7.23-7.27 (m, overlapped with CHCl3, 1H, CHHet, for each isomer), 7.33-7.38 (m, 2H,
2CHAr, for each isomer), 7.49 (d, 2H, J = 7.9 Hz, CHHet, major isomer), 7.59 (d, 1H,
J = 7.9 Hz, CHHet, major isomer), 7.74-7.78 (m, 2H, 2CHAr, for each isomer) ppm; 13C
NMR (126 MHz, CDCl3) (mixture of diastereoisomer, minor isomer indicated by
asterisk): δ = -5.33*, -5.31, 18.3*, 18.4, 21.52*, 21.54, 24.4*, 25.7, 25.96*, 25.98,
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29.40*, 29.42, 30.5*, 30.9, 34.2*, 34.5, 43.0*, 43.1, 43.7, 43.8*, 46.0, 46.6*, 62.5, 63.4,
63.5*, 63.8*, 108.76*, 108.84, 109.9, 118.89*, 118.94, 119.39, 119.43*, 121.50*, 121.53,
126.2, 126.4*, 127.7*, 127.8, 129.78*, 129.84, 130.3, 130.6*, 132.5, 133.1*, 137.2*,
137.4, 143.8*, 144.1 ppm; HRMS (ESI): m/z calcd for C24H36NO4S [M + H]+ 557.2864,
found 557.2858; IR (ATR): 3435 (br), 2927, 2855, 1470, 1341, 1164, 1091, 834 cm-1.

4.4.4. Synthesis of Miscellaneous Compounds
N-((2,3-Dibutylcycloprop-2-en-1-yl)methyl)-4-methylbenzenesulfonamide 455

To a solution of cyclopropenyl furyl sulfonamide 439aa (78.5 mg, 0.183 mmol)
in dry DCE (1.8 mL) was added HNTf2 (2.6 mg, 9.25 μmol) at 0 °C, under a nitrogen
atmosphere. The reaction was left to stir for 18 h before the solvent was removed under
reduced pressure. A 1H NMR with a mestilyene standard indicated that ~59% of the
cyclopropenyl furyl sulfonamide 439aa remained while cyclopropenyl sulfonamide 455
had been obtained in 21% NMR yield. Flash column chromatography gave the title
compound 455 as a yellow oil (15.9 mg, 47.4 μmol) in 26% yield with minor impurities.
1

H NMR (500 MHz, CDCl3): 𝛿 = 0.88 (t, 6H, J = 7.3 Hz, 2CH3), 1.25-1.34 (m, 4H,

2CH2), 1.38-1.48 (m, 5H, CH, 2CH2), 2.29 (t, 4H, J = 7.4 Hz, 2CH2), 2.42 (s, 3H, CH3),
2.88 (dd, 2H, J = 5.6, 4.6 Hz, CH2), 4.17-4.22 (m, 1H, NH), 7.29 (d, 2H, J = 7.9 Hz,
2CHAr), 7.72-7.75 (m, 2H, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 13.8, 19.3,
21.5, 22.4, 25.0, 29.6, 49.6, 114.1, 127.1, 129.6, 137.1, 143.1 ppm; HRMS (ESI): m/z
calcd for C19H29NNaO2S [M + Na]+ 358.1811, found 358.1823.
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tert-Butyl ((3-methylfuran-2-yl)methyl)(tosyl)carbamate 471

Following general procedure F, methyl 3-methylfuran-2-carboxylate (334.4 mg,
2.39 mmol) was dissolved in THF (12 mL) and to this was added DIBAL-H (1 M solution
in THF, 6.5 mL, 6.50 mmol). The reaction was stirred at –78 °C for 30 mins and was then
warmed to rt. After 1.5 h, a second portion of DIBAL-H (1 M solution in THF, 1.2 mL,
1.20 mmol) was added to push the reaction to completion. The reaction was stirred for
another 1.5 h before it was worked up to give the corresponding alcohol 470 as a green
oil (328.1 mg). NMR confirmed the desired alcohol had been obtained which was used
in the next step without further purification. 1H NMR (400 MHz, CDCl3): 𝛿 = 2.06 (s,
3H, CH3), 4.57 (s, 2H, CH2), 6.21 (d, 1H, J = 1.8 Hz, CHHet), 7.30 (d, 1H, J = 1.8 Hz,
CHHet) ppm.
Following general procedure I, the crude reside of furyl alcohol 470 was added to
a flask containing tert-butyl tosylcarbamate (653.6 mg, 2.41 mmol), PPh3 (814.4 mg,
3.10 mmol) and THF (24 mL). DIAD (0.61 mL, 3.10 mmol) was added and after 21 h the
solvent was removed and the residue was purified by flash column chromatography
(10:90 EtOAc:hex) to obtain the title compound 471 as a yellow oil (577.3 mg,
1.58 mmol) in 66% yield over two steps. 1H NMR (500 MHz, CDCl3): 𝛿 = 1.35 (s, 9H,
C(CH3)3), 2.11 (s, 3H, CH3), 2.40 (s, 3H, CH3), 5.01 (s, 2H, CH2), 6.22 (d, 1H,
J = 2.0 Hz, CHHet), 7.19 (d, 2H, J = 8.0 Hz, 2CHAr), 7.28 (d, 1H, J = 2.0 Hz, CHAr), 7.457.49 (m, 2H, 2CHAr) ppm; 13C NMR (125 MHz, CDCl3): 𝛿 = 9.9, 21.5, 27.8, 40.4, 84.4,
113.0, 118.8, 127.9, 129.0, 137.2, 141.5, 143.8, 145.8, 150.9 ppm.
NMR data is in agreement with published data.[182]
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Appendices*

Appendix 1: NMR Spectra for the Compounds Synthesised in Chapter 2 –
“Gold(I)-Catalysed Reactions of Cyclopropenylcarbinol Ethers to Form
Highly Substituted Heterocycles”

* Only spectra of novel compounds is provided
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CIF Report for 448b

checkCIF/PLATON report
Structure factors have been supplied for datablock(s) exp_86-2md1
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW
PROCEDURE FOR PUBLICATION, IT SHOULD NOT REPLACE THE
EXPERTISE OF AN EXPERIENCED CRYSTALLOGRAPHIC REFEREE.
No syntax errors found.

CIF dictionary

Interpreting this report

Datablock: exp_86-2md1

Bond precision: C-C = 0.0035 A
Cell:

Wavelength=0.71073

a=11.7737(8)
b=11.7820(8)
c=17.9734(8)
alpha=96.427(5) beta=101.078(5) gamma=109.297(6)

Temperature: 150 K
Calculated

Reported

Volume

2267.5(3)

2267.5(3)

Space group

P -1

P -1

Hall group

-P 1

-P 1

Moiety formula C24 H33 N O3 S

C24 H33 N O3 S

Sum formula

C24 H33 N O3 S

C24 H33 N O3 S

Mr

415.57

415.57

Dx,g cm-3

1.217

1.217

Z

4

4

Mu (mm-1)

0.167

0.167

F000

896.0

896.0

F000’

896.85

h,k,lmax

16,16,25

Nref
Tmin,Tmax
Tmin’

14054
0.990,0.997

16,16,25
13180
0.723,1.000

0.893

Correction method= # Reported T Limits: Tmin=0.723 Tmax=1.000
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AbsCorr = MULTI-SCAN
Data completeness= 0.938

Theta(max)= 30.683

R(reflections)= 0.0796( 7923)
S = 1.045

wR2(reflections)= 0.1597( 13180)
Npar= 549

The following ALERTS were generated. Each ALERT has the format
name_ALERT_alert-type_alert-level.

test-

Click on the hyperlinks for more details of the test.
Alert level A
PLAT027_ALERT_3_A _diffrn_reflns_theta_full value (too) Low ......

22.50 Degree

Alert level C
PLAT220_ALERT_2_C Non-Solvent Resd 1 C Ueq(max)/Ueq(min) Range

3.8 Ratio

PLAT222_ALERT_3_C Non-Solv. Resd 1 H Uiso(max)/Uiso(min) Range

4.8 Ratio

PLAT906_ALERT_3_C Large K Value in the Analysis of Variance ......

28.420 Check

PLAT906_ALERT_3_C Large K Value in the Analysis of Variance ......

4.801 Check

PLAT906_ALERT_3_C Large K Value in the Analysis of Variance ......

2.291 Check

PLAT911_ALERT_3_C Missing FCF Refl Between Thmin & STh/L= 0.600

63 Report

Alert level G
PLAT002_ALERT_2_G Number of Distance or Angle Restraints on AtSite

5 Note

PLAT003_ALERT_2_G Number of Uiso or Uij Restrained non-H Atoms ...

2 Report

PLAT063_ALERT_4_G Crystal Size Likely too Large for Beam Size ....
0.68 mm
PLAT153_ALERT_1_G The s.u.’s on the Cell Axes are Equal ..(Note) 0.0008 Ang.
PLAT176_ALERT_4_G The CIF-Embedded .res File Contains SADI Records

2 Report

PLAT187_ALERT_4_G The CIF-Embedded .res File Contains RIGU Records

1 Report

PLAT301_ALERT_3_G Main Residue Disorder ..............(Resd 1 )
PLAT398_ALERT_2_G Deviating C-O-C

Angle From 120 for O3B

PLAT398_ALERT_2_G Deviating C-O-C

Angle From 120 for O3

7% Note

PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........
PLAT793_ALERT_4_G Model has Chirality at C3AB
PLAT793_ALERT_4_G Model has Chirality at C3A
PLAT793_ALERT_4_G Model has Chirality at C6

(Centro SPGR)
(Centro SPGR)
(Centro SPGR)

101.3 Degree
101.7 Degree
24 Note
R Verify
R Verify
S Verify
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PLAT793_ALERT_4_G Model has Chirality at C6B

(Centro SPGR)

S Verify

PLAT793_ALERT_4_G Model has Chirality at C8A

(Centro SPGR)

R Verify

PLAT793_ALERT_4_G Model has Chirality at C8AB

(Centro SPGR)

R Verify

PLAT860_ALERT_3_G Number of Least-Squares Restraints .............
5 Note
PLAT883_ALERT_1_G No Info/Value for _atom_sites_solution_primary . Please Do !
PLAT910_ALERT_3_G Missing # of FCF Reflection(s) Below Theta(Min).

2 Note

PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L= 0.600

808 Note

PLAT933_ALERT_2_G Number of OMIT Records in Embedded .res File ...

2 Note

PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.

15 Info

1 ALERT level A = Most likely a serious problem - resolve or explain
0 ALERT level B = A potentially serious problem, consider carefully
6 ALERT level C = Check. Ensure it is not caused by an omission or oversight
22 ALERT level G = General information/check it is not something unexpected
2 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 7
ALERT type 2 Indicator that the structure model may be wrong or deficient
9 ALERT type 3 Indicator that the structure quality may be low 11
ALERT type 4 Improvement, methodology, query or suggestion
0 ALERT type 5 Informative message, check
It is advisable to attempt to resolve as many as possible of the alerts in all categories. Often
the minor alerts point to easily fixed oversights, errors and omissions in your CIF or
refinement strategy, so attention to these fine details can be worthwhile. In order to resolve
some of the more serious problems it may be necessary to carry out additional
measurements or structure refinements. However, the purpose of your study may justify the
reported deviations and the more serious of these should normally be commented upon in
the discussion or experimental section of a paper or in the "special_details" fields of the CIF.
checkCIF was carefully designed to identify outliers and unusual parameters, but every test
has its limitations and alerts that are not important in a particular case may appear.
Conversely, the absence of alerts does not guarantee there are no aspects of the results
needing attention. It is up to the individual to critically assess their own results and, if
necessary, seek expert advice.
Publication of your CIF in IUCr journals
A basic structural check has been run on your CIF. These basic checks will be run on all
CIFs submitted for publication in IUCr journals (Acta Crystallographica, Journal of Applied
Crystallography, Journal of Synchrotron Radiation); however, if you intend to submit to
Acta Crystallographica Section C or E or IUCrData, you should make sure that full
publication checks are run on the final version of your CIF prior to submission.
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Publication of your CIF in other journals
Please refer to the Notes for Authors of the relevant journal for any special instructions
relating to CIF submission.
Validation response form
Please find below a validation response form (VRF) that can be filled in and pasted into your
CIF.
# start Validation Reply Form
_vrf_PLAT027_exp_86-2md1
;
PROBLEM: _diffrn_reflns_theta_full value (too) Low ......

22.50 Degree RESPONSE: ...

;
# end Validation Reply Form

PLATON version of 17/03/2019; check.def file version of 04/03/2019
Datablock exp_86-2md1 - ellipsoid plot
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CIF Report for 457a

checkCIF/PLATON report
Structure factors have been supplied for datablock(s) exp_109_md2
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW
PROCEDURE FOR PUBLICATION, IT SHOULD NOT REPLACE THE
EXPERTISE OF AN EXPERIENCED CRYSTALLOGRAPHIC REFEREE.
No syntax errors found.

CIF dictionary

Interpreting this report

Datablock: exp_109_md2

Bond precision: C-C = 0.0021 A
Cell:

Wavelength=0.71073

a=7.9109(4)
b=13.3891(6)
c=14.4067(9)
alpha=71.699(5) beta=75.057(5) gamma=78.424(4) Temperature:

150 K
Calculated

Reported

Volume

1387.81(14)

1387.82(14)

Space group

P -1

P -1

Hall group

-P 1

-P 1

C27 H34 N2 O2 S [+
Moiety formula

C27 H34 N2 O2 S

solvent]
C27 H34 N2 O2 S [+
Sum formula

C27 H34 N2 O2 S

solvent]
Mr

450.62

450.62

Dx,g cm-3

1.078

1.078

Z

2

2

Mu (mm-1)

0.139

0.139

F000

484.0

484.0
517

F000’

484.42

h,k,lmax

11,19,20

Nref
Tmin,Tmax
Tmin’

10,19,20

8705

8123

0.970,0.992

0.930,1.000

0.933

Correction method= # Reported T Limits: Tmin=0.930 Tmax=1.000
AbsCorr = MULTI-SCAN
Data completeness= 0.933

Theta(max)= 30.786

R(reflections)= 0.0482( 5971)
S = 1.058

wR2(reflections)= 0.1366( 8123)
Npar= 297

The following ALERTS were generated. Each ALERT has the
format
test-name_ALERT_alert-type_alert-level. Click on the
hyperlinks for more details of the test.
Alert level C
PLAT911_ALERT_3_C Missing FCF Refl Between Thmin & STh/L= 0.600

44 Report

Alert level G
PLAT066_ALERT_1_G Predicted and Reported Tmin&Tmax Range Identical
? Check
PLAT093_ALERT_1_G No s.u.’s on H-positions, Refinement Reported as mixed Check
PLAT606_ALERT_4_G VERY LARGE Solvent Accessible VOID(S) in Structure
! Info
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........
25 Note
PLAT793_ALERT_4_G Model has Chirality at C4
(Centro SPGR)
S Verify
PLAT868_ALERT_4_G ALERTS Due to the Use of _smtbx_masks Suppressed
! Info
PLAT883_ALERT_1_G No Info/Value for _atom_sites_solution_primary . Please Do !
PLAT910_ALERT_3_G Missing # of FCF Reflection(s) Below Theta(Min).
2 Note
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L= 0.600
456 Note
PLAT933_ALERT_2_G Number of OMIT Records in Embedded .res File ...
1 Note
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.
15 Info

0 ALERT level A = Most likely a serious problem - resolve or explain
ALERT level B = A potentially serious problem, consider carefully
1 ALERT level C = Check. Ensure it is not caused by an omission or oversight
11 ALERT level G = General information/check it is not something unexpected
0

3 ALERT type 1 CIF construction/syntax error, inconsistent or missing data
2 ALERT type 2 Indicator that the structure model may be wrong or deficient
2 ALERT type 3 Indicator that the structure quality may be low
5 ALERT type 4 Improvement, methodology, query or suggestion
0 ALERT type 5 Informative message, check
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It is advisable to attempt to resolve as many as possible of the alerts in all categories. Often
the minor alerts point to easily fixed oversights, errors and omissions in your CIF or
refinement strategy, so attention to these fine details can be worthwhile. In order to resolve
some of the more serious problems it may be necessary to carry out additional
measurements or structure refinements. However, the purpose of your study may justify the
reported deviations and the more serious of these should normally be commented upon in
the discussion or experimental section of a paper or in the "special_details" fields of the CIF.
checkCIF was carefully designed to identify outliers and unusual parameters, but every test
has its limitations and alerts that are not important in a particular case may appear.
Conversely, the absence of alerts does not guarantee there are no aspects of the results
needing attention. It is up to the individual to critically assess their own results and, if
necessary, seek expert advice.
Publication of your CIF in IUCr journals
A basic structural check has been run on your CIF. These basic checks will be run on all
CIFs submitted for publication in IUCr journals (Acta Crystallographica, Journal of Applied
Crystallography, Journal of Synchrotron Radiation); however, if you intend to submit to
Acta Crystallographica Section C or E or IUCrData, you should make sure that full
publication checks are run on the final version of your CIF prior to submission.
Publication of your CIF in other journals
Please refer to the Notes for Authors of the relevant journal for any special instructions
relating to CIF submission.
PLATON version of 17/03/2019; check.def file version of 04/03/2019
Datablock exp_109_md2 - ellipsoid plot
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